amiodarone has been researched along with Arrhythmias, Cardiac in 1072 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The prevalence of thyroid dysfunction in patients with cardiac arrhythmias receiving amiodarone was considerable." | 9.41 | Prevalence of Amiodarone Induced Hypothyroidism and Hyperthyroidism in Patients with Heart Diseases: A Systematic Review and Meta-Analysis. ( Alimohamadi, Y; Dalvand, S; Johnston, TP; Karimi, L; Moshkani, M; Rahimi-Bashar, F; Sahebkar, A; Vahedian-Azimi, A, 2023) |
| "The aim of this study was to compare the effects of prophylactic dronedarone and amiodarone in prevention of arrhythmias during and following off-pump coronary artery bypass grafting (OPCAB)." | 9.24 | Prophylactic amiodarone vs dronedarone for prevention of perioperative arrhythmias in offpump coronary artery bypass grafting: A pilot randomized controlled trial. ( Goswami, A; Sen, C; Som, A, 2017) |
| "Intravenous amiodarone is considered an effective treatment option for cardiac ventricular and atrial arrhythmias." | 9.24 | Effects of injection-site splinting on the incidence of phlebitis in patients taking peripherally infused amiodarone: A randomized clinical trial. ( Ayat-Isfahani, F; Davoudi, B; Jalali, A; Pashang, M; Sadeghian, S, 2017) |
| "The aim of this study was to present our data regarding the efficacy and safety of combining amiodarone and propranolol for the management of arrhythmias in infants." | 9.17 | The efficacy of amiodarone-propranolol combination for the management of childhood arrhythmias. ( Akin, A; Alehan, D; Aykan, HH; Karagöz, T; Özer, S; Özkutlu, S, 2013) |
| "Amiodarone is an effective antiarrhythmic drug, but it has serious side effects and conducted trials did not support its prophylactic use in survivors of acute myocardial infarction." | 9.11 | Individual patterns of dynamic QT/RR relationship in survivors of acute myocardial infarction and their relationship to antiarrhythmic efficacy of amiodarone. ( Batchvarov, V; Hnatkova, K; Laguna, P; Malik, M; Pueyo, E; Smetana, P, 2004) |
| "To determine whether a brief perioperative course of oral amiodarone is an effective and safe prophylaxis for atrial tachyarrhythmias after cardiac surgery overall and in important subgroups." | 9.11 | Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial. ( Bayes, AJ; Burgess, JJ; Connolly, CJ; Exner, DV; Ferland, A; Kidd, WT; Kieser, T; MacAdams, CL; Maitland, A; Mitchell, LB; Prystai, GD; Wyse, DG, 2005) |
| "Although amiodarone was effective in suppressing ventricular arrhythmias and improving ventricular function, it did not reduce the incidence of sudden death or prolong survival among patients with heart failure, except for a trend toward reduced mortality among those with nonischemic cardiomyopathy." | 9.08 | Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. ( Colling, C; Deedwania, PC; Fisher, SG; Fletcher, RD; Lazzeri, D; Lewis, HD; Massie, BM; Singh, BN; Singh, SN, 1995) |
| "The European Myocardial Infarct Amiodarone Trial (EMIAT) was a randomised double-blind placebo-controlled trial to assess whether amiodarone reduced all-cause mortality (primary endpoint) and cardiac mortality and arrhythmic death (secondary endpoints) in survivors of myocardial infarction with a left-ventricular ejection fraction (LVEF) of 40% or less." | 9.08 | Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. ( Camm, AJ; Frangin, G; Janse, MJ; Julian, DG; Munoz, A; Schwartz, PJ; Simon, P, 1997) |
| "Amiodarone reduces the incidence of ventricular fibrillation or arrhythmic death among survivors of acute myocardial infarction with frequent or repetitive VPDs." | 9.08 | Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. ( Cairns, JA; Connolly, SJ; Gent, M; Roberts, R, 1997) |
| " However, debate continues as to whether ICD implantation is superior to amiodarone in prolonging survival in patients with life-threatening ventricular arrhythmias." | 9.08 | Mortality benefit of implantable cardioverter-defibrillator therapy in patients with persistent malignant ventricular arrhythmias despite amiodarone treatment. ( Barron, HV; Heller, K; Kalman, JM; Khan, HH; Lesh, MD; Scheinman, MM; Viskin, S, 1997) |
| "Two trial designs have been used in evaluating sotalol in patients with sustained tachyarrhythmias: open-label dose escalation and randomized comparison with reference agents." | 9.07 | Usefulness of sotalol for life-threatening ventricular arrhythmias. ( Roden, DM, 1993) |
| "In the Basel Antiarrhythmic Study of Infarct Survival trial, low-dose amiodarone improved 1-year survival in patients with asymptomatic complex ventricular arrhythmias persisting 2 weeks after myocardial infarction." | 9.07 | Long-term benefit of 1-year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction. ( Brunner, H; Burckhardt, D; Burkart, F; Kiowski, W; Pfisterer, ME, 1993) |
| "In the BASIS study, an improvement in 1 year survival of patients with asymptomatic complex ventricular arrhythmias with low-dose amiodarone was shown in comparison with an untreated control group." | 9.07 | [Long-term effect of amiodarone therapy following myocardial infarct in patients with complex ventricular arrhythmias]. ( Brunner, H; Burckhardt, D; Burkart, F; Kiowski, W; Pfisterer, M, 1993) |
| "The new protocol of amiodarone was proposed to treat and to prevent some paroxysm and refractory arrhythmias with classic treatments." | 9.07 | [New amiodarone protocol in the treatment of refractory arrhythmias]. ( Abou Jaoudé, S; Checrallah, E; Halaby, J; Salamé, E, 1992) |
| "To determine whether the beneficial effect of low-dose amiodarone on survival in patients with complex ventricular arrhythmias after myocardial infarction was dependent on left ventricular (LV) function, results of the Basel Antiarrhythmic Study of Infarct Survival were analyzed." | 9.07 | Beneficial effect of amiodarone on cardiac mortality in patients with asymptomatic complex ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular function. ( Burckhardt, D; Burkart, F; Follath, F; Kiowski, W; Pfisterer, M, 1992) |
| "In 25 patients whose chronic congestive heart failure (CHF) had recently worsened to New York Heart Association class IV, pimobendan (5 to 20 mg/day) was added to maximum conventional therapy consisting of digoxin, diuretics, angiotensin-converting enzyme inhibitors, coumadin derivatives to prevent thromboembolic complications, and amiodarone to suppress serious ventricular rhythm disturbances." | 9.07 | Intractable heart failure despite angiotensin-converting enzyme inhibitors, digoxin, and diuretics: long-term effectiveness of add-on therapy with pimobendan. ( Hagemeijer, F, 1991) |
| "Beta-blockers are known to be effective against post-infarction ventricular arrhythmias and amiodarone has recently been shown to have this property." | 9.06 | [Comparative efficacy of amiodarone and propranolol on ventricular arrhythmia in the post-infarction period]. ( Blondeau, M; Brunet, M; Fedorowsky, A; Fournier, C; Gensous, D; Kindermans, M; Tournadre, P, 1989) |
| "The effects of amiodarone in a low dosage (200 mg every 8 h for 2 weeks, then 200 mg/day) was assessed in a double-blind placebo-controlled trial in 34 patients with a history of severe congestive heart failure but no sustained ventricular arrhythmia." | 9.06 | Beneficial effects of low dose amiodarone in patients with congestive cardiac failure: a placebo-controlled trial. ( Arkles, LB; Hamer, AW; Johns, JA, 1989) |
| "The purpose of this prospective randomized trial was to compare the efficacy of propranolol and amiodarone in suppressing ventricular arrhythmias during the first 6 months following myocardial infarction (MI)." | 9.06 | Comparison of the efficacy of propranolol and amiodarone in suppressing ventricular arrhythmias following myocardial infarction. ( Bah, M; Blondeau, M; Boujon, B; Brunet, M; Fournier, C; Giudicelli, JF; Kindermans, M; Tournadre, P, 1989) |
| "Twenty two patients with heart failure were studied in a double blind crossover trial to compare amiodarone (200 mg/day) with placebo." | 9.06 | Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure. ( Cleland, JG; Dargie, HJ; Findlay, IN; Wilson, JT, 1987) |
| "A randomized, placebo-controlled study examined the effect of amiodarone on the incidence of ventricular arrhythmias after acute myocardial infarction (AMI)." | 9.06 | Effectiveness of amiodarone on ventricular arrhythmias during and after acute myocardial infarction. ( George, T; Hajar, HA; Hockings, BE; Mahrous, F; Taylor, RR, 1987) |
| " In a double-blind cross-over study against placebo, with three-month treatment periods, amiodarone, in a dose of 200 mg day-1, was found effectively to suppress ventricular arrhythmias during exercise and in the immediate post-exercise period." | 9.06 | Ventricular arrhythmias during exercise in patients with heart failure: the effect of amiodarone. ( Cleland, JG; Dargie, HJ, 1987) |
| "Fifty-two patients with refractory symptomatic supraventricular and ventricular arrhythmias were treated with amiodarone (Cordarone-X; Reckitt & Colman) and followed up for a mean period of 36,4 months (range 3-54 months)." | 9.05 | Amiodarone in the treatment of patients with refractory symptomatic ventricular and supraventricular arrhythmias. A long-term follow-up study. ( Lloyd, EA; Mabin, TA, 1983) |
| "Large initial doses of amiodarone hydrochloride for the treatment of ventricular arrhythmias refractory to conventional therapy were demonstrated to shorten the time to achieve control of the arrhythmia." | 9.05 | Amiodarone in the treatment of refractory ventricular arrhythmias. Importance and safety of initial high-dose therapy. ( Rakita, L; Sobol, SM, 1983) |
| "The clinical efficacy of a low-dosage schedule of amiodarone was tested in 58 patients with severe ventricular arrhythmias refractory to other drug treatments." | 9.05 | Multicenter controlled observation of a low-dose regimen of amiodarone for treatment of severe ventricular arrhythmias. Collaborative Group for Amiodarone Evaluation. ( , 1984) |
| "The effects on ventricular arrhythmias of a new class IA drug, flecainide, were compared with those of amiodarone in 10 patients with frequent, chronic, and stable ventricular ectopic beats (VEBs)." | 9.05 | Efficacy of flecainide in the management of ventricular arrhythmias: comparative study with amiodarone. ( Bertolasi, CA; Dubner, SJ; Elencwajg, BD; Mendelzon, R; Palma, S; Ramos, A, 1985) |
| "Low-dose (7 mg/kg per day) disopyramide administration to arrhythmic chagasic patients decreased the frequency of ventricular extrasystoles in 4 of 17 patients (24%) and suppressed most complex ventricular arrhythmias in 12 of 15 patients (80%)." | 9.05 | Effect of low oral doses of disopyramide and amiodarone on ventricular and atrial arrhythmias of chagasic patients with advanced myocardial damage. ( Carrasco, HA; Fuenmayor, A; Landaeta, A; López, F; Molina, C; Reynosa, J; Vicuña, AV; Vicuña, N, 1985) |
| "The long term efficacy of class I antiarrhythmic drugs and of amiodarone was investigated in 34 patients with severe organic heart disease accompanied by frequent complex ventricular arrhythmias." | 9.05 | Long term efficacy of class I antiarrhythmic agents and amiodarone in patients with malignant ventricular arrhythmias. ( Baedeker, W; Goedel-Meinen, L; Jahns, G; Kein, G; Linné, R; Schaudig, U; Schmidt, G; Wirtzfeld, A, 1985) |
| "Lidocaine (L) in still considered the drug of choice in the treatment of life threatening ventricular arrhythmias in the setting of acute myocardial infarction (A." | 9.05 | [Intravenous administration of lidocaine and amiodarone in patients with acute myocardial infarction]. ( Capucci, A; Magnani, B; Mantovani, B; Maresta, A; Melandri, G, 1985) |
| "Amiodarone and acupuncture (AA) are commonly used to treat cardiac arrhythmia (CA)." | 9.01 | Amiodarone and acupuncture for cardiac arrhythmia: Study protocol for a systematic review. ( Gao, WQ; Meng, XD; Sun, Z, 2019) |
| " Ventricular arrhythmias are common in patients with Chagas cardiomyopathy, and amiodarone has been widely used for this purpose." | 8.98 | Amiodarone for arrhythmia in patients with Chagas disease: A systematic review and individual patient data meta-analysis. ( Colpani, V; Cruz, LN; da Rosa, PR; Falavigna, M; Giordani, NE; Migliavaca, CB; Miguel, SRPS; Polanczyk, CA; Ribeiro, ALP; Sganzerla, D; Stein, C, 2018) |
| "Surgical treatment of amiodarone-associated thyrotoxicosis (AAT) is effective although fewer than 100 cases have been reported world wide." | 8.83 | Total thyroidectomy for amiodarone-associated thyrotoxicosis in patients with severe cardiac disease. ( Gough, IR; Gough, J, 2006) |
| "There is good evidence that amiodarone is effective against a variety of arrhythmias and that it may be superior to other drugs in some settings." | 8.81 | Amiodarone in the prevention and treatment of arrhythmia. ( Auer, J; Berent, R; Eber, B, 2002) |
| "Amiodarone in low to moderate doses is generally safe in controlling arrhythmias in patients with congestive heart failure (CHF)." | 8.80 | The current role of amiodarone in patients with congestive heart failure. ( Bello, D; Massie, BM, 1998) |
| "There have been 13 randomised controlled trials of prophylactic amiodarone in patients with recent myocardial infarction (MI) or congestive heart failure (CHF)." | 8.79 | Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators. ( , 1997) |
| "The present article reviews the experience with amiodarone therapy in life-threatening ventricular tachyarrhythmias." | 8.78 | Clinical efficacy of long-term treatment with amiodarone for life-threatening arrhythmias. ( Burckhardt, D, 1992) |
| "Amiodarone is commonly used during therapeutic hypothermia (TH) following cardiac arrest due to ventricular arrhythmias." | 8.31 | Epicardial electrical heterogeneity after amiodarone treatment increases vulnerability to ventricular arrhythmias under therapeutic hypothermia. ( Chang, SL; Chang, TY; Chao, TF; Chen, SA; Chen, YJ; Chung, FP; Hsieh, YC; Hu, YF; Liao, JN; Lin, CY; Lin, YJ; Lo, LW; Tuan, TC; Yeh, HI, 2023) |
| "Amiodarone (AM) is an antiarrhythmic drug whose chronic use has proved effective in preventing ventricular arrhythmias in a variety of patient populations, including those with heart failure (HF)." | 8.31 | Amiodarone prevents wave front-tail interactions in patients with heart failure: an in silico study. ( Franz, MR; Gray, RA, 2023) |
| "Amiodarone is a highly effective antiarrhythmic agent for the treatment and prevention of atrial and ventricular arrhythmias." | 8.12 | Liver failure caused by intravenous amiodarone and effective intervention measures: A case report. ( Jiang, Z; Li, X; Yan, R; Yi, W; Zhao, C, 2022) |
| "Amiodarone reduces recurrent ventricular tachyarrhythmias (VTA) but may worsen cardiovascular outcomes in heart failure (HF) patients." | 7.91 | Amiodarone is associated with adverse outcomes in patients with sustained ventricular arrhythmias upgraded to cardiac resynchronization therapy-defibrillators. ( Adelstein, EC; Althouse, AD; Bazaz, R; Davis, L; Jain, S; Saba, S; Schwartzman, D; Wang, N, 2019) |
| "Amiodarone, a broad-spectrum antiarrhythmic drug, is widely used for the clinical treatment of tachyarrhythmias because of its safety and efficacy." | 7.91 | Aggravation of atrial arrhythmia by amiodarone during the perinatal period: A case report. ( Chen, H; Jiang, W; Lin, W; Pan, B; Wang, Y; Ye, F, 2019) |
| "Background Amiodarone is an iodine-rich medication used to treat maternal and fetal arrhythmias, with known effects on thyroid hormone homeostasis." | 7.91 | Transient neonatal hypothyroidism following a short course of maternal amiodarone therapy. ( Huang, V; Wolf, RM, 2019) |
| "Amiodarone (AMD) is a class III anti-arrhythmic drug that is highly effective for tachyarrhythmia treatment." | 7.88 | Efficacy and Safety of Low-Dose Amiodarone Therapy for Tachyarrhythmia in Congenital Heart Disease. ( Hamamichi, Y; Inage, A; Ishii, T; Iwasawa, S; Saito, M; Uyeda, T; Yazaki, S; Yoshikawa, T, 2018) |
| "Amiodarone-induced hyperthyroidism is a known side effect of amiodarone treatment." | 7.88 | Diagnosis and Clinical Course of Three Adolescents with Amiodarone-Induced Hyperthyroidism. ( Bertsche, A; Gebauer, R; Gesing, J; Hoppmann, J; Kiess, W; Pfäffle, R, 2018) |
| "Reintroduction of amiodarone in patients with a history of amiodarone-induced thyrotoxicosis (AIT) is rarely used." | 7.83 | Amiodarone-Induced Thyrotoxicosis Recurrence After Amiodarone Reintroduction. ( Auclair, C; Batisse-Lignier, M; Citron, B; Desbiez, F; Lusson, JR; Maqdasy, S; Roche, B; Tauveron, I; Thieblot, P, 2016) |
| "There is still lack of strong evidence, based on systematic studies, that support the relationship between amiodarone use and the risk of acute pancreatitis." | 7.81 | Amiodarone use and risk of acute pancreatitis: A population-based case-control study. ( Lai, SW; Liao, KF; Lin, CL; Lin, CY, 2015) |
| "The aim of this investigation was to compare the effectiveness of long-term pretreatment with amiodarone (AMIO) and its active metabolite desethylamiodarone (DEA) on arrhythmias induced by acute myocardial infarction in rats." | 7.81 | Long-term pretreatment with desethylamiodarone (DEA) or amiodarone (AMIO) protects against coronary artery occlusion induced ventricular arrhythmias in conscious rats. ( Baczkó, I; Falkay, G; Leprán, I; Morvay, N; Papp, JG; Sztojkov-Ivanov, A; Varró, A, 2015) |
| "Cardiac disorders caused by sofosbuvir are liable to be worsened by concomitant use of one of the many drugs that provoke cardiac arrhythmia." | 7.81 | Sofosbuvir + amiodarone: bradycardia and conduction disturbances. ( , 2015) |
| " The sheep were prophylactically treated with amiodarone plus lidocaine before ligation of the four to six coronary artery branches supplying the apex of the heart (arrhythmia prevention [AP] group, n = 45) and with epinephrine (shock prevention [SP] group, n = 49), respectively." | 7.79 | Prophylactic amiodarone and lidocaine improve survival in an ovine model of large size myocardial infarction. ( Griffith, BP; Li, T; Sanchez, PG; Watkins, AC; Wei, X; Wu, ZJ, 2013) |
| "Amiodarone is a di-iodated benzofuran derivative that is commonly used to treat patients with various cardiac arrhythmias." | 7.79 | [A case of simultaneously occurred amiodarone-induced hepatitis and hypothyroidism]. ( Chae, HB; Cho, YS; Han, JH; Kang, KM; Kim, JS; Lim, JC; Park, SM, 2013) |
| ") and amiodarone on the conduction system and on reverse use-dependence in the isolated hearts of normal rats and rats with myocardial infarction (MI)." | 7.78 | The effects of allitridi and amiodarone on the conduction system and reverse use-dependence in the isolated hearts of rats with myocardial infarction. ( Chen, J; Gao, Y; Guo, L; Lu, P; Niu, W; Wang, J; Wang, S; Xing, Y; Zhao, M; Zhu, H, 2012) |
| "To evaluate the efficacy of amiodarone in dogs with refractory supraventricular and ventricular arrhythmias and to document the side effects in treated dogs." | 7.78 | Retrospective evaluation of the use of amiodarone in dogs with arrhythmias (from 2003 to 2010). ( Dukes-McEwan, J; Fonfara, S; López-Alvarez, J; Pedro, B; Stephenson, H, 2012) |
| "We prospectively collected cases of amiodarone-associated thyrotoxicosis requiring thyroidectomy due to failure of antithyroid treatment, despite amiodarone discontinuation." | 7.78 | Total thyroidectomy for amiodarone-associated thyrotoxicosis: should surgery always be delayed for pre-operative medical preparation? ( Duverger, V; Merat, S; Perrier, E; Pierret, C; Pons, Y; Tourtier, JP, 2012) |
| "The aim of this study is to observe the effect of combined amiodarone and antiarrhythmic peptide (AAP10) use on the incidence of induced ventricular arrhythmias in healed myocardial infarction (MI) rabbits." | 7.76 | [Effects of combined amiodarone and antiarrhythmic peptide use on the cardiac gap junctions and incidence of induced ventricular arrhythmias in healed myocardial infarction rabbit models]. ( Fang, Y; Li, LD; Ni, MK; Ruan, L; Wang, GQ; Wang, XF; Zhang, CT, 2010) |
| "The aim of this study was to investigate the use of prophylactic magnesium sulphate and amiodarone in treating arrhythmias that may occur following coronary bypass grafting operations." | 7.75 | Magnesium sulphate and amiodarone prophylaxis for prevention of postoperative arrhythmia in coronary by-pass operations. ( Ari, H; Demirtas, S; Huysal, K; Ozyazicioglu, A; Selimoglu, O; Tiryakioglu, O; Tiryakioglu, SK, 2009) |
| "Special attention should be paid to patients on treatment with amiodarone and/or a diagnosis of atrial fibrillation as they may have an increased risk of fracture." | 7.74 | Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case-control study. ( Mosekilde, L; Rejnmark, L; Vestergaard, P, 2007) |
| "Amiodarone-induced thyrotoxicosis is a life-threatening condition." | 7.74 | Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study. ( Ambrosini, CE; Berti, P; Bogazzi, F; Martino, E; Materazzi, G; Miccoli, P, 2007) |
| "To assess if prophylaxis with moderate doses of amiodarone in the postoperative period of cardiac surgery (coronary artery bypass grafting and/or valve surgery), reduces the incidence of atrial fibrillation in patients with high risk for developing this arrhythmia." | 7.74 | Prevention of atrial fibrillation with moderate doses of amiodarone in the postoperative period of cardiac surgery is safe and effective in patients with high risk for developing this arrhythmia. ( Alves, RJ; Brito, Gd; Geovanini, GR; Glauser, VA; Miguel, GA; Nakiri, K, 2007) |
| " Two were cases of type I amiodarone-induced thyrotoxicosis (AIT) treated with methimazole." | 7.74 | Differential diagnosis and appropriate treatment of four thyrotoxic patients with Graves' disease required to take amiodarone due to life-threatening arrhythmia. ( Kasanuki, H; Kodama, H; Obara, T; Omi, Y; Sato, K; Seki, T; Shiga, T; Takano, K; Yamada, E; Yamazaki, K, 2008) |
| "Amiodarone, which is generally classified as class III antiarrhythmic drug in the Vaughan Williams classification, is widely used for the treatments of refractory arrhythmias." | 7.73 | Antiarrhythmic properties of a prior oral loading of amiodarone in in vivo canine coronary ligation/reperfusion-induced arrhythmia model: comparison with other class III antiarrhythmic drugs. ( Chen, J; Hashimoto, K; Nagasawa, Y, 2005) |
| "Amiodarone-induced thyrotoxicosis (AIT) is a challenging management problem, since patients treated with amiodarone invariably have underlying heart disease." | 7.73 | Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality. ( Diamond, T; Lewis, M; O'Sullivan, AJ, 2006) |
| " Most respondents lived in iodine-sufficient areas and observed that amiodarone-induced hypothyroidism (AIH) is more common than AIT." | 7.73 | Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey. ( Albino, CC; Bartalena, L; Diehl, LA; Graf, H; Martino, E; Romaldini, JH; Wiersinga, WM, 2006) |
| "Antiarrhythmic activity of a membrane-protecting agent Sal'magin was studied in rats with aconitine-induced cardiac arrhythmias." | 7.73 | Antiarrhythmic activity of a membrane-protecting agent Sal'magin in rats with aconitine-induced arrhythmias. ( Klekot, AA, 2006) |
| "Amiodarone use for the prevention of recurrent atrial fibrillation or atrial flutter requires drug loading over a period of several days to weeks, whereas class 1C agents do not." | 7.72 | Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flutter. ( Hauser, TH; Josephson, ME; Pinto, DS; Zimetbaum, P, 2004) |
| "Amiodarone-associated thyrotoxicosis (AAT) is often poorly tolerated owing to underlying cardiac disease, and it is frequently refractory to conventional medical treatment." | 7.72 | Surgical management of amiodarone-associated thyrotoxicosis: Mayo Clinic experience. ( Brennan, MD; Farley, DR; Grant, CS; Houghton, SG; Thompson, GB; van Heerden, JA, 2004) |
| "The effects of short-term amiodarone and dronedarone treatments on action potential characteristics and arrhythmia (ventricular tachycardia ) induced by reperfusion after global low-flow ischemia were studied in rat hearts." | 7.71 | Beneficial effects of amiodarone and dronedarone (SR 33589b), when applied during low-flow ischemia, on arrhythmia and functional parameters asssessed during reperfusion in isolated rat hearts. ( Barbé, C; Kreher, P; Rochetaing, A, 2001) |
| "To determine the efficacy necessary to make prophylactic ICD or amiodarone therapy cost-effective in patients with myocardial infarction." | 7.71 | Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction. ( Every, NR; Heidenreich, PA; Hlatky, MA; McDonald, KM; Owens, DK; Parsons, LS; Sanders, GD, 2001) |
| "In 232 Japanese patients receiving long-term amiodarone therapy for life-threatening ventricular tachyarrhythmias, hyperthyroidism and hypothyroidism developed in 29 patients (12." | 7.71 | Amiodarone-Induced thyroid dysfunction and ventricular tachyarrhythmias during long-term therapy in Japan. ( Hagiwara, N; Kasanuki, H; Matsuda, N; Sato, K; Shiga, T; Shoda, M; Wakaumi, M, 2001) |
| "Amiodarone is an effective antiarrhythmic drug rarely associated with torsade de pointes arrhythmias (TdP)." | 7.71 | Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome. ( de Groot, SH; Leunissen, JD; Molenschot, MM; Schoenmakers, M; van Der Hulst, FF; van Opstal, JM; Verduyn, SC; Vos, MA; Wellens, HJ, 2001) |
| "Amiodarone-induced thyrotoxicosis (AIT) is a difficult management problem about which there are little published data." | 7.71 | Successful treatment of amiodarone-induced thyrotoxicosis. ( Franklyn, JA; Gammage, MD; Osman, F; Sheppard, MC, 2002) |
| "Amiodarone-induced thyrotoxicosis (AIT) may develop either in apparently normal thyroid glands (Type II AIT) or in the presence of sub-clinical thyroid abnormalities (either autonomous goiter or latent Graves' disease; Type I AIT)." | 7.71 | Iopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyroidectomy. ( Aghini-Lombardi, F; Bartalena, L; Basolo, F; Bogazzi, F; Braverman, LE; Cosci, C; Lupi, I; Martino, E; Miccoli, P; Pinchera, A; Santini, F; Tanda, ML, 2002) |
| "Baseline characteristics of the 1486 patients enrolled in EMIAT were used to investigate the all-cause mortality effect of amiodarone (intention-to-treat) in patients with a left ventricular ejection fraction 30-40% and < 30%, in patients with and without arrhythmia signs on Holter recordings, in patients with high and low baseline resting heart rate, in patients on and off beta-blocker treatment, and in a combination of these groups." | 7.70 | Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial). ( Camm, AJ; Frangin, GA; Janse, MJ; Julian, DG; Malik, M; Schwartz, PJ, 1998) |
| "We designed a postinfarction scenario wherein heart rate variability analysis on 24-h Holter monitoring was used as a screening test for 2-year amiodarone therapy in a cohort of survivors (mean age 57 years) of a recent myocardial infarction." | 7.70 | Cost-effectiveness analysis of invasive and noninvasive tests in high risk patients treated with amiodarone after acute myocardial infarction. ( Daniele, G; Mapelli, V; Migliori, GB; Pedretti, RF; Podrid, PJ; Tramarin, R, 1998) |
| "The purpose of this study was to evaluate the effect of partial arrhythmia suppression by amiodarone on indexes of heart rate variability in patients with heart failure." | 7.70 | Effect of partial arrhythmia suppression with amiodarone on heart rate variability of patients with congestive heart failure. ( Ferlin, E; Moraes, RS; Polanczyk, CA; Ribeiro, JP; Rohde, LE, 1998) |
| "Gestational exposure to amiodarone may be complicated by perinatal hypothyroidism or hyperthyroidism and possibly neurologic abnormalities, intrauterine growth retardation or fetal bradycardia." | 7.69 | Pregnancy outcome after gestational exposure to amiodarone in Canada. ( Allen, LC; Boulton, BC; Downar, E; Koren, G; Magee, LA; Sermer, M, 1995) |
| "We compared the ability of a new amiodarone-like agent, SR 33589, with that of amiodarone, D,L-sotalol, and lignocaine to reduce the incidence of ventricular fibrillation (VF) and associated arrhythmias caused by acute coronary artery occlusion in anesthetized pigs." | 7.69 | Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. ( Chatelain, P; Finance, O; Manning, A, 1995) |
| "We have assessed the ability of the new amiodarone-like antiarrhythmic agent, SR 33589, to reduce the incidence of ischemia- and reperfusion-induced arrhythmias, in comparison to amiodarone, D-sotalol, and lignocaine." | 7.69 | SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats. ( Bruyninckx, C; Chatelain, P; Manning, AS; Ramboux, J, 1995) |
| ") administered amiodarone using four canine ventricular arrhythmia models." | 7.69 | Acute antiarrhythmic effects of intravenously administered amiodarone on canine ventricular arrhythmia. ( Awaji, T; Hashimoto, K; Wu, ZJ, 1995) |
| "Amiodarone-induced chemical, sterile epididymitis has previously been reported." | 7.69 | Amiodarone-induced epididymitis. Report of 2 cases. ( Hamoud, K; Kaneti, J; Lissmer, L; Smailowitz, Z, 1996) |
| "Because little has been published on early effects of treatment with amiodarone on thyroid function, we studied serum total and free thyroid hormone, reverse T3, and TSH levels in patients with cardiac arrhythmias during the first 10 days of treatment with a loading dose of amiodarone by iv infusion." | 7.69 | Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia. ( Berti, S; Biagini, A; Bonini, R; Carpi, A; Chopra, IJ; Clerico, A; Iervasi, G; Manfredi, C; Palmieri, C; Ravani, M, 1997) |
| " in both euthyroid and hyperthyroid patients treated with amiodarone." | 7.69 | 201Tl scintigraphy does not allow visualization of the thyroid in euthyroid and hyperthyroid patients treated with amiodarone. ( Dierckx, RA; Kaufman, JM; Monsieurs, M; Osmanagaoglu, K; van de Wiele, C; van Laere, K, 1997) |
| "Amiodarone is a choice drug for the treatment of patients suffering from life-threatening hyperkinetic ventricular arrhythmias and depressed ventricular function." | 7.69 | [Clinical tolerance of oral loading with elevated doses of amiodarone in a group of patients with heart failure]. ( Caramanno, G; Di Giovanna, F; Innocente, P, 1997) |
| "Amiodarone appears to produce benefits in patients with cardiac failure with atrial and ventricular arrhythmias." | 7.68 | [Amiodarone in cardiac failure]. ( Barbosa Filho, J; Barbosa, PR; Soares, JP, 1993) |
| "Because the relative efficacy of antiarrhythmic agents on halothane-epinephrine arrhythmias has not been well characterized, this study was undertaken to comparatively evaluate the antiarrhythmic action of Na(+)-, K(+)- and Ca(2+)-channel blockers on epinephrine-induced ventricular arrhythmias during halothane anesthesia in rats." | 7.68 | Comparative efficacy of antiarrhythmic agents in preventing halothane-epinephrine arrhythmias in rats. ( Hayashi, Y; Kamibayashi, T; Kawabata, K; Sumikawa, K; Takada, K; Yamatodani, A; Yoshiya, I, 1993) |
| "Amiodarone treatment in pregnancy might be difficult to handle because of the long half-life of the drug (14-28 days up to 2 months) and because it reduces maternal and neonatal thyroid activity." | 7.68 | Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome. ( Civitella, C; Garzetti, GG; Romanini, C; Valensise, H, 1992) |
| "kg-1 iv increased the dose of ouabain required to induce ventricular arrhythmias in guinea pigs." | 7.68 | Protective effect of cycloprotobuxine-A against cardiac arrhythmias induced by ouabain. ( Sheng, BH; Tan, YH; Wang, YX, 1992) |
| "Flecainide (100 mg twice daily) was used for prevention of paroxysmal atrial fibrillation (PAF) in 52 patients with frequent symptomatic attacks that were resistant or intolerant to quinidine (600-900 mg/day)." | 7.68 | Flecainide in quinidine-resistant atrial fibrillation. ( Chouty, F; Coumel, P; Denjoy, I; Leclercq, JF; Slama, R, 1992) |
| "Five cases are studied in which amiodarone (AM) was given during pregnancy, in two of them also during the breast feeding period, to estimate the risks for adverse effects." | 7.68 | Use of amiodarone during pregnancy. ( de Vijlder, JJ; Plomp, TA; Vulsma, T, 1992) |
| "The safety and efficacy of short intravenous therapy with amiodarone were evaluated in 44 patients (24 males, 20 females), aged 21-84 years, with supraventricular tachyarrhythmias newly arisen in less than 24 hours." | 7.68 | Efficacy and safety of short intravenous amiodarone in supraventricular tachyarrhythmias. ( Burzio, P; Latini, R; Marchisio, U; Veglio, F; Vietti-Ramus, G, 1992) |
| "Oral amiodarone given in loading doses produces rapid and dramatic reductions in spontaneous ventricular arrhythmias within 72 hours." | 7.68 | Rapid suppression of spontaneous ventricular arrhythmias during oral amiodarone loading. ( Chou, R; Desai, B; Ferrick, KJ; Fisher, JD; Kim, SG; Mannino, MM; Roth, JA; Roth, S, 1992) |
| "105 sequential patients with ventricular arrhythmias in a basal ECG-H recording, that were evaluated within 1 year with a new recording on amiodarone or propafenone, without major clinical events or therapeutic changes between the two recordings." | 7.68 | [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia]. ( Adragão, P; Bonhorst, D; Seabra-Gomes, R; Ventosa, A, 1990) |
| "The antiarrhythmic effect of an 8-week oral amiodarone regimen was studied in dogs with 1-week-old myocardial infarction and reproducibly inducible sustained ventricular tachycardia (VT) or ventricular fibrillation (VF)." | 7.68 | Antiarrhythmic effect of chronic oral amiodarone treatment in dogs with myocardial infarction and reproducibly inducible sustained ventricular arrhythmias. ( Abdollah, H; Brennan, FJ; Brien, JF, 1990) |
| "The relationship between the antiarrhythmic effect of amiodarone and its myocardial concentration was studied in dogs with 1-week-old myocardial infarction and reproducibly inducible sustained ventricular tachycardia or ventricular fibrillation." | 7.68 | Relationship between myocardial amiodarone concentration and antiarrhythmic effect in dogs with myocardial infarction and electrically induced ventricular arrhythmias. ( Abdollah, H; Brennan, FJ; Brien, JF; Jimmo, S, 1991) |
| " Recently, amiodarone has been shown to be rapidly effective in suppressing sustained, incessant ventricular tachycardia and ventricular fibrillation in this setting." | 7.68 | Amiodarone versus bretylium for suppression of reperfusion arrhythmias in dogs. ( Horrigan, TP; Mostow, ND; Noon, DL; Rosalion, A; Snow, NJ, 1991) |
| " Coadministration of amiodarone, and, moreover, the presence of heart failure increase the C/D ratio, from 2." | 7.68 | Flecainide acetate dose-concentration relationship in cardiac arrhythmias: influence of heart failure and amiodarone. ( Coumel, P; Denjoy, I; Leclercq, JF; Mentré, F, 1990) |
| "To evaluate the efficacy of amiodarone in tachyarrhythmias occurring acutely, in patients with different nosological entities of the heart." | 7.68 | [The effectiveness of amiodarone seems to depend highly on the pathology underlying the arrhythmia]. ( de Castro, JJ; Mota, E; Quadrado, C; Soares, Ade O, 1990) |
| "To shorten the delay in the onset of antiarrhythmic effect when using amiodarone for the conversion of refractory atrial tachyarrhythmias to sinus rhythm, 19 patients were given oral amiodarone according to a high-dose loading protocol." | 7.68 | Rapid control of refractory atrial tachyarrhythmias with high-dose oral amiodarone. ( Mostow, ND; Noon, D; Rakita, L; Vrobel, TR, 1990) |
| " Amiodarone and desethylamiodarone concentration in serum (control group n = 33) and in erythrocyte haemolysate (control group n = 13) were determined in relapses of ventricular tachycardias (n = 7) and in pulmonary fibrosis as serious side effect (n = 3)." | 7.67 | [Control of anti-arrhythmia therapy with amiodarone. Value of the determination of blood levels]. ( Lüderitz, B; Nitsch, J, 1984) |
| "Thirty-three consecutively referred patients with cardiac arrest from ventricular arrhythmias unassociated with a new acute myocardial infarction (AMI) were commenced on amiodarone therapy and followed for a minimum of 12 months." | 7.67 | Prognosis after sudden cardiac death without associated myocardial infarction: one year follow-up of empiric therapy with amiodarone. ( Hamer, A; Mandel, WJ; Peter, T; Weiss, D, 1984) |
| "Amiodarone was administered orally to 30 patients with chronic stable coronary artery disease and severe ventricular arrhythmias." | 7.67 | Efficacy of amiodarone during long-term treatment of potentially dangerous ventricular arrhythmias in patients with chronic stable ischemic heart disease. ( Elizari, MV; Girotti, LA; Goldbarg, A; Kaski, JC; Lázzari, JO; Rosenbaum, MB; Tambussi, A, 1984) |
| "Oral amiodarone was administered to 24 patients with chronic chagasic myocarditis (CCM) and malignant ventricular arrhythmias." | 7.67 | Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis. ( Chiale, PA; Elizari, MV; Halpern, MS; Lázzari, JO; Nau, GJ; Przybylski, J; Rosenbaum, MB; Tambussi, AM, 1984) |
| "Forty patients with atrial fibrillation (AF), 23 patients with ventricular extrasystoles (VES), and 11 patients with various arrhythmias (VA) were treated with amiodarone (0." | 7.67 | Amiodarone--application and clinical pharmacology in atrial fibrillation and other arrhythmias. ( Anastasiou-Nana, M; Levis, GM; Moulopoulos, SD, 1984) |
| " To determine their relative antiarrhythmic efficacy, amiodarone and its desethyl metabolite, desethylamiodarone, were administered to mongrel dogs with ventricular tachycardia 24 hr after ligation of the left anterior descending coronary artery." | 7.67 | The antiarrhythmic efficacy of amiodarone and desethylamiodarone, alone and in combination, in dogs with acute myocardial infarction. ( Davies, M; Nattel, S; Quantz, M, 1988) |
| "The case of a 77-year-old patient who suffered from clinically severe and persistent hyperthyroidism induced by amiodarone is described." | 7.67 | [Therapy resistance of amiodarone-induced hyperthyroidism]. ( Althaus, B; Bucher, H; Schön, H; Vogt, T, 1988) |
| "To exploit the antiarrhythmic effect of amiodarone when patients develop the side effect of thyrotoxicosis three patients with hyperthyroidism induced by amiodarone were given simultaneously 1 g potassium perchlorate a day for 40 days and a starting dose of 40 mg methimazole a day while they continued to take amiodarone." | 7.67 | Treatment of amiodarone induced hyperthyroidism with potassium perchlorate and methimazole during amiodarone treatment. ( de Rooy, HA; Reichert, LJ, 1989) |
| "The effects of amiodarone and its metabolite desethylamiodarone on arrhythmias induced by ischaemia and reperfusion were studied in vivo in the anaesthetised rat with transient regional ischaemia (7 min of left coronary artery occlusion) and reperfusion (10 min)." | 7.67 | Anti-arrhythmic effects of amiodarone and desethylamiodarone on malignant ventricular arrhythmias arising as a consequence of ischaemia and reperfusion in the anaesthetised rat. ( Hearse, DJ; Riva, E, 1989) |
| " The aim of our study was to evaluate the effects of amiodarone (400 mg day-1 for seven days and then 200 mg day-1, five days a week, for 60 days) in 20 patients with chronic ischaemic heart disease ascertained by stress test, thallium-201 myocardial scintigraphy and coronary angiography and with qualitatively and quantitatively similar cardiac arrhythmias in two continuous ECG monitoring sessions performed before starting treatment." | 7.67 | Effects of low doses of amiodarone on cardiac arrhythmias in patients with chronic ischaemic heart disease. ( Abrignani, MG; Alaimo, G; Cutietta, A; Immordino, R; Indovina, A; Licata, G; Novo, S; Strano, A, 1988) |
| "The effect of low-dose amiodarone was prospectively evaluated in 110 patients with potentially lethal ventricular arrhythmias and structural heart disease." | 7.67 | Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone. ( Aragon, E; Blevins, RD; Faitel, K; Frumin, H; Jarandilla, R; Kerin, NZ; Luarca, R; Marinescu, G; Rubenfire, M, 1988) |
| "Out of 20 subjects selected for refractory arrhythmias, amiodarone therapy (200 mg/day) was efficacious in 85%." | 7.67 | Amiodarone and thyroid status in refractory arrhythmias. ( Codecà, L; Colamussi, V; Giganti, M; Giovannini, G; Pelizzola, D; Piffanelli, A; Ricci, L, 1988) |
| "Few data are available on intravenous amiodarone therapy in refractory arrhythmias." | 7.67 | Efficacy and safety of intravenous amiodarone in acute refractory arrhythmias. ( Binner, L; König, W; Mayer, U; Schmidt, A; Stauch, M, 1988) |
| "Fourteen patients with established atrial fibrillation (longer than three months) that was refractory to treatment were studied to compare the clinical and electrophysiological effects of amiodarone and bepridil." | 7.67 | A comparison of bepridil with amiodarone in the treatment of established atrial fibrillation. ( Krikler, DM; McKenna, WJ; Perelman, MS; Rowland, E, 1987) |
| "The relation of clinical and electrophysiologic variables to outcome was evaluated in 121 patients treated with amiodarone for sustained ventricular tachyarrhythmias." | 7.67 | Usefulness of electrophysiologic study to determine the clinical tolerance of arrhythmia recurrences during amiodarone therapy. ( Buxton, AE; Flores, B; Josephson, ME; Kadish, AH; Marchlinski, FE; Waxman, HL, 1987) |
| "The value of serial electropharmacologic testing during long-term oral amiodarone therapy for prediction of long-term drug efficacy as well as characteristics of arrhythmia recurrence is controversial." | 7.67 | Predictors of efficacy of amiodarone and characteristics of recurrence of arrhythmia in patients with sustained ventricular tachycardia and coronary artery disease. ( DiMarco, JP; Haines, DE; Lerman, BB; Zhu, J, 1987) |
| "Although amiodarone is effective for the suppression of complex ventricular arrhythmias, a major problem with its use is the long delay between the initiation of therapy and the onset of effective suppression of arrhythmia." | 7.67 | Rapid suppression of complex ventricular arrhythmias with high-dose oral amiodarone. ( Mostow, ND; Noon, D; Rakita, L; Vrobel, TR, 1986) |
| "For the 5-year period 1979 to 1983, 242 patients were followed up who had received amiodarone treatment, 156 for supraventricular tachycardia (SVT) and 86 for ventricular arrhythmias." | 7.67 | Long-term tolerance of amiodarone treatment for cardiac arrhythmias. ( Lubbe, WF; Mercer, J; Roche, AH; Rutherford, JD; Smith, WM; Whitlock, RM, 1986) |
| "The efficacy and safety of combined amiodarone and mexiletine treatment was investigated in 16 patients with chronic complex ventricular arrhythmias previously refractory to conventional antiarrhythmic agents and, in a lesser degree, to mexiletine or amiodarone." | 7.67 | [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias]. ( Bilancini, A; Blandini, A; Costantini, C; Curzi, G; Massacci, C; Pigini, G; Purcaro, A, 1986) |
| "Oral amiodarone was administered to 30 children (aged one week to 14 years) for treatment of resistant or life threatening tachycardias." | 7.67 | Intravenous and oral amiodarone for arrhythmias in children. ( Bucknall, CA; Curry, PV; Holt, DW; Keeton, BR; Sutherland, GR; Tynan, MJ, 1986) |
| "During treatment with amiodarone, digoxin and nadolol, asystole occurred repeatedly in a patient with chronic persistent automatic atrial tachycardia." | 7.67 | Asystole during treatment with amiodarone in a patient with persistent atrial tachycardia. ( Kuo, CS; Paciotti, MV; Reddy, CP, 1985) |
| "Over a 10-year period 130 patients with drug-resistant cardiac arrhythmias associated mainly with coronary artery disease and its complications were treated with amiodarone." | 7.67 | Amiodarone for refractory cardiac arrhythmias: 10-year study. ( Eydt, JN; Leak, D, 1986) |
| "Eleven critically ill patients with life-threatening cardiac arrhythmias refractory to currently approved antiarrhythmic drugs were treated with intravenous amiodarone." | 7.67 | Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient. ( Leak, D, 1986) |
| "Seventy-four patients with sustained ventricular tachyarrhythmias had 22 +/- 3 hours of Holter monitoring before and after 11 +/- 6 days of amiodarone treatment." | 7.67 | Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone. ( Buxton, AE; Doherty, JU; Flores, BT; Josephson, ME; Marchlinski, FE; Waxman, HL, 1985) |
| "In 65 patients a single oral dose of amiodarone (30 mg/kg) produced an antiarrhythmic effect on supraventricular or ventricular arrhythmias within 3 to 8 hours and lasted for 17 to 19 hours." | 7.67 | Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations. ( Cheymol, G; Coumel, P; Escoubet, B; Jaillon, P; Lagier, G; Leclercq, JF; Maison-Blanche, P; Menasche, P; Piwnica, A; Poirier, JM, 1985) |
| "Two cases are reported in which amiodarone was administered during pregnancy for longer periods than has been reported previously." | 7.67 | Use of amiodarone during pregnancy. ( Holt, DW; Jeeva Raj, MV; Robson, DJ; Storey, GC, 1985) |
| "We report two patients who developed symptomatic life-threatening ventricular tachyarrhythmias with changing QRS axes (resembling torsades de pointes), during treatment of their supraventricular tachycardias with oral amiodarone." | 7.67 | Life-threatening ventricular arrhythmias provoked by amiodarone treatment. ( Eydt, J; Kumana, CR; Tanser, P, 1985) |
| "Oral amiodarone's slow absorption handicaps rapid treatment of life-threatening arrhythmias." | 7.67 | Intravenous amiodarone in the treatment of refractory arrhythmias. ( Alves, LE; Cahill, TB; Rose, EP, 1985) |
| "The clinical efficacy of amiodarone in the management of patients with complex cardiac arrhythmias refractory to therapy with two or more conventional or other investigational anti-arrhythmic agents was studied by long-term follow-up of patients who had received the drug for a period of at least three months." | 7.67 | Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long term follow-up. ( Hamer, A; Mandel, WJ; Peter, T, 1985) |
| "The electrophysiologic basis for the use of amiodarone in the treatment of cardiac arrhythmias is outlined, with reference to studies in isolated cardiac tissues, whole animal, and human studies." | 7.66 | The electrophysiologic basis for the use of amiodarone for treatment of cardiac arrhythmias. ( Hamer, AW; Karagueuzin, HS; Mandel, WJ; Peter, T; Zaher, CA, 1983) |
| "Amiodarone was used in 40 patients with life-threatening or refractory tachyarrhythmias." | 7.66 | Amiodarone therapy for life threatening or refractory cardiac arrhythmias. ( Anderson, ST; Currie, PJ; Federman, J; Harper, RW; Johns, JA; Pitt, A, 1983) |
| "Amiodarone was administered to 121 patients (82 males, 39 females; average age 59 years) with refractory atrial tachyarrhythmias." | 7.66 | Efficacy of amiodarone for refractory supraventricular tachyarrhythmias. ( Graboys, TB; Lown, B; Podrid, PJ, 1983) |
| "The clinical antiarrhythmic efficacy of amiodarone treatment was examined in 196 patients with recurrent ventricular tachycardia (VT) or ventricular fibrillation (VF) resistant to other antiarrhythmic drugs." | 7.66 | Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation. ( Heger, JJ; Prystowsky, EN; Zipes, DP, 1983) |
| "The clinical efficacy of amiodarone in the management of complex cardiac arrhythmias refractory to therapy with two or more conventional or other investigational antiarrhythmic agents was determined by long-term follow-up in patients who had received the drug for at least 3 months." | 7.66 | Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long-term follow-up. ( Hamer, A; Mandel, WJ; Peter, T; Weiss, D, 1983) |
| "Amiodarone was used to treat cardiac arrhythmias that had been refractory to conventional medical therapy." | 7.66 | Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias. ( Gorham, JP; Graham, EL; Greene, HL; Gross, BW; Kudenchuk, PJ; Sears, GK; Trobaugh, GB; Werner, JA, 1983) |
| "Ninety-six patients with life-threatening ventricular arrhythmias refractory to two or more conventional agents were treated with amiodarone and followed for 6 to 40 months (mean, 15 months)." | 7.66 | Amiodarone in refractory life-threatening ventricular arrhythmias. ( Cannom, DS; Feld, G; Hendrickson, J; Intarachot, V; Lopez, B; Nademanee, K; Singh, BN; Weiss, JL, 1983) |
| "Five cases of amiodarone-induced polymorphous ventricular tachycardia (torsade de pointes) are presented." | 7.66 | Amiodarone-induced polymorphous ventricular tachycardia. ( Agmon, J; Arditti, A; Kracoff, O; Lewin, RF; Sclarovsky, S; Strasberg, B, 1983) |
| "Ninety-six patients with recurrent, drug-refractory tachyarrhythmias were treated with amiodarone for 8." | 7.66 | Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias. ( Anderson, KP; Fogoros, RN; Mason, JW; Swerdlow, CD; Winkle, RA, 1983) |
| "Amiodarone was used in 30 patients with tachyarrhythmias refractory to treatment with several antiarrhythmic agents." | 7.66 | Amiodarone in long term management of refractory cardiac tachyarrhythmias. ( Lowe, JB; Lubbe, WF; Mercer, CJ; Roche, AH, 1981) |
| "Six patients are presented who developed pulmonary infiltrates of undetermined origin while being treated for severe ventricular arrhythmias with amiodarone hydrochloride." | 7.66 | Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug. ( Rakita, L; Sobol, SM, 1982) |
| "Detailed electrophysiologic studies were performed in nine patients with chronic refractory ventricular arrhythmias before and after 7 to 20 weeks (mean 11 weeks) of amiodarone therapy." | 7.66 | Electrophysiologic effects of chronic amiodarone therapy in patients with ventricular arrhythmias. ( Finerman, WB; Hamer, A; Mandel, WJ; Peter, T; Weiss, D, 1982) |
| "Six patients treated with a combination of amiodarone and class I antiarrhythmic agents for a minor arrhythmia developed atypical ventricular tachycardia "en torsades de pointe"." | 7.66 | [Harmful interactions of amiodarone and class I anti-arrhythmia agents]. ( Kappenberger, L; Steinbrunn, W; Tartini, R, 1982) |
| "Amiodarone was utilized in 70 patients with symptomatic, sustained refractory tachyarrhythmias." | 7.66 | Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias. ( Lown, B; Podrid, PJ, 1981) |
| "A patient with the familial syndrome of Q-T prolongation, ventricular arrhythmias, and syncope was effectively treated with amiodarone." | 7.66 | Effective management of the long q-t syndrome with amiodarone. ( Bashour, T; Cheng, TO; Jokhadar, M, 1981) |
| "The efficacy of amiodarone in the treatment of cardiac arrhythmias is discussed in the light of published results and our own experience." | 7.66 | [The treatment of arrhythmias with amiodarone]. ( Stäubli, M; Studer, H, 1981) |
| "Nine patients with life-threatening ventricular arrhythmias were administered oral amiodarone over a period of months." | 7.66 | Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias. ( Finerman, WB; Hamer, AW; Mandel, WJ; Peter, T, 1981) |
| "Oral amiodarone has been used to treat 21 patients with various supraventricular arrhythmias; 13 had Wolff-Parkinson-White syndrome, which was complicated by atrial fibrillation and re-entry atrioventricular tachycardia in four, and re-entry tachycardia alone in the other nine." | 7.66 | Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias. ( Krikler, DM; Rowland, E, 1980) |
| "Amiodarone is used in the treatment of previously drug-resistant supraventricular and ventricular arrhythmias." | 7.66 | Effectiveness of amiodarone in resistant arrhythmias. ( Hollman, A; Holt, PM, 1980) |
| "Amiodarone hydrochloride was used to treat 19 patients with symptomatic arrhythmias refractory to quinidine sulfate, procainamide hydrochloride, disopyramide phosphate, antazoline hydrochloride, lidocaine hydrochloride, bretylium tosylate, propranolol hydrochloride, phenytoin sodium, and practotol acetanilide given to the limit of tolerance." | 7.66 | Control of refractory cardiac arrhythmias with amiodarone. ( Eydt, JN; Leak, D, 1979) |
| "The authors report four new cases of hyperthyroidism associated with prolonged treatment with amiodarone." | 7.65 | [Hyperthyroidism caused by amiodarone. Apropos of 4 clinical cases]. ( Chapelle, M; Naouri, R; Wolff, F, 1976) |
| "15 patients with ventricular and supraventricular arrhythmias treated with Amiodarone hydrochloride via oral were studied." | 7.65 | [Clinical evaluation of amiodarone hydrochloride as an anti-arrhythmia agent]. ( Cordeiro, B; Huguet, R; Malpartida, F; Noguera, J; Sala, J; Triola, M, 1975) |
| "Amiodarone is a Class III Vaughan-Williams anti-arrhythmic drug widely used in ventricular arrhythmias for its efficacy and low pro-arrhythmogenic effect." | 6.72 | Amiodarone in ventricular arrhythmias: still a valuable resource? ( Baldetti, L; Brugliera, L; Cianfanelli, L; D'Angelo, G; De Blasi, G; Della Bella, P; Falasconi, G; Frontera, A; Gulletta, S; Landoni, G; Malatino, L; Margonato, A; Melillo, F; Ossola, P; Pannone, L; Vergara, P; Zacchetti, D, 2021) |
| "Amiodarone has pharmacokinetic interactions with a number of therapeutic drugs, including warfarin, phenytoin, flecainide, and cyclosporine." | 6.72 | Effect of amiodarone on the serum concentration/dose ratio of metoprolol in patients with cardiac arrhythmia. ( Fukumoto, K; Kamakura, S; Kato, R; Kitakaze, M; Kobayashi, T; Komamura, K; Tachibana, K; Tanaka, K; Ueno, K, 2006) |
| "Amiodarone was used in 37 pediatric subjects aging 1 day--16 years." | 6.70 | [Amiodarone for long term treatment of arrhythmia in children]. ( Durmała, J; Nowakowska, E; Rokicki, W, 2001) |
| "Patients with severe congestive heart failure (CHF) are at increased risk for atrial and ventricular arrhythmias and sudden cardiac death." | 6.68 | Acute electrophysiologic effects of amiodarone in patients with congestive heart failure. ( Feliciano, Z; Gold, MR; Gottlieb, SS; Peters, RW; Riggio, DW; Shorofsky, SR, 1995) |
| "Sudden cardiac death is a common cause of mortality in patients with congestive heart failure." | 6.67 | Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy. ( Das, SK; Krikler, SJ; McKenna, WJ; Mickelson, JK; Morady, F; Nicklas, JM; Pitt, B; Quain, LA; Schork, MA; Stewart, RA, 1991) |
| "Amiodarone is an iodinated benzofuran derivative, a highly lipophilic drug with unpredictable pharmacokinetics." | 6.66 | The role of amiodarone in contemporary management of complex cardiac arrhythmias. ( Dobrev, D; Marinković, M; Mujović, N; Potpara, TS; Russo, V, 2020) |
| "Sotalol was compared with amiodarone in this open randomized multicentre study of patients with ventricular tachycardia or fibrillation not associated with acute myocardial infarction refractory to or intolerant of Class I drugs." | 6.66 | Multicentre randomized trial of sotalol vs amiodarone for chronic malignant ventricular tachyarrhythmias. Amiodarone vs Sotalol Study Group. ( , 1989) |
| "Amiodarone is an iodinated compound, and the possibility that its molecule may be modified with or without elimination of the iodine is being tested." | 6.44 | Amiodarone as paradigm for developing new drugs for atrial fibrillation. ( Singh, BN, 2008) |
| "Amiodarone can cause thyroid dysfunction in patients with or without previous thyroid disease." | 6.42 | Surgical management of amiodarone-induced thyrotoxicosis. ( Fan, CY; Franzese, CB; Stack, BC, 2003) |
| "Ventricular arrhythmias represented 13% of the rhythmic indications." | 6.38 | The value of oral amiodarone in the treatment of ventricular arrhythmias in heart disease. ( Levy, S, 1991) |
| "Eighty-four cases of ventricular arrhythmia-induced shock and ROSC (return of spontaneous circulation) were divided into the prior amiodarone or β-blockers use group (Aβ group, n = 27) and the non-amiodarone and non-β-blockers use group (non-Aβ group; n = 57) based on treatment before the onset of those arrhythmias." | 5.62 | Prognostic benefits of prior amiodarone or β-blocker use before the onset of ventricular arrhythmia with hemodynamic collapse. ( Nagao, K; Tachibana, E; Ueki, Y; Yamasaki, M; Yokoyama, M; Yonemoto, N; Yoshie, K, 2021) |
| "Amiodarone effectively inhibit arrhythmia by improving the myocardial biomechanical properties and weakening the sensitivity of mechanical stretch stimulation." | 5.56 | Amiodarone inhibits arrhythmias in hypertensive rats by improving myocardial biomechanical properties. ( Han, D; He, Y; Li, X; Liu, Y; Nie, Y, 2020) |
| "Amiodarone has been used a first-line agent to treat ventricular arrhythmias post-LVAD implantation." | 5.51 | Left Ventricular Assist Device Thrombosis-Amiodarone-Induced Hyperthyroidism: Causal Link? ( Acharya, D; Hornbuckle, L; Joly, J; Pamboukian, S; Rajapreyar, I; Sharpton, J; Tallaj, J, 2019) |
| "The prevalence of thyroid dysfunction in patients with cardiac arrhythmias receiving amiodarone was considerable." | 5.41 | Prevalence of Amiodarone Induced Hypothyroidism and Hyperthyroidism in Patients with Heart Diseases: A Systematic Review and Meta-Analysis. ( Alimohamadi, Y; Dalvand, S; Johnston, TP; Karimi, L; Moshkani, M; Rahimi-Bashar, F; Sahebkar, A; Vahedian-Azimi, A, 2023) |
| "The score of arrhythmia severity also decreased, but was statistically significant only in the Amio group (p < 0." | 5.40 | Efficacy of Melissa officinalis in suppressing ventricular arrhythmias following ischemia-reperfusion of the heart: a comparison with amiodarone. ( Bashiri, A; Joukar, S; Sepehri, G; Zarisfi, Z, 2014) |
| "0) for the maximal plasma concentration and the area under the curve during the dosing interval for both amiodarone and desethylamiodarone, tolvaptan coadministration had no effect on either amiodarone and desethylamiodarone disposition, as all the geometric mean ratios (amiodarone + tolvaptan [30 or 90 mg] vs amiodarone alone) were approximately 1." | 5.33 | Tolvaptan administration does not affect steady state amiodarone concentrations in patients with cardiac arrhythmias. ( Barbagelata, NA; Bramer, SL; Elizari, MV; Grinfeld, LR; Lerman, J; Orlandi, C; Sekar, K; Shoaf, SE; Trongé, J; Wang, Z, 2005) |
| "Examining the course of cardiac arrhythmias (CA) in developed TT has established that this condition gives rise to their recurrence." | 5.32 | [The specific features of thyrotoxicosis and euthyroid hyperthyroxinemia developed due to the use of cordarone]. ( Bakalov, SA; Domogadskiĭ, SP; Golitsyn, SP; Kolesnikova, GS; Masenko, VP; Molashenko, NV; Platonova, NM; Serdiuk, SE; Sviridenko, NIu, 2004) |
| "The initial arrhythmia was 2/1 atrial flutter (n = 4), 1/1 atrial flutter (n = 2) and atrial fibrillation (n = 1)." | 5.31 | [Atrial flutter with 1/1 nodo-ventricular conduction with amiodarone. From physiopathology to diagnosis]. ( Aouate, P; Dubois-Randé, JL; Elbaz, N; Fontaine, G; Frank, R; Klug, D; Lacotte, J; Lelouche, D; Raguin, D; Tonet, J, 2002) |
| "D-sotalol and almokalant evoked torsade de pointes (TdP) and other arrhythmics, frequently." | 5.31 | Proarrhythmic effects of intravenous quinidine, amiodarone, D-sotalol, and almokalant in the anesthetized rabbit model of torsade de pointes. ( Farkas, A; Leprán, I; Papp, JG, 2002) |
| "Amiodarone has pharmacokinetic interactions with various therapeutic agents, including phenytoin, flecainide, and cyclosporine." | 5.31 | Lack of interaction between amiodarone and mexiletine in cardiac arrhythmia patients. ( Hashimoto, H; Kamakura, S; Komamura, K; Matsumoto, K; Miyatake, K; Tachibana, M; Tanaka, K; Ueno, K; Yonezawa, E, 2002) |
| "Amiodarone hydrochloride is a potent antiarrhythmic agent recently approved for use by the Food and Drug Administration." | 5.29 | Progression of amiodarone induced cataracts. ( Dolan, BJ; Flach, AJ, 1993) |
| "The duration of arrhythmias induced by reperfusion following 5 min of ischaemia was also less in the rats which had received amiodarone than in the controls (43." | 5.28 | Amiodarone, adrenoceptor responsiveness and ischaemia- and reperfusion-induced arrhythmias. ( Chess-Williams, R; Coker, SJ, 1991) |
| "Amiodarone was particularly effective in suppressing complex ventricular arrhythmias." | 5.28 | Long term efficacy and toxicity of amiodarone in the treatment of refractory cardiac arrhythmias. ( Agha, A; Giorgi, C; Nadeau, R; Primeau, R; Shenasa, M, 1989) |
| "Amiodarone hydrochloride is a relatively new antiarrhythmic agent, the properties of which differ in a significant manner electrophysiologically, pharmacokinetically and structurally from those of conventional as well as other investigational antidysrhythmic compounds." | 5.27 | The clinical results of amiodarone in cardiac arrhythmias: optimal dosing. ( Ikeda, N; Kannan, R; Nademanee, K; Singh, BN, 1984) |
| "Propafenone was less effective (mean effect 3." | 5.27 | European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias. ( Assayag, P; Coumel, P; Leclercq, JF, 1984) |
| "The atrial tachyarrhythmias were successfully controlled in 45 of 54 patients (83%) during a mean follow-up of 10." | 5.27 | Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias. ( Alpert, JS; Asdourian, G; Canada, AT; Haffajee, CI; Lesko, LJ; Love, JC, 1983) |
| "Amiodarone was administered in a loading dose of 1." | 5.27 | Treatment of ventricular arrhythmia after corrective cardiac surgery in a neonate with intravenous amiodarone. ( Bogers, AJ; Huysmans, HA; Ottenkamp, J; Quaegebeur, JM, 1987) |
| "Amiodarone has a good antiarrhythmic effect administered either acutely or chronically." | 5.27 | [Acute antiarrhythmia treatment with amiodarone and blood levels of thyroid hormones]. ( Fazzini, PF; Gheri, RG; Marchi, F; Multinu, D; Paladini, S; Zambaldi, G, 1987) |
| "Amiodarone is a widely used antiarrhythmic drug, which contains 75 mg of iodide per 200 mg of active substance." | 5.27 | Amiodarone-induced hypothyroidism. A common complication of prolonged therapy: a report of eight cases. ( Atkinson, AB; Campbell, NP; Ferguson, WR; Geddes, JS; Hawthorne, GC; Postlethwaite, W; Sheridan, B, 1985) |
| "Nonetheless, arrhythmias in these patients were by no means abolished despite correction of these neuroendocrine and electrolyte abnormalities." | 5.27 | Arrhythmias in heart failure--the role of amiodarone. ( Cleland, JG; Dargie, HJ, 1988) |
| "Amiodarone, a drug that has electrophysiologic actions resembling those of hypothyroidism, increases serum levels of T4 and reverse T3 (rT3) and decreases T3." | 5.27 | Amiodarone, thyroid hormone indexes, and altered thyroid function: long-term serial effects in patients with cardiac arrhythmias. ( Callahan, B; Hendrickson, JA; Hershman, JM; Nademanee, K; Singh, BN, 1986) |
| "Ventricular arrhythmias were present in 62 (95." | 5.27 | Ventricular arrhythmias in dilated cardiomyopathy: efficacy of amiodarone. ( Camerini, F; Mestroni, L; Neri, R; Pandullo, C; Salvi, A, 1987) |
| "The time to optimal ventricular arrhythmia control was shorter for group B (20 +/- 18 vs 105 +/- 83 days, p less than 0." | 5.27 | Intravenous and oral loading versus oral loading alone with amiodarone for chronic refractory ventricular arrhythmias. ( Blevins, RD; Faitel, K; Frumin, H; Kerin, NZ; Rubenfire, M, 1985) |
| "Amiodarone has been used in the therapy of supraventricular and ventricular tachycardia, and has often been categorised as a class III rather than a class I agent." | 5.27 | Amiodarone treatment in patients with ventricular arrhythmias. ( Heger, JJ; Miles, WM; Prystowsky, EN; Zipes, DP, 1985) |
| "Oral amiodarone was evaluated in 24 patients with complex forms of ventricular premature depolarizations (VPD) by means of ECG monitoring and measurement of systolic time intervals." | 5.26 | Oral amiodarone in high-risk ventricular arrhythmias. ( Cabrera-Alonso, C; García-Barreto, D; González-Gómez, A; Hernández-Cañero, A; Llerena, L; Ramos-Emperador, C; Sellén, J; Toruncha, A, 1982) |
| "Amiodarone i." | 5.26 | [Experience with intravenous amiodarone in hyperkinetic supraventricular arrhythmias]. ( Bianchi, C; Bonifazi, C; Coppetti, S; Distante, S; Ferrari, O; Ricevuti, A; Rinaldo, R; Rizzi, M; Tavecchi, L; Zampaglione, G; Ziletti, G, 1981) |
| "Oral amiodarone was given to 135 children (mean age, 10." | 5.26 | Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases. ( Coumel, P; Fidelle, J, 1980) |
| "Amiodarone was administered in five patients with life-threatening ventricular arrhythmias resistant to other antiarrhythmic agents: Suppression was obtained in one of two patients with recurrent ventricular tachycardias and control was achieved in three patients with repetitive ventricular tachycardia and ventricular fibrillation, allowing the effective use of intra-aortic balloon counterpulsation (IABP) needed for hemodynamic support." | 5.26 | Intravenous amiodarone in the treatment of various arrhythmias following cardiac operations. ( Charles, S; Gadisseux, P; Installe, E; Schoevaerdts, JC; Tremouroux, J, 1981) |
| "The aim of this study was to compare the effects of prophylactic dronedarone and amiodarone in prevention of arrhythmias during and following off-pump coronary artery bypass grafting (OPCAB)." | 5.24 | Prophylactic amiodarone vs dronedarone for prevention of perioperative arrhythmias in offpump coronary artery bypass grafting: A pilot randomized controlled trial. ( Goswami, A; Sen, C; Som, A, 2017) |
| "Intravenous amiodarone is considered an effective treatment option for cardiac ventricular and atrial arrhythmias." | 5.24 | Effects of injection-site splinting on the incidence of phlebitis in patients taking peripherally infused amiodarone: A randomized clinical trial. ( Ayat-Isfahani, F; Davoudi, B; Jalali, A; Pashang, M; Sadeghian, S, 2017) |
| "Amiodarone can be used in a variety of arrhythmias." | 5.22 | Amiodarone-induced cutaneous leukocytoclastic vasculitis: a case report and a review of the literature. ( Agirgol, S; Ak, T; Algan, RN; Hascicek, SO; Turkoglu, Z, 2022) |
| "The aim of this study was to present our data regarding the efficacy and safety of combining amiodarone and propranolol for the management of arrhythmias in infants." | 5.17 | The efficacy of amiodarone-propranolol combination for the management of childhood arrhythmias. ( Akin, A; Alehan, D; Aykan, HH; Karagöz, T; Özer, S; Özkutlu, S, 2013) |
| "Intravenous amiodarone (AIV) is used to treat cardiac arrhythmias." | 5.14 | Evaluation of the effects of PM101, a cyclodextrin-based formulation of intravenous amiodarone, on blood pressure in healthy humans. ( Adams, MP; Cooper, WD; Cushing, DJ; Kowey, PR; Lipicky, RJ; Zhang, B, 2009) |
| " The heart rhythm was monitored continuously and ventricular arrhythmias were treated with amiodarone and cardioversion." | 5.12 | Decreased mortality in a rat model of acute postinfarction heart failure. ( Lorentzon, M; Omerovic, E; Råmunddal, T, 2006) |
| "Amiodarone is an effective antiarrhythmic drug, but it has serious side effects and conducted trials did not support its prophylactic use in survivors of acute myocardial infarction." | 5.11 | Individual patterns of dynamic QT/RR relationship in survivors of acute myocardial infarction and their relationship to antiarrhythmic efficacy of amiodarone. ( Batchvarov, V; Hnatkova, K; Laguna, P; Malik, M; Pueyo, E; Smetana, P, 2004) |
| "To determine whether a brief perioperative course of oral amiodarone is an effective and safe prophylaxis for atrial tachyarrhythmias after cardiac surgery overall and in important subgroups." | 5.11 | Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial. ( Bayes, AJ; Burgess, JJ; Connolly, CJ; Exner, DV; Ferland, A; Kidd, WT; Kieser, T; MacAdams, CL; Maitland, A; Mitchell, LB; Prystai, GD; Wyse, DG, 2005) |
| "Magnesium sulfate is an effective and safe antiarrhythmic agent for arrhythmias developed after open-heart surgery." | 5.10 | Antiarrhythmic effect of magnesium sulfate after open heart surgery: effect of blood levels. ( Akalin, H; Aral, A; Eren, NT; Eyileten, ZB; Kiziltepe, U; Sirlak, M; Tasoz, R; Uysalel, A, 2003) |
| "In the Canadian Implantable Defibrillator Study (CIDS), 659 patients with resuscitated ventricular tachyarrhythmias were randomly assigned to receive an ICD or amiodarone and were then followed for a mean of 3 years." | 5.09 | Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study. ( Connolly, S; Gardner, M; Gent, M; Krahn, A; Roberts, R; Sheldon, R, 2000) |
| "The EMIAT randomized 1,486 survivors of acute myocardial infarction (MI) aged < or =75 years with left ventricular ejection fraction (LVEF) < or =40% to amiodarone or placebo." | 5.09 | Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial). ( Camm, AJ; Frangin, GA; Janse, MJ; Julian, DG; Malik, M; Schwartz, PJ, 2000) |
| "Although amiodarone was effective in suppressing ventricular arrhythmias and improving ventricular function, it did not reduce the incidence of sudden death or prolong survival among patients with heart failure, except for a trend toward reduced mortality among those with nonischemic cardiomyopathy." | 5.08 | Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. ( Colling, C; Deedwania, PC; Fisher, SG; Fletcher, RD; Lazzeri, D; Lewis, HD; Massie, BM; Singh, BN; Singh, SN, 1995) |
| "The purpose of this study was to analyze the efficacy and safety of intravenous amiodarone in young patients with critical, drug-resistant arrhythmias." | 5.08 | Pediatric use of intravenous amiodarone: efficacy and safety in critically ill patients from a multicenter protocol. ( Fenrich, AL; Friedman, RA; Hulse, JE; Lamberti, JJ; Perry, JC; Triedman, JK, 1996) |
| "The European Myocardial Infarct Amiodarone Trial (EMIAT) was a randomised double-blind placebo-controlled trial to assess whether amiodarone reduced all-cause mortality (primary endpoint) and cardiac mortality and arrhythmic death (secondary endpoints) in survivors of myocardial infarction with a left-ventricular ejection fraction (LVEF) of 40% or less." | 5.08 | Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. ( Camm, AJ; Frangin, G; Janse, MJ; Julian, DG; Munoz, A; Schwartz, PJ; Simon, P, 1997) |
| "Amiodarone reduces the incidence of ventricular fibrillation or arrhythmic death among survivors of acute myocardial infarction with frequent or repetitive VPDs." | 5.08 | Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. ( Cairns, JA; Connolly, SJ; Gent, M; Roberts, R, 1997) |
| " However, debate continues as to whether ICD implantation is superior to amiodarone in prolonging survival in patients with life-threatening ventricular arrhythmias." | 5.08 | Mortality benefit of implantable cardioverter-defibrillator therapy in patients with persistent malignant ventricular arrhythmias despite amiodarone treatment. ( Barron, HV; Heller, K; Kalman, JM; Khan, HH; Lesh, MD; Scheinman, MM; Viskin, S, 1997) |
| "The objective of the European Myocardial Infarct Amiodarone Trial (EMIAT) is to assess the efficacy of amiodarone on mortality of patients with depressed left ventricular (LV) function following myocardial infarction (MI)." | 5.07 | The European Myocardial Infarct Amiodarone Trial (EMIAT). EMIAT Investigators. ( Camm, AJ; Frangin, G; Janse, G; Julian, D; Munoz, A; Schwartz, P; Simon, P, 1993) |
| "Two trial designs have been used in evaluating sotalol in patients with sustained tachyarrhythmias: open-label dose escalation and randomized comparison with reference agents." | 5.07 | Usefulness of sotalol for life-threatening ventricular arrhythmias. ( Roden, DM, 1993) |
| "In the Basel Antiarrhythmic Study of Infarct Survival trial, low-dose amiodarone improved 1-year survival in patients with asymptomatic complex ventricular arrhythmias persisting 2 weeks after myocardial infarction." | 5.07 | Long-term benefit of 1-year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction. ( Brunner, H; Burckhardt, D; Burkart, F; Kiowski, W; Pfisterer, ME, 1993) |
| "In the BASIS study, an improvement in 1 year survival of patients with asymptomatic complex ventricular arrhythmias with low-dose amiodarone was shown in comparison with an untreated control group." | 5.07 | [Long-term effect of amiodarone therapy following myocardial infarct in patients with complex ventricular arrhythmias]. ( Brunner, H; Burckhardt, D; Burkart, F; Kiowski, W; Pfisterer, M, 1993) |
| "The new protocol of amiodarone was proposed to treat and to prevent some paroxysm and refractory arrhythmias with classic treatments." | 5.07 | [New amiodarone protocol in the treatment of refractory arrhythmias]. ( Abou Jaoudé, S; Checrallah, E; Halaby, J; Salamé, E, 1992) |
| "Although many patients waiting for heart transplantation will die of arrhythmias before a donor heart is found, the use of amiodarone has been limited by concern about increased complications in the perioperative period." | 5.07 | Amiodarone therapy does not compromise subsequent heart transplantation. ( Brownfield, ED; Chelimsky-Fallick, C; Drinkwater, D; Hamilton, MA; Kobashigawa, J; Laks, H; Middlekauff, HR; Moriguchi, J; Saxon, LA; Stevenson, WG, 1992) |
| "To determine whether the beneficial effect of low-dose amiodarone on survival in patients with complex ventricular arrhythmias after myocardial infarction was dependent on left ventricular (LV) function, results of the Basel Antiarrhythmic Study of Infarct Survival were analyzed." | 5.07 | Beneficial effect of amiodarone on cardiac mortality in patients with asymptomatic complex ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular function. ( Burckhardt, D; Burkart, F; Follath, F; Kiowski, W; Pfisterer, M, 1992) |
| "In 25 patients whose chronic congestive heart failure (CHF) had recently worsened to New York Heart Association class IV, pimobendan (5 to 20 mg/day) was added to maximum conventional therapy consisting of digoxin, diuretics, angiotensin-converting enzyme inhibitors, coumadin derivatives to prevent thromboembolic complications, and amiodarone to suppress serious ventricular rhythm disturbances." | 5.07 | Intractable heart failure despite angiotensin-converting enzyme inhibitors, digoxin, and diuretics: long-term effectiveness of add-on therapy with pimobendan. ( Hagemeijer, F, 1991) |
| "Beta-blockers are known to be effective against post-infarction ventricular arrhythmias and amiodarone has recently been shown to have this property." | 5.06 | [Comparative efficacy of amiodarone and propranolol on ventricular arrhythmia in the post-infarction period]. ( Blondeau, M; Brunet, M; Fedorowsky, A; Fournier, C; Gensous, D; Kindermans, M; Tournadre, P, 1989) |
| "The effects of amiodarone in a low dosage (200 mg every 8 h for 2 weeks, then 200 mg/day) was assessed in a double-blind placebo-controlled trial in 34 patients with a history of severe congestive heart failure but no sustained ventricular arrhythmia." | 5.06 | Beneficial effects of low dose amiodarone in patients with congestive cardiac failure: a placebo-controlled trial. ( Arkles, LB; Hamer, AW; Johns, JA, 1989) |
| "The purpose of this prospective randomized trial was to compare the efficacy of propranolol and amiodarone in suppressing ventricular arrhythmias during the first 6 months following myocardial infarction (MI)." | 5.06 | Comparison of the efficacy of propranolol and amiodarone in suppressing ventricular arrhythmias following myocardial infarction. ( Bah, M; Blondeau, M; Boujon, B; Brunet, M; Fournier, C; Giudicelli, JF; Kindermans, M; Tournadre, P, 1989) |
| "Twenty two patients with heart failure were studied in a double blind crossover trial to compare amiodarone (200 mg/day) with placebo." | 5.06 | Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure. ( Cleland, JG; Dargie, HJ; Findlay, IN; Wilson, JT, 1987) |
| "A randomized, placebo-controlled study examined the effect of amiodarone on the incidence of ventricular arrhythmias after acute myocardial infarction (AMI)." | 5.06 | Effectiveness of amiodarone on ventricular arrhythmias during and after acute myocardial infarction. ( George, T; Hajar, HA; Hockings, BE; Mahrous, F; Taylor, RR, 1987) |
| " In a double-blind cross-over study against placebo, with three-month treatment periods, amiodarone, in a dose of 200 mg day-1, was found effectively to suppress ventricular arrhythmias during exercise and in the immediate post-exercise period." | 5.06 | Ventricular arrhythmias during exercise in patients with heart failure: the effect of amiodarone. ( Cleland, JG; Dargie, HJ, 1987) |
| "Amiodarone is an effective antiarrhythmic medication frequently used in practice for both ventricular and atrial arrhythmias." | 5.05 | Amiodarone: A Comprehensive Guide for Clinicians. ( Abudayyeh, I; Choksi, D; Contractor, T; Desai, P; Evans, J; Hamilton, D; Hauschild, C; Hilliard, A; Lan, H; Nandkeolyar, S, 2020) |
| "Fifty-two patients with refractory symptomatic supraventricular and ventricular arrhythmias were treated with amiodarone (Cordarone-X; Reckitt & Colman) and followed up for a mean period of 36,4 months (range 3-54 months)." | 5.05 | Amiodarone in the treatment of patients with refractory symptomatic ventricular and supraventricular arrhythmias. A long-term follow-up study. ( Lloyd, EA; Mabin, TA, 1983) |
| "Large initial doses of amiodarone hydrochloride for the treatment of ventricular arrhythmias refractory to conventional therapy were demonstrated to shorten the time to achieve control of the arrhythmia." | 5.05 | Amiodarone in the treatment of refractory ventricular arrhythmias. Importance and safety of initial high-dose therapy. ( Rakita, L; Sobol, SM, 1983) |
| "The clinical efficacy of a low-dosage schedule of amiodarone was tested in 58 patients with severe ventricular arrhythmias refractory to other drug treatments." | 5.05 | Multicenter controlled observation of a low-dose regimen of amiodarone for treatment of severe ventricular arrhythmias. Collaborative Group for Amiodarone Evaluation. ( , 1984) |
| "Oral long-term treatment with various antiarrhythmic drugs (aprindine, mexiletine, disopyramide, amiodarone) was assessed in 82 patients with recurrent tachycardias demonstrated in the ECG using programmed ventricular stimulation." | 5.05 | [Long-term drug therapy in ventricular cardiac arrhythmias. Is an improvement of the prognosis possible?]. ( Lüderitz, B; Manz, M; Steinbeck, G, 1983) |
| "The effects on ventricular arrhythmias of a new class IA drug, flecainide, were compared with those of amiodarone in 10 patients with frequent, chronic, and stable ventricular ectopic beats (VEBs)." | 5.05 | Efficacy of flecainide in the management of ventricular arrhythmias: comparative study with amiodarone. ( Bertolasi, CA; Dubner, SJ; Elencwajg, BD; Mendelzon, R; Palma, S; Ramos, A, 1985) |
| "Low-dose (7 mg/kg per day) disopyramide administration to arrhythmic chagasic patients decreased the frequency of ventricular extrasystoles in 4 of 17 patients (24%) and suppressed most complex ventricular arrhythmias in 12 of 15 patients (80%)." | 5.05 | Effect of low oral doses of disopyramide and amiodarone on ventricular and atrial arrhythmias of chagasic patients with advanced myocardial damage. ( Carrasco, HA; Fuenmayor, A; Landaeta, A; López, F; Molina, C; Reynosa, J; Vicuña, AV; Vicuña, N, 1985) |
| "The long term efficacy of class I antiarrhythmic drugs and of amiodarone was investigated in 34 patients with severe organic heart disease accompanied by frequent complex ventricular arrhythmias." | 5.05 | Long term efficacy of class I antiarrhythmic agents and amiodarone in patients with malignant ventricular arrhythmias. ( Baedeker, W; Goedel-Meinen, L; Jahns, G; Kein, G; Linné, R; Schaudig, U; Schmidt, G; Wirtzfeld, A, 1985) |
| "Lidocaine (L) in still considered the drug of choice in the treatment of life threatening ventricular arrhythmias in the setting of acute myocardial infarction (A." | 5.05 | [Intravenous administration of lidocaine and amiodarone in patients with acute myocardial infarction]. ( Capucci, A; Magnani, B; Mantovani, B; Maresta, A; Melandri, G, 1985) |
| "Amiodarone, administered orally in doses of 200 to 600 mg/day, was remarkably effective in the treatment and prevention of a wide variety of atrial and ventricular arrhythmias." | 5.04 | Clinical efficacy of amiodarone as an antiarrhythmic agent. ( Chiale, PA; Elizari, MV; Halpern, MS; Lázzari, JO; Levi, RJ; Nau, GJ; Przybylski, J; Rosenbaum, MB, 1976) |
| "Amiodarone and acupuncture (AA) are commonly used to treat cardiac arrhythmia (CA)." | 5.01 | Amiodarone and acupuncture for cardiac arrhythmia: Study protocol for a systematic review. ( Gao, WQ; Meng, XD; Sun, Z, 2019) |
| " Our case report describes a patient with an arrhythmia who suffered reversible dysosmia and hypogeusia after taking metoprolol and amiodarone, respectively." | 4.98 | Antiarrhythmic drug-induced smell and taste disturbances: A case report and literature review. ( Che, X; Fang, Y; Li, Y; Reis, C; Wang, H, 2018) |
| " Ventricular arrhythmias are common in patients with Chagas cardiomyopathy, and amiodarone has been widely used for this purpose." | 4.98 | Amiodarone for arrhythmia in patients with Chagas disease: A systematic review and individual patient data meta-analysis. ( Colpani, V; Cruz, LN; da Rosa, PR; Falavigna, M; Giordani, NE; Migliavaca, CB; Miguel, SRPS; Polanczyk, CA; Ribeiro, ALP; Sganzerla, D; Stein, C, 2018) |
| "We made a review of available publications in PUBMED referring the amiodaroneinduced thyroid pathology, focusing on the differential diagnosis, made by nuclear medicine tests, of hypothyroidism (AIH) and hyperthyroidism expressed as: type I amiodarone induced thyrotoxicosis (AIT I), type II amiodarone induced thyrotoxicosis (AIT II), and less frequently as a mixt form, type III amiodarone induced thyrotoxicosis (AIT III)." | 4.95 | The Role of Radiopharmaceuticals in Amiodarone-Induced Thyroid Pathology. ( Irimie, A; Piciu, D, 2017) |
| "Amiodarone, an iodinated benzofuran derivative with Class I, II, III, and IV antiarrhythmic properties, is the most commonly used antiarrhythmic drug used to treat supraventricular and ventricular arrhythmias." | 4.93 | Practical Management Guide for Clinicians Who Treat Patients with Amiodarone. ( Epstein, AE; Goldschlager, N; Kennedy, JI; Murphy, EJ; Naccarelli, GV; Olshansky, B, 2016) |
| "Amiodarone is an effective antiarrhythmic drug for supraventricular and ventricular arrhythmias." | 4.91 | [Treatment with amiodarone]. ( Adelborg, K; Ebbehøj, E; Grove, EL; Nielsen, JC, 2015) |
| " Amiodarone is commonly used to control cardiac arrhythmias; however, it is recognized as having a narrow therapeutic window with potential for significant drug toxicity." | 4.90 | Amiodarone and concurrent antiretroviral therapy: a case report and review of the literature. ( Fong, I; la Porte, C; Naccarato, M; Yoong, D, 2014) |
| "Amiodarone is an effective antiarrhythmic drug for supra-ven-tri-cular and ventricular arrhythmias." | 4.90 | [Treatment with amiodarone]. ( Adelborg, K; Ebbehøj, E; Grove, EL; Nielsen, JC, 2014) |
| "Amiodarone is the most widely used antiarrhythmic agent, with demonstrated effectiveness against all the spectrum of cardiac tachyarrhythmias." | 4.88 | Examining the safety of amiodarone. ( Bai, R; Burkhardt, JD; Di Biase, L; Mohanty, P; Natale, A; Pump, A; Santangeli, P, 2012) |
| "Intravenous amiodarone (A-IV) is used to manage ventricular and atrial arrhythmias." | 4.86 | PM101: intravenous amiodarone formulation changes can improve medication safety. ( Cooper, WD; Cushing, DJ; Souney, PF, 2010) |
| "Amiodarone is a class 3 antiarrhythmic agent used for a broad range of arrhythmias including adenosine-resistant supraventricular tachycardia, junctional ectopic tachycardia, and ventricular tachycardia." | 4.86 | Amiodarone for the emergency care of children. ( Bolte, RG; Etheridge, SP; Gausche-Hill, M; Lane, RD; Nguyen, KT; Niemann, JT, 2010) |
| "Although amiodarone is approved by the US Food and Drug Administration only for refractory ventricular arrhythmias, it is one of the most frequently prescribed antiarrhythmic medications in the United States." | 4.84 | Prescribing amiodarone: an evidence-based review of clinical indications. ( Trohman, RG; Vassallo, P, 2007) |
| "sanofi-aventis (formerly Sanofi-Synthelabo) is developing the oral class III anti-arrhythmic agent dronedarone (Multaq) for the potential treatment and prevention of atrial fibrillation." | 4.83 | Drug evaluation: dronedarone, a novel non-iodinated anti-arrhythmic agent. ( Le Grand, B; Sablayrolles, S, 2006) |
| "Surgical treatment of amiodarone-associated thyrotoxicosis (AAT) is effective although fewer than 100 cases have been reported world wide." | 4.83 | Total thyroidectomy for amiodarone-associated thyrotoxicosis in patients with severe cardiac disease. ( Gough, IR; Gough, J, 2006) |
| " More efforts are needed to improve the success rate of out-of-hospital resuscitation through better warning systems, the use of amiodarone for refractory arrhythmias, and the widespread availability of automated defibrillation devices to allow early defibrillation." | 4.82 | Sudden cardiac death: prevention and treatment. ( Kwok, KM; Lau, CP; Lee, KL; Tse, HF, 2003) |
| "Many patients with cardiac arrhythmias require concomitant therapy with warfarin and amiodarone." | 4.82 | Complex drug-drug-disease interactions between amiodarone, warfarin, and the thyroid gland. ( Ezra, D; Farfel, Z; Halkin, H; Kurnik, D; Loebstein, R; Olchovsky, D, 2004) |
| "Of the antiarrhythmic drugs in current use, amiodarone is one of the most effective and is associated with a comparatively low risk of drug-induced pro-arrhythmia, probably due to its multiple pharmacological actions on cardiac ion channels and receptors." | 4.82 | Dronedarone: an amiodarone analogue. ( Doggrell, SA; Hancox, JC, 2004) |
| " Treatment with amiodarone may lead to changes in thyroid tests results and to development of hypothyroidism or thyrotoxicosis." | 4.82 | [Thyroid and cardiovascular disorders]. ( Gajek, J; Zyśko, D, 2004) |
| " Trials that assessed whether amiodarone prophylaxis decreases the incidence of postoperative atrial tachyarrhythmias have had mixed results and were not specifically powered to detect changes in cardiovascular morbidity, length of stay, or mortality." | 4.82 | Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: a meta-analysis. ( Aasbo, JD; Kim, MH; Krishnan, K; Lawrence, AT; Trohman, RG, 2005) |
| "There is good evidence that amiodarone is effective against a variety of arrhythmias and that it may be superior to other drugs in some settings." | 4.81 | Amiodarone in the prevention and treatment of arrhythmia. ( Auer, J; Berent, R; Eber, B, 2002) |
| "Amiodarone is a benzofuran derivative used to treat cardiac arrhythmias." | 4.81 | Visual changes secondary to initiation of amiodarone: a case report and review involving ocular management in cardiac polypharmacy. ( Castells, DD; Teitelbaum, BA; Tresley, DJ, 2002) |
| "Amiodarone in low to moderate doses is generally safe in controlling arrhythmias in patients with congestive heart failure (CHF)." | 4.80 | The current role of amiodarone in patients with congestive heart failure. ( Bello, D; Massie, BM, 1998) |
| "Amiodarone is an antiarrhythmic agent commonly used in the treatment of supraventricular and ventricular tachyarrhythmias." | 4.80 | Amiodarone: clinical trials. ( Luck, JC; Naccarelli, GV; Patel, HM; Wolbrette, DL, 2000) |
| "Amiodarone is widely used in intensive care units for the treatment of a variety of arrhythmias." | 4.80 | Intravenous amiodarone in intensive care. Time for a reappraisal? ( Binning, A; Hughes, M, 2000) |
| "Animal and clinical studies involving the pharmacology and electrophysiology of amiodarone and clinical trials in which amiodarone was used as therapy for the arrhythmias noted above were reviewed." | 4.79 | Amiodarone: reevaluation of an old drug. ( Podrid, PJ, 1995) |
| " Amiodarone and d-1 sotalol are representative class III drugs commonly used for drug resistant arrhythmias." | 4.79 | [Class III antiarrhythmic drugs]. ( Aiba, T; Kamakura, S, 1996) |
| "Intravenous amiodarone is a potentially valuable therapy for perioperative patients experiencing life-threatening ventricular arrhythmias refractory to conventional antiarrhythmic agents perioperatively." | 4.79 | The rational use of intravenous amiodarone in the perioperative period. ( Balser, JR, 1997) |
| "Amiodarone is useful in the treatment of patients with ventricular arrhythmias after acute myocardial infarction and was equally useful when these arrhythmias were associated with CHF." | 4.79 | Amiodarone: a late comer. ( Futterman, LG; Lemberg, L, 1997) |
| "There have been 13 randomised controlled trials of prophylactic amiodarone in patients with recent myocardial infarction (MI) or congestive heart failure (CHF)." | 4.79 | Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators. ( , 1997) |
| "The present article reviews the therapeutic efficacy of class III antiarrhythmic agents, particularly amiodarone, in patients with atrial and ventricular arrhythmias in the setting of different cardiac disorders." | 4.78 | Therapy with and assessment of class III antiarrhythmic agents in different patient populations. ( Podrid, PJ, 1992) |
| "The present article reviews the experience with amiodarone therapy in life-threatening ventricular tachyarrhythmias." | 4.78 | Clinical efficacy of long-term treatment with amiodarone for life-threatening arrhythmias. ( Burckhardt, D, 1992) |
| "Amiodarone, an anti-ischaemic and anti-arrhythmic drug, has been the object of numerous studies and seems to be highly effective in the treatment of severe ventricular arrhythmias on dilated cardiomyopathies, as well as of hypertrophic or ischaemic heart diseases." | 4.78 | [Does amiodarone have a benefit effect on mortality?]. ( Kahn, JC; Pathé, M, 1991) |
| "Amiodarone is an effective antiarrhythmic drug which has been used successfully to treat a variety of cardiac arrhythmias." | 4.76 | Serious adverse effects of amiodarone. ( Garan, H; McGovern, B; Ruskin, JN, 1984) |
| "Amiodarone, an investigational drug in the United States, has had considerable use in this country and worldwide in the treatment of cardiac arrhythmias." | 4.76 | Clinical use and pharmacology of amiodarone. ( Heger, JJ; Miles, WM; Prystowsky, EN; Zipes, DP, 1984) |
| "Amiodarone is commonly used during therapeutic hypothermia (TH) following cardiac arrest due to ventricular arrhythmias." | 4.31 | Epicardial electrical heterogeneity after amiodarone treatment increases vulnerability to ventricular arrhythmias under therapeutic hypothermia. ( Chang, SL; Chang, TY; Chao, TF; Chen, SA; Chen, YJ; Chung, FP; Hsieh, YC; Hu, YF; Liao, JN; Lin, CY; Lin, YJ; Lo, LW; Tuan, TC; Yeh, HI, 2023) |
| "Amiodarone is one of the most commonly used and effective antiarrhythmic drugs to treat ventricular and supraventricular arrhythmias." | 4.31 | Amiodarone-induced blue man syndrome: a case report. ( Javanshir, N; Negaresh, M; Salimi, M; Samadi Takaldani, AH, 2023) |
| "Amiodarone (AM) is an antiarrhythmic drug whose chronic use has proved effective in preventing ventricular arrhythmias in a variety of patient populations, including those with heart failure (HF)." | 4.31 | Amiodarone prevents wave front-tail interactions in patients with heart failure: an in silico study. ( Franz, MR; Gray, RA, 2023) |
| "Amiodarone is a highly effective antiarrhythmic agent for the treatment and prevention of atrial and ventricular arrhythmias." | 4.12 | Liver failure caused by intravenous amiodarone and effective intervention measures: A case report. ( Jiang, Z; Li, X; Yan, R; Yi, W; Zhao, C, 2022) |
| "Background Atrial and ventricular arrhythmias are commonly encountered in patients with advanced heart failure, with amiodarone being the most commonly used antiarrhythmic drug in continuous-flow left ventricular assist device (CF-LVAD) recipients." | 4.12 | Amiodarone Use and All-Cause Mortality in Patients With a Continuous-Flow Left Ventricular Assist Device. ( Ahmed, MM; Al Ahmad, A; Bhan, A; Bhat, G; Cowger, J; Di Biase, L; Gopinathannair, R; K Ravichandran, A; Lakkireddy, D; Natale, A; Pothineni, NVK; Roukoz, H; Slaughter, MS; Trivedi, JR, 2022) |
| "Amiodarone is one of the more frequently used drugs in the treatment of supraventricular and ventricular arrhythmias." | 4.02 | Amiodarone induced pulmonary toxicity. ( Brázdil, V; Doubková, M; Hetmer, M; Hudec, M; Kala, P; Poloczek, M; Vysočanová, P, 2021) |
| "Amiodarone, one of the most widely prescribed antiarrhythmic drugs to treat both ventricular and supraventricular arrhythmias, has been identified as a candidate drug for use against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)." | 3.96 | Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection? ( Laukkanen, JA; Lavie, CJ; Morin, DP; Perez, MV; Perez-Quilis, C; Sanchis-Gomar, F, 2020) |
| "Amiodarone reduces recurrent ventricular tachyarrhythmias (VTA) but may worsen cardiovascular outcomes in heart failure (HF) patients." | 3.91 | Amiodarone is associated with adverse outcomes in patients with sustained ventricular arrhythmias upgraded to cardiac resynchronization therapy-defibrillators. ( Adelstein, EC; Althouse, AD; Bazaz, R; Davis, L; Jain, S; Saba, S; Schwartzman, D; Wang, N, 2019) |
| "Amiodarone, a broad-spectrum antiarrhythmic drug, is widely used for the clinical treatment of tachyarrhythmias because of its safety and efficacy." | 3.91 | Aggravation of atrial arrhythmia by amiodarone during the perinatal period: A case report. ( Chen, H; Jiang, W; Lin, W; Pan, B; Wang, Y; Ye, F, 2019) |
| "Background Amiodarone is an iodine-rich medication used to treat maternal and fetal arrhythmias, with known effects on thyroid hormone homeostasis." | 3.91 | Transient neonatal hypothyroidism following a short course of maternal amiodarone therapy. ( Huang, V; Wolf, RM, 2019) |
| "Amiodarone is used in patients with arrhythmias, but thyroid dysfunction [amiodarone-induced thyrotoxicosis (AIT) or amiodarone-induced hypothyroidism (AIH)] is a common adverse effect." | 3.91 | The Effects of Amiodarone on Thyroid Function in Pediatric and Young Adult Patients. ( Barrett, B; Bauer, AJ; Hawkes, CP; Isaza, A, 2019) |
| "Amiodarone (AMD) is a class III anti-arrhythmic drug that is highly effective for tachyarrhythmia treatment." | 3.88 | Efficacy and Safety of Low-Dose Amiodarone Therapy for Tachyarrhythmia in Congenital Heart Disease. ( Hamamichi, Y; Inage, A; Ishii, T; Iwasawa, S; Saito, M; Uyeda, T; Yazaki, S; Yoshikawa, T, 2018) |
| "Patients with chronic Chagas cardiopathy (CCC), which may be associated with cardiac arrhythmias, frequently use amiodarone, an antiarrhythmic drug that, experimentally, appears to modulate the cardiac autonomic function." | 3.88 | Cardiac autonomic modulation and long-term use of amiodarone in patients with chronic Chagasic cardiopathy. ( Correia, D; de Almeida, RS; Dias da Silva, VJ; Fortes Silva, HE; Llaguno, M; Resende, LAPR; Silveira, DB, 2018) |
| "The aim of this study was to assess ventricular repolarization wave variations during the amiodarone treatment course for patients with ventricular arrhythmias and atrial fibrillation." | 3.88 | Ventricular repolarization wave variations during the amiodarone treatment course. ( Ge, Q; Gu, D; Zhao, H, 2018) |
| "Amiodarone-induced hyperthyroidism is a known side effect of amiodarone treatment." | 3.88 | Diagnosis and Clinical Course of Three Adolescents with Amiodarone-Induced Hyperthyroidism. ( Bertsche, A; Gebauer, R; Gesing, J; Hoppmann, J; Kiess, W; Pfäffle, R, 2018) |
| " Thus, the aim of this work was to determine the Th1/Th17 (IL-6, IL-2, TNF, IL-17 and IFN-γ) and Th2 (IL-4 and IL-10) serum profile in Venezuelan Chagasic patients stratified according amiodarone treatment, hypertension and arrhythmias." | 3.85 | Differential cytokine profiling in Chagasic patients according to their arrhythmogenic-status. ( Fresno, M; Gironès, N; Marques, J; Mendoza, I; Mijares, A; Rodríguez-Angulo, H; Villegas, M, 2017) |
| "Amiodarone is the most effective agent in the therapy of arrhythmias." | 3.85 | Therapeutic monitoring of amiodarone: pharmacokinetics and evaluation of the relationship between effect and dose/concentration. ( Duricova, J; Grundmann, M; Hrudikova Vyskocilova, E; Kacirova, I, 2017) |
| "Amiodarone is used for the maintenance of sinus rhythm in patients with arrhythmias, but thyroid dysfunction (amiodarone-induced thyrotoxicosis (AIT) or amiodarone-induced hypothyroidism (AIH)) is a common adverse effect." | 3.85 | The clinical value of regular thyroid function tests during amiodarone treatment. ( Benjamens, S; Dullaart, RPF; Links, TP; Rienstra, M; Sluiter, WJ; van Gelder, IC, 2017) |
| " These cutaneous lesions had appeared less than 2 months after initiation of amiodarone for supra-ventricular arrhythmia." | 3.85 | [Amiodarone-induced immune complex cutaneous vasculitis]. ( Fardet, L; Lebrun-Vignes, B; Ndiaye, M; Ortonne, N, 2017) |
| " In the ICD group, adequate interventions appear mainly in the initial observation period (HR 2,01), in patients with left ventricular hypertrophy (HR 2,98) and ventricular arrhythmias (HR 6,78) and not treated with amiodarone (HR 4,31)." | 3.85 | [Predictive parameters of occurrence of adequate interventions in patients with implanted cardioverter-defibrillators with or without resynchronisation therapy in primary prevention of sudden cardiac death in dilated cardiomyopathy]. ( Lelakowska, M; Lelakowski, J; Piekarz, J; Pudło, J; Rydlewska, A, 2017) |
| "Reintroduction of amiodarone in patients with a history of amiodarone-induced thyrotoxicosis (AIT) is rarely used." | 3.83 | Amiodarone-Induced Thyrotoxicosis Recurrence After Amiodarone Reintroduction. ( Auclair, C; Batisse-Lignier, M; Citron, B; Desbiez, F; Lusson, JR; Maqdasy, S; Roche, B; Tauveron, I; Thieblot, P, 2016) |
| "There is still lack of strong evidence, based on systematic studies, that support the relationship between amiodarone use and the risk of acute pancreatitis." | 3.81 | Amiodarone use and risk of acute pancreatitis: A population-based case-control study. ( Lai, SW; Liao, KF; Lin, CL; Lin, CY, 2015) |
| "The aim of this investigation was to compare the effectiveness of long-term pretreatment with amiodarone (AMIO) and its active metabolite desethylamiodarone (DEA) on arrhythmias induced by acute myocardial infarction in rats." | 3.81 | Long-term pretreatment with desethylamiodarone (DEA) or amiodarone (AMIO) protects against coronary artery occlusion induced ventricular arrhythmias in conscious rats. ( Baczkó, I; Falkay, G; Leprán, I; Morvay, N; Papp, JG; Sztojkov-Ivanov, A; Varró, A, 2015) |
| "Cardiac disorders caused by sofosbuvir are liable to be worsened by concomitant use of one of the many drugs that provoke cardiac arrhythmia." | 3.81 | Sofosbuvir + amiodarone: bradycardia and conduction disturbances. ( , 2015) |
| "Between January 1, 2000 and March 10, 2012, a total of 930 consecutive patients who had been treated with amiodarone for arrhythmia were reviewed retrospectively." | 3.80 | The incidence and predictors of overall adverse effects caused by low dose amiodarone in real-world clinical practice. ( Chung, WY; Kim, HL; Kim, MA; Kim, SH; Seo, JB; Zo, JH, 2014) |
| " The sheep were prophylactically treated with amiodarone plus lidocaine before ligation of the four to six coronary artery branches supplying the apex of the heart (arrhythmia prevention [AP] group, n = 45) and with epinephrine (shock prevention [SP] group, n = 49), respectively." | 3.79 | Prophylactic amiodarone and lidocaine improve survival in an ovine model of large size myocardial infarction. ( Griffith, BP; Li, T; Sanchez, PG; Watkins, AC; Wei, X; Wu, ZJ, 2013) |
| "Amiodarone is a di-iodated benzofuran derivative that is commonly used to treat patients with various cardiac arrhythmias." | 3.79 | [A case of simultaneously occurred amiodarone-induced hepatitis and hypothyroidism]. ( Chae, HB; Cho, YS; Han, JH; Kang, KM; Kim, JS; Lim, JC; Park, SM, 2013) |
| "Although amiodarone is an effective treatment for severe paediatric arrhythmias, uncertainties about adverse effects such as hypotension, bradycardia and excessive serum drug concentrations persist." | 3.79 | Pharmacokinetics of intravenous amiodarone in children. ( Läer, S; Lagler, FB; Meibohm, B; Paul, T; Ramusovic, S, 2013) |
| "Targeting the delivery of liposomal amiodarone to ischemic/reperfused myocardium reduces the mortality due to lethal arrhythmia and the negative hemodynamic changes caused by amiodarone." | 3.79 | Liposomal amiodarone augments anti-arrhythmic effects and reduces hemodynamic adverse effects in an ischemia/reperfusion rat model. ( Asai, T; Asakura, M; Asano, Y; Asanuma, H; Fu, HY; Kitakaze, M; Komuro, I; Matsuzaki, T; Minamino, T; Oku, N; Okuda, K; Sanada, S; Shigematsu, H; Takahama, H; Yamato, M, 2013) |
| "Amiodarone has a moderate slowing effect on the VT cycle length." | 3.79 | Interactions between implantable cardioverter-defibrillators and class III agents. ( Marchlinski, FE; Movsowitz, C, 1998) |
| " After amiodarone administration, the electrocardiogram showed marked QT prolongation associated with ventricular arrhythmias, including an episode of torsade de pointes requiring immediate electrical cardioversion." | 3.78 | A dangerous fruit juice. ( Agosti, S; Barsotti, A; Bertero, G; Brunelli, C; Casalino, L; Morelloni, S, 2012) |
| ") and amiodarone on the conduction system and on reverse use-dependence in the isolated hearts of normal rats and rats with myocardial infarction (MI)." | 3.78 | The effects of allitridi and amiodarone on the conduction system and reverse use-dependence in the isolated hearts of rats with myocardial infarction. ( Chen, J; Gao, Y; Guo, L; Lu, P; Niu, W; Wang, J; Wang, S; Xing, Y; Zhao, M; Zhu, H, 2012) |
| "To evaluate the efficacy of amiodarone in dogs with refractory supraventricular and ventricular arrhythmias and to document the side effects in treated dogs." | 3.78 | Retrospective evaluation of the use of amiodarone in dogs with arrhythmias (from 2003 to 2010). ( Dukes-McEwan, J; Fonfara, S; López-Alvarez, J; Pedro, B; Stephenson, H, 2012) |
| "Amiodarone is a widely used antiarrythmic drug for various atrial and ventricular arrhythmias." | 3.78 | Amiodarone-induced T-U fusion. ( Omar, HR, 2012) |
| "We prospectively collected cases of amiodarone-associated thyrotoxicosis requiring thyroidectomy due to failure of antithyroid treatment, despite amiodarone discontinuation." | 3.78 | Total thyroidectomy for amiodarone-associated thyrotoxicosis: should surgery always be delayed for pre-operative medical preparation? ( Duverger, V; Merat, S; Perrier, E; Pierret, C; Pons, Y; Tourtier, JP, 2012) |
| "To characterize the frequency and type of cardiac events, including torsade de pointes, associated with dronedarone and its structural analog, amiodarone, outside of the clinical trial setting." | 3.78 | Proarrhythmic potential of dronedarone: emerging evidence from spontaneous adverse event reporting. ( Hiatt, WR; Kao, DP; Krantz, MJ, 2012) |
| "Amiodarone and cisapride are both known to prolong the QT interval, yet the two drugs have different effects on arrhythmia." | 3.78 | Impact of amiodarone and cisapride on simulated human ventricular electrophysiology and electrocardiograms. ( Dössel, O; Rombach, C; Scholz, EP; Seemann, G; Wilhelms, M, 2012) |
| "Amiodarone protects patients with left ventricular systolic dysfunction (LVSD) against serious arrhythmias, but it also has numerous side effects on non-cardiac organs, such as the thyroid." | 3.77 | Thyroid hormone, amiodarone therapy, and prognosis in left ventricular systolic dysfunction. ( Carpeggiani, C; Coceani, M; Iervasi, G; L'abbate, A; Landi, P; Molinaro, S; Pingitore, A; Scalese, M, 2011) |
| "We included 303 consecutive patients with amiodarone therapy for cardiac arrhythmias (260 with atrial fibrillation and 43 with ventricular arrhythmias)." | 3.77 | Determinants and outcome of amiodarone-associated thyroid dysfunction. ( Ahmed, S; Links, TP; Van Gelder, IC; Van Veldhuisen, DJ; Wiesfeld, AC, 2011) |
| "This study is to investigate the effects of phenytoin sodium, lidocaine (sodium channel blockers), propranolol (beta-adrenergic receptor antagonist), amiodarone (drugs prolonging the action potential duration) and verapamil (calcium channel blockers) on arrhythmia of mice induced by Bufonis Venenum (Chansu) and isolated mouse hearts lethal dose of Chansu." | 3.77 | [Effect of anti-arrhythmia drugs on mouse arrhythmia induced by Bufonis Venenum]. ( Ding, AW; Duan, JA; Lü, GH; Lu, WJ; Ma, HY; You, FQ; Zhou, J, 2011) |
| " In the first case, the drugs venlafaxine, amiodarone and domperidone may have contributed to QT interval prolongation in a patient with hypokalemia and hypomagnesaemia." | 3.76 | Multifactorial QT interval prolongation. ( Baranchuk, A; Digby, G; Machaalany, J; Malik, P; Methot, M; Redfearn, D; Simpson, CS, 2010) |
| "Amiodarone-induced thyrotoxicosis (AIT) should be included in differential diagnoses of thyrotoxicosis in presence of a suggestive drug history." | 3.76 | [A rare cause of thyreotoxicosis]. ( Fend, F; Kurth, R; Müssig, K; Sauer-Schulz, A; Schnauder, G; Teichmann, R, 2010) |
| "The aim of this study is to observe the effect of combined amiodarone and antiarrhythmic peptide (AAP10) use on the incidence of induced ventricular arrhythmias in healed myocardial infarction (MI) rabbits." | 3.76 | [Effects of combined amiodarone and antiarrhythmic peptide use on the cardiac gap junctions and incidence of induced ventricular arrhythmias in healed myocardial infarction rabbit models]. ( Fang, Y; Li, LD; Ni, MK; Ruan, L; Wang, GQ; Wang, XF; Zhang, CT, 2010) |
| "The aim of this study was to investigate the use of prophylactic magnesium sulphate and amiodarone in treating arrhythmias that may occur following coronary bypass grafting operations." | 3.75 | Magnesium sulphate and amiodarone prophylaxis for prevention of postoperative arrhythmia in coronary by-pass operations. ( Ari, H; Demirtas, S; Huysal, K; Ozyazicioglu, A; Selimoglu, O; Tiryakioglu, O; Tiryakioglu, SK, 2009) |
| "Amiodarone (Cordarone, Wyeth-Ayerst Pharmaceuticals) is a clinically available drug used to treat a wide variety of cardiac arrhythmias." | 3.74 | Trace amine-associated receptor 1 (TAAR1) is activated by amiodarone metabolites. ( Miyakawa, M; Scanlan, TS; Snead, AN; Tan, ES, 2008) |
| "2%) corresponding to patients in AVID where the risk was moderate and ICD/PM and amiodarone had equal efficacy, demonstrated a two-fold higher risk of sudden arrhythmic than non-arrhythmic death and hence would be expected to benefit from antiarrhythmia therapy." | 3.74 | Clinical criteria for predicting benefit of ICD/PM in post myocardial infarction patients: an AVID and CAST analysis. ( Hallstrom, AP; McAnulty, J; Wyse, DG, 2008) |
| "Special attention should be paid to patients on treatment with amiodarone and/or a diagnosis of atrial fibrillation as they may have an increased risk of fracture." | 3.74 | Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case-control study. ( Mosekilde, L; Rejnmark, L; Vestergaard, P, 2007) |
| "Amiodarone-induced thyrotoxicosis is a life-threatening condition." | 3.74 | Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study. ( Ambrosini, CE; Berti, P; Bogazzi, F; Martino, E; Materazzi, G; Miccoli, P, 2007) |
| "To assess if prophylaxis with moderate doses of amiodarone in the postoperative period of cardiac surgery (coronary artery bypass grafting and/or valve surgery), reduces the incidence of atrial fibrillation in patients with high risk for developing this arrhythmia." | 3.74 | Prevention of atrial fibrillation with moderate doses of amiodarone in the postoperative period of cardiac surgery is safe and effective in patients with high risk for developing this arrhythmia. ( Alves, RJ; Brito, Gd; Geovanini, GR; Glauser, VA; Miguel, GA; Nakiri, K, 2007) |
| " Two were cases of type I amiodarone-induced thyrotoxicosis (AIT) treated with methimazole." | 3.74 | Differential diagnosis and appropriate treatment of four thyrotoxic patients with Graves' disease required to take amiodarone due to life-threatening arrhythmia. ( Kasanuki, H; Kodama, H; Obara, T; Omi, Y; Sato, K; Seki, T; Shiga, T; Takano, K; Yamada, E; Yamazaki, K, 2008) |
| "Amiodarone, which is generally classified as class III antiarrhythmic drug in the Vaughan Williams classification, is widely used for the treatments of refractory arrhythmias." | 3.73 | Antiarrhythmic properties of a prior oral loading of amiodarone in in vivo canine coronary ligation/reperfusion-induced arrhythmia model: comparison with other class III antiarrhythmic drugs. ( Chen, J; Hashimoto, K; Nagasawa, Y, 2005) |
| "The European Myocardial Infarct Amiodarone Trial (EMIAT) investigated the effects of amiodarone versus placebo in patients after myocardial infarction who had left ventricular ejection fraction | 3.73 | Usefulness of ventricular repolarization dynamicity in predicting arrhythmic deaths in patients with ischemic cardiomyopathy (from the European Myocardial Infarct Amiodarone Trial). ( Badilini, F; Benchetrit, C; Coumel, P; Leenhardt, A; Maisonblanche, P; Milliez, P; Siliste, C; Vicaut, E, 2005) |
| "Amiodarone, an iodine -- rich benzofurane derivate, is a highly effective agent for the prophylaxis and treatment of various cardiac arrhythmias, but it is associated with numerous side effects." | 3.73 | [Dermatological adverse reactions of amiodarone]. ( Reĭngardene, DI; Zhilene, VI, 2005) |
| "Amiodarone-induced thyrotoxicosis (AIT) is a challenging management problem, since patients treated with amiodarone invariably have underlying heart disease." | 3.73 | Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality. ( Diamond, T; Lewis, M; O'Sullivan, AJ, 2006) |
| "A retrospective audit was carried out on all patients aged 15 years or older, with a primary discharge diagnosis of tachyarrhythmia and who were commenced and discharged alive on amiodarone between 1 January 2000 and 30 June 2002 from Wellington and Kenepuru Hospitals, Capital and Coast District Health Board, Wellington, New Zealand." | 3.73 | Monitoring the use of amiodarone: compliance with guidelines. ( Blaikie, A; Burgess, C; Ingham, T; Narasimhan, S; Robinson, G, 2006) |
| "The present study implies that initiation of amiodarone therapy in pts with structural heart disease and AF that are concomitantly treated with beta-blockers and digitalis may have an increased risk of amiodarone-associated pro-arrhythmia." | 3.73 | Pro-arrhythmic effects of amiodarone and concomitant rate-control medication. ( Bielik, H; Bitzen, A; Lewalter, T; Lüderitz, B; Schrickel, JW; Schwab, JO; Yang, A, 2006) |
| " Most respondents lived in iodine-sufficient areas and observed that amiodarone-induced hypothyroidism (AIH) is more common than AIT." | 3.73 | Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey. ( Albino, CC; Bartalena, L; Diehl, LA; Graf, H; Martino, E; Romaldini, JH; Wiersinga, WM, 2006) |
| "Antiarrhythmic activity of a membrane-protecting agent Sal'magin was studied in rats with aconitine-induced cardiac arrhythmias." | 3.73 | Antiarrhythmic activity of a membrane-protecting agent Sal'magin in rats with aconitine-induced arrhythmias. ( Klekot, AA, 2006) |
| " Therapy with beta-adrenoblockers, amiodarone and sotalol in patients with ventricular arrhythmias was associated with improvement of parameters of SA ECG, lowering of sympathetic and augmentation of parasympathetic activity without sings of arrhrythmogenic and negative inotropic effects." | 3.72 | [Anti-arrhythmic therapy: diagnostic possibilities of signal-averaged electrocardiography and heart rate variability]. ( Morozova, OI; Pozdniakova, NV; Shevyrev, VA; Tatarchenko, IP, 2003) |
| "To analyze action of digoxin and some non-digitalis drugs (beta-blockers, verapamil, amiodarone, d,l-sotalol) and their combinations on electrical activity of atria, frequency and structure of ventricular rhythm in patients with permanent atrial fibrillation." | 3.72 | [Correction of rate and structure of ventricular rhythm in permanent atrial fibrillation: a novel pathogenetic approach]. ( Blagova, OV; Bogdanova, EA; Nedostup, AV; Platonova, AA, 2004) |
| "Amiodarone use for the prevention of recurrent atrial fibrillation or atrial flutter requires drug loading over a period of several days to weeks, whereas class 1C agents do not." | 3.72 | Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flutter. ( Hauser, TH; Josephson, ME; Pinto, DS; Zimetbaum, P, 2004) |
| "Baroreflex sensitivity was assessed in 287 patients with history of myocardial infarction and left ventricular ejection fraction < or =40% by phenylephrine test and was found to be depressed (4." | 3.72 | [Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction]. ( Bozhko, AA; Kanopskiĭ, SG; Staritskiĭ, AG, 2004) |
| "Amiodarone-associated thyrotoxicosis (AAT) is often poorly tolerated owing to underlying cardiac disease, and it is frequently refractory to conventional medical treatment." | 3.72 | Surgical management of amiodarone-associated thyrotoxicosis: Mayo Clinic experience. ( Brennan, MD; Farley, DR; Grant, CS; Houghton, SG; Thompson, GB; van Heerden, JA, 2004) |
| "Matrine and berbamine significantly increased the dose of aconitine for induction of ventricular premature and ventricular tachycardia in rats, decreased the number of arrhythmias induced by coronary artery ligation in rats and increased ventricular fibrillation threshold (VFT) induced by electric stimulation in rabbits, but the anti-arrhythmic potency of matrine and berbamine was lower than that of amiodarone and RP58866." | 3.72 | [Comparison of the anti-arrhythmic effects of matrine and berbamine with amiodarone and RP58866]. ( Chen, QW; Dong, DL; Du, ZM; Gong, DM; Xu, CQ; Yang, BF, 2004) |
| "Amiodarone-induced thyrotoxicosis developed in 31 patients (49." | 3.72 | Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency. ( Barbu, C; Bunghez, R; Coculescu, M; Fica, S; Trifănescu, R; Ursu, H; Vârtej, I, 2004) |
| " The incidence of clinical torsade de pointes (TdP) associated with amiodarone has been reported to be low and the present study compared the proarrhythmic potential of amiodarone with that of a selective IKr channel blocker, sematilide, using a canine chronic atrioventrucular block model." | 3.71 | Comparison of the in vivo electrophysiological and proarrhythmic effects of amiodarone with those of a selective class III drug, sematilide, using a canine chronic atrioventricular block model. ( Hashimoto, K; Ishida, Y; Kugiyama, K; Satoh, Y; Sugiyama, A; Yoneyama, M; Yoshida, H, 2002) |
| "The effects of short-term amiodarone and dronedarone treatments on action potential characteristics and arrhythmia (ventricular tachycardia ) induced by reperfusion after global low-flow ischemia were studied in rat hearts." | 3.71 | Beneficial effects of amiodarone and dronedarone (SR 33589b), when applied during low-flow ischemia, on arrhythmia and functional parameters asssessed during reperfusion in isolated rat hearts. ( Barbé, C; Kreher, P; Rochetaing, A, 2001) |
| "To determine the efficacy necessary to make prophylactic ICD or amiodarone therapy cost-effective in patients with myocardial infarction." | 3.71 | Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction. ( Every, NR; Heidenreich, PA; Hlatky, MA; McDonald, KM; Owens, DK; Parsons, LS; Sanders, GD, 2001) |
| "In 232 Japanese patients receiving long-term amiodarone therapy for life-threatening ventricular tachyarrhythmias, hyperthyroidism and hypothyroidism developed in 29 patients (12." | 3.71 | Amiodarone-Induced thyroid dysfunction and ventricular tachyarrhythmias during long-term therapy in Japan. ( Hagiwara, N; Kasanuki, H; Matsuda, N; Sato, K; Shiga, T; Shoda, M; Wakaumi, M, 2001) |
| "Amiodarone is an effective antiarrhythmic drug rarely associated with torsade de pointes arrhythmias (TdP)." | 3.71 | Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome. ( de Groot, SH; Leunissen, JD; Molenschot, MM; Schoenmakers, M; van Der Hulst, FF; van Opstal, JM; Verduyn, SC; Vos, MA; Wellens, HJ, 2001) |
| "Amiodarone is an antiarrhythmic agent commonly used to treat cardiac arrhythmias." | 3.71 | Intravenous amiodarone modifies autonomic balance and increases baroreflex sensitivity in conscious rats. ( de Melo Alves, R; Dias da Silva Valdo, J; Fazan, R; Malliani, A; Montano, N; Porta, A; Ruscone, TG; Salgado, HC; Viana Públio, CC, 2002) |
| "Amiodarone-induced thyrotoxicosis (AIT) is a difficult management problem about which there are little published data." | 3.71 | Successful treatment of amiodarone-induced thyrotoxicosis. ( Franklyn, JA; Gammage, MD; Osman, F; Sheppard, MC, 2002) |
| "Amiodarone-induced thyrotoxicosis (AIT) may develop either in apparently normal thyroid glands (Type II AIT) or in the presence of sub-clinical thyroid abnormalities (either autonomous goiter or latent Graves' disease; Type I AIT)." | 3.71 | Iopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyroidectomy. ( Aghini-Lombardi, F; Bartalena, L; Basolo, F; Bogazzi, F; Braverman, LE; Cosci, C; Lupi, I; Martino, E; Miccoli, P; Pinchera, A; Santini, F; Tanda, ML, 2002) |
| "Baseline characteristics of the 1486 patients enrolled in EMIAT were used to investigate the all-cause mortality effect of amiodarone (intention-to-treat) in patients with a left ventricular ejection fraction 30-40% and < 30%, in patients with and without arrhythmia signs on Holter recordings, in patients with high and low baseline resting heart rate, in patients on and off beta-blocker treatment, and in a combination of these groups." | 3.70 | Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial). ( Camm, AJ; Frangin, GA; Janse, MJ; Julian, DG; Malik, M; Schwartz, PJ, 1998) |
| "We designed a postinfarction scenario wherein heart rate variability analysis on 24-h Holter monitoring was used as a screening test for 2-year amiodarone therapy in a cohort of survivors (mean age 57 years) of a recent myocardial infarction." | 3.70 | Cost-effectiveness analysis of invasive and noninvasive tests in high risk patients treated with amiodarone after acute myocardial infarction. ( Daniele, G; Mapelli, V; Migliori, GB; Pedretti, RF; Podrid, PJ; Tramarin, R, 1998) |
| "The purpose of this study was to evaluate the effect of partial arrhythmia suppression by amiodarone on indexes of heart rate variability in patients with heart failure." | 3.70 | Effect of partial arrhythmia suppression with amiodarone on heart rate variability of patients with congestive heart failure. ( Ferlin, E; Moraes, RS; Polanczyk, CA; Ribeiro, JP; Rohde, LE, 1998) |
| "A 33-year-old woman with congenital heart disease and atrial and ventricular arrhythmias, managed over the long term with an implantable cardioverter defibrillator, epicardial pacing system, and amiodarone, experienced an increase in palpitations and a shock from her defibrillator." | 3.70 | Impact of rifampin on serum amiodarone concentrations in a patient with congenital heart disease. ( Costanzo, MR; Fischer, SA; Porter, MT; Santucci, PA; Trohman, RG; Zarembski, DG, 1999) |
| "We studied the effects of dronedarone (SR 33589) on the action potentials, membrane ionic currents, and arrhythmic activity in control rats and in rats after myocardial infarction, a model known to develop anomalous electrical activity." | 3.70 | Cellular and in vivo electrophysiological effects of dronedarone in normal and postmyocardial infarcted rats. ( Aimond, F; Beck, L; Chérif, OK; Davy, JM; Gautier, P; Lorente, P; Nisato, D; Vassort, G, 2000) |
| "Effects of amiodarone, an antiarrhythmic drug that is effective in suppressing severe ventricular arrhythmias that are refractory to other antiarrhythmic drugs, were evaluated in 2 dogs with cardiac disease." | 3.70 | Positive Coombs' test results in two dogs treated with amiodarone. ( Calvert, CA; Pickus, C; Sammarco, C, 2000) |
| "Amiodarone has become an important drug for the treatment of supraventricular and ventricular arrhythmias, in short-term inpatient and outpatient settings." | 3.70 | Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology. ( Epstein, AE; Goldschlager, N; Naccarelli, G; Olshansky, B; Singh, B, 2000) |
| "The objective of the submitted work was to assess, using programmed stimulation of the cardiac ventricles during antiarrhythmic treatment (amiodarone and propafenon administered orally), the presence of indicators suggesting imminent ventricular ectopic proarrhythmia." | 3.69 | [Importance of programmed ventricular stimulation in the evaluation of proarrhythmic effects of orally administered anti-arrhythmia agents]. ( Parízek, P; Pidrman, V; Pleskot, M; Tilser, P, 1995) |
| "The treatment of life-threatening arrhythmias with amiodarone or an implantable cardioverter/defibrillator prolongs patient survival but with significant comorbidity." | 3.69 | The quality of life of patients with life-threatening arrhythmias. ( Arteaga, WJ; Windle, JR, 1995) |
| "Gestational exposure to amiodarone may be complicated by perinatal hypothyroidism or hyperthyroidism and possibly neurologic abnormalities, intrauterine growth retardation or fetal bradycardia." | 3.69 | Pregnancy outcome after gestational exposure to amiodarone in Canada. ( Allen, LC; Boulton, BC; Downar, E; Koren, G; Magee, LA; Sermer, M, 1995) |
| " 1 and 2, atrial fibrillation was treated with either quinidine or quinidine and sotalol in combination." | 3.69 | Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports. ( Faber, TS; Hohnloser, S; Just, H; Van de Loo, A; Zehender, M, 1994) |
| "The effect of long-term treatment with propafenone, metoprolol and amiodarone was studied on the activity of Na,K-adenosine triphosphatase in lymphocytes and the plasma level of cAMP in patients with ventricular arrhythmias." | 3.69 | [The effect of treatment with propafenone, metoprolol and amiodarone on lymphocyte sodium efflux and level of cAMP in serum]. ( Kosmala, W, 1995) |
| "We compared the ability of a new amiodarone-like agent, SR 33589, with that of amiodarone, D,L-sotalol, and lignocaine to reduce the incidence of ventricular fibrillation (VF) and associated arrhythmias caused by acute coronary artery occlusion in anesthetized pigs." | 3.69 | Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. ( Chatelain, P; Finance, O; Manning, A, 1995) |
| "We have assessed the ability of the new amiodarone-like antiarrhythmic agent, SR 33589, to reduce the incidence of ischemia- and reperfusion-induced arrhythmias, in comparison to amiodarone, D-sotalol, and lignocaine." | 3.69 | SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats. ( Bruyninckx, C; Chatelain, P; Manning, AS; Ramboux, J, 1995) |
| "Amiodarone is an antiarrhythmic agent used for the treatment of supraventricular and ventricular arrhythmias." | 3.69 | Measurement of serum amiodarone and desethylamiodarone by HPLC: its usefulness in the follow-up of arrhythmic patients treated with amiodarone. ( Berti, S; Biagini, A; Cazzuola, F; Clerico, A; Iervasi, G; Manfredi, C; Sabatino, L; Turchi, S, 1995) |
| ") administered amiodarone using four canine ventricular arrhythmia models." | 3.69 | Acute antiarrhythmic effects of intravenously administered amiodarone on canine ventricular arrhythmia. ( Awaji, T; Hashimoto, K; Wu, ZJ, 1995) |
| "Amiodarone-induced chemical, sterile epididymitis has previously been reported." | 3.69 | Amiodarone-induced epididymitis. Report of 2 cases. ( Hamoud, K; Kaneti, J; Lissmer, L; Smailowitz, Z, 1996) |
| "Because little has been published on early effects of treatment with amiodarone on thyroid function, we studied serum total and free thyroid hormone, reverse T3, and TSH levels in patients with cardiac arrhythmias during the first 10 days of treatment with a loading dose of amiodarone by iv infusion." | 3.69 | Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia. ( Berti, S; Biagini, A; Bonini, R; Carpi, A; Chopra, IJ; Clerico, A; Iervasi, G; Manfredi, C; Palmieri, C; Ravani, M, 1997) |
| " in both euthyroid and hyperthyroid patients treated with amiodarone." | 3.69 | 201Tl scintigraphy does not allow visualization of the thyroid in euthyroid and hyperthyroid patients treated with amiodarone. ( Dierckx, RA; Kaufman, JM; Monsieurs, M; Osmanagaoglu, K; van de Wiele, C; van Laere, K, 1997) |
| "Amiodarone is a choice drug for the treatment of patients suffering from life-threatening hyperkinetic ventricular arrhythmias and depressed ventricular function." | 3.69 | [Clinical tolerance of oral loading with elevated doses of amiodarone in a group of patients with heart failure]. ( Caramanno, G; Di Giovanna, F; Innocente, P, 1997) |
| "Amiodarone appears to produce benefits in patients with cardiac failure with atrial and ventricular arrhythmias." | 3.68 | [Amiodarone in cardiac failure]. ( Barbosa Filho, J; Barbosa, PR; Soares, JP, 1993) |
| " "Conventional" antiarrhythmic agents, which primarily block cardiac sodium channels, are relatively ineffective in preventing arrhythmia recurrence; amiodarone and sotalol appear to be effective in reducing recurrence and mortality rates, although the extent of benefit is not well understood." | 3.68 | The implantable defibrillator and antiarrhythmic drugs--competitive and complementary treatment for severe ventricular arrhythmia. ( Dorian, P; Newman, D, 1993) |
| "Long-term therapy with amiodarone has been associated with a high incidence of adverse side effects, that precludes its indication for common cardiac arrhythmias." | 3.68 | [Efficacy and secondary effects of chronic treatment with amiodarone]. ( Fajuri, A; García, E; González, R; Jalil, J; Molgo, M; Rodríguez, JA; Soza, M; Valenzuela, P, 1993) |
| "Two patients with coronary heart disease and previous myocardial infarction, treated with amiodarone for severe ventricular arrhythmias, developed pulmonary toxicity." | 3.68 | [Pulmonary toxicity due to amiodarone]. ( Ferrari, G; Galli, M; Politi, A, 1993) |
| "Because the relative efficacy of antiarrhythmic agents on halothane-epinephrine arrhythmias has not been well characterized, this study was undertaken to comparatively evaluate the antiarrhythmic action of Na(+)-, K(+)- and Ca(2+)-channel blockers on epinephrine-induced ventricular arrhythmias during halothane anesthesia in rats." | 3.68 | Comparative efficacy of antiarrhythmic agents in preventing halothane-epinephrine arrhythmias in rats. ( Hayashi, Y; Kamibayashi, T; Kawabata, K; Sumikawa, K; Takada, K; Yamatodani, A; Yoshiya, I, 1993) |
| "Amiodarone treatment in pregnancy might be difficult to handle because of the long half-life of the drug (14-28 days up to 2 months) and because it reduces maternal and neonatal thyroid activity." | 3.68 | Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome. ( Civitella, C; Garzetti, GG; Romanini, C; Valensise, H, 1992) |
| "Amiodarone is a drug used to treat refractory tachyarrhythmias." | 3.68 | [Pneumopathy induced by amiodarone. Radiological data]. ( Balmaseda, C; Bordas, Y; Led, A; Mazas-Artasona, L, 1992) |
| "kg-1 iv increased the dose of ouabain required to induce ventricular arrhythmias in guinea pigs." | 3.68 | Protective effect of cycloprotobuxine-A against cardiac arrhythmias induced by ouabain. ( Sheng, BH; Tan, YH; Wang, YX, 1992) |
| "Flecainide (100 mg twice daily) was used for prevention of paroxysmal atrial fibrillation (PAF) in 52 patients with frequent symptomatic attacks that were resistant or intolerant to quinidine (600-900 mg/day)." | 3.68 | Flecainide in quinidine-resistant atrial fibrillation. ( Chouty, F; Coumel, P; Denjoy, I; Leclercq, JF; Slama, R, 1992) |
| "Five cases are studied in which amiodarone (AM) was given during pregnancy, in two of them also during the breast feeding period, to estimate the risks for adverse effects." | 3.68 | Use of amiodarone during pregnancy. ( de Vijlder, JJ; Plomp, TA; Vulsma, T, 1992) |
| "The safety and efficacy of short intravenous therapy with amiodarone were evaluated in 44 patients (24 males, 20 females), aged 21-84 years, with supraventricular tachyarrhythmias newly arisen in less than 24 hours." | 3.68 | Efficacy and safety of short intravenous amiodarone in supraventricular tachyarrhythmias. ( Burzio, P; Latini, R; Marchisio, U; Veglio, F; Vietti-Ramus, G, 1992) |
| "Oral amiodarone given in loading doses produces rapid and dramatic reductions in spontaneous ventricular arrhythmias within 72 hours." | 3.68 | Rapid suppression of spontaneous ventricular arrhythmias during oral amiodarone loading. ( Chou, R; Desai, B; Ferrick, KJ; Fisher, JD; Kim, SG; Mannino, MM; Roth, JA; Roth, S, 1992) |
| "A 67 years-old man under amiodarone treatment for thirteen months due to a cardiac arrhythmia developed a mixed sensory-motor neuropathy." | 3.68 | [Peripheral neuropathy possibly caused by amiodarone therapy]. ( de Carvalho, FB; Oliveira Júnior, W; Oliveira, LF, 1991) |
| "105 sequential patients with ventricular arrhythmias in a basal ECG-H recording, that were evaluated within 1 year with a new recording on amiodarone or propafenone, without major clinical events or therapeutic changes between the two recordings." | 3.68 | [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia]. ( Adragão, P; Bonhorst, D; Seabra-Gomes, R; Ventosa, A, 1990) |
| "The antiarrhythmic effect of an 8-week oral amiodarone regimen was studied in dogs with 1-week-old myocardial infarction and reproducibly inducible sustained ventricular tachycardia (VT) or ventricular fibrillation (VF)." | 3.68 | Antiarrhythmic effect of chronic oral amiodarone treatment in dogs with myocardial infarction and reproducibly inducible sustained ventricular arrhythmias. ( Abdollah, H; Brennan, FJ; Brien, JF, 1990) |
| " As the arrhythmia did not respond to any kind of therapy, amiodarone treatment was started, which the patient received in a maintenance dose of 600-400 mg/day for 4 years." | 3.68 | [Amidaron-induced dermatopathy resulting from unnecessary Cordarone therapy of ventricular parasystole]. ( Fazekas, T; Korom, I; Mágori, A; Pogátsa, G; Ungi, I, 1991) |
| "The relationship between the antiarrhythmic effect of amiodarone and its myocardial concentration was studied in dogs with 1-week-old myocardial infarction and reproducibly inducible sustained ventricular tachycardia or ventricular fibrillation." | 3.68 | Relationship between myocardial amiodarone concentration and antiarrhythmic effect in dogs with myocardial infarction and electrically induced ventricular arrhythmias. ( Abdollah, H; Brennan, FJ; Brien, JF; Jimmo, S, 1991) |
| " Recently, amiodarone has been shown to be rapidly effective in suppressing sustained, incessant ventricular tachycardia and ventricular fibrillation in this setting." | 3.68 | Amiodarone versus bretylium for suppression of reperfusion arrhythmias in dogs. ( Horrigan, TP; Mostow, ND; Noon, DL; Rosalion, A; Snow, NJ, 1991) |
| " Coadministration of amiodarone, and, moreover, the presence of heart failure increase the C/D ratio, from 2." | 3.68 | Flecainide acetate dose-concentration relationship in cardiac arrhythmias: influence of heart failure and amiodarone. ( Coumel, P; Denjoy, I; Leclercq, JF; Mentré, F, 1990) |
| "To evaluate the efficacy of amiodarone in tachyarrhythmias occurring acutely, in patients with different nosological entities of the heart." | 3.68 | [The effectiveness of amiodarone seems to depend highly on the pathology underlying the arrhythmia]. ( de Castro, JJ; Mota, E; Quadrado, C; Soares, Ade O, 1990) |
| "To shorten the delay in the onset of antiarrhythmic effect when using amiodarone for the conversion of refractory atrial tachyarrhythmias to sinus rhythm, 19 patients were given oral amiodarone according to a high-dose loading protocol." | 3.68 | Rapid control of refractory atrial tachyarrhythmias with high-dose oral amiodarone. ( Mostow, ND; Noon, D; Rakita, L; Vrobel, TR, 1990) |
| " Amiodarone and desethylamiodarone concentration in serum (control group n = 33) and in erythrocyte haemolysate (control group n = 13) were determined in relapses of ventricular tachycardias (n = 7) and in pulmonary fibrosis as serious side effect (n = 3)." | 3.67 | [Control of anti-arrhythmia therapy with amiodarone. Value of the determination of blood levels]. ( Lüderitz, B; Nitsch, J, 1984) |
| "Amiodarone is a potent antiarrhythmic agent that is effective in controlling both atrial and ventricular arrhythmias." | 3.67 | Hemodynamic effects of intravenous amiodarone. ( Albin, JB; Kosinski, EJ; LeLand, OS; Lewis, SM; Young, E, 1984) |
| "The relationship of apparent steady-state serum concentrations of amiodarone and its metabolite, desethylamiodarone, to therapeutic and toxic effects was assessed in 127 patients who had treatment-resistant ventricular or supraventricular arrhythmias or were intolerant to other agents." | 3.67 | Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity. ( Belhassen, B; Greenspan, AM; Greenspon, AJ; Horowitz, LN; Rotmensch, HH; Shoshani, D; Spielman, SR; Swanson, BN; Vlasses, PH, 1984) |
| "6 mg/min for 4-40 hrs), Propafenone (1-2 mg/Kg in 5 min + continuous infusion of 10-15 mcg/Kg/min for 24 hrs) and Mexiletine (250 mg in 15 min + 250 mg in 1 hr) have been evaluated in patients with acute myocardial infarction complicated by sinus tachycardia and hyperdynamic pattern, ventricular or supraventricular arrhythmias." | 3.67 | Hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction. ( Ambrosini, F; Finzi, A; Lo Masto, M; Lotto, A; Massari, FM; Pagnoni, F; Valentini, R, 1984) |
| "Fifty-three patients with hypertrophic cardiomyopathy who had serious arrhythmias (45 patients), refractory chest pain (5 patients) or a high risk of sudden death (3 patients) received amiodarone for 6 to 96 months (median 18) after completion of a loading and an initial maintenance period." | 3.67 | Amiodarone for long-term management of patients with hypertrophic cardiomyopathy. ( Goodwin, JF; Harris, L; Kleinebenne, A; Krikler, DM; McKenna, WJ; Oakley, CM; Rowland, E, 1984) |
| "Thirty-three consecutively referred patients with cardiac arrest from ventricular arrhythmias unassociated with a new acute myocardial infarction (AMI) were commenced on amiodarone therapy and followed for a minimum of 12 months." | 3.67 | Prognosis after sudden cardiac death without associated myocardial infarction: one year follow-up of empiric therapy with amiodarone. ( Hamer, A; Mandel, WJ; Peter, T; Weiss, D, 1984) |
| "Amiodarone was administered orally to 30 patients with chronic stable coronary artery disease and severe ventricular arrhythmias." | 3.67 | Efficacy of amiodarone during long-term treatment of potentially dangerous ventricular arrhythmias in patients with chronic stable ischemic heart disease. ( Elizari, MV; Girotti, LA; Goldbarg, A; Kaski, JC; Lázzari, JO; Rosenbaum, MB; Tambussi, A, 1984) |
| "Oral amiodarone was administered to 24 patients with chronic chagasic myocarditis (CCM) and malignant ventricular arrhythmias." | 3.67 | Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis. ( Chiale, PA; Elizari, MV; Halpern, MS; Lázzari, JO; Nau, GJ; Przybylski, J; Rosenbaum, MB; Tambussi, AM, 1984) |
| "Clinical and chemical variables of thyroid function were studied in 26 patients with symptomatic ventricular tachyarrhythmias before and during long-term oral treatment with amiodarone." | 3.67 | Clinical and chemical assessment of thyroid function during therapy with amiodarone. ( Alpert, B; Amico, JA; Klein, I; Richardson, V, 1984) |
| "Twenty-two patients were given amiodarone for refractory cardiac arrhythmias, and pre- and post-amiodarone serum digoxin levels were studied." | 3.67 | Amiodarone-digoxin interaction. Clinical and experimental observations. ( Heydorn, WH; Oetgen, WJ; Rakita, L; Sobol, SM; Tri, TB, 1984) |
| "Two patients, one with and one without preexisting conduction system abnormalities, were treated with amiodarone for refractory ventricular arrhythmias." | 3.67 | Amiodarone-induced intra-His block. ( Batsford, WP; Kennedy, EE, 1984) |
| "Forty patients with atrial fibrillation (AF), 23 patients with ventricular extrasystoles (VES), and 11 patients with various arrhythmias (VA) were treated with amiodarone (0." | 3.67 | Amiodarone--application and clinical pharmacology in atrial fibrillation and other arrhythmias. ( Anastasiou-Nana, M; Levis, GM; Moulopoulos, SD, 1984) |
| " Individual differences between the longest and the shortest RV MAP durations indicate that: normally (40 subjects) ventricular repolarization is almost synchronous; QT prolongation due either to bradycardia or to amiodarone treatment (eight cases) may be the result of a uniform lengthening of ventricular repolarization, when ventricular arrhythmias are not present; in long QT syndromes (LQTSs) of differing etiology (10 cases), in which severe ventricular arrhythmias are present, marked individual differences in RV MAP duration are present and correspond with pathological asynchrony of ventricular repolarization." | 3.67 | Monophasic action potential studies in human subjects with prolonged ventricular repolarization and long QT syndromes. ( Bonatti, V; Botti, G; Rolli, A, 1985) |
| " To determine their relative antiarrhythmic efficacy, amiodarone and its desethyl metabolite, desethylamiodarone, were administered to mongrel dogs with ventricular tachycardia 24 hr after ligation of the left anterior descending coronary artery." | 3.67 | The antiarrhythmic efficacy of amiodarone and desethylamiodarone, alone and in combination, in dogs with acute myocardial infarction. ( Davies, M; Nattel, S; Quantz, M, 1988) |
| "The case of a 77-year-old patient who suffered from clinically severe and persistent hyperthyroidism induced by amiodarone is described." | 3.67 | [Therapy resistance of amiodarone-induced hyperthyroidism]. ( Althaus, B; Bucher, H; Schön, H; Vogt, T, 1988) |
| "To exploit the antiarrhythmic effect of amiodarone when patients develop the side effect of thyrotoxicosis three patients with hyperthyroidism induced by amiodarone were given simultaneously 1 g potassium perchlorate a day for 40 days and a starting dose of 40 mg methimazole a day while they continued to take amiodarone." | 3.67 | Treatment of amiodarone induced hyperthyroidism with potassium perchlorate and methimazole during amiodarone treatment. ( de Rooy, HA; Reichert, LJ, 1989) |
| "The effects of amiodarone and its metabolite desethylamiodarone on arrhythmias induced by ischaemia and reperfusion were studied in vivo in the anaesthetised rat with transient regional ischaemia (7 min of left coronary artery occlusion) and reperfusion (10 min)." | 3.67 | Anti-arrhythmic effects of amiodarone and desethylamiodarone on malignant ventricular arrhythmias arising as a consequence of ischaemia and reperfusion in the anaesthetised rat. ( Hearse, DJ; Riva, E, 1989) |
| "We describe a 59-year-old patient who was treated with amiodarone for severe ventricular arrhythmia." | 3.67 | [Lung changes in amiodarone therapy]. ( Frank, H; Hübsch, P; Prayer, L, 1989) |
| " Amiodarone was used by them to treat refractory cardiac arrhythmia since 4 and 6 years before, respectively." | 3.67 | [Neuropathy caused by amiodarone: clinico-pathologic study of 2 cases]. ( Maciel Júnior, JA; Queiroz, L, 1989) |
| "Amiodarone is an effective agent in the treatment of life-threatening ventricular arrhythmias." | 3.67 | Amiodarone-induced pulmonary mass. ( Faber, LP; Piccione, W; Rosenberg, MS, 1989) |
| "Amiodarone hydrochloride, an iodinated benzofuran derivative, is effective for treatment of supraventricular and ventricular arrhythmias." | 3.67 | Amiodarone toxicity: recurrence of interstitial pneumonitis after withdrawal of the drug. ( Morera, J; Navas, JJ; Ojanguren, I; Parra, O; Ruiz, J, 1989) |
| "The effect of amiodarone after acute and chronic pretreatment was studied in the early phase of arrhythmias induced by coronary artery ligation in conscious rats." | 3.67 | Antiarrhythmic effect of acute and chronic amiodarone treatment in conscious rats. ( Rabloczky, G; Varró, A, 1986) |
| "The effect of desethylamiodarone, a metabolite of amiodarone, was studied in the early phase of arrhythmias induced by coronary artery ligation in conscious rats." | 3.67 | Antiarrhythmic effect of desethylamiodarone in conscious rats. ( Bódi, I; Rabloczky, G; Varró, A, 1987) |
| "In the adult, Amiodarone is a very effective drug in the treatment of ventricular and supraventricular arrhythmias." | 3.67 | [Amiodarone therapy in childhood: efficacy and side effects]. ( Austoni, P; Danzi, GB; Fancini, P; Figini, A; Mascarello, M; Vignati, G, 1985) |
| " Only 6 of the 14 patients with hyperthyroxinaemia had TSH-U values in the hyperthyroid range: only one of these patients had an increased triiodothyronine." | 3.67 | [Ultra-sensitive TSH levels: an aid in the screening for amiodarone-induced thyroid dysfunction]. ( Chabrier, G; Dickelé, MC; Fellinger, F; Gasser, F; Roul, G; Sacrez, A; Sapin, R; Schlienger, JL, 1986) |
| "To assess the incidence of adverse effects associated with long-term amiodarone therapy, we reviewed the records of 217 consecutive patients who were treated for refractory arrhythmia." | 3.67 | Side effects and complications of amiodarone therapy. ( Lown, B; Podrid, PJ; Raeder, EA, 1985) |
| " The aim of our study was to evaluate the effects of amiodarone (400 mg day-1 for seven days and then 200 mg day-1, five days a week, for 60 days) in 20 patients with chronic ischaemic heart disease ascertained by stress test, thallium-201 myocardial scintigraphy and coronary angiography and with qualitatively and quantitatively similar cardiac arrhythmias in two continuous ECG monitoring sessions performed before starting treatment." | 3.67 | Effects of low doses of amiodarone on cardiac arrhythmias in patients with chronic ischaemic heart disease. ( Abrignani, MG; Alaimo, G; Cutietta, A; Immordino, R; Indovina, A; Licata, G; Novo, S; Strano, A, 1988) |
| "The effect of low-dose amiodarone was prospectively evaluated in 110 patients with potentially lethal ventricular arrhythmias and structural heart disease." | 3.67 | Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone. ( Aragon, E; Blevins, RD; Faitel, K; Frumin, H; Jarandilla, R; Kerin, NZ; Luarca, R; Marinescu, G; Rubenfire, M, 1988) |
| "Out of 20 subjects selected for refractory arrhythmias, amiodarone therapy (200 mg/day) was efficacious in 85%." | 3.67 | Amiodarone and thyroid status in refractory arrhythmias. ( Codecà, L; Colamussi, V; Giganti, M; Giovannini, G; Pelizzola, D; Piffanelli, A; Ricci, L, 1988) |
| "A 16-yr-old boy who was receiving amiodarone for ventricular arrhythmias developed a Reye's syndrome-like illness several days after an upper respiratory infection." | 3.67 | Reye's syndrome-like illness in a patient receiving amiodarone. ( Baranski, B; Hoofnagle, JH; Jones, DB; Mullick, FG, 1988) |
| "Few data are available on intravenous amiodarone therapy in refractory arrhythmias." | 3.67 | Efficacy and safety of intravenous amiodarone in acute refractory arrhythmias. ( Binner, L; König, W; Mayer, U; Schmidt, A; Stauch, M, 1988) |
| "Fourteen patients with established atrial fibrillation (longer than three months) that was refractory to treatment were studied to compare the clinical and electrophysiological effects of amiodarone and bepridil." | 3.67 | A comparison of bepridil with amiodarone in the treatment of established atrial fibrillation. ( Krikler, DM; McKenna, WJ; Perelman, MS; Rowland, E, 1987) |
| "Amiodarone therapy for cardiac arrhythmias is increasingly being recognized to be associated with pulmonary toxicity." | 3.67 | Life-threatening postoperative pulmonary complications in patients with previous amiodarone pulmonary toxicity undergoing cardiothoracic operations. ( Fishbein, MC; Gang, ES; Kass, RM; Mandel, WJ; Nalos, PC; Peter, T, 1987) |
| "The relation of clinical and electrophysiologic variables to outcome was evaluated in 121 patients treated with amiodarone for sustained ventricular tachyarrhythmias." | 3.67 | Usefulness of electrophysiologic study to determine the clinical tolerance of arrhythmia recurrences during amiodarone therapy. ( Buxton, AE; Flores, B; Josephson, ME; Kadish, AH; Marchlinski, FE; Waxman, HL, 1987) |
| "The relationship of steady-state serum levels of amiodarone and its major metabolite, desethylamiodarone, to therapeutic and toxic effects was evaluated in 111 patients treated for supraventricular and ventricular arrhythmias." | 3.67 | Relationship of steady-state serum concentrations of amiodarone and desethylamiodarone to therapeutic efficacy and adverse effects. ( Falik, R; Flores, BT; Gibson, GA; Josephson, ME; Marchlinski, FE; Shaw, L, 1987) |
| "The value of serial electropharmacologic testing during long-term oral amiodarone therapy for prediction of long-term drug efficacy as well as characteristics of arrhythmia recurrence is controversial." | 3.67 | Predictors of efficacy of amiodarone and characteristics of recurrence of arrhythmia in patients with sustained ventricular tachycardia and coronary artery disease. ( DiMarco, JP; Haines, DE; Lerman, BB; Zhu, J, 1987) |
| "ES was, therefore, of diagnostic value in more than half of the patients with syncope of unknown cause and long-term treatment based on ES was successful in the prevention of S (remission rate of 93% in patients treated with amiodarone or pacemaker)." | 3.67 | [Usefulness of the electrophysiologic study in the prognostic evaluation of patients with syncope of uncertain origin]. ( Bernardi, G; Feruglio, GA; Fontanelli, A; Gianfagna, P; Proclemer, A, 1987) |
| "Although amiodarone is effective for the suppression of complex ventricular arrhythmias, a major problem with its use is the long delay between the initiation of therapy and the onset of effective suppression of arrhythmia." | 3.67 | Rapid suppression of complex ventricular arrhythmias with high-dose oral amiodarone. ( Mostow, ND; Noon, D; Rakita, L; Vrobel, TR, 1986) |
| "The time to onset of action of amiodarone is often long in patients treated for arrhythmias; one reason might be a slow entry of the drug into the target organ, the heart." | 3.67 | Amiodarone and desethylamiodarone distribution in the atrium and adipose tissue of patients undergoing short- and long-term treatment with amiodarone. ( Barbieri, E; Conti, F; d'Aranno, V; Latini, R; Trevi, GP; Zampieri, P; Zardini, P, 1986) |
| "For the 5-year period 1979 to 1983, 242 patients were followed up who had received amiodarone treatment, 156 for supraventricular tachycardia (SVT) and 86 for ventricular arrhythmias." | 3.67 | Long-term tolerance of amiodarone treatment for cardiac arrhythmias. ( Lubbe, WF; Mercer, J; Roche, AH; Rutherford, JD; Smith, WM; Whitlock, RM, 1986) |
| "The efficacy and safety of combined amiodarone and mexiletine treatment was investigated in 16 patients with chronic complex ventricular arrhythmias previously refractory to conventional antiarrhythmic agents and, in a lesser degree, to mexiletine or amiodarone." | 3.67 | [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias]. ( Bilancini, A; Blandini, A; Costantini, C; Curzi, G; Massacci, C; Pigini, G; Purcaro, A, 1986) |
| "The effects of chronic amiodarone treatment on several thyroid and cardiac function parameters were studied in 50 euthyroid patients with refractory ventricular arrhythmias, divided in responders and nonresponders according to their sensitivity to the antiarrhythmic action of the drug." | 3.67 | Evidence for an inhibition of thyroid hormone effects during chronic treatment with amiodarone. ( Beck-Peccoz, P; Cattaneo, MG; Faglia, G; Giani, P; Landolina, M; Maggioni, AP; Piscitelli, G; Tognoni, G; Volpi, A, 1986) |
| "Oral amiodarone was administered to 30 children (aged one week to 14 years) for treatment of resistant or life threatening tachycardias." | 3.67 | Intravenous and oral amiodarone for arrhythmias in children. ( Bucknall, CA; Curry, PV; Holt, DW; Keeton, BR; Sutherland, GR; Tynan, MJ, 1986) |
| " There were no differences in age, sex, dose of amiodarone, type or severity of underlying heart disease or baseline serum thyroxine levels in patients who developed hypothyroidism (n = 32) or hyperthyroidism (n = 5) or remained euthyroid (n = 62)." | 3.67 | Thyroid dysfunction during chronic amiodarone therapy. ( Albert, SG; Alves, LE; Rose, EP, 1987) |
| "Disc swelling and hemorrhages appeared in three eyes of two men receiving amiodarone hydrochloride for cardiac arrhythmias." | 3.67 | Papillopathy caused by amiodarone. ( Asdourian, GK; Gittinger, JW, 1987) |
| "During treatment with amiodarone, digoxin and nadolol, asystole occurred repeatedly in a patient with chronic persistent automatic atrial tachycardia." | 3.67 | Asystole during treatment with amiodarone in a patient with persistent atrial tachycardia. ( Kuo, CS; Paciotti, MV; Reddy, CP, 1985) |
| "Therapeutic use of the potent antiarrhythmic drug amiodarone requires early detection of impending hyperthyroidism, a potentially life-threatening adverse reaction in cardiac patients." | 3.67 | Amiodarone-treated patients with suppressed TSH test are at risk of thyrotoxicosis. ( Stäubli, M; Studer, H, 1985) |
| "Over a 10-year period 130 patients with drug-resistant cardiac arrhythmias associated mainly with coronary artery disease and its complications were treated with amiodarone." | 3.67 | Amiodarone for refractory cardiac arrhythmias: 10-year study. ( Eydt, JN; Leak, D, 1986) |
| "Eleven critically ill patients with life-threatening cardiac arrhythmias refractory to currently approved antiarrhythmic drugs were treated with intravenous amiodarone." | 3.67 | Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient. ( Leak, D, 1986) |
| "Seventy-four patients with sustained ventricular tachyarrhythmias had 22 +/- 3 hours of Holter monitoring before and after 11 +/- 6 days of amiodarone treatment." | 3.67 | Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone. ( Buxton, AE; Doherty, JU; Flores, BT; Josephson, ME; Marchlinski, FE; Waxman, HL, 1985) |
| "In 65 patients a single oral dose of amiodarone (30 mg/kg) produced an antiarrhythmic effect on supraventricular or ventricular arrhythmias within 3 to 8 hours and lasted for 17 to 19 hours." | 3.67 | Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations. ( Cheymol, G; Coumel, P; Escoubet, B; Jaillon, P; Lagier, G; Leclercq, JF; Maison-Blanche, P; Menasche, P; Piwnica, A; Poirier, JM, 1985) |
| "Both hyperthyroidism and hypothyroidism have been noted to occur in some patients treated with amiodarone for cardiac arrhythmias." | 3.67 | Effect of long-term amiodarone therapy on thyroid hormone levels and thyroid function. ( Borowski, GD; Garofano, CD; Greenspan, AM; Horowitz, LN; Rose, LI; Rotmensch, HR; Spielman, SR, 1985) |
| "Two cases are reported in which amiodarone was administered during pregnancy for longer periods than has been reported previously." | 3.67 | Use of amiodarone during pregnancy. ( Holt, DW; Jeeva Raj, MV; Robson, DJ; Storey, GC, 1985) |
| "We report two patients who developed symptomatic life-threatening ventricular tachyarrhythmias with changing QRS axes (resembling torsades de pointes), during treatment of their supraventricular tachycardias with oral amiodarone." | 3.67 | Life-threatening ventricular arrhythmias provoked by amiodarone treatment. ( Eydt, J; Kumana, CR; Tanser, P, 1985) |
| "To determine whether failure of procainamide to prevent initiation of ventricular tachyarrhythmias during electrophysiologic testing predicted failure of other antiarrhythmic regimens, 81 consecutive patients with coronary artery disease whose ventricular tachyarrhythmias remained inducible during procainamide administration were studied." | 3.67 | Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapy. ( Greenspan, AM; Horowitz, LN; Rae, AP; Sokoloff, NM; Spielman, SR; Webb, CR, 1985) |
| "Oral amiodarone's slow absorption handicaps rapid treatment of life-threatening arrhythmias." | 3.67 | Intravenous amiodarone in the treatment of refractory arrhythmias. ( Alves, LE; Cahill, TB; Rose, EP, 1985) |
| "The clinical efficacy of amiodarone in the management of patients with complex cardiac arrhythmias refractory to therapy with two or more conventional or other investigational anti-arrhythmic agents was studied by long-term follow-up of patients who had received the drug for a period of at least three months." | 3.67 | Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long term follow-up. ( Hamer, A; Mandel, WJ; Peter, T, 1985) |
| "The electrophysiologic basis for the use of amiodarone in the treatment of cardiac arrhythmias is outlined, with reference to studies in isolated cardiac tissues, whole animal, and human studies." | 3.66 | The electrophysiologic basis for the use of amiodarone for treatment of cardiac arrhythmias. ( Hamer, AW; Karagueuzin, HS; Mandel, WJ; Peter, T; Zaher, CA, 1983) |
| "Our use of amiodarone in 200 patients during an 8-year period confirms our previous experience which indicated that the drug was close to being the ideal antiarrhythmic agent in children's arrhythmias." | 3.66 | The use of amiodarone in children. ( Coumel, P; Do Ngoc, D; Lucet, V, 1983) |
| "Amiodarone, a drug used to treat refractory cardiac arrhythmias, produced a peripheral neuropathy in 5 of 50 cases (10%)." | 3.66 | Amiodarone neuropathy. ( Martinez-Arizala, A; McCarty, GE; Nichols, BR; Rakita, L; Sobol, SM, 1983) |
| "Amiodarone was administered to 80 patients with recurrent cardiac tachyarrhythmias previously resistant to drug treatment." | 3.66 | Adverse reactions during treatment with amiodarone hydrochloride. ( Garan, H; Kelly, E; McGovern, B; Ruskin, JN, 1983) |
| "Amiodarone, an iodinated benzofuran derivative, has electrophysiologic effects on cardiac muscle akin to those of hypothyroidism." | 3.66 | Amiodarone and thyroid function: clinical implications during antiarrhythmic therapy. ( Nademanee, K; Singh, BN, 1983) |
| "Amiodarone was used in 40 patients with life-threatening or refractory tachyarrhythmias." | 3.66 | Amiodarone therapy for life threatening or refractory cardiac arrhythmias. ( Anderson, ST; Currie, PJ; Federman, J; Harper, RW; Johns, JA; Pitt, A, 1983) |
| "Amiodarone was administered to 121 patients (82 males, 39 females; average age 59 years) with refractory atrial tachyarrhythmias." | 3.66 | Efficacy of amiodarone for refractory supraventricular tachyarrhythmias. ( Graboys, TB; Lown, B; Podrid, PJ, 1983) |
| "The clinical utility of electrophysiologic testing in assessing the long-term efficacy of amiodarone for treatment of life-threatening ventricular arrhythmias is controversial, most investigators reporting little or no correlation between the early effects of the drug on arrhythmia inducibility and subsequent prognosis." | 3.66 | Ventricular arrhythmias: use of electrophysiologic studies. ( Greenspan, AM; Horowitz, LN; Kay, HR; Spielman, SR; Webb, CR, 1983) |
| "The clinical antiarrhythmic efficacy of amiodarone treatment was examined in 196 patients with recurrent ventricular tachycardia (VT) or ventricular fibrillation (VF) resistant to other antiarrhythmic drugs." | 3.66 | Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation. ( Heger, JJ; Prystowsky, EN; Zipes, DP, 1983) |
| "The clinical efficacy of amiodarone in the management of complex cardiac arrhythmias refractory to therapy with two or more conventional or other investigational antiarrhythmic agents was determined by long-term follow-up in patients who had received the drug for at least 3 months." | 3.66 | Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long-term follow-up. ( Hamer, A; Mandel, WJ; Peter, T; Weiss, D, 1983) |
| "Arrhythmias may be controlled in most patients with recurrent supraventricular tachycardia or atrial fibrillation with small to moderate maintenance doses of amiodarone (100 to 400 mg/day)." | 3.66 | Ten years of experience with amiodarone. ( Chiale, PA; Elizari, MV; Haedo, A; Lázzari, JO; Rosenbaum, MB, 1983) |
| "Two patients in chronic renal failure receiving amiodarone for the treatment of refractory arrhythmias were commenced on dialysis, in one case, intermittent peritoneal dialysis, in the other, haemodialysis." | 3.66 | Renal elimination of amiodarone and its desethyl metabolite. ( Harris, L; Hind, CR; Holt, DW; Krikler, SJ; McKenna, WJ; Savage, C; Storey, GC, 1983) |
| "Amiodarone was used to treat cardiac arrhythmias that had been refractory to conventional medical therapy." | 3.66 | Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias. ( Gorham, JP; Graham, EL; Greene, HL; Gross, BW; Kudenchuk, PJ; Sears, GK; Trobaugh, GB; Werner, JA, 1983) |
| "Ninety-six patients with life-threatening ventricular arrhythmias refractory to two or more conventional agents were treated with amiodarone and followed for 6 to 40 months (mean, 15 months)." | 3.66 | Amiodarone in refractory life-threatening ventricular arrhythmias. ( Cannom, DS; Feld, G; Hendrickson, J; Intarachot, V; Lopez, B; Nademanee, K; Singh, BN; Weiss, JL, 1983) |
| "Five cases of amiodarone-induced polymorphous ventricular tachycardia (torsade de pointes) are presented." | 3.66 | Amiodarone-induced polymorphous ventricular tachycardia. ( Agmon, J; Arditti, A; Kracoff, O; Lewin, RF; Sclarovsky, S; Strasberg, B, 1983) |
| "Ninety-six patients with recurrent, drug-refractory tachyarrhythmias were treated with amiodarone for 8." | 3.66 | Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias. ( Anderson, KP; Fogoros, RN; Mason, JW; Swerdlow, CD; Winkle, RA, 1983) |
| "Amiodarone was used in 30 patients with tachyarrhythmias refractory to treatment with several antiarrhythmic agents." | 3.66 | Amiodarone in long term management of refractory cardiac tachyarrhythmias. ( Lowe, JB; Lubbe, WF; Mercer, CJ; Roche, AH, 1981) |
| "Six patients are presented who developed pulmonary infiltrates of undetermined origin while being treated for severe ventricular arrhythmias with amiodarone hydrochloride." | 3.66 | Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug. ( Rakita, L; Sobol, SM, 1982) |
| "Amiodarone hydrochloride, a benzofurane derivative used for the treatment of cardiac arrhythmias, is known to cause a verticillate epithelial keratopathy, which has been classified into three stages." | 3.66 | Amiodarone keratopathy. Correlation to dosage and duration. ( Cappaert, WE; Kaplan, LJ, 1982) |
| "Detailed electrophysiologic studies were performed in nine patients with chronic refractory ventricular arrhythmias before and after 7 to 20 weeks (mean 11 weeks) of amiodarone therapy." | 3.66 | Electrophysiologic effects of chronic amiodarone therapy in patients with ventricular arrhythmias. ( Finerman, WB; Hamer, A; Mandel, WJ; Peter, T; Weiss, D, 1982) |
| "Six patients treated with a combination of amiodarone and class I antiarrhythmic agents for a minor arrhythmia developed atypical ventricular tachycardia "en torsades de pointe"." | 3.66 | [Harmful interactions of amiodarone and class I anti-arrhythmia agents]. ( Kappenberger, L; Steinbrunn, W; Tartini, R, 1982) |
| "Amiodarone was utilized in 70 patients with symptomatic, sustained refractory tachyarrhythmias." | 3.66 | Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias. ( Lown, B; Podrid, PJ, 1981) |
| "A patient with the familial syndrome of Q-T prolongation, ventricular arrhythmias, and syncope was effectively treated with amiodarone." | 3.66 | Effective management of the long q-t syndrome with amiodarone. ( Bashour, T; Cheng, TO; Jokhadar, M, 1981) |
| "The efficacy of amiodarone in the treatment of cardiac arrhythmias is discussed in the light of published results and our own experience." | 3.66 | [The treatment of arrhythmias with amiodarone]. ( Stäubli, M; Studer, H, 1981) |
| "Nine patients with life-threatening ventricular arrhythmias were administered oral amiodarone over a period of months." | 3.66 | Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias. ( Finerman, WB; Hamer, AW; Mandel, WJ; Peter, T, 1981) |
| "Oral amiodarone has been used to treat 21 patients with various supraventricular arrhythmias; 13 had Wolff-Parkinson-White syndrome, which was complicated by atrial fibrillation and re-entry atrioventricular tachycardia in four, and re-entry tachycardia alone in the other nine." | 3.66 | Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias. ( Krikler, DM; Rowland, E, 1980) |
| "Amiodarone is used in the treatment of previously drug-resistant supraventricular and ventricular arrhythmias." | 3.66 | Effectiveness of amiodarone in resistant arrhythmias. ( Hollman, A; Holt, PM, 1980) |
| "The electrophysiological effects of L 9394 (benzoyl-indolizine), a substance chemically related to amiodarone, but devoid of iodine atoms, were investigated by programmed electrical stimulation of the heart in 12 patients with various forms of tachycardia." | 3.66 | Electrophysiological effects of L 9394 (benzoyl-indolizine) in man. ( Bordalo, A; Bruninx, P; Kulbertus, HE; Waleffe, A; Wellens, HJ, 1979) |
| "Amiodarone hydrochloride was used to treat 19 patients with symptomatic arrhythmias refractory to quinidine sulfate, procainamide hydrochloride, disopyramide phosphate, antazoline hydrochloride, lidocaine hydrochloride, bretylium tosylate, propranolol hydrochloride, phenytoin sodium, and practotol acetanilide given to the limit of tolerance." | 3.66 | Control of refractory cardiac arrhythmias with amiodarone. ( Eydt, JN; Leak, D, 1979) |
| "The authors report four new cases of hyperthyroidism associated with prolonged treatment with amiodarone." | 3.65 | [Hyperthyroidism caused by amiodarone. Apropos of 4 clinical cases]. ( Chapelle, M; Naouri, R; Wolff, F, 1976) |
| "In vivo and in vitro experiments showed that Verapamil dilates the coronaries, prevents coronary spasm, produces Ca++-antagonism, offers protection against myocardial necrosis, prevents arrhythmia, reduces pressure, increases the purinergic reactivity and produces inhibition of platelet aggregation." | 3.65 | [Experimental analysis of some cardiovascular effects of Verapamil]. ( Brita, G; Caputi, AP; Chieppa, S; Coscia, L; Marmo, E; Rossi, F, 1975) |
| "15 patients with ventricular and supraventricular arrhythmias treated with Amiodarone hydrochloride via oral were studied." | 3.65 | [Clinical evaluation of amiodarone hydrochloride as an anti-arrhythmia agent]. ( Cordeiro, B; Huguet, R; Malpartida, F; Noguera, J; Sala, J; Triola, M, 1975) |
| " Recent studies have also demonstrated increased morbidity and mortality with the use of digoxin and other AAD which interact with P-gp." | 2.82 | Drug Interactions Affecting Antiarrhythmic Drug Use. ( Chung, MK; Dukes, JW; Ezekowitz, M; Gopinathannair, R; Horbal, P; Lakkireddy, D; Lip, GYH; Mar, PL; Miletello, M; Noseworthy, PA; Olshansky, B; Reiffel, JA; Tisdale, JE, 2022) |
| "AFL accounts for 30% of fetal tachyarrhythmias, 11% to 18% of neonatal tachyarrhythmias, and 8% of supraventricular tachyarrhythmias in children older than 1 year of age." | 2.82 | Atrial Flutter in Pediatric Patients. ( Drago, F; Tamborrino, PP, 2022) |
| "In the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT), a significant fraction of the patients with congestive heart failure ultimately did not die suddenly of arrhythmic causes." | 2.80 | SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death. ( Anderson, J; Au-Yeung, WT; Bardy, GH; Fletcher, RD; Johnson, G; Lee, KL; Mark, DB; Moore, HJ; Poole, JE; Reinhall, PG, 2015) |
| "Amiodarone is a Class III Vaughan-Williams anti-arrhythmic drug widely used in ventricular arrhythmias for its efficacy and low pro-arrhythmogenic effect." | 2.72 | Amiodarone in ventricular arrhythmias: still a valuable resource? ( Baldetti, L; Brugliera, L; Cianfanelli, L; D'Angelo, G; De Blasi, G; Della Bella, P; Falasconi, G; Frontera, A; Gulletta, S; Landoni, G; Malatino, L; Margonato, A; Melillo, F; Ossola, P; Pannone, L; Vergara, P; Zacchetti, D, 2021) |
| "Amiodarone is a class III antiarrhythmic drug containing 37% iodine by weight, with a structure similar to that of thyroid hormones." | 2.72 | Evaluation and Treatment of Amiodarone-Induced Thyroid Disorders. ( Burman, KD; Wartofsky, L; Ylli, D, 2021) |
| "Amiodarone has pharmacokinetic interactions with a number of therapeutic drugs, including warfarin, phenytoin, flecainide, and cyclosporine." | 2.72 | Effect of amiodarone on the serum concentration/dose ratio of metoprolol in patients with cardiac arrhythmia. ( Fukumoto, K; Kamakura, S; Kato, R; Kitakaze, M; Kobayashi, T; Komamura, K; Tachibana, K; Tanaka, K; Ueno, K, 2006) |
| "Treatment with amiodarone may have a positive or neutral survival benefit." | 2.71 | Amiodarone versus Implantable Defibrillator (AMIOVIRT): background, rationale, design, methods, results and implications. ( Strickberger, SA; Wijetunga, M, 2003) |
| "Amiodarone was used in 37 pediatric subjects aging 1 day--16 years." | 2.70 | [Amiodarone for long term treatment of arrhythmia in children]. ( Durmała, J; Nowakowska, E; Rokicki, W, 2001) |
| "Patients with severe congestive heart failure (CHF) are at increased risk for atrial and ventricular arrhythmias and sudden cardiac death." | 2.68 | Acute electrophysiologic effects of amiodarone in patients with congestive heart failure. ( Feliciano, Z; Gold, MR; Gottlieb, SS; Peters, RW; Riggio, DW; Shorofsky, SR, 1995) |
| "Sudden cardiac death is a common cause of mortality in patients with congestive heart failure." | 2.67 | Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy. ( Das, SK; Krikler, SJ; McKenna, WJ; Mickelson, JK; Morady, F; Nicklas, JM; Pitt, B; Quain, LA; Schork, MA; Stewart, RA, 1991) |
| "Amiodarone was given after surgery in a loading bolus of 300 mg for 2 hours followed by 1200 mg every 24 hours for 2 days and 900 mg every 24 hours for the next 2 days." | 2.67 | Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study. ( Dammbacher, T; Fraedrich, G; Hohnloser, SH; Jähnchen, E; Just, H; Meinertz, T; Steiert, K; Zehender, M, 1991) |
| "Amiodarone is an iodinated benzofuran derivative, a highly lipophilic drug with unpredictable pharmacokinetics." | 2.66 | The role of amiodarone in contemporary management of complex cardiac arrhythmias. ( Dobrev, D; Marinković, M; Mujović, N; Potpara, TS; Russo, V, 2020) |
| "Sotalol was compared with amiodarone in this open randomized multicentre study of patients with ventricular tachycardia or fibrillation not associated with acute myocardial infarction refractory to or intolerant of Class I drugs." | 2.66 | Multicentre randomized trial of sotalol vs amiodarone for chronic malignant ventricular tachyarrhythmias. Amiodarone vs Sotalol Study Group. ( , 1989) |
| "Amiodarone concentration was lower in red blood cells than in plasma and in myocardium." | 2.66 | Amiodarone and N-desethylamiodarone concentrations in plasma, red blood cells, and myocardium after a single oral dose: relation to hemodynamic effects in surgical patients. ( Berger, Y; Commin, P; Echter, E; Escoubet, B; Jaillon, P; Menasché, P; Piwnica, A, 1986) |
| "Many sudden deaths are presumed to be due to an arrhythmia, but the drugs best known for antiarrhythmic activity, the local anesthetic agents, have not been suitable prophylactic agents because of their toxicities and other undesirable pharmacologic characteristics." | 2.65 | Selection of an antiarrhythmic drug for a sudden-death-prevention trial. ( Duff, HJ; Oates, JA; Roden, DM; Woosley, RL, 1982) |
| "Amiodarone was given intravenously over 30 seconds in a dose of 300 mg; in 15 of the patients a further dose of 150 mg was given after ten minutes." | 2.64 | [Anti-arrhythmic effects of injectable amiodarone. Apropos of 100 cases]. ( Benaim, R; Chapelle, M; Chiche, P; Denizeau, JP; Domengie, B; Kolsky, H; Melon, J, 1976) |
| "Amiodarone has been associated with adverse events that may restrict its use." | 2.61 | Meta-Analysis Comparing the Relative Risk of Adverse Events for Amiodarone Versus Placebo. ( Aboujamous, NM; Foy, AJ; Ghahramani, M; Mandrola, J; Moroi, MK; Naccarelli, GV; Ruzieh, M, 2019) |
| "IV sotalol has a rapid onset of action with linear pharmacokinetics." | 2.58 | Intravenous Sotalol: An Under Used Treatment Strategy. ( Kerin, NZ, 2018) |
| "Arrhythmogenic right ventricular cardiomyopathy is a genetic cardiomyopathy characterized by replacement of right ventricular myocardium by fibrofatty infiltrates, leading to significant ventricular arrhythmias with sudden death and right ventricular dysfunction." | 2.50 | [Anesthetic management of patients with arrhythmogenic right ventricular cardiomyopathy]. ( Kato, Y, 2014) |
| " Of all the antiarrhythmic drugs hitherto used, AM has the most adverse effects on the thyroid gland." | 2.48 | [Effect of amiodarone on the thyroid function and safety of the therapy--what's new]. ( Czarnywojtek, A; Florek, E; Hen, K; Ruchała, M; Stangierski, A; Warmuz-Stangierska, I; Zdanowska, J, 2012) |
| "Due to the complicated pathogenesis of cardiac arrhythmia, the safe and effective therapeutic strategies for cardiac arrhythmia remain an urgent medical problems in the recent years." | 2.47 | [The research practice of anti-arrhythmic agents targeting on potassium ion channel]. ( Tang, YQ; Wang, XJ; Yang, Q; You, QD, 2011) |
| "Treatment of amiodarone pulmonary toxicity consists primarily of stopping amiodarone." | 2.46 | Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect? ( Berghaus, T; Haeckel, T; Schwaiblmair, M; von Scheidt, W; Wagner, T, 2010) |
| "Dronedarone is an antiarrhythmic agent recently approved by the United States Food and Drug Administration for the reduction of cardiovascular-related hospitalizations in patients with paroxysmal or persistent atrial fibrillation or atrial flutter." | 2.46 | Dronedarone: a new antiarrhythmic agent. ( Hofmann, PO; Oyetayo, OO; Rogers, CE, 2010) |
| "Oral dronedarone is a non-iodinated benzofurane derivative structurally related to amiodarone." | 2.45 | Dronedarone. ( Hoy, SM; Keam, SJ, 2009) |
| "Cardiac arrhythmias are a common problem in the perioperative period." | 2.44 | [Amiodaron for treatment of perioperative cardiac arrythmia: a broad spectrum antiarrythmetic agent?]. ( Böttiger, BW; Butte, N; Teschendorf, P, 2008) |
| "Emergencies include arrhythmias, acute coronary syndrome, peripartum cardiomyopathy and hypertensive disorders." | 2.44 | [Arrhythmias during pregnancy]. ( Trappe, HJ, 2008) |
| "Amiodarone is an iodinated compound, and the possibility that its molecule may be modified with or without elimination of the iodine is being tested." | 2.44 | Amiodarone as paradigm for developing new drugs for atrial fibrillation. ( Singh, BN, 2008) |
| "The treatment of cardiac arrhythmias has undergone a sea change with the advent of catheter ablative procedures (radiofrequency ablation) and use of implantable cardioverter defibrillator (ICD)." | 2.44 | Antiarrhythmic drugs: present and future. ( Sharma, S, 2007) |
| "Thyrotoxicosis is associated with increased cardiovascular morbidity and mortality, primarily due to heart failure and thromboembolism." | 2.43 | Thyrotoxicosis and the cardiovascular system. ( Brandle, M; Cattaneo, F; Roffi, M, 2005) |
| "The short QT syndrome has been recently recognised as a genetic ion channel dysfunction." | 2.43 | Short QT syndrome: a case report and review of literature. ( Cao, Q; Lu, LX; Yu, K; Zhang, X; Zhou, W; Zhu, C, 2006) |
| " Amiodarone effectively controls a wide spectrum of atrial and ventricular antiarrhythmic disorders, but its limiting side effects, such as thyroid dysfunction, pulmonary fibrosis, and dermatologic changes, may limit its long-term use in some patients." | 2.43 | Amiodarone: a multifaceted antiarrhythmic drug. ( Singh, BN, 2006) |
| " Here, we discuss safety issues relating to the long-term use of oral amiodarone in adults." | 2.42 | Using oral amiodarone safely. ( , 2003) |
| " Class III antiarrhythmic drugs may interact with other drugs by two major processes: pharmacodynamic and pharmacokinetic interactions." | 2.42 | Potentially significant drug interactions of class III antiarrhythmic drugs. ( DeBisschop, M; Lower, DL; Martin, LG; Yamreudeewong, W, 2003) |
| "Amiodarone is a complicated drug, and its optimal use requires careful patient surveillance with respect to potential adverse effects." | 2.42 | Role of amiodarone in the era of the implantable cardioverter defibrillator. ( Dorian, P; Mangat, I, 2003) |
| "Amiodarone is a highly efficacious antiarrhythmic agent for many cardiac arrhythmias, ranging from atrial fibrillation to malignant ventricular tachyarrhythmias, and seems to be superior to other antiarrhythmic agents." | 2.42 | Arrhythmias in the intensive care patient. ( Brandts, B; Trappe, HJ; Weismueller, P, 2003) |
| "Amiodarone can cause thyroid dysfunction in patients with or without previous thyroid disease." | 2.42 | Surgical management of amiodarone-induced thyrotoxicosis. ( Fan, CY; Franzese, CB; Stack, BC, 2003) |
| "The prevalence of arrhythmia in the population is increasing as more people survive for longer with cardiovascular disease." | 2.42 | A benefit-risk assessment of class III antiarrhythmic agents. ( Brendorp, B; Elming, H; Køber, L; Pedersen, OD; Pehrson, S; Torp-Petersen, C, 2004) |
| "amiodarone) because of atrial fibrillation or non-sustained VT that may activate the device." | 2.41 | Antiarrhythmic therapy in heart failure. ( Breithardt, G; Eckardt, L; Haverkamp, W, 2002) |
| "Sotalol was recently shown to be effective in reducing tachyarrhythmias in patients with ICDs." | 2.41 | New advances in class III antiarrhythmic drug therapy. ( Sager, PT, 2000) |
| "Supraventricular arrhythmias such as paroxysmal or chronic atrial fibrillation may also cause serious complications in those patients due to acute loss of atrial contraction, pump failure during rapid ventricular response and embolic events." | 2.41 | [Antiarrhythmic therapy in patients with heart failure]. ( Faber, TS; Zehender, M, 2000) |
| " Sotalol requires careful patient selection due to the risk of proarrhythmia and although cardiac effects are rare with amiodarone therapy, potentially serious non-cardiac adverse effects can limit the long-term use of this agent." | 2.41 | The role of class III antiarrhythmic agents in maintaining sinus rhythm. ( Brachmann, J, 2000) |
| "Cardiac arrhythmias are common in the perioperative period." | 2.41 | Postoperative arrhythmias and conduction disorders. ( Sloan, SB; Weitz, HH, 2001) |
| " Though often effective, these drugs also pose a risk because all of them have a variety of potential adverse effects associated with their use." | 2.41 | Review of common adverse effects of selected antiarrhythmic drugs. ( Earnest, J; Reyes, J; Wooten, JM, 2000) |
| "Patients with other supraventricular arrhythmias may be treated with adenosine, a calcium channel blocker, or a short-acting beta blocker to disrupt reentrant pathways." | 2.41 | Management of common arrhythmias: Part I. Supraventricular arrhythmias. ( Hebbar, AK; Hueston, WJ, 2002) |
| "Amiodarone was introduced as an antiarrhythmic compound in the early 1970s and was approved in the U." | 2.40 | Amiodarone: the expanding antiarrhythmic role and how to follow a patient on chronic therapy. ( Singh, BN, 1997) |
| "Drugs can cause cardiac arrhythmias in a number of clinical situations, and many of the implicated agents are used to treat non-cardiac conditions." | 2.40 | Drug-induced cardiac arrhythmias: incidence, prevention and management. ( Doig, JC, 1997) |
| "These include catheter ablation of cardiac arrhythmias, certain surgical techniques that in selected patients offer prospects of cure, and the development of implantable ventricular and atrial cardioverter defibrillators, which allow the evaluation of drugs versus placebo against the background of the defibrillator." | 2.40 | Controlling cardiac arrhythmias: an overview with a historical perspective. ( Singh, BN, 1997) |
| "Cardiac arrhythmias frequently respond only to drugs that have as their predominant electrophysiologic effect the prolongation of repolarization and refractoriness." | 2.40 | Pharmacologic and pharmacokinetic profile of class III antiarrhythmic drugs. ( Bharucha, D; Kowey, PR; Marinchak, RA; Rials, SJ, 1997) |
| "Torsades de pointes is the classic form of proarrhythmia observed during therapy with any drug that prolongs repolarization, for example, the class III agents." | 2.40 | Proarrhythmia with class III antiarrhythmic drugs: types, risks, and management. ( Hohnloser, SH, 1997) |
| "The treatment of ventricular arrhythmias in the elderly population is a challenging problem." | 2.39 | Antiarrhythmic agents in older patients. Current state of knowledge. ( Akiyama, T; Daubert, JP; Kim, CH, 1994) |
| "Amiodarone was prescribed at a loading dose of 500 mg/m2 and at a maintenance dose of 250 mg/m2." | 2.39 | [Long-term efficacy and tolerability of amiodarone in children]. ( Bosser, G; Lethor, JP; Marçon, F; Worms, AM, 1995) |
| "Pharmacological therapy of cardiac arrhythmias continues to evolve, with an increasing shift from class I to class III compounds and beta-blockers." | 2.39 | Class III antiarrhythmic drugs. ( Ahmed, R; Singh, BN, 1994) |
| "The definition of proarrhythmia has changed since controlled clinical studies showed a dichotomy between arrhythmia suppression and mortality." | 2.39 | Proarrhythmia with class III antiarrhythmic drugs: definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implications. ( Hohnloser, SH; Singh, BN, 1995) |
| "The most important manifestation of proarrhythmia is sudden arrhythmic death." | 2.39 | What have clinical trials taught us about proarrhythmia? ( Green, MS; Skanes, AC, 1996) |
| "Patients with risk factors for sudden death, in particular those who have a severe impairment of left ventricular function and/or severe ischemia in the stress test, would be able to take advantage of a revascularization procedure when the culprit vessel remains occluded." | 2.39 | [Stratification of arrhythmia risk and therapeutic options in survivors of acute myocardial infarction]. ( Arós Borau, F; Loma-Osorio, A; Torres Bosco, A, 1996) |
| "When the arrhythmia is symptomatic (sustained ventricular tachycardia or ventricular fibrillation), class I antiarrhythmics are not effective enough in the prevention of sudden death; betablockers and amiodarone may give good results but should be compared with implantable defibrillators in the future." | 2.39 | [Anti-arrhythmic therapy and cardiac failure]. ( Babuty, D; Charniot, JC; Cosnay, P; Fauchier, JP; Fauchier, L, 1995) |
| "For some arrhythmias, such as atrial fibrillation, it seems likely that drug therapy will remain an important part of treatment." | 2.39 | Is there a need for new antiarrhythmic drugs? ( Roden, DM, 1996) |
| "The role of arrhythmias in the pathogenesis of sudden cardiac death in hypertrophic cardiomyopathy is reviewed together with the role of programmed ventricular stimulation." | 2.39 | Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathy. ( Camm, AJ; Slade, AK, 1996) |
| "Amiodarone is an unusual class III antiarrhythmic that produces each of the four main types of antiarrhythmic action in addition to other effects, such as vasodilatory, selective antithyroid, and other activities that may be therapeutically relevant." | 2.39 | Intravenous amiodarone: pharmacology, pharmacokinetics, and clinical use. ( Chow, MS, 1996) |
| "Ventricular arrhythmia hypothesis was based on the thought that the patients' prognosis would be improved by suppression of ventricular arrhythmias with antiarrhythmic agents." | 2.39 | [Arrhythmias with normal heart rate]. ( Matsuo, H; Segawa, K; Yoshimoto, N, 1996) |
| "Amiodarone is a viable drug for preventing sudden cardiac death, particularly during the first year after MI." | 2.38 | Amiodarone and post-MI patients. ( Nademanee, K; Singh, BN; Stevenson, WG; Weiss, JN, 1993) |
| " It should be stressed that the drug was administered at a low dosage level (200 mg/day) to 98 patients and did not cause serious side effects." | 2.38 | Secondary prevention after myocardial infarction with class III antiarrhythmic drugs. ( Ceremuzyński, L, 1993) |
| "Serum drug level monitoring facilitates dosage optimization of agents with a narrow therapeutic index." | 2.38 | The utility of serum drug level monitoring during therapy with class III antiarrhythmic agents. ( Follath, F, 1992) |
| "The Cardiac Arrhythmia Suppression Trial, which was designed to have the power to test the hypothesis that suppression of ventricular arrhythmias is associated with a decrease in mortality following myocardial infarction, even showed an increase in mortality with two drugs with class I activity." | 2.38 | [Mishaps with anti-arrhythmic agents used to reduce mortality after infarction]. ( Funck-Brentano, C, 1992) |
| "Torsades de pointes arrhythmia is an undesirable side-effect closely coupled to specific class-III action that may limit their future use." | 2.38 | [New anti-arrhythmia agents]. ( Honerjäger, P; Schmidt, G, 1992) |
| "Ventricular arrhythmias are a common accompaniment of CHF." | 2.38 | Clinical significance and management of arrhythmias in the heart failure patient. ( Greene, HL, 1992) |
| "Ventricular arrhythmias represented 13% of the rhythmic indications." | 2.38 | The value of oral amiodarone in the treatment of ventricular arrhythmias in heart disease. ( Levy, S, 1991) |
| "Amiodarone is a class III antiarrhythmic drug with sympatholytic properties, which prolongs the refractory period of all cardiac tissues, depresses sinus node automaticity and atrioventricular nodal conduction." | 2.38 | Practical aspects of the use of amiodarone. ( Puech, P, 1991) |
| "Amiodarone was also more beneficial than individual antiarrhythmic therapy (mortality 10/100 patients, 10%)." | 2.38 | [What is the latest in anti-arrhythmia therapy?]. ( Gloor, HO, 1991) |
| "Amiodarone is a unique antiarrhythmic agent originally developed as a vasodilator." | 2.38 | Pharmacology and pharmacokinetics of amiodarone. ( Freedman, MD; Somberg, JC, 1991) |
| "Benign arrhythmias occur in the setting of structurally normal hearts and do not require therapy unless associated with debilitating symptoms." | 2.38 | Clinical implications of new studies in the treatment of benign, potentially malignant and malignant ventricular arrhythmias. ( Anderson, JL, 1990) |
| "Amiodarone has been reported to cause asymptomatic increases in liver function tests in 15-55% of patients." | 2.38 | Hepatotoxicity associated with amiodarone therapy. ( Chase, SL; Flaharty, KK; Rubin, R; Yaghsezian, HM, 1989) |
| "Amiodarone is an antiarrhythmic agent with unique electrophysiological and pharmacokinetic properties and a wide spectrum of antiarrhythmic activity." | 2.38 | Amiodarone. ( Reddy, CP; Smith, WC, 1989) |
| "This article discusses arrhythmias in hypertrophic and dilated cardiomyopathy in relation to clinical significance and treatment; when possible, the authors comment on etiology." | 2.37 | Arrhythmias in dilated and hypertrophic cardiomyopathy. ( Goodwin, JF; Krikler, DM; McKenna, WJ, 1984) |
| "Amiodarone has a reduced clearance rate, large volume of distribution, low bioavailability and a long half-life that may last 2 months in patients receiving short-term therapy." | 2.37 | Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects. ( Heger, JJ; Prystowsky, EN; Zipes, DP, 1984) |
| " Serious adverse reactions necessitate a change in antiarrhythmic therapy, as opposed to lowering drug dosage to an ineffective level." | 2.37 | Antiarrhythmic drug therapy. Recent advances and current status. ( Somberg, J, 1985) |
| "The frequency of ventricular arrhythmias increases with age." | 2.37 | Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment. ( Morganroth, J; Nestico, PF, 1986) |
| "While treatment of ventricular arrhythmias is completely justifiable for patients with symptoms, their use to prevent sudden cardiac death has not yet been established." | 2.37 | Antiarrhythmic agents for chronic ventricular arrhythmias. ( Morganroth, J; Nestico, PF, 1987) |
| "They include progressive and acute mitral insufficiency, infective endocarditis, arrhythmias, motor or sensitive neurological complications, and sudden death." | 2.36 | [Idiopathic mitral valve prolapse]. ( Barbato, G; Martelli, M; Saponaro, A, 1983) |
| "Cardiac arrhythmias may be caused by abnormalities of impulse initiation, impulse propagation, or a combination of the two." | 2.36 | Electropharmacology of antiarrhythmic drugs. ( Rosen, MR; Wit, AL, 1983) |
| "Awake patients in ventricular fibrillation is a phenomenon limited to patients who are mechanically supported." | 1.91 | Stable Ventricular Fibrillation: A Paradigm Rather Than Septal Shift? ( Bracy, CL; Gupta, R; Hockstein, MA; Hockstein, MJ; Kobres, PY; Lam, PH; Rao, SD; Sheikh, FH, 2023) |
| "Ventricular tachycardia was detected by electrocardiography." | 1.72 | Primary hypothyroidism with an episode of ventricular tachycardia in a patient with COVID-19: A case report. ( Cheng, YC; Lee, IT; Liao, PH; Liu, PY, 2022) |
| "Eighty-four cases of ventricular arrhythmia-induced shock and ROSC (return of spontaneous circulation) were divided into the prior amiodarone or β-blockers use group (Aβ group, n = 27) and the non-amiodarone and non-β-blockers use group (non-Aβ group; n = 57) based on treatment before the onset of those arrhythmias." | 1.62 | Prognostic benefits of prior amiodarone or β-blocker use before the onset of ventricular arrhythmia with hemodynamic collapse. ( Nagao, K; Tachibana, E; Ueki, Y; Yamasaki, M; Yokoyama, M; Yonemoto, N; Yoshie, K, 2021) |
| "Atrial flutter (AFL) is an uncommon arrhythmia in the pediatric population." | 1.56 | Atrial Flutter-Unique Arrhythmia in Neonatal Population, Presentation of 3 Cases. ( Kędziora, P; Stasiak, A, 2020) |
| "Amiodarone effectively inhibit arrhythmia by improving the myocardial biomechanical properties and weakening the sensitivity of mechanical stretch stimulation." | 1.56 | Amiodarone inhibits arrhythmias in hypertensive rats by improving myocardial biomechanical properties. ( Han, D; He, Y; Li, X; Liu, Y; Nie, Y, 2020) |
| "Amiodarone has been used a first-line agent to treat ventricular arrhythmias post-LVAD implantation." | 1.51 | Left Ventricular Assist Device Thrombosis-Amiodarone-Induced Hyperthyroidism: Causal Link? ( Acharya, D; Hornbuckle, L; Joly, J; Pamboukian, S; Rajapreyar, I; Sharpton, J; Tallaj, J, 2019) |
| "Secondary endpoints comprised ES recurrences, rehospitalization, and major adverse cardiac events (MACE) at 4 years." | 1.51 | Impact of Different Pharmacotherapies on Long-Term Outcomes in Patients with Electrical Storm. ( Akin, I; Akin, M; Behnes, M; Bertsch, T; Bollow, A; Borggrefe, M; Ellguth, D; Engelke, N; Kim, SH; Mashayekhi, K; Müller, J; Nienaber, C; Reichelt, T; Reiser, L; Schupp, T; Taton, G, 2019) |
| "Amiodarone is a commonly used antiarrhythmic drug." | 1.51 | [Experts' suggestions of normative application of amiodarone]. ( , 2019) |
| "Idiopathic ventricular tachycardia: Frequent monomorphic premature ventricular contractions or non-sustained ventricular tachycardia without underlying structural heart disease is not a rare condition and may cause significant symptoms." | 1.48 | [Update Ventricular Tachycardia]. ( Fürnkranz, A; Makimoto, H, 2018) |
| "Amiodarone is a highly effective antiarrhythmic therapy, however its toxicity profile often limits treatment." | 1.48 | Adverse effects of amiodarone therapy in adults with congenital heart disease. ( Celermajer, DS; Cordina, RL; McGuire, MA; Moore, BM, 2018) |
| "Carvedilol is an effective additional therapy for the patients with chronic heart failure already receiving Amiodarone." | 1.46 | THE SAFETY AND EFFICACY OF AMIODARONE AND CARVEDILOL COMBINATION IN TREATMENT OF PATIENTS WITH SEVERE CARDIAC RHYTHM DISORDERS. ( Khintibidze, I; Tsetskhladze, E, 2017) |
| "Severe ventricular arrhythmias are frequent during heart failure; they are a life-threatening condition due to the increased risk of sudden death." | 1.46 | [Severe ventricular arrhythmias in a patient with dilated cardiomyopathy and automated implantable defibrillator (AID)]. ( Ellenga-Mbolla, B; Gombet, TR; Ikama, SM; Kimbally-Kaky, G; Makani, J; Ondze-Kafata, LI, 2017) |
| "The goal of this study was to evaluate the number and frequency of adverse effects in a population of clinical canine patients receiving Nexterone." | 1.43 | Retrospective evaluation of intravenous premixed amiodarone use and adverse effects in dogs (17 cases: 2011-2014). ( Koenigshof, AM; Levy, NA; Sanders, RA, 2016) |
| "Amiodarone is known to cause a slate grey pigmentation of skin and cornea, but we believe this is the first report of amiodarone-induced pigmentation of the synovium." | 1.43 | Intra-Articular Pigmentation of Synovium: An Unusual Cause. ( Hamilton, S; Liew, SM; Verma, S, 2016) |
| " These antiarrhythmic medications can cause undesirable adverse outcomes in the intensive care setting." | 1.42 | Evaluating the Safety of Intraoperative Antiarrhythmics in Pediatric Cardiac Surgery Patients. ( Beaty, RS; Hall, S; Kim, J; Moffett, BS, 2015) |
| "Amiodarone-induced SIADH is a rare but serious side effect of this drug." | 1.40 | Amiodarone-induced SIADH: two cases report. ( Giagulli, VA; Guastamacchia, E; Iacoviello, M; Iovine, N; Iovino, M; Licchelli, B; Petrosino, A; Triggiani, V, 2014) |
| "The score of arrhythmia severity also decreased, but was statistically significant only in the Amio group (p < 0." | 1.40 | Efficacy of Melissa officinalis in suppressing ventricular arrhythmias following ischemia-reperfusion of the heart: a comparison with amiodarone. ( Bashiri, A; Joukar, S; Sepehri, G; Zarisfi, Z, 2014) |
| "Sheep experiencing life-threatening arrhythmias, most commonly ventricular fibrillation, were either resuscitated according to operator-driven instructions or the standardized protocol." | 1.39 | Benefits of standardizing the treatment of arrhythmias in the sheep (Ovis aries) model of chronic heart failure after myocardial infarction. ( Cheng, Y; Conditt, GB; Dardenne, A; Feeney, WP; Fernandez, C; Granada, JF; Kaluza, GL; Milewski, K; Mount, PA; Ordanes, DR; Tellez, A; Wagner, A; Yi, GH, 2013) |
| " DFT testing after initiation of amiodarone was safe as there were no complications that led to a prolonged hospital stay." | 1.38 | Evaluation of defibrillation safety margin in modern implantable cardioverter defibrillators after administration of amiodarone. ( Breithardt, G; Dechering, DG; Eckardt, L; Köbe, J; Reinke, F, 2012) |
| " Analysis of the pharmacokinetics of AMD was accomplished using a 1-compartment open pharmacokinetic model." | 1.37 | Population pharmacokinetic investigation for optimization of amiodarone therapy in Japanese patients. ( Araki, R; Fukuchi, H; Nakashima, M; Nakashima, MN; Sasaki, H; Yano, K; Yukawa, E, 2011) |
| "Cardiac arrhythmias include problems with impulse formation and/or conduction abnormalities." | 1.36 | Evolving cardiac conduction phenotypes in developing zebrafish larvae: implications to drug sensitivity. ( Adlerz, K; Chen, JN; Chi, N; Hamdan, MH; Hsiai, TK; Huang, J; Jadvar, H; Yu, F, 2010) |
| "Treatment with amiodarone solution containing high concentration of calcium had a lower potentiating effect compared with that of perfusion with either of them." | 1.35 | [Possible role of sarcoplasmatic reticulum in anti-arrhythmic effects of the class III agent amiodarone]. ( Afanas'ev, SA; Falaleeva, LP; Kondrat'eva, DS; Popov, SV, 2009) |
| " Compared with patients without AITD, there was no difference regarding dosage or duration of therapy, heart rhythm disorder or baseline cardiac condition." | 1.35 | How frequently should a patient taking amiodarone be screened for thyroid dysfunction? ( Campos, D; de Jesus, AM; Maciel, BC; Maciel, LM; Magalhães, PK; Melato, LH; Pazin-Filho, A, 2009) |
| " The secondary endpoint was the frequency of warfarin dosage changes." | 1.35 | Characteristics of the amiodarone-warfarin interaction during long-term follow-up. ( Asinger, RW; Lu, Y; Nelson, BJ; Qi, D; Rausch, DJ; Won, KA, 2008) |
| "Mapping of arrhythmias was performed with both systems when possible." | 1.34 | Comparison of noncontact and electroanatomic mapping to identify scar and arrhythmia late after the Fontan procedure. ( Abrams, DJ; Cullen, S; Deanfield, JE; Earley, MJ; Gatzoulis, MA; Kistler, PM; Lowe, MD; Mullen, MJ; Schilling, RJ; Sporton, SC; Till, JA; Walker, F, 2007) |
| "Amiodarone and sotalol were found to have a neutral effect on survival." | 1.33 | Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators. ( Ho, AT; Pai, RG; Pai, SM; Timothy, P, 2005) |
| "To establish a novel arrhythmia model in rats." | 1.33 | [Establishment of a novel arrhythmia model in rats]. ( Dong, DL; Du, ZM; Jiao, JD; Pan, ZW; Wang, ZY; Yang, BF, 2005) |
| "0) for the maximal plasma concentration and the area under the curve during the dosing interval for both amiodarone and desethylamiodarone, tolvaptan coadministration had no effect on either amiodarone and desethylamiodarone disposition, as all the geometric mean ratios (amiodarone + tolvaptan [30 or 90 mg] vs amiodarone alone) were approximately 1." | 1.33 | Tolvaptan administration does not affect steady state amiodarone concentrations in patients with cardiac arrhythmias. ( Barbagelata, NA; Bramer, SL; Elizari, MV; Grinfeld, LR; Lerman, J; Orlandi, C; Sekar, K; Shoaf, SE; Trongé, J; Wang, Z, 2005) |
| "All arrhythmias were treated successfully by pacemaker/ICD implantation, radiofrequency catheter ablation and/or medications." | 1.33 | The utility of implantable loop recorders for diagnosing unexplained syncope in 100 consecutive patients: five-year, single-center experience. ( Cohen, T; Inamdar, V; Juang, G; Mehta, S, 2006) |
| "After 10 h a ruptured abdominal aortic aneurysm was diagnosed and the patient underwent implantation of an aorto-bi-iliac Y-prosthesis." | 1.33 | QT prolongation due to aortic aneurysm rupture and amiodarone in a patient with a H558R polymorphism in the cardiac sodium channel gene SCN5A. ( Chen, S; Finsterer, J; Steger, C; Stöllberger, C; Wang, Q; Yilmaz-Kaymaz, N, 2006) |
| "The same changes and cardiac arrhythmias are characteristic of second-degree hypopolarization." | 1.33 | Simulation of cardiac hypopolarization arrhythmias and evaluation of cardiomyocyte membrane hypopolarization in experimental animals. ( Lipnitskii, TN; Moroz, VM, 2006) |
| "Examining the course of cardiac arrhythmias (CA) in developed TT has established that this condition gives rise to their recurrence." | 1.32 | [The specific features of thyrotoxicosis and euthyroid hyperthyroxinemia developed due to the use of cordarone]. ( Bakalov, SA; Domogadskiĭ, SP; Golitsyn, SP; Kolesnikova, GS; Masenko, VP; Molashenko, NV; Platonova, NM; Serdiuk, SE; Sviridenko, NIu, 2004) |
| "Amiodarone therapy was then discontinued, but there was no considerable improvement and after 6 weeks visual loss occurred in the left eye as well." | 1.31 | [First unilateral, later bilateral optic neuropathy. Amiodarone as the cause?]. ( Gerke, E; Uebermuth, CA, 2002) |
| "Flutter-like arrhythmias occur mainly after atrial surgery (closure of atrial septal defects, Mustard, Senning or Fontan procedures)." | 1.31 | [Arrhythmias after surgery for congenital heart disease]. ( Lucet, V, 2002) |
| "The initial arrhythmia was 2/1 atrial flutter (n = 4), 1/1 atrial flutter (n = 2) and atrial fibrillation (n = 1)." | 1.31 | [Atrial flutter with 1/1 nodo-ventricular conduction with amiodarone. From physiopathology to diagnosis]. ( Aouate, P; Dubois-Randé, JL; Elbaz, N; Fontaine, G; Frank, R; Klug, D; Lacotte, J; Lelouche, D; Raguin, D; Tonet, J, 2002) |
| "We report cases of serious arrhythmias associated with apical hypertrophic cardiomyopathy (AHCM)." | 1.31 | Serious arrhythmias in patients with apical hypertrophic cardiomyopathy. ( Azegami, K; Itoh, K; Okishige, K; Sasano, T; Suzuki, K; Yano, K, 2001) |
| "D-sotalol and almokalant evoked torsade de pointes (TdP) and other arrhythmics, frequently." | 1.31 | Proarrhythmic effects of intravenous quinidine, amiodarone, D-sotalol, and almokalant in the anesthetized rabbit model of torsade de pointes. ( Farkas, A; Leprán, I; Papp, JG, 2002) |
| "Amiodarone has pharmacokinetic interactions with various therapeutic agents, including phenytoin, flecainide, and cyclosporine." | 1.31 | Lack of interaction between amiodarone and mexiletine in cardiac arrhythmia patients. ( Hashimoto, H; Kamakura, S; Komamura, K; Matsumoto, K; Miyatake, K; Tachibana, M; Tanaka, K; Ueno, K; Yonezawa, E, 2002) |
| "Amiodarone was administered by i." | 1.30 | Acute effects of intravenous amiodarone on sulphate metabolites of thyroid hormones in arrhythmic patients. ( Biagini, A; Chopra, IJ; Clerico, A; Iervasi, G; Manfredi, C; Sabatino, L, 1997) |
| "Although syncope is a frequent clinical entity, the evaluation and treatment of patients with syncope without a clear etiology still remains undefined." | 1.30 | [Patients with structural heart disease, syncope of unknown etiology and inducible ventricular arrhythmias treated with implantable defibrillators]. ( Aguinaga, L; Anguera, I; Brugada, J; Matas, M; Mont, L; Valentino, M, 1998) |
| "For patients with an ICD, infrequent arrhythmias and a low probability of inappropriate device discharges, no antiarrhythmic therapy is required." | 1.30 | Implantable defibrillators and/or amiodarone: alternatives or complementary therapies. ( Dorian, P; Greene, M; Newman, D, 1998) |
| " However, because the discoloration developed before surgery and was bilateral, long-term administration of amiodarone may also have played a role." | 1.30 | Progressive brown discoloration of silicone intraocular lenses after vitrectomy in a patient on amiodarone. ( Katai, N; Yokoyama, R; Yoshimura, N, 1999) |
| "Amiodarone is a potent antiarrhythmic agent that is also frequently used in the treatment of patients with refractory ventricular arrhythmias." | 1.29 | Can amiodarone pulmonary toxicity be predicted in patients undergoing implantable cardioverter defibrillator implantation? ( Damiano, RJ; Ellenbogen, KA; Hawthorne, HR; Stambler, BS; Wood, MA, 1993) |
| "Noncardiovascular adverse effects associated with amiodarone result in substantial morbidity." | 1.29 | Risk factors for the development of specific noncardiovascular adverse effects associated with amiodarone. ( Follin, SL; Ordelova, A; Tisdale, JE; Webb, CR, 1995) |
| "It is stated that CHD patients with arrhythmia develop latent hypothyrosis of T3-low-syndrome type." | 1.29 | [The effect of kordaron on thyroid function in patients with ischemic heart disease]. ( Tereshchenko, IV; Tsepelev, VV, 1995) |
| "Amiodarone hydrochloride is a potent antiarrhythmic agent recently approved for use by the Food and Drug Administration." | 1.29 | Progression of amiodarone induced cataracts. ( Dolan, BJ; Flach, AJ, 1993) |
| "45), daily digoxin dosage of > or = 0." | 1.29 | The impact of age on risk of adverse drug reactions to digoxin. For The Gruppo Italiano di Farmacovigilanza nell' Anziano. ( Bernabei, R; Carbonin, P; Carosella, L; Gambassi, G; Guralnik, JM; Pahor, M, 1993) |
| "Occurrence rates of arrhythmias treated with drugs tested for efficacy either by suppression of inducible arrhythmias or by suppression of spontaneous ectopy were higher and equivalent for both testing methods." | 1.29 | From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials. ( Lazzara, R, 1996) |
| "The duration of arrhythmias induced by reperfusion following 5 min of ischaemia was also less in the rats which had received amiodarone than in the controls (43." | 1.28 | Amiodarone, adrenoceptor responsiveness and ischaemia- and reperfusion-induced arrhythmias. ( Chess-Williams, R; Coker, SJ, 1991) |
| "Amiodarone was clinically useful in 32 (68%) patients." | 1.28 | Use of amiodarone for short-term and adjuvant therapy in young patients. ( Benson, DW; Deal, BJ; Pongiglione, G; Strasburger, JF, 1991) |
| "Amiodarone proved to be an effective drug also for the long-term treatment of ventricular tachycardia, and possibly for the prevention of sudden cardiac death." | 1.28 | [Long-term treatment with amiodarone]. ( Baedeker, W; Barthel, P; Blömer, H; Goedel-Meinen, L; Hofmann, M; Schmidt, G, 1991) |
| "Amiodarone has been shown to interact with the nongenetically determined hepatic elimination of several drugs, including phenytoin and digoxin." | 1.28 | Influence of amiodarone on genetically determined drug metabolism in humans. ( Funck-Brentano, C; Jacqz-Aigrain, E; Jaillon, P; Leenhardt, A; Poirier, JM; Roux, A, 1991) |
| "The treatment of atrial arrhythmias remains traditional: reduction by drugs or electrotherapy and prevention of recurrences, or simply slowing the ventricular response." | 1.28 | [Treatment of arrhythmias in chronic cardiac insufficiency]. ( Drieu, L; Motté, G; Slama, M, 1990) |
| "With amiodarone, VT was no longer inducible or was more difficult to induce in 11 patients (31%), and the drug abolished VT during Holter monitoring in all patients." | 1.28 | Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with amiodarone. ( Epstein, SE; Fananapazir, L, 1991) |
| " A standardized dosing regimen (cumulative dose 10." | 1.28 | Plasma concentration time course and pharmacological effects of a standardized oral amiodarone dosing regimen in humans. ( Armstrong, PW; Brennan, FJ; Brien, JF, 1991) |
| "Desethylamiodarone was more toxic than amiodarone in the cultured hepatocytes." | 1.28 | Amiodarone- and desethylamiodarone-induced myelinoid inclusion bodies and toxicity in cultured rat hepatocytes. ( Bandyopadhyay, S; Gross, SA; Klaunig, JE; Somani, P, 1990) |
| "3." | 1.28 | Effect of amiodarone on erythrocyte shape and membrane properties. ( Reinhart, WH; Rohner, F, 1990) |
| " Chronic administration of oral cordarone in doses of 200 to 300 mg a day had a low effect on cardiac hemodynamic parameters." | 1.28 | [Effects of cordarone on the contractile function of the left ventricle]. ( Pavlov, AV, 1990) |
| " The mean maintenance dosage was 7." | 1.28 | Long-term follow-up of amiodarone therapy in the young: continued efficacy, unimpaired growth, moderate side effects. ( Garson, A; Guccione, P; Paul, T, 1990) |
| "The presence of a left bundle branch block (LBBB) may hamper the electrocardiographic diagnosis of diseases that involve the QRS complexes." | 1.28 | [Drug-induced major anomalies of ventricular repolarization masked by a left branch block]. ( Dujardin, JJ; Haiat, R; Joly, P; Kacet, S; Nicolai, P, 1989) |
| "When amiodarone was not employed, as a first choice, in conformity with a specific protocol, it was utilized as a second choice after verapamil or flecainide." | 1.28 | [Supraventricular tachyarrhythmia of recent onset in the absence of documented cardiac pathology: different therapeutic approaches]. ( Bechi, S; Cordoni, M; Franchini, C; Mazza, F; Micheli, G; Scalzini, A, 1989) |
| "Amiodarone was particularly effective in suppressing complex ventricular arrhythmias." | 1.28 | Long term efficacy and toxicity of amiodarone in the treatment of refractory cardiac arrhythmias. ( Agha, A; Giorgi, C; Nadeau, R; Primeau, R; Shenasa, M, 1989) |
| "Amiodarone (Cordarone) is an antiarrhythmic drug that may cause toxic pulmonary reactions." | 1.28 | [Pneumonitis following amiodarone therapy]. ( Cleeren, P; Denis, L; Reymen, I, 1989) |
| "In amiodarone-treated patients, the major findings were as follows: a 50% incidence of hepatic dysfunction with a tenfold increase in concentrations of serum glutamic-oxaloacetic transaminase and serum glutamic-pyruvic transaminase; a 25% incidence of pulmonary dysfunction necessitating a fourfold increase in the number of days of ventilator support; and a 19% incidence of low cardiac output syndrome with two deaths." | 1.28 | Amiodarone-induced complications after cardiac operation for obstructive hypertrophic cardiomyopathy. ( Clark, RE; Kupferschmid, JP; Leon, MB; McIntosh, CL; Rosengart, TK, 1989) |
| "In 29 patients with cardiac arrhythmias, refractory periods (RP) of the atrium, atrioventricular node and ventricle were defined before and after intravenous administration of cordarone in a dose of 5 mg/kg body weight." | 1.28 | [Myocardial refractory changes after single intravenous administration of cordarone (electrophysiologic study of the heart)]. ( Grishkin, IuN, 1989) |
| "Amiodarone hydrochloride is a relatively new antiarrhythmic agent, the properties of which differ in a significant manner electrophysiologically, pharmacokinetically and structurally from those of conventional as well as other investigational antidysrhythmic compounds." | 1.27 | The clinical results of amiodarone in cardiac arrhythmias: optimal dosing. ( Ikeda, N; Kannan, R; Nademanee, K; Singh, BN, 1984) |
| "Propafenone was less effective (mean effect 3." | 1.27 | European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias. ( Assayag, P; Coumel, P; Leclercq, JF, 1984) |
| "The amiodarone was withdrawn." | 1.27 | Neuropathy and fatal hepatitis in a patient receiving amiodarone. ( Hole, DW; Lim, PK; Storey, GC; Trewby, PN, 1984) |
| "Hypothyroidism was diagnosed in 11 patients (12%), and a further 11 had tests consistent with a "failing thyroid." | 1.27 | Effect of amiodarone on thyroid hormone economy. ( Glick, S; Posner, J; Sobel, RJ, 1984) |
| "A worsening of arrhythmias was observed in 4/101 (3." | 1.27 | Worsening of arrhythmias during pharmacological treatment. ( Bettini, R; Dal Forno, P; Disertori, M; Furlanello, F; Gramegna, L; Inama, G; Vergara, G, 1984) |
| "Oral amiodarone is a potent antiarrhythmic agent with a slow onset of action." | 1.27 | Electrophysiologic effects of amiodarone: experimental and clinical observation relative to serum and tissue drug concentrations. ( Ikeda, N; Kannan, R; Nademanee, K; Singh, BN, 1984) |
| "At the time of the second study congestive heart failure was manifest in 19%, and there was a trend suggesting that congestive heart failure was more likely if the initial LVEF was less than or equal to 35% (p = 0." | 1.27 | Effect of amiodarone on ventricular function as measured by gated radionuclide angiography. ( Gorham, JR; Graham, EL; Greene, HL; Gross, BW; Kingston, E; Kudenchuk, PJ; Sears, GK; Trobaugh, GB; Tutt, RC; Werner, JA, 1984) |
| "Amiodarone is a very active antiarrhythmic agent, but true incidence of Amiodarone-related side effects is still questionable." | 1.27 | Side effects during therapy with low dosage amiodarone. ( Beck Peccoz, P; Ferrario, G; Galletti, F; Giani, P; Landolina, M; Maggioni, AP; Piscitelli, G; Tognoni, G; Volpi, A, 1984) |
| "under AM therapy the initial arrhythmias were no longer detectable in 41% of the patients." | 1.27 | [Antiarrhythmic effect and side effects of amiodarone]. ( Haddad, R; Konrad, K; Mainitz, M; Mlczoch, J; Probst, P; Scheibelhofer, W; Weber, H; Weissel, M, 1984) |
| " On the other hand digitalis administered according to age, sex, weight, kidney function, together with amiodarone, can be given at full dosage in patients without cardiac failure." | 1.27 | [Pharmacological and clinical research on the interaction of digitalis and amiodarone in heart disease patients with varying degrees of cardiac insufficiency]. ( Aquili, C; Ferrari, M; Fornaro, G; Fortina, A; Padrini, R; Piovan, D; Rossi, P; Tomassini, G, 1984) |
| "Amiodarone was therefore studied in 40 consecutive patients (with previous cardiac arrests) in whom conventional antiarrhythmic therapy had proved ineffective or was not tolerated." | 1.27 | Control of sudden recurrent arrhythmic deaths: role of amiodarone. ( Cannom, DS; Feld, G; Nademanee, K; Singh, BN; Stevenson, WG; Weiss, J, 1983) |
| "The available data concerning amiodarone dosing may be summarized as follows: (1) there is an empirically demonstrated improvement in lag before onset of antiarrhythmic effect if amiodarone is given initially in large "loading" doses." | 1.27 | Amiodarone dosing: a proposal based on its pharmacokinetics. ( McAllister, CB; Roden, DM; Siddoway, LA; Wilkinson, GR; Woosley, RL, 1983) |
| "Ventricular tachycardia is detected during electrocardiographic monitoring in 20 to 30% of patients; this arrhythmia is a sensitive but non-specific marker of those patients who are at particular risk of sudden death." | 1.27 | Arrhythmia and prognosis in hypertrophic cardiomyopathy. ( McKenna, WJ, 1983) |
| "To our knowledge, this recurrence of amiodarone pulmonary toxicity has not been reported previously." | 1.27 | Possible recurrence of amiodarone pulmonary toxicity following corticosteroid therapy. ( Cole, S; Conway, M; Joelson, J; Kluger, J, 1984) |
| "The atrial tachyarrhythmias were successfully controlled in 45 of 54 patients (83%) during a mean follow-up of 10." | 1.27 | Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias. ( Alpert, JS; Asdourian, G; Canada, AT; Haffajee, CI; Lesko, LJ; Love, JC, 1983) |
| "Control of arrhythmias was satisfactory in all 12 evaluable patients, when the serum amiodarone level exceeded 1." | 1.27 | Serum concentrations of amiodarone during long term therapy. Relation to dose, efficacy and toxicity. ( Bircher, J; Galeazzi, RL; Remund, H; Stäubli, M; Studer, H, 1983) |
| "The authors studied 13 cases of arrhythmia following pneumonectomy in a series of 94 pneumonectomies performed in the Thoracic Surgery Unit." | 1.27 | [Cardiac rhythm disorders after pneumonectomy]. ( Debesse, B; Dumouchel, A; Hubsch, JP; Zukerman, C, 1985) |
| "Association of long QT with arrhythmia does not, therefore, invalidate the principle that homogeneously prolonged APD should be anti-arrhythmic." | 1.27 | Delayed ventricular repolarization as an anti-arrhythmic principle. ( Vaughan Williams, EM, 1985) |
| "The prevalence of ventricular arrhythmias was not different before and after the pacemaker implantation." | 1.27 | [Arrhythmia in patients with a DDD bicameral pacemaker]. ( Magnani, A; Occhetta, E; Perucca, A; Prando, MD; Rognoni, G; Rossi, L; Rossi, P, 1986) |
| "The potential antiarrhythmic and electrophysiological effects of prolonged oral dosing with amiodarone (20 mg/kg/day) or disopyramide (25 or 50 mg/kg b." | 1.27 | Effects of diet-induced hypokalaemia on the antiarrhythmic and electrophysiological actions of prolonged oral treatment with either amiodarone or disopyramide in the anaesthetised rat. ( Hope, FG; Marshall, RJ; Winslow, E, 1987) |
| "Amiodarone was administered in a loading dose of 1." | 1.27 | Treatment of ventricular arrhythmia after corrective cardiac surgery in a neonate with intravenous amiodarone. ( Bogers, AJ; Huysmans, HA; Ottenkamp, J; Quaegebeur, JM, 1987) |
| "Amiodarone has a good antiarrhythmic effect administered either acutely or chronically." | 1.27 | [Acute antiarrhythmia treatment with amiodarone and blood levels of thyroid hormones]. ( Fazzini, PF; Gheri, RG; Marchi, F; Multinu, D; Paladini, S; Zambaldi, G, 1987) |
| "The mechanisms underlying the cause of sudden death have not been clearly elucidated." | 1.27 | [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences]. ( Kleinebenne, A; McKenna, WJ, 1985) |
| " Also, no difference in efficacy of either drug was observed and changes in dosing of digoxin were not required." | 1.27 | Drug interaction studies and encainide use in renal and hepatic impairment. ( Gallo, DG; Quart, BD; Sami, MH; Wood, AJ, 1986) |
| "Amiodarone is a widely used antiarrhythmic drug, which contains 75 mg of iodide per 200 mg of active substance." | 1.27 | Amiodarone-induced hypothyroidism. A common complication of prolonged therapy: a report of eight cases. ( Atkinson, AB; Campbell, NP; Ferguson, WR; Geddes, JS; Hawthorne, GC; Postlethwaite, W; Sheridan, B, 1985) |
| "The presence of ventricular arrhythmias was related to the severity of left ventricular dysfunction, exercise intolerance, and neurohormonal activation, suggesting that such arrhythmias are multifactorial in origin and may not simply be related to electrolyte abnormalities." | 1.27 | Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure. ( Cleland, JG; Dargie, HJ; East, BW; Ford, I; Inglis, CG; Leckie, BJ, 1987) |
| "Propafenone has significantly improved our ability to control postoperative JET." | 1.27 | Newer antiarrhythmic drugs in children. ( Garson, A; Moak, JP; Smith, RT, 1987) |
| " However, this association could interact with these drugs because amiodarone appears to have a definite action on the kinetics of several cardiovascular drugs." | 1.27 | Amiodarone drug interactions: potential beneficial and adverse effects. ( Fontaine, G, 1987) |
| "Nonetheless, arrhythmias in these patients were by no means abolished despite correction of these neuroendocrine and electrolyte abnormalities." | 1.27 | Arrhythmias in heart failure--the role of amiodarone. ( Cleland, JG; Dargie, HJ, 1988) |
| "Amiodarone has been reported to be a remarkably safe and effective drug in the European and South American experience but American investigators have published conflicting data." | 1.27 | Safety and efficacy of amiodarone. The low-dose perspective. ( Friehling, TD; Kowey, PR; Marinchak, RA; Stohler, JL; Sulpizi, AM, 1988) |
| "Amiodarone is a powerful anti-arrhythmic drug." | 1.27 | Noncardiac side-effects of long-term oral amiodarone in the elderly. ( Bailey, RJ; Hyatt, RH; Martin, A; Sinha, B; Vallon, A, 1988) |
| "70% of cases) in hypertrophic cardiomyopathy is well recognized: episodes of ventricular tachycardia are present in 20% of cases and are related to an elevated risk of sudden death." | 1.27 | [Ambulatory ECG in cardiomyopathies]. ( Camerini, F; Di Lenarda, A; Mestroni, L; Miani, D; Neri, R, 1987) |
| "In a model of arrhythmias induced by anoxic stress in rats, all the tested compounds were found active, with prifuroline and disopyramide providing complete protection at high dose levels." | 1.27 | Antiarrhythmic and hemodynamic effects of prifuroline. ( Benharkate, M; Legeai, J; Plassard, G; Worcel, M, 1986) |
| " Sixty-three patients (55%) had one or more adverse effects attributed to amiodarone." | 1.27 | Relation between amiodarone and desethylamiodarone plasma concentrations and electrophysiologic effects, efficacy and toxicity. ( DiMarco, JP; Greenberg, ML; Kaiser, DL; Lerman, BB; Shipe, JR, 1987) |
| "Amiodarone was also discontinued in 2 other cases (4%) with elevated thyroid function indices but without clinical symptoms." | 1.27 | Alterations in thyroid function induced by chronic administration of amiodarone. ( Cavagnini, F; Dubini, D; Massari, D; Rumolo, R; Tronci, M; Vitolo, E, 1987) |
| "Ventricular arrhythmias could be induced in 69% of patients with aborted sudden death but inducibility could be suppressed in only 20% of them." | 1.27 | Electrophysiologic testing and follow-up of patients with aborted sudden death. ( Eldar, M; Sauve, MJ; Scheinman, MM, 1987) |
| "Thirty-three patients treated with an abbreviated oral amiodarone loading regimen for ventricular tachycardia underwent electrophysiologic testing in the control state, after 1 week of high-dose (1170 +/- 88 mg/day) inpatient therapy; and after an 8-week intermediate (669 +/- 129 mg/day) dosing phase." | 1.27 | Dissociation of electrophysiologic and pharmacologic stability during an abbreviated oral loading regimen of amiodarone. ( Batsford, WP; Bookbinder, MJ; Kennedy, EE; McPherson, CA; Perlmutter, RA; Rosenfeld, LF, 1987) |
| "Amiodarone was used for recurrent supraventricular tachycardia in four cases and frequent ventricular extra systoles complicating congenital QT prolongation in the remaining case." | 1.27 | Amiodarone-induced torsades de pointes. ( Brown, MA; Lubbe, WF; Norris, RM; Smith, WM, 1986) |
| "Amiodarone, a drug that has electrophysiologic actions resembling those of hypothyroidism, increases serum levels of T4 and reverse T3 (rT3) and decreases T3." | 1.27 | Amiodarone, thyroid hormone indexes, and altered thyroid function: long-term serial effects in patients with cardiac arrhythmias. ( Callahan, B; Hendrickson, JA; Hershman, JM; Nademanee, K; Singh, BN, 1986) |
| "Ventricular arrhythmias were present in 62 (95." | 1.27 | Ventricular arrhythmias in dilated cardiomyopathy: efficacy of amiodarone. ( Camerini, F; Mestroni, L; Neri, R; Pandullo, C; Salvi, A, 1987) |
| " Plasma pharmacokinetic profile was determined and the calculated t1/2 beta of 3." | 1.27 | Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion. ( McManus, K; Simon, VA; Somani, P, 1985) |
| "Fetal cardiac arrhythmias are usually first suspected on the basis of auscultatory findings during routine examination in pregnancy." | 1.27 | Treatment of fetal cardiac arrhythmias. ( Stewart, PA; Wladimiroff, JW, 1985) |
| "Thirty-one patients had ventricular arrhythmias (ventricular extrasystoles, VES, isolated or in salvos: 22 cases, and ventricular tachycardia, VT: 19 cases)." | 1.27 | [Anti-arrhythmic effect of amiodarone in the 24 hours following a single oral loading dose. Clinical and pharmacological study]. ( Coumel, P; Escoubet, B; Jaillon, P; Leclercq, JF; Maison-Blanche, P; Poirier, JM; Slama, R, 1985) |
| "Amiodarone is an antiarrhythmic agent known to cause prolongation of action potential duration which is reflected in the electrocardiogram as a prolongation of the QT interval." | 1.27 | QT prolongation and the antiarrhythmic efficacy of amiodarone. ( Flowers, D; Keefe, D; Lam, S; Miura, DS; Somberg, JC; Tepper, D; Torres, V; Wynn, J, 1986) |
| "Amiodarone was the only one of the four drugs that caused a substantial reduction of ventricular premature complexes (logarithmic mean 97." | 1.27 | Comparative antiarrhythmic efficacy of verapamil, 17-monochloracetylajmaline, mexiletine and amiodarone in patients with severe chagasic myocarditis: relation with the underlying arrhythmogenic mechanisms. ( Bandieri, JD; Chiale, PA; Elizari, MV; Haedo, AH; Lázzari, JO; Rosenbaum, MB, 1986) |
| "Oral amiodarone therapy was given to seven patients already taking oral flecainide regularly." | 1.27 | Flecainide and amiodarone interaction. ( Kim, SS; Lal, R; Ruffy, R; Schechtman, K; Shea, P, 1986) |
| "The time to optimal ventricular arrhythmia control was shorter for group B (20 +/- 18 vs 105 +/- 83 days, p less than 0." | 1.27 | Intravenous and oral loading versus oral loading alone with amiodarone for chronic refractory ventricular arrhythmias. ( Blevins, RD; Faitel, K; Frumin, H; Kerin, NZ; Rubenfire, M, 1985) |
| "Protection from arrhythmias seems to be related to the combined presence of a noncompetitive adrenergic blockade associated with salutary effects on coronary circulation." | 1.27 | The effect of antiarrhythmic drugs on life-threatening arrhythmias induced by the interaction between acute myocardial ischemia and sympathetic hyperactivity. ( Schwartz, PJ; Vanoli, E; Zaza, A; Zuanetti, G, 1985) |
| "Amiodarone has been used in the therapy of supraventricular and ventricular tachycardia, and has often been categorised as a class III rather than a class I agent." | 1.27 | Amiodarone treatment in patients with ventricular arrhythmias. ( Heger, JJ; Miles, WM; Prystowsky, EN; Zipes, DP, 1985) |
| "cent of cases of supraventricular arrhythmia and in 92." | 1.27 | [Efficacy and side effects of long-term treatment with amiodarone. Retrospective study. Apropos of 460 cases]. ( Farges, D; Fontaine, G; Frank, R; Grosgogeat, Y; Komajda, M; Michat, L, 1985) |
| "In the MVP group, the following arrhythmias were induced: nonsustained polymorphic VT in 10, VF in three, and ventricular flutter in one." | 1.27 | The yield of programmed ventricular stimulation in mitral valve prolapse patients with ventricular arrhythmias. ( Gang, ES; Hamer, A; Mandel, WJ; Oseran, DS; Peter, T; Rosenthal, ME, 1985) |
| "After treatment of ischemia and/or failure, specific antiarrhythmic agents, conventional and investigational, alone or in combination, are systematically selected." | 1.26 | Ventricular ectopy: etiology, evaluation, and therapy. ( Reid, PR; Vlay, SC, 1982) |
| "Oral amiodarone was evaluated in 24 patients with complex forms of ventricular premature depolarizations (VPD) by means of ECG monitoring and measurement of systolic time intervals." | 1.26 | Oral amiodarone in high-risk ventricular arrhythmias. ( Cabrera-Alonso, C; García-Barreto, D; González-Gómez, A; Hernández-Cañero, A; Llerena, L; Ramos-Emperador, C; Sellén, J; Toruncha, A, 1982) |
| "Amiodarone i." | 1.26 | [Experience with intravenous amiodarone in hyperkinetic supraventricular arrhythmias]. ( Bianchi, C; Bonifazi, C; Coppetti, S; Distante, S; Ferrari, O; Ricevuti, A; Rinaldo, R; Rizzi, M; Tavecchi, L; Zampaglione, G; Ziletti, G, 1981) |
| "Oral amiodarone was given to 135 children (mean age, 10." | 1.26 | Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases. ( Coumel, P; Fidelle, J, 1980) |
| "Amiodarone was administered in five patients with life-threatening ventricular arrhythmias resistant to other antiarrhythmic agents: Suppression was obtained in one of two patients with recurrent ventricular tachycardias and control was achieved in three patients with repetitive ventricular tachycardia and ventricular fibrillation, allowing the effective use of intra-aortic balloon counterpulsation (IABP) needed for hemodynamic support." | 1.26 | Intravenous amiodarone in the treatment of various arrhythmias following cardiac operations. ( Charles, S; Gadisseux, P; Installe, E; Schoevaerdts, JC; Tremouroux, J, 1981) |
| "Frequent ventricular arrhythmias were recorded in 58 p." | 1.26 | [Continuous ambulatory electrocardiographic recordings using the Holter system in the late phase of hospitalization for recent myocardial infarct. Value and limitations studied in a series of 100 patients]. ( Alibelli, MJ; Baradat, G; Berthoumieu, H; Constans, R; Dardenne, P; Marco, J, 1979) |
| "Provided the arrhythmia is stable, this method allows an estimation of the onset and duration of action of the drug and gives guidelines for the choice of an appropriate drug regimen." | 1.26 | [Quantitative evaluation of the efficacy of anti-arrhythmia agents in chronic ventricular arrhythmia]. ( Attuel, P; Coumel, P; Leclercq, JF; Milosevic, D, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 473 (44.12) | 18.7374 |
| 1990's | 253 (23.60) | 18.2507 |
| 2000's | 188 (17.54) | 29.6817 |
| 2010's | 123 (11.47) | 24.3611 |
| 2020's | 35 (3.26) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, L | 1 |
| Sun, H | 1 |
| Nakamura, K | 2 |
| Neidig, LE | 1 |
| Yang, X | 1 |
| Weber, GJ | 1 |
| El-Nachef, D | 1 |
| Tsuchida, H | 1 |
| Dupras, S | 1 |
| Kalucki, FA | 1 |
| Jayabalu, A | 1 |
| Futakuchi-Tsuchida, A | 1 |
| Nakamura, DS | 1 |
| Marchianò, S | 1 |
| Bertero, A | 1 |
| Robinson, MR | 1 |
| Cain, K | 1 |
| Whittington, D | 1 |
| Tian, R | 1 |
| Reinecke, H | 2 |
| Pabon, L | 1 |
| Knollmann, BC | 2 |
| Kattman, S | 1 |
| Thies, RS | 1 |
| MacLellan, WR | 1 |
| Murry, CE | 1 |
| Pannone, L | 1 |
| D'Angelo, G | 1 |
| Gulletta, S | 1 |
| Falasconi, G | 1 |
| Brugliera, L | 1 |
| Frontera, A | 1 |
| Cianfanelli, L | 1 |
| Baldetti, L | 1 |
| Ossola, P | 1 |
| Melillo, F | 1 |
| De Blasi, G | 1 |
| Malatino, L | 1 |
| Landoni, G | 1 |
| Margonato, A | 1 |
| Della Bella, P | 1 |
| Zacchetti, D | 1 |
| Vergara, P | 1 |
| Jiang, Z | 1 |
| Zhao, C | 1 |
| Li, X | 2 |
| Yi, W | 1 |
| Yan, R | 1 |
| Malcolm, EL | 1 |
| Saunders, AB | 1 |
| Vitt, JP | 1 |
| Boutet, BG | 1 |
| Hamer, SA | 1 |
| Hudec, M | 1 |
| Vysočanová, P | 1 |
| Brázdil, V | 1 |
| Poloczek, M | 1 |
| Hetmer, M | 1 |
| Doubková, M | 1 |
| Kala, P | 1 |
| Mar, PL | 1 |
| Horbal, P | 1 |
| Chung, MK | 1 |
| Dukes, JW | 1 |
| Ezekowitz, M | 1 |
| Lakkireddy, D | 2 |
| Lip, GYH | 1 |
| Miletello, M | 1 |
| Noseworthy, PA | 1 |
| Reiffel, JA | 1 |
| Tisdale, JE | 2 |
| Olshansky, B | 4 |
| Gopinathannair, R | 2 |
| Ak, T | 1 |
| Algan, RN | 1 |
| Agirgol, S | 1 |
| Hascicek, SO | 1 |
| Turkoglu, Z | 1 |
| Pothineni, NVK | 1 |
| Trivedi, JR | 1 |
| Roukoz, H | 1 |
| Cowger, J | 1 |
| Ahmed, MM | 1 |
| Bhan, A | 1 |
| K Ravichandran, A | 1 |
| Bhat, G | 1 |
| Al Ahmad, A | 1 |
| Natale, A | 2 |
| Di Biase, L | 2 |
| Slaughter, MS | 1 |
| Liao, PH | 1 |
| Cheng, YC | 1 |
| Liu, PY | 1 |
| Lee, IT | 1 |
| Gelfman, DM | 1 |
| Yang, PS | 1 |
| Kim, D | 2 |
| Joung, B | 1 |
| Rahimi-Bashar, F | 1 |
| Vahedian-Azimi, A | 1 |
| Dalvand, S | 1 |
| Karimi, L | 1 |
| Moshkani, M | 1 |
| Alimohamadi, Y | 1 |
| Johnston, TP | 1 |
| Sahebkar, A | 1 |
| Drago, F | 1 |
| Tamborrino, PP | 1 |
| Hagino, M | 1 |
| Ota, C | 1 |
| Onoki, T | 1 |
| Iwasawa, S | 2 |
| Larson, J | 2 |
| Gondi, K | 2 |
| Chou, A | 2 |
| Deshmukh, A | 2 |
| Cascino, TM | 2 |
| Ghannam, M | 2 |
| Judge, EC | 2 |
| Latchamsetty, R | 2 |
| Jongnarangsin, K | 2 |
| Aaronson, KD | 2 |
| Pagani, FD | 2 |
| Bogun, F | 2 |
| Liang, JJ | 2 |
| Cuk, N | 1 |
| Braunstein, ED | 1 |
| Lin, CY | 3 |
| Chang, TY | 1 |
| Hu, YF | 1 |
| Hsieh, YC | 1 |
| Chen, YJ | 2 |
| Yeh, HI | 1 |
| Lin, YJ | 1 |
| Chang, SL | 2 |
| Lo, LW | 1 |
| Chao, TF | 1 |
| Chung, FP | 1 |
| Liao, JN | 1 |
| Tuan, TC | 1 |
| Chen, SA | 2 |
| Yetmiş, F | 1 |
| Babayigit, E | 1 |
| Görenek, B | 1 |
| Samadi Takaldani, AH | 1 |
| Negaresh, M | 1 |
| Salimi, M | 1 |
| Javanshir, N | 1 |
| Bracy, CL | 1 |
| Kobres, PY | 1 |
| Hockstein, MJ | 1 |
| Rao, SD | 1 |
| Gupta, R | 1 |
| Lam, PH | 1 |
| Sheikh, FH | 1 |
| Hockstein, MA | 1 |
| Gray, RA | 1 |
| Franz, MR | 3 |
| Huang, ST | 1 |
| Hsu, WF | 1 |
| Huang, HS | 1 |
| Yen, JH | 1 |
| Lin, MC | 1 |
| Peng, CY | 1 |
| Yen, HR | 1 |
| Ruzieh, M | 1 |
| Moroi, MK | 1 |
| Aboujamous, NM | 1 |
| Ghahramani, M | 1 |
| Naccarelli, GV | 3 |
| Mandrola, J | 1 |
| Foy, AJ | 1 |
| Mujović, N | 1 |
| Dobrev, D | 1 |
| Marinković, M | 1 |
| Russo, V | 1 |
| Potpara, TS | 1 |
| Moll-Bernardes, RJ | 1 |
| Saraiva, RM | 1 |
| Oliveira, RS | 1 |
| Pinheiro, MVT | 1 |
| Camargo, GC | 1 |
| Brito, ASX | 1 |
| Almeida, SA | 1 |
| Siqueira, FPR | 1 |
| Mendes, FSNS | 1 |
| Barbosa, RM | 1 |
| Xavier, SS | 1 |
| Rosado de Castro, PH | 1 |
| Sousa, AS | 1 |
| Hamilton, D | 1 |
| Nandkeolyar, S | 1 |
| Lan, H | 1 |
| Desai, P | 1 |
| Evans, J | 1 |
| Hauschild, C | 1 |
| Choksi, D | 1 |
| Abudayyeh, I | 1 |
| Contractor, T | 1 |
| Hilliard, A | 1 |
| Mazzanti, A | 1 |
| Guz, D | 1 |
| Trancuccio, A | 1 |
| Pagan, E | 1 |
| Kukavica, D | 1 |
| Chargeishvili, T | 1 |
| Olivetti, N | 1 |
| Biernacka, EK | 1 |
| Sacilotto, L | 1 |
| Sarquella-Brugada, G | 1 |
| Campuzano, O | 1 |
| Nof, E | 1 |
| Anastasakis, A | 1 |
| Sansone, VA | 1 |
| Jimenez-Jaimez, J | 1 |
| Cruz, F | 1 |
| Sánchez-Quiñones, J | 1 |
| Hernandez-Afonso, J | 1 |
| Fuentes, ME | 1 |
| Średniawa, B | 1 |
| Garoufi, A | 1 |
| Andršová, I | 1 |
| Izquierdo, M | 1 |
| Marinov, R | 1 |
| Danon, A | 1 |
| Expósito-García, V | 1 |
| Garcia-Fernandez, A | 1 |
| Muñoz-Esparza, C | 1 |
| Ortíz, M | 2 |
| Zienciuk-Krajka, A | 1 |
| Tavazzani, E | 1 |
| Monteforte, N | 1 |
| Bloise, R | 1 |
| Marino, M | 1 |
| Memmi, M | 1 |
| Napolitano, C | 1 |
| Zorio, E | 1 |
| Monserrat, L | 1 |
| Bagnardi, V | 1 |
| Priori, SG | 1 |
| Kędziora, P | 1 |
| Stasiak, A | 1 |
| Simonen, P | 1 |
| Li, S | 1 |
| Chua, NK | 1 |
| Lampi, AM | 1 |
| Piironen, V | 1 |
| Lommi, J | 1 |
| Sinisalo, J | 1 |
| Brown, AJ | 1 |
| Ikonen, E | 1 |
| Gylling, H | 1 |
| Sanchis-Gomar, F | 1 |
| Lavie, CJ | 1 |
| Morin, DP | 1 |
| Perez-Quilis, C | 1 |
| Laukkanen, JA | 1 |
| Perez, MV | 1 |
| Harmon, E | 1 |
| Blackwell, JN | 1 |
| Pan, JA | 1 |
| Miller, M | 1 |
| Laja, O | 1 |
| Brock, L | 1 |
| Adams, J | 1 |
| Dunn, S | 1 |
| Voss, J | 1 |
| Mehta, N | 1 |
| Ylli, D | 1 |
| Wartofsky, L | 1 |
| Burman, KD | 1 |
| Pravdin, SF | 1 |
| Epanchintsev, TI | 1 |
| Panfilov, AV | 1 |
| Nie, Y | 1 |
| He, Y | 1 |
| Han, D | 1 |
| Liu, Y | 1 |
| Yoshie, K | 1 |
| Yamasaki, M | 1 |
| Yokoyama, M | 1 |
| Ueki, Y | 1 |
| Tachibana, E | 1 |
| Yonemoto, N | 1 |
| Nagao, K | 1 |
| Kimura, A | 1 |
| Murakami, S | 1 |
| Kapustnick, Y | 1 |
| Lutsenko, R | 1 |
| Sуdorenko, A | 1 |
| Rodríguez-Angulo, H | 1 |
| Marques, J | 1 |
| Mendoza, I | 1 |
| Villegas, M | 1 |
| Mijares, A | 1 |
| Gironès, N | 1 |
| Fresno, M | 1 |
| Hrudikova Vyskocilova, E | 1 |
| Grundmann, M | 1 |
| Duricova, J | 1 |
| Kacirova, I | 1 |
| Benjamens, S | 1 |
| Dullaart, RPF | 1 |
| Sluiter, WJ | 1 |
| Rienstra, M | 1 |
| van Gelder, IC | 2 |
| Links, TP | 2 |
| Luo, C | 1 |
| Wang, K | 1 |
| Zhang, H | 1 |
| Tsetskhladze, E | 1 |
| Khintibidze, I | 1 |
| Ikama, SM | 1 |
| Makani, J | 1 |
| Ellenga-Mbolla, B | 1 |
| Ondze-Kafata, LI | 1 |
| Gombet, TR | 1 |
| Kimbally-Kaky, G | 1 |
| Irimie, A | 1 |
| Piciu, D | 1 |
| Ndiaye, M | 1 |
| Lebrun-Vignes, B | 1 |
| Ortonne, N | 1 |
| Fardet, L | 1 |
| Bachani, N | 1 |
| Bera, D | 1 |
| Jankharia, B | 1 |
| Panicker, GK | 1 |
| Lokhandwala, Y | 1 |
| Som, A | 1 |
| Sen, C | 1 |
| Goswami, A | 1 |
| Balik, M | 1 |
| Maly, M | 1 |
| Brozek, T | 1 |
| Brestovansky, P | 1 |
| Fürnkranz, A | 1 |
| Makimoto, H | 2 |
| Khoury, J | 1 |
| Azzam, ZS | 1 |
| Cerrato, N | 1 |
| Calzolari, G | 1 |
| Tizzani, P | 1 |
| Actis Perinetto, E | 1 |
| Dellavalle, A | 1 |
| Aluffi, E | 1 |
| Rajapreyar, I | 1 |
| Acharya, D | 1 |
| Tallaj, J | 1 |
| Hornbuckle, L | 1 |
| Sharpton, J | 1 |
| Joly, J | 1 |
| Pamboukian, S | 1 |
| Uyeda, T | 1 |
| Saito, M | 1 |
| Ishii, T | 1 |
| Inage, A | 1 |
| Hamamichi, Y | 1 |
| Yazaki, S | 1 |
| Yoshikawa, T | 1 |
| Soar, J | 1 |
| Fortes Silva, HE | 1 |
| de Almeida, RS | 1 |
| Silveira, DB | 1 |
| Llaguno, M | 1 |
| Resende, LAPR | 1 |
| Dias da Silva, VJ | 1 |
| Correia, D | 1 |
| Desai, CK | 1 |
| Bhatnagar, U | 1 |
| Stys, M | 1 |
| Kerin, NZ | 4 |
| Che, X | 1 |
| Li, Y | 2 |
| Fang, Y | 2 |
| Reis, C | 1 |
| Wang, H | 1 |
| Levin, MD | 1 |
| Saitta, SC | 1 |
| Gripp, KW | 1 |
| Wenger, TL | 1 |
| Ganesh, J | 1 |
| Kalish, JM | 1 |
| Epstein, MR | 1 |
| Smith, R | 1 |
| Czosek, RJ | 1 |
| Ware, SM | 1 |
| Goldenberg, P | 1 |
| Myers, A | 1 |
| Chatfield, KC | 1 |
| Gillespie, MJ | 1 |
| Zackai, EH | 1 |
| Lin, AE | 1 |
| Stein, C | 1 |
| Migliavaca, CB | 1 |
| Colpani, V | 1 |
| da Rosa, PR | 1 |
| Sganzerla, D | 1 |
| Giordani, NE | 1 |
| Miguel, SRPS | 1 |
| Cruz, LN | 1 |
| Polanczyk, CA | 2 |
| Ribeiro, ALP | 1 |
| Falavigna, M | 1 |
| Zhao, H | 1 |
| Gu, D | 1 |
| Ge, Q | 1 |
| Moore, BM | 1 |
| Cordina, RL | 1 |
| McGuire, MA | 1 |
| Celermajer, DS | 1 |
| Gesing, J | 1 |
| Hoppmann, J | 1 |
| Gebauer, R | 1 |
| Pfäffle, R | 1 |
| Bertsche, A | 1 |
| Kiess, W | 1 |
| Brunetti, L | 1 |
| Lee, SM | 1 |
| Nahass, RG | 1 |
| Suh, D | 1 |
| Miao, B | 1 |
| Bucek, J | 1 |
| Kim, OK | 1 |
| Suh, DC | 1 |
| Adelstein, EC | 1 |
| Althouse, AD | 1 |
| Davis, L | 1 |
| Schwartzman, D | 1 |
| Bazaz, R | 1 |
| Jain, S | 1 |
| Wang, N | 1 |
| Saba, S | 1 |
| Schupp, T | 1 |
| Behnes, M | 1 |
| Ellguth, D | 1 |
| Müller, J | 1 |
| Reiser, L | 1 |
| Bollow, A | 1 |
| Taton, G | 1 |
| Reichelt, T | 1 |
| Engelke, N | 1 |
| Kim, SH | 2 |
| Nienaber, C | 2 |
| Akin, M | 1 |
| Mashayekhi, K | 1 |
| Bertsch, T | 1 |
| Borggrefe, M | 3 |
| Akin, I | 1 |
| Ye, F | 1 |
| Jiang, W | 1 |
| Wang, Y | 1 |
| Lin, W | 1 |
| Chen, H | 1 |
| Pan, B | 1 |
| Meng, XD | 1 |
| Gao, WQ | 1 |
| Sun, Z | 1 |
| Creo, A | 1 |
| Anderson, H | 1 |
| Cannon, B | 1 |
| Lteif, A | 1 |
| Kumar, S | 1 |
| Tebben, P | 1 |
| Iqbal, AM | 1 |
| Ramakrishna, A | 1 |
| Pittock, S | 1 |
| Huang, V | 1 |
| Wolf, RM | 1 |
| Barrett, B | 1 |
| Hawkes, CP | 1 |
| Isaza, A | 1 |
| Bauer, AJ | 1 |
| Hen, K | 1 |
| Czarnywojtek, A | 1 |
| Stangierski, A | 1 |
| Warmuz-Stangierska, I | 1 |
| Zdanowska, J | 1 |
| Florek, E | 1 |
| Ruchała, M | 1 |
| Akin, A | 1 |
| Karagöz, T | 1 |
| Aykan, HH | 1 |
| Özer, S | 1 |
| Alehan, D | 1 |
| Özkutlu, S | 1 |
| Moffett, BS | 2 |
| Valdes, SO | 1 |
| Kim, JJ | 2 |
| Li, T | 1 |
| Wei, X | 1 |
| Watkins, AC | 1 |
| Sanchez, PG | 1 |
| Wu, ZJ | 2 |
| Griffith, BP | 1 |
| Dardenne, A | 1 |
| Fernandez, C | 1 |
| Wagner, A | 1 |
| Milewski, K | 1 |
| Ordanes, DR | 1 |
| Mount, PA | 1 |
| Cheng, Y | 1 |
| Yi, GH | 1 |
| Conditt, GB | 1 |
| Tellez, A | 1 |
| Kaluza, GL | 1 |
| Granada, JF | 1 |
| Feeney, WP | 1 |
| Said, SM | 2 |
| Hahn, J | 1 |
| Alexander, S | 1 |
| Braun-Dullaeus, RC | 2 |
| Esperer, HD | 2 |
| Cho, YS | 1 |
| Han, JH | 1 |
| Chae, HB | 1 |
| Kim, JS | 1 |
| Kang, KM | 1 |
| Park, SM | 1 |
| Lim, JC | 1 |
| Kumar, K | 1 |
| Zimetbaum, PJ | 1 |
| Ramusovic, S | 1 |
| Läer, S | 2 |
| Meibohm, B | 1 |
| Lagler, FB | 1 |
| Paul, T | 2 |
| Naccarato, M | 1 |
| Yoong, D | 1 |
| la Porte, C | 1 |
| Fong, I | 1 |
| Barlamov, PN | 1 |
| Mokrushina, IuS | 1 |
| Shchekotov, VV | 1 |
| Xie, B | 1 |
| Wei, W | 1 |
| Kato, Y | 1 |
| Iovino, M | 1 |
| Iovine, N | 1 |
| Petrosino, A | 1 |
| Licchelli, B | 1 |
| Giagulli, VA | 1 |
| Iacoviello, M | 1 |
| Guastamacchia, E | 1 |
| Triggiani, V | 1 |
| Joukar, S | 1 |
| Zarisfi, Z | 1 |
| Sepehri, G | 1 |
| Bashiri, A | 1 |
| Lai, SW | 2 |
| Lin, CL | 2 |
| Liao, KF | 2 |
| Kim, HL | 1 |
| Seo, JB | 1 |
| Chung, WY | 1 |
| Kim, MA | 1 |
| Zo, JH | 1 |
| Adelborg, K | 2 |
| Ebbehøj, E | 2 |
| Nielsen, JC | 2 |
| Grove, EL | 2 |
| Shen, HN | 1 |
| Zhang, X | 2 |
| Beebe, T | 1 |
| Jen, N | 1 |
| Lee, CA | 1 |
| Tai, Y | 1 |
| Hsiai, TK | 2 |
| Beaty, RS | 1 |
| Hall, S | 1 |
| Kim, J | 1 |
| Au-Yeung, WT | 1 |
| Reinhall, PG | 1 |
| Poole, JE | 1 |
| Anderson, J | 1 |
| Johnson, G | 1 |
| Fletcher, RD | 4 |
| Moore, HJ | 1 |
| Mark, DB | 1 |
| Lee, KL | 2 |
| Bardy, GH | 1 |
| Huikuri, HV | 3 |
| Morvay, N | 1 |
| Baczkó, I | 1 |
| Sztojkov-Ivanov, A | 1 |
| Falkay, G | 1 |
| Papp, JG | 2 |
| Varró, A | 3 |
| Leprán, I | 2 |
| Almotrefi, AA | 1 |
| Bukhari, IA | 1 |
| Alhumayyd, MS | 1 |
| Epstein, AE | 4 |
| Kennedy, JI | 1 |
| Murphy, EJ | 1 |
| Goldschlager, N | 2 |
| Levy, NA | 1 |
| Koenigshof, AM | 1 |
| Sanders, RA | 1 |
| Maqdasy, S | 1 |
| Batisse-Lignier, M | 1 |
| Auclair, C | 1 |
| Desbiez, F | 1 |
| Citron, B | 1 |
| Thieblot, P | 1 |
| Roche, B | 1 |
| Lusson, JR | 1 |
| Tauveron, I | 1 |
| Ünal, E | 1 |
| Perkin, P | 1 |
| Konca Değertekin, C | 1 |
| Ergül, G | 1 |
| Mumma, BE | 1 |
| Umarov, T | 1 |
| Yu, C | 1 |
| Zhu, TG | 1 |
| Liu, WL | 1 |
| Huang, WF | 1 |
| Ghembaza, Mel A | 1 |
| Lounici, A | 1 |
| Löbe, S | 1 |
| John, S | 1 |
| Kornej, J | 1 |
| Hindricks, G | 1 |
| Bollmann, A | 1 |
| Husser, D | 1 |
| Verma, S | 1 |
| Hamilton, S | 1 |
| Liew, SM | 1 |
| Alnawaiseh, M | 1 |
| Zumhagen, L | 1 |
| Zumhagen, S | 1 |
| Schulte, L | 1 |
| Rosentreter, A | 1 |
| Schubert, F | 1 |
| Eter, N | 1 |
| Mönnig, G | 1 |
| Glancy, DL | 1 |
| Dogan, M | 1 |
| Kucuk, U | 1 |
| Yalcin, M | 1 |
| Kardesoglu, E | 1 |
| Saguil, A | 1 |
| Pereira, MM | 1 |
| Jung, S | 1 |
| Wooldridge, AA | 1 |
| Ayat-Isfahani, F | 1 |
| Pashang, M | 1 |
| Davoudi, B | 1 |
| Sadeghian, S | 1 |
| Jalali, A | 1 |
| Lelakowski, J | 1 |
| Rydlewska, A | 1 |
| Lelakowska, M | 1 |
| Pudło, J | 1 |
| Piekarz, J | 1 |
| Butte, N | 1 |
| Böttiger, BW | 1 |
| Teschendorf, P | 1 |
| Dahl, P | 1 |
| Danzi, S | 1 |
| Klein, I | 3 |
| Snead, AN | 1 |
| Miyakawa, M | 1 |
| Tan, ES | 1 |
| Scanlan, TS | 1 |
| Trappe, HJ | 2 |
| Hallstrom, AP | 3 |
| Wyse, DG | 3 |
| McAnulty, J | 2 |
| Singh, BN | 27 |
| Kalimullah, EA | 1 |
| Bryant, SM | 1 |
| Bodalski, R | 1 |
| Maryniak, A | 1 |
| Walczak, F | 1 |
| Szumowski, L | 1 |
| Jedynak, Z | 1 |
| Tiryakioglu, O | 1 |
| Demirtas, S | 1 |
| Ari, H | 1 |
| Tiryakioglu, SK | 1 |
| Huysal, K | 1 |
| Selimoglu, O | 1 |
| Ozyazicioglu, A | 1 |
| Lopriore, E | 1 |
| Aziz, MI | 1 |
| Nagel, HT | 1 |
| Blom, NA | 1 |
| Rozendaal, L | 1 |
| Kanhai, HH | 1 |
| Vandenbussche, FP | 1 |
| Bolderman, RW | 1 |
| Hermans, JJ | 1 |
| Maessen, JG | 1 |
| Preobrazhenskiĭ, DV | 3 |
| Kondrat'eva, DS | 1 |
| Afanas'ev, SA | 1 |
| Falaleeva, LP | 1 |
| Popov, SV | 2 |
| Pazin-Filho, A | 1 |
| de Jesus, AM | 1 |
| Magalhães, PK | 1 |
| Melato, LH | 1 |
| Campos, D | 1 |
| Maciel, BC | 1 |
| Maciel, LM | 1 |
| Traynor, K | 1 |
| Hoy, SM | 1 |
| Keam, SJ | 1 |
| Cushing, DJ | 2 |
| Adams, MP | 1 |
| Cooper, WD | 2 |
| Zhang, B | 1 |
| Lipicky, RJ | 1 |
| Kowey, PR | 3 |
| Stiefelhagen, P | 1 |
| Mason, PK | 1 |
| DiMarco, JP | 3 |
| Tafreshi, J | 1 |
| Chui, MA | 1 |
| Riley, AB | 1 |
| Souney, PF | 1 |
| Tanawuttiwat, T | 1 |
| Harindhanavudhi, T | 1 |
| Hanif, S | 1 |
| Sahloul, MZ | 1 |
| Lane, RD | 1 |
| Nguyen, KT | 1 |
| Niemann, JT | 1 |
| Bolte, RG | 1 |
| Etheridge, SP | 1 |
| Gausche-Hill, M | 1 |
| Digby, G | 1 |
| Machaalany, J | 1 |
| Malik, P | 1 |
| Methot, M | 1 |
| Simpson, CS | 1 |
| Redfearn, D | 1 |
| Baranchuk, A | 1 |
| Schwaiblmair, M | 1 |
| Berghaus, T | 1 |
| Haeckel, T | 1 |
| Wagner, T | 1 |
| von Scheidt, W | 1 |
| Kuz'min, VS | 1 |
| Rozenshtraukh, LV | 2 |
| Khoo, CW | 1 |
| Lim, HS | 1 |
| Lip, GY | 2 |
| Oyetayo, OO | 1 |
| Rogers, CE | 1 |
| Hofmann, PO | 1 |
| Sauer-Schulz, A | 1 |
| Müssig, K | 1 |
| Kurth, R | 1 |
| Fend, F | 1 |
| Teichmann, R | 1 |
| Schnauder, G | 1 |
| van Erven, L | 1 |
| Schalij, MJ | 1 |
| Lopez, KN | 1 |
| Decker, JA | 1 |
| Friedman, RA | 2 |
| Yu, F | 1 |
| Huang, J | 1 |
| Adlerz, K | 1 |
| Jadvar, H | 1 |
| Hamdan, MH | 1 |
| Chi, N | 1 |
| Chen, JN | 1 |
| Agosti, S | 1 |
| Casalino, L | 1 |
| Bertero, G | 1 |
| Barsotti, A | 1 |
| Brunelli, C | 1 |
| Morelloni, S | 1 |
| Coceani, M | 1 |
| Molinaro, S | 1 |
| Scalese, M | 1 |
| Landi, P | 1 |
| Carpeggiani, C | 1 |
| L'abbate, A | 1 |
| Iervasi, G | 4 |
| Pingitore, A | 1 |
| Li, LD | 1 |
| Zhang, CT | 1 |
| Ruan, L | 1 |
| Ni, MK | 1 |
| Wang, GQ | 1 |
| Wang, XF | 1 |
| Duckers, HJ | 1 |
| Houtgraaf, J | 1 |
| Hehrlein, C | 1 |
| Schofer, J | 1 |
| Waltenberger, J | 1 |
| Gershlick, A | 1 |
| Bartunek, J | 1 |
| Macaya, C | 1 |
| Peters, N | 1 |
| Smits, P | 1 |
| Siminiak, T | 1 |
| van Mieghem, W | 1 |
| Legrand, V | 2 |
| Serruys, PW | 1 |
| Yang, Q | 1 |
| Wang, XJ | 1 |
| Tang, YQ | 1 |
| You, QD | 1 |
| Ahmed, S | 1 |
| Wiesfeld, AC | 1 |
| Van Veldhuisen, DJ | 1 |
| Scott, PA | 1 |
| Yue, AM | 1 |
| Watts, E | 1 |
| Zeb, M | 1 |
| Roberts, PR | 1 |
| Morgan, JM | 1 |
| Kozlowski, D | 1 |
| Budrejko, S | 1 |
| Mikhailidis, DP | 1 |
| Rysz, J | 1 |
| Raczak, G | 2 |
| Banach, M | 1 |
| Jurado Román, A | 1 |
| Rubio Alonso, B | 1 |
| Martín Asenjo, R | 1 |
| Salguero Bodes, R | 1 |
| López Gil, M | 1 |
| Arribas Ynsaurriaga, F | 1 |
| Xing, Y | 1 |
| Chen, J | 2 |
| Wang, J | 1 |
| Gao, Y | 1 |
| Niu, W | 1 |
| Zhao, M | 1 |
| Zhu, H | 1 |
| Guo, L | 1 |
| Lu, P | 1 |
| Wang, S | 1 |
| Noda, T | 1 |
| Kurita, T | 2 |
| Nakajima, I | 1 |
| Yokoyama, T | 1 |
| Doi, A | 1 |
| Yamada, Y | 1 |
| Okamura, H | 1 |
| Satomi, K | 2 |
| Aiba, T | 2 |
| Shimizu, W | 1 |
| Suyama, K | 1 |
| Aihara, N | 1 |
| Kamakura, S | 4 |
| Köbe, J | 1 |
| Reinke, F | 1 |
| Dechering, DG | 1 |
| Breithardt, G | 7 |
| Eckardt, L | 4 |
| Pedro, B | 1 |
| López-Alvarez, J | 1 |
| Fonfara, S | 1 |
| Stephenson, H | 1 |
| Dukes-McEwan, J | 1 |
| Araki, R | 1 |
| Yukawa, E | 1 |
| Nakashima, MN | 1 |
| Fukuchi, H | 1 |
| Sasaki, H | 1 |
| Yano, K | 2 |
| Nakashima, M | 1 |
| Omar, HR | 1 |
| Lu, WJ | 1 |
| Zhou, J | 1 |
| Ma, HY | 1 |
| Lü, GH | 1 |
| You, FQ | 1 |
| Ding, AW | 1 |
| Duan, JA | 1 |
| Santangeli, P | 1 |
| Burkhardt, JD | 1 |
| Bai, R | 1 |
| Mohanty, P | 1 |
| Pump, A | 1 |
| Jadoul, M | 1 |
| Thumma, J | 1 |
| Fuller, DS | 1 |
| Tentori, F | 1 |
| Morgenstern, H | 1 |
| Mendelssohn, D | 1 |
| Tomo, T | 1 |
| Ethier, J | 1 |
| Port, F | 1 |
| Robinson, BM | 1 |
| Kluba, K | 1 |
| Genz, C | 1 |
| Wiedemann, AK | 1 |
| Boenigk, H | 1 |
| Herold, J | 1 |
| Schmeisser, A | 1 |
| Flanagan, EP | 1 |
| Harper, CM | 1 |
| St Louis, EK | 1 |
| Silber, MH | 1 |
| Josephs, KA | 1 |
| Pierret, C | 1 |
| Tourtier, JP | 1 |
| Pons, Y | 1 |
| Merat, S | 1 |
| Duverger, V | 1 |
| Perrier, E | 1 |
| Sriganesh, K | 1 |
| Rajgopal, R | 1 |
| Rao, GS | 1 |
| Kao, DP | 1 |
| Hiatt, WR | 1 |
| Krantz, MJ | 1 |
| Kasprzak, JD | 1 |
| Stępińska, J | 1 |
| Wożakowska Kapłon, B | 1 |
| Drożdż, J | 1 |
| Grajek, S | 1 |
| Opolski, G | 1 |
| Rynkiewicz, A | 1 |
| Tykarski, A | 1 |
| Filipiak, KJ | 1 |
| Wilhelms, M | 1 |
| Rombach, C | 1 |
| Scholz, EP | 1 |
| Dössel, O | 1 |
| Seemann, G | 1 |
| Bauman, JL | 1 |
| Takahama, H | 1 |
| Shigematsu, H | 1 |
| Asai, T | 1 |
| Matsuzaki, T | 1 |
| Sanada, S | 1 |
| Fu, HY | 1 |
| Okuda, K | 1 |
| Yamato, M | 1 |
| Asanuma, H | 1 |
| Asano, Y | 1 |
| Asakura, M | 1 |
| Oku, N | 1 |
| Komuro, I | 1 |
| Kitakaze, M | 2 |
| Minamino, T | 1 |
| Hanafy, DA | 1 |
| Chen, YC | 1 |
| Lu, YY | 1 |
| Lin, YK | 1 |
| Kao, YH | 1 |
| Uebermuth, CA | 1 |
| Gerke, E | 1 |
| Kaneko, Y | 1 |
| Kurabayashi, M | 1 |
| Irvine, J | 1 |
| Dorian, P | 7 |
| Baker, B | 1 |
| O'Brien, BJ | 1 |
| Roberts, R | 3 |
| Gent, M | 3 |
| Newman, D | 4 |
| Connolly, SJ | 3 |
| Auer, J | 1 |
| Berent, R | 1 |
| Eber, B | 1 |
| Yoshida, H | 1 |
| Sugiyama, A | 1 |
| Satoh, Y | 1 |
| Ishida, Y | 1 |
| Yoneyama, M | 1 |
| Kugiyama, K | 1 |
| Hashimoto, K | 3 |
| Castells, DD | 1 |
| Teitelbaum, BA | 1 |
| Tresley, DJ | 1 |
| Grönefeld, GC | 1 |
| Hohnloser, SH | 5 |
| Sauro, SC | 1 |
| DeCarolis, DD | 1 |
| Pierpont, GL | 1 |
| Gornick, CC | 1 |
| McLemore, R | 1 |
| Sharma, S | 3 |
| Bhambi, B | 1 |
| Ishimori, T | 1 |
| Wilkoff, BL | 1 |
| Cook, JR | 2 |
| Greene, HL | 5 |
| Hsia, H | 1 |
| Kutalek, SP | 1 |
| Sharma, A | 1 |
| Lucet, V | 3 |
| Aouate, P | 1 |
| Elbaz, N | 1 |
| Klug, D | 1 |
| Lacotte, J | 1 |
| Raguin, D | 1 |
| Frank, R | 5 |
| Lelouche, D | 1 |
| Dubois-Randé, JL | 1 |
| Tonet, J | 1 |
| Fontaine, G | 5 |
| Haverkamp, W | 2 |
| Kirchhof, P | 1 |
| Degen, H | 1 |
| Fabritz, L | 1 |
| Milberg, P | 1 |
| Neumann, J | 1 |
| Yamreudeewong, W | 1 |
| DeBisschop, M | 1 |
| Martin, LG | 1 |
| Lower, DL | 1 |
| Farré, J | 1 |
| Nisam, S | 2 |
| Kiziltepe, U | 1 |
| Eyileten, ZB | 1 |
| Sirlak, M | 1 |
| Tasoz, R | 1 |
| Aral, A | 1 |
| Eren, NT | 1 |
| Uysalel, A | 1 |
| Akalin, H | 1 |
| Ermis, C | 1 |
| Zadeii, G | 1 |
| Zhu, AX | 1 |
| Fabian, W | 1 |
| Collins, J | 1 |
| Lurie, KG | 1 |
| Sakaguchi, S | 1 |
| Benditt, DG | 1 |
| Sweeney, MO | 1 |
| Tatarchenko, IP | 2 |
| Pozdniakova, NV | 1 |
| Shevyrev, VA | 1 |
| Morozova, OI | 1 |
| Tiroke, A | 1 |
| Ganeeva, ON | 1 |
| Vergely, C | 1 |
| Renard, C | 1 |
| Moreau, D | 1 |
| Perrin- Sarrado, C | 1 |
| Roubaud, V | 1 |
| Tuccio, B | 1 |
| Rochette, L | 1 |
| Mangat, I | 1 |
| Brandts, B | 1 |
| Weismueller, P | 1 |
| Seggewiss, H | 1 |
| Rigopoulos, A | 1 |
| Mazur, NA | 2 |
| Sosonkina, OV | 1 |
| Kwok, KM | 1 |
| Lau, CP | 1 |
| Tse, HF | 1 |
| Franzese, CB | 1 |
| Fan, CY | 1 |
| Stack, BC | 1 |
| Doggrell, SA | 2 |
| Petrov, VI | 1 |
| Spasov, AA | 1 |
| Anisimova, VA | 1 |
| Kirillov, OV | 1 |
| Li, WZ | 1 |
| Kurnik, D | 1 |
| Loebstein, R | 1 |
| Farfel, Z | 1 |
| Ezra, D | 1 |
| Halkin, H | 1 |
| Olchovsky, D | 1 |
| Nedostup, AV | 1 |
| Blagova, OV | 1 |
| Bogdanova, EA | 1 |
| Platonova, AA | 1 |
| Pollak, PT | 4 |
| Shafer, SL | 1 |
| Wijetunga, M | 1 |
| Strickberger, SA | 1 |
| Grimm, W | 1 |
| Hancox, JC | 1 |
| Hauser, TH | 1 |
| Pinto, DS | 1 |
| Josephson, ME | 5 |
| Zimetbaum, P | 1 |
| Rankin, JS | 2 |
| Orozco, RE | 1 |
| Addai, TR | 1 |
| Rodgers, TL | 1 |
| Tuttle, RH | 1 |
| Shaw, LK | 1 |
| Glower, DD | 1 |
| Pinna, GD | 1 |
| Maestri, R | 1 |
| Daniłowicz-Szymanowicz, L | 1 |
| Szwoch, M | 1 |
| Lubinski, A | 1 |
| Kempa, M | 1 |
| La Rovere, MT | 1 |
| Swiatecka, G | 1 |
| Wellens, HJ | 4 |
| Kharash, LM | 1 |
| Chenzbraun, AI | 1 |
| Kanopskiĭ, SG | 1 |
| Staritskiĭ, AG | 1 |
| Bozhko, AA | 1 |
| Smetana, P | 1 |
| Pueyo, E | 1 |
| Hnatkova, K | 1 |
| Batchvarov, V | 1 |
| Laguna, P | 1 |
| Malik, M | 4 |
| Houghton, SG | 1 |
| Farley, DR | 1 |
| Brennan, MD | 1 |
| van Heerden, JA | 1 |
| Thompson, GB | 1 |
| Grant, CS | 1 |
| Elming, H | 1 |
| Brendorp, B | 1 |
| Pehrson, S | 1 |
| Pedersen, OD | 1 |
| Køber, L | 1 |
| Torp-Petersen, C | 1 |
| Zyśko, D | 1 |
| Gajek, J | 1 |
| Xu, CQ | 1 |
| Dong, DL | 2 |
| Du, ZM | 2 |
| Chen, QW | 1 |
| Gong, DM | 1 |
| Yang, BF | 2 |
| Molashenko, NV | 2 |
| Sviridenko, NIu | 2 |
| Platonova, NM | 2 |
| Kolesnikova, GS | 1 |
| Golitsyn, SP | 1 |
| Bakalov, SA | 1 |
| Serdiuk, SE | 1 |
| Masenko, VP | 1 |
| Domogadskiĭ, SP | 1 |
| Nagasawa, Y | 1 |
| Milliez, P | 1 |
| Leenhardt, A | 3 |
| Maisonblanche, P | 2 |
| Vicaut, E | 1 |
| Badilini, F | 1 |
| Siliste, C | 1 |
| Benchetrit, C | 1 |
| Coumel, P | 16 |
| Kozák, M | 1 |
| Izákovicová Hollá, L | 1 |
| Krivan, L | 1 |
| Vasků, A | 1 |
| Sepsi, M | 1 |
| Semrád, B | 1 |
| Vácha, J | 1 |
| Reĭngardene, DI | 2 |
| Zhilene, VI | 1 |
| Turdumambetova, G | 1 |
| Bredehorn, T | 1 |
| Duncker, GI | 1 |
| Roffi, M | 1 |
| Cattaneo, F | 1 |
| Brandle, M | 1 |
| Olesin, AI | 1 |
| Shabrov, AV | 1 |
| Sinenko, VI | 1 |
| Popik, GS | 1 |
| Boldueva, SA | 1 |
| Leonova, IA | 1 |
| Poloskina, OA | 1 |
| Ho, AT | 1 |
| Pai, SM | 1 |
| Timothy, P | 1 |
| Pai, RG | 1 |
| Razavi, M | 1 |
| Aasbo, JD | 1 |
| Lawrence, AT | 1 |
| Krishnan, K | 1 |
| Kim, MH | 1 |
| Trohman, RG | 3 |
| Pan, ZW | 1 |
| Wang, ZY | 1 |
| Jiao, JD | 1 |
| Shoaf, SE | 1 |
| Elizari, MV | 7 |
| Wang, Z | 1 |
| Sekar, K | 1 |
| Grinfeld, LR | 1 |
| Barbagelata, NA | 1 |
| Lerman, J | 1 |
| Bramer, SL | 1 |
| Trongé, J | 1 |
| Orlandi, C | 1 |
| Trifănescu, R | 1 |
| Fica, S | 1 |
| Barbu, C | 1 |
| Vârtej, I | 1 |
| Ursu, H | 1 |
| Bunghez, R | 1 |
| Coculescu, M | 1 |
| Mitchell, LB | 3 |
| Exner, DV | 2 |
| Connolly, CJ | 1 |
| Prystai, GD | 1 |
| Bayes, AJ | 1 |
| Kidd, WT | 1 |
| Kieser, T | 1 |
| Burgess, JJ | 1 |
| Ferland, A | 1 |
| MacAdams, CL | 1 |
| Maitland, A | 1 |
| Podgoreanu, MV | 1 |
| Mathew, JP | 1 |
| Råmunddal, T | 1 |
| Lorentzon, M | 1 |
| Omerovic, E | 1 |
| Haïssaguerre, M | 1 |
| Hocini, M | 1 |
| Sanders, P | 1 |
| Takahashi, Y | 1 |
| Rotter, M | 1 |
| Sacher, F | 1 |
| Rostock, T | 1 |
| Hsu, LF | 1 |
| Jonsson, A | 1 |
| O'Neill, MD | 1 |
| Bordachar, P | 1 |
| Reuter, S | 1 |
| Roudaut, R | 1 |
| Clémenty, J | 1 |
| Jaïs, P | 1 |
| Yuge, M | 1 |
| Niwano, S | 1 |
| Moriguchi, M | 1 |
| Sasaki, T | 1 |
| Hirasawa, S | 1 |
| Imaki, R | 1 |
| Sato, D | 1 |
| Izumi, T | 1 |
| Bratulescu, M | 1 |
| Zemba, M | 1 |
| Gheorghieva, V | 1 |
| Andrei, S | 1 |
| Cucu, B | 1 |
| Dobrescu, N | 1 |
| Atarashi, H | 1 |
| Otsuka, T | 1 |
| Yamashita, T | 1 |
| Fujiki, A | 1 |
| Dedov, II | 1 |
| Mel'nichenko, GA | 1 |
| Egorov, AV | 1 |
| O'Sullivan, AJ | 1 |
| Lewis, M | 1 |
| Diamond, T | 1 |
| Kaszala, K | 1 |
| Kenigsberg, DN | 1 |
| Krishnan, SC | 1 |
| Burgess, C | 1 |
| Blaikie, A | 1 |
| Ingham, T | 1 |
| Robinson, G | 1 |
| Narasimhan, S | 1 |
| Schrickel, JW | 1 |
| Schwab, JO | 1 |
| Yang, A | 1 |
| Bielik, H | 1 |
| Bitzen, A | 1 |
| Lüderitz, B | 6 |
| Lewalter, T | 1 |
| Inamdar, V | 1 |
| Mehta, S | 1 |
| Juang, G | 1 |
| Cohen, T | 1 |
| Takatsuki, S | 1 |
| Yokoyama, Y | 1 |
| Chinushi, M | 1 |
| Tsuboi, N | 1 |
| Nitta, T | 1 |
| Shoda, M | 2 |
| Mitamura, H | 1 |
| Lu, LX | 1 |
| Zhou, W | 1 |
| Cao, Q | 1 |
| Yu, K | 1 |
| Zhu, C | 1 |
| Paul, G | 1 |
| Yusuf, S | 2 |
| Russell, SJ | 1 |
| Saltissi, S | 1 |
| Diehl, LA | 1 |
| Romaldini, JH | 1 |
| Graf, H | 1 |
| Bartalena, L | 2 |
| Martino, E | 3 |
| Albino, CC | 1 |
| Wiersinga, WM | 1 |
| Brodsky, MA | 1 |
| Zipes, DP | 12 |
| Baessler, C | 1 |
| Sablayrolles, S | 1 |
| Le Grand, B | 1 |
| Stöllberger, C | 1 |
| Steger, C | 1 |
| Yilmaz-Kaymaz, N | 1 |
| Chen, S | 1 |
| Wang, Q | 1 |
| Finsterer, J | 1 |
| Buescher, T | 1 |
| Jahangir, A | 1 |
| Gough, J | 1 |
| Gough, IR | 1 |
| Pil'vinis, VK | 1 |
| Rejnmark, L | 1 |
| Vestergaard, P | 1 |
| Mosekilde, L | 1 |
| Berti, P | 1 |
| Materazzi, G | 1 |
| Bogazzi, F | 2 |
| Ambrosini, CE | 1 |
| Miccoli, P | 2 |
| Leong-Sit, P | 1 |
| Gula, LJ | 1 |
| Diamantouros, P | 1 |
| Krahn, AD | 1 |
| Skanes, AC | 2 |
| Yee, R | 1 |
| Klein, GJ | 1 |
| Fukumoto, K | 1 |
| Kobayashi, T | 1 |
| Tachibana, K | 1 |
| Kato, R | 1 |
| Tanaka, K | 2 |
| Komamura, K | 2 |
| Ueno, K | 2 |
| Klekot, AA | 1 |
| Abrams, DJ | 1 |
| Earley, MJ | 1 |
| Sporton, SC | 1 |
| Kistler, PM | 1 |
| Gatzoulis, MA | 1 |
| Mullen, MJ | 1 |
| Till, JA | 1 |
| Cullen, S | 1 |
| Walker, F | 1 |
| Lowe, MD | 1 |
| Deanfield, JE | 1 |
| Schilling, RJ | 1 |
| Younge, BR | 2 |
| Shiga, T | 3 |
| Hagiwara, N | 2 |
| Kasanuki, H | 3 |
| Nishii, N | 1 |
| Ohe, T | 1 |
| Moroz, VM | 1 |
| Lipnitskii, TN | 1 |
| Alves, RJ | 1 |
| Geovanini, GR | 1 |
| Brito, Gd | 1 |
| Miguel, GA | 1 |
| Glauser, VA | 1 |
| Nakiri, K | 1 |
| Vassallo, P | 1 |
| Wu, L | 1 |
| Rajamani, S | 1 |
| Shryock, JC | 1 |
| Li, H | 1 |
| Ruskin, J | 1 |
| Antzelevitch, C | 1 |
| Belardinelli, L | 1 |
| Kapoor, JR | 1 |
| Fuchs, T | 1 |
| Groysman, R | 1 |
| Meilichov, I | 1 |
| Lima, CE | 1 |
| Martinelli Filho, M | 2 |
| Silva, RT | 1 |
| Tamaki, WT | 1 |
| Oliveira, JC | 1 |
| Martins, DC | 1 |
| Nishióka, SA | 1 |
| Pedrosa, AA | 1 |
| Siqueira, SF | 1 |
| Costa, R | 1 |
| Sato, K | 2 |
| Omi, Y | 1 |
| Kodama, H | 1 |
| Obara, T | 1 |
| Yamazaki, K | 1 |
| Yamada, E | 1 |
| Seki, T | 1 |
| Takano, K | 1 |
| Lu, Y | 1 |
| Won, KA | 1 |
| Nelson, BJ | 1 |
| Qi, D | 1 |
| Rausch, DJ | 1 |
| Asinger, RW | 1 |
| Sanna, GP | 1 |
| Colgan, T | 1 |
| Simon, GT | 1 |
| Kay, JM | 1 |
| Pugsley, SO | 1 |
| Eydt, J | 2 |
| Opie, LH | 1 |
| Gottdiener, JS | 1 |
| DiBianco, R | 1 |
| Leclercq, JF | 8 |
| Georgiopoulos, G | 1 |
| Halkidis, H | 1 |
| Attuel, P | 4 |
| Tartini, R | 2 |
| Kappenberger, L | 2 |
| Steinbrunn, W | 2 |
| Meyer, UA | 2 |
| Vlay, SC | 1 |
| Reid, PR | 1 |
| Hoffmann, A | 4 |
| Follath, F | 6 |
| Burckhardt, D | 9 |
| Manresa, F | 1 |
| Cequier, A | 1 |
| Escarrabill, J | 1 |
| Pérez Ayuso, MJ | 1 |
| Sabater, X | 1 |
| Gausi, C | 1 |
| Martelli, M | 1 |
| Barbato, G | 1 |
| Saponaro, A | 1 |
| Kovaleva, LI | 4 |
| Paleev, NR | 4 |
| Vinogradova, TS | 1 |
| Nikiforova, TB | 3 |
| Kel'man, IM | 2 |
| Corbalán, R | 2 |
| Braun, S | 1 |
| Chamorro, G | 1 |
| Zegpi, M | 1 |
| Henneberger, K | 1 |
| Woosley, RL | 3 |
| Roden, DM | 7 |
| Duff, HJ | 2 |
| Oates, JA | 1 |
| Hamer, AW | 3 |
| Mandel, WJ | 9 |
| Zaher, CA | 1 |
| Karagueuzin, HS | 1 |
| Peter, T | 10 |
| Do Ngoc, D | 2 |
| Nademanee, K | 15 |
| Kannan, R | 4 |
| Ikeda, N | 3 |
| Rosenbaum, MB | 7 |
| Chiale, PA | 5 |
| Kaski, JC | 3 |
| Assayag, P | 1 |
| McKenna, WJ | 17 |
| Krikler, DM | 9 |
| Goodwin, JF | 5 |
| Motté, G | 2 |
| Harris, L | 6 |
| Rowland, E | 7 |
| Holt, DW | 6 |
| Storey, GC | 5 |
| Martinez-Arizala, A | 1 |
| Sobol, SM | 4 |
| McCarty, GE | 1 |
| Nichols, BR | 1 |
| Rakita, L | 7 |
| Lim, PK | 1 |
| Trewby, PN | 1 |
| Hole, DW | 1 |
| Lloyd, EA | 1 |
| Mabin, TA | 1 |
| McGovern, B | 2 |
| Garan, H | 3 |
| Ruskin, JN | 2 |
| Prystowsky, EN | 8 |
| Heger, JJ | 8 |
| Marcus, FI | 3 |
| Miles, WM | 4 |
| Josephson, MA | 1 |
| Venkatesh, N | 1 |
| Kelly, E | 1 |
| Samanta, A | 1 |
| Jones, GR | 1 |
| Burden, AC | 1 |
| Rosen, MR | 2 |
| Wit, AL | 1 |
| Manz, M | 1 |
| Steinbeck, G | 2 |
| Nitsch, J | 2 |
| Posner, J | 1 |
| Sobel, RJ | 1 |
| Glick, S | 1 |
| Rossi, L | 2 |
| Mead, RH | 1 |
| Harrison, DC | 3 |
| Tonet, JL | 1 |
| Furlanello, F | 3 |
| Gramegna, L | 1 |
| Dal Forno, P | 2 |
| Vergara, G | 3 |
| Bettini, R | 2 |
| Inama, G | 4 |
| Disertori, M | 4 |
| Pratt, CM | 1 |
| Luck, JC | 2 |
| Mann, DE | 1 |
| Wyndham, CR | 1 |
| Anderson, GJ | 1 |
| Zeman, K | 1 |
| Lupínek, Z | 1 |
| Toman, J | 1 |
| Kosinski, EJ | 1 |
| Albin, JB | 1 |
| Young, E | 1 |
| Lewis, SM | 1 |
| LeLand, OS | 1 |
| de los Angeles Valenzuela, M | 1 |
| Bianchi, C | 2 |
| Meruane, J | 1 |
| Pineda, G | 1 |
| Weissel, M | 2 |
| Weber, H | 2 |
| Probst, P | 2 |
| Höfer, R | 1 |
| Rotmensch, HH | 3 |
| Belhassen, B | 3 |
| Swanson, BN | 1 |
| Shoshani, D | 1 |
| Spielman, SR | 5 |
| Greenspon, AJ | 2 |
| Greenspan, AM | 5 |
| Vlasses, PH | 2 |
| Horowitz, LN | 6 |
| Santinelli, V | 2 |
| Chiariello, M | 2 |
| Clarizia, M | 1 |
| Riviezzo, G | 1 |
| Condorelli, M | 2 |
| Dick, M | 1 |
| Campbell, RM | 1 |
| Trobaugh, GB | 2 |
| Kudenchuk, PJ | 2 |
| Tutt, RC | 1 |
| Kingston, E | 1 |
| Gorham, JR | 1 |
| Gross, BW | 2 |
| Graham, EL | 3 |
| Sears, GK | 3 |
| Werner, JA | 3 |
| Walter, JF | 1 |
| Bradner, H | 1 |
| Curtis, GP | 1 |
| Landolina, M | 2 |
| Beck Peccoz, P | 1 |
| Piscitelli, G | 2 |
| Maggioni, AP | 3 |
| Volpi, A | 3 |
| Galletti, F | 1 |
| Tognoni, G | 3 |
| Ferrario, G | 1 |
| Giani, P | 3 |
| Wishnitzer, R | 1 |
| Estrov, Z | 1 |
| Caspi, A | 1 |
| Eliraz, A | 1 |
| Lotto, A | 2 |
| Finzi, A | 1 |
| Massari, FM | 1 |
| Pagnoni, F | 1 |
| Valentini, R | 1 |
| Ambrosini, F | 1 |
| Lo Masto, M | 1 |
| Haddad, R | 1 |
| Scheibelhofer, W | 1 |
| Konrad, K | 1 |
| Mlczoch, J | 1 |
| Mainitz, M | 1 |
| Tao, P | 1 |
| Trusz-Gluza, M | 2 |
| Giec, L | 3 |
| Kośmider, J | 2 |
| Strzelczyk, B | 1 |
| Klingele, TG | 2 |
| Alves, LE | 8 |
| Rose, EP | 8 |
| Fornaro, G | 1 |
| Rossi, P | 2 |
| Padrini, R | 2 |
| Piovan, D | 1 |
| Ferrari, M | 2 |
| Fortina, A | 1 |
| Tomassini, G | 1 |
| Aquili, C | 1 |
| Ferguson, RK | 2 |
| Kleinebenne, A | 2 |
| Oakley, CM | 1 |
| Smith, A | 1 |
| Smith, W | 1 |
| Johns, JA | 2 |
| Harper, RW | 1 |
| Currie, PJ | 1 |
| Federman, J | 1 |
| Anderson, ST | 1 |
| Pitt, A | 1 |
| Fraunfelder, FT | 1 |
| Meyer, SM | 1 |
| Schwartz, A | 1 |
| Shen, E | 1 |
| Morady, F | 3 |
| Gillespie, K | 1 |
| Scheinman, M | 2 |
| Chatterjee, K | 2 |
| Graboys, TB | 2 |
| Podrid, PJ | 7 |
| Lown, B | 3 |
| Webb, CR | 3 |
| Kay, HR | 2 |
| Cannom, DS | 5 |
| Weiss, J | 1 |
| Feld, G | 2 |
| Stevenson, WG | 6 |
| Haffajee, CI | 2 |
| Love, JC | 2 |
| Alpert, JS | 2 |
| Asdourian, GK | 2 |
| Sloan, KC | 1 |
| Hamer, A | 8 |
| Weiss, D | 4 |
| Siddoway, LA | 1 |
| McAllister, CB | 1 |
| Wilkinson, GR | 1 |
| Haedo, A | 2 |
| Lázzari, JO | 5 |
| Hind, CR | 1 |
| Savage, C | 1 |
| Krikler, SJ | 2 |
| Millar, RN | 1 |
| Obel, IW | 1 |
| Cesnik, B | 1 |
| Pickardt, CR | 1 |
| del Río Ligorit, A | 1 |
| Casasnovas Lenguas, JA | 1 |
| González Carretero, M | 1 |
| Lozano, HC | 1 |
| Ferreira Montero, IJ | 1 |
| Cuomo, A | 1 |
| De Feo, ME | 1 |
| Maresca, N | 1 |
| Pasquale, A | 1 |
| Piccenna, L | 1 |
| Watanabe, Y | 1 |
| Katoh, T | 1 |
| Hu, ZM | 1 |
| Gorham, JP | 1 |
| Vitale, P | 1 |
| Agretto, A | 1 |
| Torre, G | 1 |
| Casale, D | 1 |
| Porreca, GP | 1 |
| Jacono, A | 2 |
| Fidelle, J | 3 |
| White, RA | 2 |
| Joelson, J | 1 |
| Kluger, J | 2 |
| Cole, S | 1 |
| Conway, M | 1 |
| Girotti, LA | 1 |
| Goldbarg, A | 1 |
| Tambussi, A | 1 |
| Halpern, MS | 2 |
| Nau, GJ | 2 |
| Tambussi, AM | 1 |
| Przybylski, J | 2 |
| Amico, JA | 1 |
| Richardson, V | 1 |
| Alpert, B | 1 |
| Criée, CP | 1 |
| Wilhelms, E | 1 |
| Kneba, M | 1 |
| Kreuzer, H | 1 |
| Saal, AK | 1 |
| Drzewiecki, J | 1 |
| Szcześniak, S | 1 |
| Aleksandrow, D | 1 |
| Aleksandrow, W | 1 |
| Dyduszyński, A | 1 |
| Wegrzyn, B | 1 |
| Frenkel', VI | 1 |
| Eremeev, VG | 1 |
| Zvenitskiĭ, IL | 1 |
| Schütz, E | 1 |
| White, R | 1 |
| Rod, JL | 1 |
| Shenasa, M | 3 |
| Oetgen, WJ | 1 |
| Tri, TB | 1 |
| Heydorn, WH | 1 |
| Denker, S | 1 |
| Mahmud, R | 1 |
| Lehmann, M | 1 |
| Estrada, A | 1 |
| Akhtar, M | 1 |
| Kennedy, EE | 2 |
| Batsford, WP | 2 |
| Piwowarska, W | 2 |
| Sniezek-Maciejewska, M | 2 |
| Szczepkowski, J | 1 |
| Simon, JB | 1 |
| Manley, PN | 1 |
| Brien, JF | 5 |
| Armstrong, PW | 2 |
| Anastasiou-Nana, M | 1 |
| Levis, GM | 1 |
| Moulopoulos, SD | 1 |
| Schlesinger, P | 1 |
| da Rocha, PJ | 1 |
| Benchimol, AB | 1 |
| Do-Ngoc, D | 1 |
| Moysey, JO | 1 |
| Jaggarao, NS | 2 |
| Grundy, EN | 1 |
| Chamberlain, DA | 3 |
| Benchimol, A | 1 |
| Desser, KB | 1 |
| Hess, D | 1 |
| Cho, YW | 1 |
| Kuemmerle, HP | 1 |
| Keefe, DL | 2 |
| Kates, RE | 2 |
| Zhang, YZ | 1 |
| Yin, SY | 1 |
| Cui, G | 1 |
| Huang, W | 1 |
| Urthaler, F | 1 |
| Zaher, C | 1 |
| Mandel, W | 1 |
| Cizmárová, E | 1 |
| Vrsanská, V | 1 |
| Bzdúch, V | 1 |
| Masura, J | 1 |
| Halás, M | 1 |
| Whitelaw, A | 1 |
| Storey, G | 1 |
| Holt, D | 1 |
| Hendrickson, J | 2 |
| Intarachot, V | 1 |
| Lopez, B | 1 |
| Weiss, JL | 1 |
| Sclarovsky, S | 1 |
| Lewin, RF | 1 |
| Kracoff, O | 1 |
| Strasberg, B | 1 |
| Arditti, A | 1 |
| Agmon, J | 1 |
| Jost, M | 1 |
| Canada, AT | 1 |
| Lesko, LJ | 1 |
| Asdourian, G | 1 |
| Fogoros, RN | 1 |
| Anderson, KP | 1 |
| Winkle, RA | 4 |
| Swerdlow, CD | 2 |
| Mason, JW | 3 |
| Waxman, HL | 3 |
| Maggi, A | 1 |
| D'Aranno, V | 2 |
| Pickoff, AS | 1 |
| Singh, S | 1 |
| Flinn, CJ | 1 |
| Wolff, GS | 1 |
| Gelband, H | 1 |
| Stäubli, M | 6 |
| Bircher, J | 2 |
| Galeazzi, RL | 1 |
| Remund, H | 1 |
| Studer, H | 5 |
| van Zandwijk, N | 1 |
| Darmanata, JI | 1 |
| Düren, DR | 1 |
| Alberts, C | 1 |
| Durrer, D | 1 |
| Wagenvoort, CA | 1 |
| Mestroni, L | 3 |
| Fonda, F | 1 |
| Camerini, F | 3 |
| Zeng, GY | 1 |
| Guarnerio, M | 2 |
| Botti, G | 2 |
| Bonatti, V | 2 |
| Rolli, A | 3 |
| Lubbe, WF | 3 |
| Mercer, CJ | 1 |
| Roche, AH | 2 |
| Lowe, JB | 1 |
| Fontaine, GH | 1 |
| Grosgogeat, Y | 2 |
| Ginestes, J | 1 |
| Griffin, JC | 2 |
| Ross, DL | 1 |
| Clusin, WT | 1 |
| Singh, BH | 1 |
| Kaplan, LJ | 1 |
| Cappaert, WE | 1 |
| Scheinman, MM | 5 |
| Vaughan Williams, EM | 2 |
| Heinbecker, PP | 1 |
| Frawley, TF | 1 |
| Ingram, DV | 2 |
| Finerman, WB | 2 |
| Flaker, GC | 1 |
| Munuswamy, K | 1 |
| Kulbertus, HE | 3 |
| Demoulin, JC | 2 |
| Bertholet, M | 1 |
| César, LA | 1 |
| Ping, WC | 1 |
| Miyasato, AN | 1 |
| Mansur, A | 1 |
| Rossi, E | 1 |
| Yamano, J | 1 |
| Choui, AF | 1 |
| Carneiro, L | 1 |
| Bellotti, GM | 1 |
| Pileggi, FJ | 1 |
| Toruncha, A | 1 |
| García-Barreto, D | 1 |
| González-Gómez, A | 1 |
| Llerena, L | 1 |
| Sellén, J | 1 |
| Ramos-Emperador, C | 1 |
| Cabrera-Alonso, C | 1 |
| Hernández-Cañero, A | 1 |
| Tobin, G | 1 |
| de Buitléir, M | 1 |
| Maurer, B | 1 |
| Mulcahy, R | 1 |
| Franco, PD | 1 |
| Souza, Rde O | 1 |
| Perez, G | 1 |
| Oakley, C | 1 |
| Greco, OT | 1 |
| Lorga, AM | 1 |
| Garzon, SA | 1 |
| Younan, I | 1 |
| Bellini, AJ | 1 |
| Bilaqui, A | 1 |
| de Araújo, JD | 1 |
| Nicolau, JC | 1 |
| Jacob, JL | 1 |
| Ardito, RV | 1 |
| Ayoub, JC | 1 |
| Braile, DM | 1 |
| Jorge, PA | 1 |
| Bittencourt, LA | 1 |
| Manigot, DA | 1 |
| Bocchi, EA | 1 |
| dos Santos, LA | 1 |
| Mangione, JA | 1 |
| Leite, PF | 1 |
| Savioli, RM | 1 |
| de Brito, FS | 1 |
| Nassif, M | 1 |
| Ortiz, J | 1 |
| Barreto, AC | 1 |
| Del Nero Junior, E | 1 |
| Bashour, T | 1 |
| Jokhadar, M | 1 |
| Cheng, TO | 1 |
| Hendrickson, JA | 3 |
| Goldreyer, BN | 1 |
| Korting, HC | 1 |
| Kolz, R | 1 |
| Schmoeckel, C | 1 |
| Balda, BR | 1 |
| Cieśliński, A | 1 |
| Jasiński, K | 1 |
| Vitolo, E | 2 |
| Tronci, M | 2 |
| Larovere, MT | 1 |
| Rumolo, R | 2 |
| Melmed, S | 1 |
| Reed, AW | 1 |
| Hershman, JM | 3 |
| Bischof, P | 1 |
| Wimpfheimer, C | 1 |
| Molinis, G | 1 |
| Valente, M | 1 |
| Tuniz, D | 1 |
| Maisano, G | 1 |
| Ricevuti, A | 1 |
| Bonifazi, C | 1 |
| Coppetti, S | 1 |
| Ferrari, O | 1 |
| Rinaldo, R | 1 |
| Rizzi, M | 1 |
| Tavecchi, L | 1 |
| Zampaglione, G | 1 |
| Ziletti, G | 1 |
| Distante, S | 1 |
| Chadid, P | 1 |
| Fernández, M | 1 |
| Luco, C | 1 |
| Casanegra, P | 1 |
| Campbell, RW | 4 |
| Schirripa, V | 1 |
| Attisano, N | 1 |
| Sarica, G | 1 |
| Grenci, G | 1 |
| Gurevich, MA | 1 |
| Hollman, A | 1 |
| Holt, PM | 1 |
| Installe, E | 1 |
| Schoevaerdts, JC | 1 |
| Gadisseux, P | 1 |
| Charles, S | 1 |
| Tremouroux, J | 1 |
| Germiniani, H | 1 |
| Branco, CL | 1 |
| Pleskot, M | 3 |
| Pidrman, V | 3 |
| Tilser, P | 2 |
| Parízek, P | 2 |
| Ahmad, S | 1 |
| Hawthorne, HR | 1 |
| Wood, MA | 1 |
| Stambler, BS | 1 |
| Damiano, RJ | 1 |
| Ellenbogen, KA | 2 |
| Singer, I | 1 |
| Kim, CH | 1 |
| Daubert, JP | 2 |
| Akiyama, T | 1 |
| Singh, SN | 3 |
| Fisher, SG | 2 |
| Lewis, HD | 1 |
| Deedwania, PC | 1 |
| Massie, BM | 2 |
| Colling, C | 1 |
| Lazzeri, D | 1 |
| Arteaga, WJ | 1 |
| Windle, JR | 1 |
| Garretto, NS | 1 |
| Rey, RD | 1 |
| Kohler, G | 1 |
| Cocorullo, S | 1 |
| Monteverde, DA | 1 |
| Ravera, BI | 1 |
| Sica, RE | 1 |
| Sainte-Beuve, C | 1 |
| Victor, J | 1 |
| Penisson, I | 1 |
| Tadei, A | 1 |
| Bosser, G | 1 |
| Marçon, F | 1 |
| Lethor, JP | 1 |
| Worms, AM | 1 |
| Follin, SL | 1 |
| Ordelova, A | 1 |
| Middlekauff, HR | 3 |
| Saxon, LA | 3 |
| Stevenson, LW | 2 |
| Weiss, JN | 1 |
| Curtis, AB | 1 |
| Magee, LA | 1 |
| Downar, E | 4 |
| Sermer, M | 1 |
| Boulton, BC | 1 |
| Allen, LC | 1 |
| Koren, G | 1 |
| Dodo, H | 1 |
| Gow, RM | 1 |
| Hamilton, RM | 1 |
| Freedom, RM | 1 |
| Moro Serrano, C | 1 |
| Hernández Madrid, A | 1 |
| Lage Silveira, J | 1 |
| Vivas Alvarez, E | 1 |
| Kanjhi, M | 1 |
| Seidl, K | 1 |
| Hauer, B | 1 |
| Schwick, N | 1 |
| Buechele, T | 1 |
| Schilling, I | 1 |
| Senges, J | 1 |
| Dotti, MT | 1 |
| Federico, A | 1 |
| Riggio, DW | 1 |
| Peters, RW | 1 |
| Feliciano, Z | 1 |
| Gottlieb, SS | 1 |
| Shorofsky, SR | 1 |
| Gold, MR | 1 |
| Valle, JM | 1 |
| Alvarez, D | 1 |
| Antúnez, J | 1 |
| Valdés, L | 1 |
| Tereshchenko, IV | 2 |
| Tsepelev, VV | 2 |
| McMurray, J | 1 |
| Rankin, A | 1 |
| Bokarev, IN | 1 |
| Fomina, IG | 1 |
| Djian, J | 1 |
| Goedel-Meinen, L | 3 |
| Satoh, H | 1 |
| Papiris, SA | 1 |
| Maniati, MA | 1 |
| Manoussakis, MN | 1 |
| Constantopoulos, SH | 1 |
| Ivanova, ES | 1 |
| Faber, TS | 2 |
| Zehender, M | 4 |
| Van de Loo, A | 1 |
| Hohnloser, S | 1 |
| Just, H | 3 |
| Ahmed, R | 1 |
| Flach, AJ | 1 |
| Dolan, BJ | 1 |
| Gonska, BD | 1 |
| Pahor, M | 1 |
| Guralnik, JM | 1 |
| Gambassi, G | 1 |
| Bernabei, R | 1 |
| Carosella, L | 1 |
| Carbonin, P | 1 |
| Ceremuzyński, L | 1 |
| Camm, AJ | 9 |
| Julian, D | 1 |
| Janse, G | 1 |
| Munoz, A | 2 |
| Schwartz, P | 1 |
| Simon, P | 2 |
| Frangin, G | 2 |
| Barbosa Filho, J | 1 |
| Barbosa, PR | 1 |
| Soares, JP | 1 |
| Fajuri, A | 1 |
| Rodríguez, JA | 1 |
| González, R | 1 |
| Jalil, J | 1 |
| García, E | 1 |
| Molgo, M | 1 |
| Soza, M | 1 |
| Valenzuela, P | 1 |
| Nattel, S | 2 |
| Talajic, M | 1 |
| Beaudoin, D | 1 |
| Matthews, C | 1 |
| Roy, D | 1 |
| Nicholson, AA | 1 |
| Caplin, JL | 1 |
| Steventon, DM | 1 |
| Politi, A | 1 |
| Galli, M | 1 |
| Ferrari, G | 1 |
| Campbell, TJ | 1 |
| Takada, K | 1 |
| Sumikawa, K | 1 |
| Kamibayashi, T | 1 |
| Hayashi, Y | 1 |
| Yamatodani, A | 1 |
| Kawabata, K | 1 |
| Yoshiya, I | 1 |
| Sharma, AD | 2 |
| Carruthers, SG | 2 |
| Weinberg, BA | 1 |
| Klein, LS | 2 |
| Bolander, JE | 1 |
| Dusman, RE | 1 |
| Stanton, MS | 1 |
| Langefeld, C | 1 |
| Pfisterer, ME | 1 |
| Kiowski, W | 4 |
| Brunner, H | 2 |
| Burkart, F | 4 |
| Hii, JT | 1 |
| Gillis, AM | 1 |
| Sheldon, RS | 1 |
| Pfisterer, M | 4 |
| Shuler, CO | 1 |
| Case, CL | 1 |
| Gillette, PC | 1 |
| Bardají, A | 1 |
| Vidal, F | 1 |
| Richart, C | 1 |
| Kosmala, W | 1 |
| Ducceschi, V | 1 |
| Sarubbi, B | 1 |
| Esposito, R | 1 |
| Manzo, G | 1 |
| Mayer, MS | 1 |
| Santangelo, L | 1 |
| Iacono, A | 1 |
| Sleight, P | 1 |
| Finance, O | 1 |
| Manning, A | 1 |
| Chatelain, P | 2 |
| Manning, AS | 1 |
| Bruyninckx, C | 1 |
| Ramboux, J | 1 |
| Manfredi, C | 3 |
| Clerico, A | 3 |
| Turchi, S | 1 |
| Cazzuola, F | 1 |
| Berti, S | 2 |
| Sabatino, L | 2 |
| Biagini, A | 3 |
| Awaji, T | 1 |
| Perry, JC | 1 |
| Fenrich, AL | 1 |
| Hulse, JE | 1 |
| Triedman, JK | 1 |
| Lamberti, JJ | 1 |
| Green, MS | 1 |
| Kautzner, J | 1 |
| Mannino, MM | 2 |
| Mehta, D | 1 |
| Langan, NM | 1 |
| Gomes, JA | 1 |
| Opasich, C | 1 |
| Sinagra, G | 1 |
| Rapezzi, C | 1 |
| Spirito, P | 1 |
| Assadi, S | 1 |
| Edoute, Y | 1 |
| Arós Borau, F | 1 |
| Loma-Osorio, A | 1 |
| Torres Bosco, A | 1 |
| Ridker, PM | 1 |
| Sanderson, J | 1 |
| Osswald, S | 1 |
| Rickenbacher, P | 1 |
| Buser, PT | 1 |
| Cosnay, P | 1 |
| Babuty, D | 1 |
| Charniot, JC | 1 |
| Fauchier, L | 1 |
| Fauchier, JP | 2 |
| Slade, AK | 1 |
| Gaete, L | 1 |
| Asenjo, R | 1 |
| Fernández, F | 1 |
| Saavedra, I | 1 |
| Lazzara, R | 2 |
| Hamoud, K | 1 |
| Kaneti, J | 1 |
| Smailowitz, Z | 1 |
| Lissmer, L | 1 |
| Chow, MS | 1 |
| Segawa, K | 1 |
| Yoshimoto, N | 1 |
| Matsuo, H | 1 |
| Ector, H | 1 |
| Jordaens, L | 1 |
| Vanhaecke, J | 1 |
| Ha, HR | 1 |
| Candinas, R | 1 |
| Stieger, B | 1 |
| Bonini, R | 1 |
| Ravani, M | 1 |
| Palmieri, C | 1 |
| Carpi, A | 1 |
| Chopra, IJ | 2 |
| Heuck, A | 1 |
| Mattke, S | 1 |
| Seemann, M | 1 |
| Müller, D | 1 |
| Beuers, U | 1 |
| Huber, A | 1 |
| Reiser, M | 1 |
| Julian, DG | 4 |
| Janse, MJ | 3 |
| Schwartz, PJ | 6 |
| Cairns, JA | 2 |
| Balser, JR | 1 |
| Horton, RP | 1 |
| Canby, RC | 1 |
| Román, CA | 1 |
| Hull, ML | 1 |
| Kaye, SA | 1 |
| Jessen, ME | 1 |
| Page, RL | 2 |
| Futterman, LG | 1 |
| Lemberg, L | 1 |
| Barron, HV | 1 |
| Khan, HH | 1 |
| Viskin, S | 1 |
| Heller, K | 1 |
| Kalman, JM | 1 |
| Lesh, MD | 1 |
| Thomas, O | 1 |
| Deharo, JC | 1 |
| Durand, A | 1 |
| Macaluso, G | 1 |
| Malaterre, H | 1 |
| Le Tallec, L | 1 |
| Panagides, D | 1 |
| Bory, M | 1 |
| Djiane, P | 1 |
| McAlister, FA | 1 |
| Teo, KK | 1 |
| van de Wiele, C | 1 |
| Osmanagaoglu, K | 1 |
| Monsieurs, M | 1 |
| van Laere, K | 1 |
| Kaufman, JM | 1 |
| Dierckx, RA | 1 |
| Hancock, EW | 1 |
| Doig, JC | 1 |
| Marinchak, RA | 2 |
| Rials, SJ | 1 |
| Bharucha, D | 1 |
| Kennedy, HL | 1 |
| Myerburg, RJ | 3 |
| Castellanos, A | 2 |
| Cole, TJ | 1 |
| Proto, AV | 1 |
| Werkö, L | 1 |
| Galenko-Iaroshevskiĭ, PA | 1 |
| Kryzhanovskiĭ, SA | 1 |
| Uvarov, AV | 1 |
| Turovaia, AIu | 1 |
| Popov, PB | 1 |
| Khankoeva, AI | 1 |
| Behrens, S | 1 |
| Li, C | 1 |
| Halkin, A | 1 |
| Shibolet, O | 1 |
| Frangin, GA | 2 |
| Zamorski, M | 1 |
| Caramanno, G | 1 |
| Innocente, P | 1 |
| Di Giovanna, F | 1 |
| Pedretti, RF | 1 |
| Migliori, GB | 1 |
| Mapelli, V | 1 |
| Daniele, G | 1 |
| Tramarin, R | 1 |
| Hlatky, MA | 2 |
| Owens, DK | 2 |
| Rohde, LE | 1 |
| Moraes, RS | 1 |
| Ferlin, E | 1 |
| Ribeiro, JP | 1 |
| Aguinaga, L | 1 |
| Mont, L | 1 |
| Anguera, I | 1 |
| Valentino, M | 1 |
| Matas, M | 1 |
| Brugada, J | 1 |
| Movsowitz, C | 1 |
| Marchlinski, FE | 5 |
| Pathmanathan, RK | 1 |
| Lau, EW | 1 |
| Cooper, J | 1 |
| Newton, L | 1 |
| Skehan, JD | 1 |
| Garratt, CJ | 1 |
| Griffith, MJ | 1 |
| Fries, R | 1 |
| Heisel, A | 1 |
| Schieffer, H | 1 |
| Bello, D | 1 |
| Greene, M | 1 |
| Hara, M | 1 |
| Matsumori, A | 1 |
| Domanski, MJ | 2 |
| Zarembski, DG | 1 |
| Fischer, SA | 1 |
| Santucci, PA | 1 |
| Porter, MT | 1 |
| Costanzo, MR | 1 |
| Tan, MH | 1 |
| Katai, N | 1 |
| Yokoyama, R | 1 |
| Yoshimura, N | 1 |
| Kühlkamp, V | 1 |
| Mewis, C | 1 |
| Suchalla, R | 1 |
| Mermi, J | 1 |
| Dörnberger, V | 1 |
| Seipel, L | 1 |
| Laurenzi, F | 1 |
| Avella, A | 1 |
| Adinolfi, E | 1 |
| Dini, P | 1 |
| Rabe, J | 1 |
| Kulinna, W | 1 |
| Lehmann, KJ | 1 |
| Georgi, M | 1 |
| Riihelä, K | 1 |
| Mäntyjärvi, M | 1 |
| Aimond, F | 1 |
| Beck, L | 1 |
| Gautier, P | 1 |
| Chérif, OK | 1 |
| Davy, JM | 2 |
| Lorente, P | 1 |
| Nisato, D | 1 |
| Vassort, G | 1 |
| Naccarella, F | 1 |
| Lepera, G | 1 |
| Sager, PT | 1 |
| Wolbrette, DL | 1 |
| Patel, HM | 1 |
| Tsikouris, JP | 1 |
| White, CM | 1 |
| Sheldon, R | 1 |
| Connolly, S | 1 |
| Krahn, A | 1 |
| Gardner, M | 1 |
| Maruyama, T | 1 |
| Ueda, N | 1 |
| Kaji, Y | 1 |
| Kanaya, S | 1 |
| Fujino, T | 1 |
| Niho, Y | 1 |
| Calvert, CA | 1 |
| Sammarco, C | 1 |
| Pickus, C | 1 |
| Naccarelli, G | 1 |
| Singh, B | 1 |
| Obel, OA | 1 |
| Sheridan, DJ | 1 |
| Fogel, RI | 1 |
| Taylor, R | 1 |
| Racht, E | 1 |
| Karaguezian, HS | 1 |
| Micuda, S | 1 |
| Hodac, M | 1 |
| Sispera, L | 1 |
| Cerman, J | 1 |
| Maláková, J | 1 |
| Martínková, J | 1 |
| Joglar, JA | 1 |
| Ojamaa, K | 1 |
| Brachmann, J | 1 |
| Hughes, M | 1 |
| Binning, A | 1 |
| Rokicki, W | 1 |
| Durmała, J | 1 |
| Nowakowska, E | 1 |
| Okishige, K | 1 |
| Sasano, T | 1 |
| Azegami, K | 1 |
| Suzuki, K | 1 |
| Itoh, K | 1 |
| Hein, L | 1 |
| Sakuma, T | 1 |
| Nakayasu, K | 1 |
| Kanai, A | 1 |
| Sarma, JS | 1 |
| Sloan, SB | 1 |
| Weitz, HH | 1 |
| Rochetaing, A | 1 |
| Barbé, C | 1 |
| Kreher, P | 1 |
| Sanders, GD | 1 |
| Every, NR | 1 |
| McDonald, KM | 1 |
| Heidenreich, PA | 1 |
| Parsons, LS | 1 |
| Gyönös, I | 1 |
| Agoston, M | 1 |
| Kovács, A | 1 |
| Szénási, G | 1 |
| Vereckei, A | 1 |
| Wakaumi, M | 1 |
| Matsuda, N | 1 |
| Raatikainen, MJ | 1 |
| van Opstal, JM | 1 |
| Schoenmakers, M | 1 |
| Verduyn, SC | 1 |
| de Groot, SH | 1 |
| Leunissen, JD | 1 |
| van Der Hulst, FF | 1 |
| Molenschot, MM | 1 |
| Vos, MA | 1 |
| Farkas, A | 1 |
| Gronda, E | 1 |
| Mangiavacchi, M | 1 |
| Andreuzzi, B | 1 |
| Municinò, A | 1 |
| Biran, I | 1 |
| Steiner, I | 1 |
| Wooten, JM | 1 |
| Earnest, J | 1 |
| Reyes, J | 1 |
| Yonezawa, E | 1 |
| Matsumoto, K | 1 |
| Tachibana, M | 1 |
| Hashimoto, H | 1 |
| Miyatake, K | 1 |
| Dias da Silva Valdo, J | 1 |
| Viana Públio, CC | 1 |
| de Melo Alves, R | 1 |
| Fazan, R | 1 |
| Ruscone, TG | 1 |
| Porta, A | 1 |
| Malliani, A | 1 |
| Salgado, HC | 1 |
| Montano, N | 1 |
| Osman, F | 1 |
| Franklyn, JA | 3 |
| Sheppard, MC | 3 |
| Gammage, MD | 2 |
| Moss, AJ | 1 |
| Zareba, W | 1 |
| Hall, WJ | 1 |
| Klein, H | 1 |
| Wilber, DJ | 1 |
| Higgins, SL | 1 |
| Brown, MW | 1 |
| Andrews, ML | 1 |
| Gombotz, H | 1 |
| Vicenzi, M | 1 |
| Mahla, E | 1 |
| Rehak, P | 1 |
| Metzler, H | 1 |
| Aghini-Lombardi, F | 1 |
| Cosci, C | 1 |
| Lupi, I | 1 |
| Santini, F | 1 |
| Tanda, ML | 1 |
| Basolo, F | 1 |
| Pinchera, A | 1 |
| Braverman, LE | 1 |
| Hebbar, AK | 1 |
| Hueston, WJ | 1 |
| Bilchick, KC | 1 |
| Fetics, B | 1 |
| Djoukeng, R | 1 |
| Nevo, E | 1 |
| Berger, RD | 1 |
| O'Byrne, P | 1 |
| Ledouarin, B | 1 |
| Loisance, D | 1 |
| Rosanval, O | 1 |
| Jewitt, DE | 1 |
| Donaldson, RM | 1 |
| Ryndina, MG | 1 |
| Blizniak, GV | 1 |
| Marco, J | 1 |
| Baradat, G | 1 |
| Constans, R | 1 |
| Alibelli, MJ | 1 |
| Berthoumieu, H | 1 |
| Dardenne, P | 1 |
| Van Schepdael, J | 1 |
| Solvay, H | 1 |
| Zakharov, VN | 1 |
| Kuznetsov, KK | 1 |
| Brochier, M | 1 |
| Piffanelli, A | 2 |
| Pelizzola, D | 2 |
| Ricci, L | 2 |
| Codecá, L | 2 |
| Masoni, A | 1 |
| Romelli, PB | 1 |
| Krikler, D | 1 |
| Bargero, G | 1 |
| Bellini, R | 1 |
| Botta, M | 1 |
| Griseri, M | 1 |
| Montalenti, P | 1 |
| Vaughan-Williams, EM | 1 |
| Milosevic, D | 1 |
| Frabetti, L | 1 |
| Perticucci, R | 1 |
| De Garaté, S | 1 |
| Bracchetti, D | 1 |
| Magnani, B | 2 |
| Waleffe, A | 1 |
| Bordalo, A | 1 |
| Bruninx, P | 1 |
| Wheeler, PJ | 1 |
| Puritz, R | 1 |
| Leak, D | 3 |
| Eydt, JN | 2 |
| Della Cuna Fabio, R | 1 |
| Stefano, G | 1 |
| Marchi, F | 2 |
| da Cunha, GP | 1 |
| da Cunha, CL | 1 |
| Zuttere, D | 1 |
| Tao, KS | 1 |
| Sun, JP | 2 |
| Pelucco, D | 1 |
| Bernabò Di Negro, G | 1 |
| Pucciarelli, G | 1 |
| Caso, P | 1 |
| Anderson, JL | 2 |
| Meffin, PJ | 1 |
| Troup, PJ | 2 |
| Casillas Ruíz, JA | 1 |
| Fernández Berridi, D | 1 |
| Malpartida de Torres, F | 1 |
| Quintanilla Gutiérrez, E | 1 |
| Modica, A | 1 |
| Gabasio, S | 1 |
| Cattaneo, RG | 1 |
| Zardo, L | 1 |
| Levi, RJ | 1 |
| Simeoni, L | 1 |
| Guerra, G | 1 |
| Piva, M | 1 |
| Benaim, R | 2 |
| Denizeau, JP | 1 |
| Melon, J | 2 |
| Domengie, B | 1 |
| Kolsky, H | 1 |
| Chapelle, M | 2 |
| Chiche, P | 2 |
| Touboul, P | 1 |
| Huerta, F | 1 |
| Porte, J | 1 |
| Delahaye, JP | 1 |
| Naouri, R | 1 |
| Wolff, F | 1 |
| Dreifus, LS | 1 |
| Ogawa, S | 1 |
| Telichowski, C | 1 |
| Krzysztoń, Z | 1 |
| Michat, L | 2 |
| Cabrol, C | 1 |
| Mattei, MF | 1 |
| Gobin, F | 1 |
| Bourel, LM | 1 |
| Grandjbakhch, I | 1 |
| Guiraudon, G | 1 |
| Fidelle, JE | 1 |
| Toumieux, MC | 2 |
| Coutte, R | 1 |
| Dragodanne, C | 1 |
| Phan-Thuc, H | 1 |
| Facquet, J | 1 |
| Warembourg, H | 2 |
| Ducloux, G | 1 |
| Raineri, A | 1 |
| Hoffmann, E | 1 |
| Mercadante, G | 1 |
| Sammartano, S | 1 |
| Traina, M | 1 |
| Modica, G | 1 |
| Ferrante, R | 1 |
| Marmo, E | 1 |
| Coscia, L | 1 |
| Rossi, F | 1 |
| Chieppa, S | 1 |
| Brita, G | 1 |
| Caputi, AP | 1 |
| Trigano, JA | 1 |
| Torresani, J | 1 |
| Malpartida, F | 1 |
| Triola, M | 1 |
| Huguet, R | 1 |
| Sala, J | 1 |
| Noguera, J | 1 |
| Cordeiro, B | 1 |
| Zabel, M | 1 |
| Meinertz, T | 2 |
| Valensise, H | 1 |
| Civitella, C | 1 |
| Garzetti, GG | 1 |
| Romanini, C | 1 |
| Funck-Brentano, C | 2 |
| Mazas-Artasona, L | 1 |
| Led, A | 1 |
| Balmaseda, C | 1 |
| Bordas, Y | 1 |
| von Planta, M | 1 |
| Chamberlain, D | 1 |
| Salamé, E | 1 |
| Checrallah, E | 1 |
| Abou Jaoudé, S | 1 |
| Halaby, J | 1 |
| Gasińska, T | 1 |
| Mandecki, T | 1 |
| Szydło, E | 1 |
| Szulc, A | 1 |
| Nowakowska, M | 1 |
| Honerjäger, P | 1 |
| Schmidt, G | 3 |
| Gill, J | 1 |
| Heel, RC | 1 |
| Fitton, A | 1 |
| Davies, PH | 1 |
| Brakhmann, I | 1 |
| Shmitt, K | 1 |
| Baĭer, T | 1 |
| Valdeker, B | 1 |
| Khilbel, T | 1 |
| Kiubler, V | 1 |
| Zirm, B | 1 |
| Zirm, A | 1 |
| Kargl, R | 1 |
| Hartter, E | 1 |
| Wang, YX | 1 |
| Tan, YH | 1 |
| Sheng, BH | 1 |
| Mayuga, RD | 1 |
| Singer, DH | 1 |
| Chelimsky-Fallick, C | 1 |
| Kobashigawa, J | 1 |
| Moriguchi, J | 1 |
| Brownfield, ED | 1 |
| Hamilton, MA | 1 |
| Drinkwater, D | 1 |
| Laks, H | 1 |
| Chouty, F | 1 |
| Denjoy, I | 3 |
| Slama, R | 2 |
| Shetty, HG | 1 |
| Woodhouse, KW | 1 |
| Campbell, R | 1 |
| Loaiza, A | 1 |
| Plomp, TA | 1 |
| Vulsma, T | 1 |
| de Vijlder, JJ | 1 |
| Vietti-Ramus, G | 1 |
| Veglio, F | 1 |
| Marchisio, U | 1 |
| Burzio, P | 1 |
| Latini, R | 3 |
| Krieg, P | 1 |
| Schipper, I | 1 |
| Ulrik, CS | 1 |
| Backer, V | 1 |
| Aldershvile, J | 2 |
| Pietersen, AH | 1 |
| Kim, SG | 2 |
| Chou, R | 1 |
| Roth, S | 1 |
| Roth, JA | 1 |
| Desai, B | 1 |
| Ferrick, KJ | 1 |
| Fisher, JD | 2 |
| Coker, SJ | 1 |
| Chess-Williams, R | 1 |
| Oliveira, LF | 1 |
| Oliveira Júnior, W | 1 |
| de Carvalho, FB | 1 |
| Toivonen, L | 1 |
| Viitasalo, M | 1 |
| Pongiglione, G | 1 |
| Strasburger, JF | 1 |
| Deal, BJ | 1 |
| Benson, DW | 1 |
| Ventosa, A | 1 |
| Adragão, P | 1 |
| Bonhorst, D | 1 |
| Seabra-Gomes, R | 1 |
| Abdollah, H | 3 |
| Brennan, FJ | 4 |
| Winslow, E | 2 |
| Campbell, JK | 1 |
| Barron, E | 1 |
| Baedeker, W | 2 |
| Hofmann, M | 1 |
| Barthel, P | 1 |
| Blömer, H | 1 |
| Levy, S | 1 |
| Puech, P | 1 |
| Katritsis, D | 1 |
| Fazekas, T | 1 |
| Korom, I | 1 |
| Mágori, A | 1 |
| Pogátsa, G | 1 |
| Ungi, I | 1 |
| Gloor, HO | 1 |
| Herndon, JC | 1 |
| Cook, AO | 1 |
| Ramsay, MA | 1 |
| Swygert, TH | 1 |
| Capehart, J | 1 |
| Freedman, MD | 1 |
| Somberg, JC | 3 |
| Somberg, J | 2 |
| Kreamer, J | 1 |
| Camba, N | 1 |
| Bennett, BH | 1 |
| Pathé, M | 1 |
| Kahn, JC | 1 |
| Hagemeijer, F | 1 |
| Furberg, CD | 1 |
| Morelli, S | 1 |
| Guido, V | 1 |
| De Marzio, P | 1 |
| Aguglia, F | 1 |
| Balsano, F | 1 |
| Zuanetti, G | 2 |
| Neilson, JM | 1 |
| Ewing, DJ | 1 |
| Jimmo, S | 1 |
| Jacqz-Aigrain, E | 1 |
| Roux, A | 1 |
| Poirier, JM | 3 |
| Jaillon, P | 4 |
| Jolly, E | 1 |
| Belloti, MS | 1 |
| Lowenstein, J | 1 |
| Luna, C | 1 |
| Avagnina, A | 1 |
| Elsner, B | 1 |
| Mazzei, JA | 1 |
| Nicklas, JM | 2 |
| Stewart, RA | 1 |
| Mickelson, JK | 1 |
| Das, SK | 1 |
| Schork, MA | 1 |
| Quain, LA | 1 |
| Pitt, B | 1 |
| Slama, M | 2 |
| Drieu, L | 1 |
| Dammbacher, T | 1 |
| Steiert, K | 1 |
| Jähnchen, E | 1 |
| Fraedrich, G | 1 |
| Rosalion, A | 1 |
| Snow, NJ | 1 |
| Horrigan, TP | 1 |
| Noon, DL | 1 |
| Mostow, ND | 4 |
| Fananapazir, L | 1 |
| Epstein, SE | 1 |
| Kopacz, DJ | 1 |
| Shestakova, NV | 1 |
| Kurbanov, RD | 2 |
| Khodzhakuliev, BG | 1 |
| Naumov, VG | 1 |
| Leleko, VV | 1 |
| Belenkov, IuN | 1 |
| Albert, SG | 2 |
| Dabrowski, A | 1 |
| Ostrowska, B | 1 |
| Bacior, B | 1 |
| Fryśna-Dmuchowska, B | 1 |
| Kargul, W | 1 |
| Król, J | 1 |
| Królikowski, Z | 1 |
| Luczak, D | 1 |
| Malczewska, B | 1 |
| Nessler, J | 1 |
| Remme, WJ | 2 |
| van Hoogenhuyze, DC | 2 |
| Tamargo, J | 1 |
| Valenzuela, C | 1 |
| Delpón, E | 1 |
| Warren, R | 1 |
| Vohra, J | 1 |
| Hunt, D | 1 |
| Mentré, F | 1 |
| Chassard, D | 1 |
| George, M | 2 |
| Guiraud, M | 1 |
| Lehot, JJ | 2 |
| Bastien, O | 2 |
| Hercule, C | 2 |
| Villard, J | 2 |
| Estanove, S | 2 |
| Politi, G | 1 |
| Romanini, B | 1 |
| Tos, M | 1 |
| Pucci, C | 1 |
| Rescalli, S | 1 |
| Ferro, C | 1 |
| Somani, P | 2 |
| Bandyopadhyay, S | 1 |
| Klaunig, JE | 1 |
| Gross, SA | 1 |
| Reinhart, WH | 1 |
| Rohner, F | 1 |
| Golovina, VA | 1 |
| Quadrado, C | 1 |
| Soares, Ade O | 1 |
| de Castro, JJ | 1 |
| Mota, E | 1 |
| Zhou, ZB | 1 |
| McAlister, HF | 1 |
| Luke, RA | 1 |
| Whitlock, RM | 2 |
| Smith, WM | 3 |
| Vrobel, TR | 3 |
| Noon, D | 2 |
| Keung, EC | 1 |
| Pavlov, AV | 1 |
| Mathias, K | 1 |
| Lambers, U | 1 |
| Hoffmann, J | 1 |
| Rankin, AC | 1 |
| Pringle, SD | 1 |
| Cobbe, SM | 1 |
| Teasdale, S | 1 |
| Guccione, P | 1 |
| Garson, A | 2 |
| Herre, JM | 2 |
| Ross, BA | 1 |
| Saby, MA | 1 |
| Batisse, A | 1 |
| Klein, G | 1 |
| Stewart, D | 1 |
| Finch, N | 1 |
| Kratz, J | 1 |
| Leman, RB | 1 |
| Zukerman, C | 1 |
| Hubsch, JP | 1 |
| Dumouchel, A | 1 |
| Debesse, B | 1 |
| Oleĭnikov, VE | 1 |
| Zhivotovskaia, GG | 1 |
| Tatti, V | 1 |
| Ramelli, G | 1 |
| Waspe, LE | 1 |
| Johnston, DR | 1 |
| Occhetta, E | 1 |
| Magnani, A | 1 |
| Prando, MD | 1 |
| Perucca, A | 1 |
| Rognoni, G | 1 |
| Roupe, G | 1 |
| Larkö, O | 1 |
| Olsson, SB | 1 |
| Marshall, RJ | 1 |
| Hope, FG | 1 |
| Bogers, AJ | 1 |
| Quaegebeur, JM | 1 |
| Ottenkamp, J | 1 |
| Huysmans, HA | 1 |
| Gheri, RG | 1 |
| Zambaldi, G | 1 |
| Multinu, D | 1 |
| Paladini, S | 1 |
| Fazzini, PF | 1 |
| Davies, M | 1 |
| Quantz, M | 1 |
| Althaus, B | 1 |
| Bucher, H | 1 |
| Schön, H | 1 |
| Vogt, T | 1 |
| Fournier, C | 2 |
| Brunet, M | 2 |
| Kindermans, M | 2 |
| Fedorowsky, A | 1 |
| Tournadre, P | 2 |
| Gensous, D | 2 |
| Blondeau, M | 2 |
| Liem, LB | 1 |
| Skluth, H | 1 |
| Grauer, K | 1 |
| Gums, J | 1 |
| Haiat, R | 1 |
| Nicolai, P | 1 |
| Dujardin, JJ | 1 |
| Joly, P | 1 |
| Kacet, S | 1 |
| Cordoni, M | 1 |
| Scalzini, A | 1 |
| Bechi, S | 1 |
| Franchini, C | 1 |
| Mazza, F | 1 |
| Micheli, G | 1 |
| Minardo, JD | 1 |
| Reichert, LJ | 1 |
| de Rooy, HA | 1 |
| Riva, E | 2 |
| Hearse, DJ | 1 |
| Prayer, L | 1 |
| Hübsch, P | 1 |
| Frank, H | 1 |
| Castro, I | 1 |
| Poma, N | 1 |
| Rodrigues, R | 1 |
| Maciel Júnior, JA | 1 |
| Queiroz, L | 1 |
| Flaharty, KK | 1 |
| Chase, SL | 1 |
| Yaghsezian, HM | 1 |
| Rubin, R | 1 |
| Smith, WC | 1 |
| Reddy, CP | 2 |
| Kreamer, JW | 1 |
| Zevitz, M | 1 |
| Counihan, PJ | 1 |
| Gärtner, R | 1 |
| Arkles, LB | 1 |
| Bah, M | 1 |
| Boujon, B | 1 |
| Giudicelli, JF | 1 |
| Primeau, R | 1 |
| Agha, A | 1 |
| Giorgi, C | 1 |
| Nadeau, R | 1 |
| Robinson, K | 1 |
| Mulrow, JP | 1 |
| Piccione, W | 1 |
| Faber, LP | 1 |
| Rosenberg, MS | 1 |
| Denis, L | 1 |
| Reymen, I | 1 |
| Cleeren, P | 1 |
| Mattioni, TA | 1 |
| Zheutlin, TA | 1 |
| Sarmiento, JJ | 1 |
| Parker, M | 1 |
| Lesch, M | 1 |
| Kehoe, RF | 1 |
| Kupferschmid, JP | 1 |
| Rosengart, TK | 1 |
| McIntosh, CL | 1 |
| Leon, MB | 1 |
| Clark, RE | 1 |
| Parra, O | 1 |
| Ruiz, J | 1 |
| Ojanguren, I | 1 |
| Navas, JJ | 1 |
| Morera, J | 1 |
| Grishkin, IuN | 1 |
| Morganroth, J | 3 |
| Quart, BD | 1 |
| Gallo, DG | 1 |
| Sami, MH | 1 |
| Wood, AJ | 1 |
| Rabloczky, G | 2 |
| Bódi, I | 1 |
| Vignati, G | 1 |
| Danzi, GB | 1 |
| Austoni, P | 1 |
| Fancini, P | 1 |
| Mascarello, M | 1 |
| Figini, A | 1 |
| Hawthorne, GC | 1 |
| Campbell, NP | 1 |
| Geddes, JS | 1 |
| Ferguson, WR | 1 |
| Postlethwaite, W | 1 |
| Sheridan, B | 1 |
| Atkinson, AB | 1 |
| Costa, C | 1 |
| Visalli, N | 1 |
| Natoli, A | 1 |
| Liu, FL | 1 |
| Cohen, RD | 1 |
| Butany, JW | 1 |
| Edelson, JD | 1 |
| Rebuck, AS | 1 |
| Dargie, HJ | 5 |
| Cleland, JG | 5 |
| Leckie, BJ | 1 |
| Inglis, CG | 1 |
| East, BW | 1 |
| Ford, I | 1 |
| Nestico, PF | 2 |
| Huang, SK | 1 |
| Chiale, P | 1 |
| Elizari, M | 1 |
| Keeton, BR | 2 |
| Bucknall, CA | 2 |
| Curry, PV | 2 |
| Joseph, MC | 1 |
| Sutherland, GR | 2 |
| Gosling, RH | 1 |
| Wildey, S | 1 |
| Wirth, MA | 1 |
| Cowan, JC | 1 |
| Moak, JP | 1 |
| Smith, RT | 1 |
| Schlienger, JL | 1 |
| Dickelé, MC | 1 |
| Roul, G | 1 |
| Sapin, R | 1 |
| Chabrier, G | 1 |
| Gasser, F | 1 |
| Fellinger, F | 1 |
| Sacrez, A | 1 |
| Goldstein, H | 1 |
| Tanida, E | 1 |
| Mills, LC | 1 |
| Ward, MJ | 1 |
| Routledge, PA | 1 |
| Hutchings, A | 1 |
| Morris, JM | 1 |
| Köhler, U | 1 |
| Neyses, L | 1 |
| Lanza, GA | 1 |
| Tamburi, S | 1 |
| Mondello Malvestiti, FM | 1 |
| Rebuzzi, AG | 1 |
| Lucente, M | 1 |
| Raeder, EA | 1 |
| Lakatos, A | 2 |
| Török, L | 2 |
| Szücs, M | 2 |
| Oze, B | 1 |
| Blossey, HC | 1 |
| Peitsch, W | 1 |
| Chen, JC | 1 |
| Min, Y | 1 |
| Pan, XX | 1 |
| Beukema, WP | 1 |
| Gimrikh, EO | 1 |
| Gushchin, IV | 1 |
| Chekhov, AM | 1 |
| Mikhaĭlenko, AI | 1 |
| Zamotaev, IP | 1 |
| Lozinskiĭ, LG | 1 |
| Kerimova, RE | 1 |
| Maĭchuk, IuF | 1 |
| Makarova, LG | 1 |
| Novo, S | 1 |
| Alaimo, G | 1 |
| Abrignani, MG | 1 |
| Immordino, R | 1 |
| Cutietta, A | 1 |
| Indovina, A | 1 |
| Licata, G | 1 |
| Strano, A | 1 |
| Rubenfire, M | 2 |
| Blevins, RD | 2 |
| Frumin, H | 2 |
| Faitel, K | 2 |
| Jarandilla, R | 1 |
| Aragon, E | 1 |
| Marinescu, G | 1 |
| Luarca, R | 1 |
| Kiiakbaev, GK | 1 |
| Maling, T | 1 |
| Findlay, IN | 1 |
| Wilson, JT | 1 |
| Robinson, KC | 1 |
| Shatunova, IM | 1 |
| Friehling, TD | 1 |
| Sulpizi, AM | 1 |
| Stohler, JL | 1 |
| Fragu, P | 1 |
| Schlumberger, M | 1 |
| Berdeaux, A | 1 |
| Ardura, J | 1 |
| Hermoso, F | 1 |
| Bermejo, J | 1 |
| Kelly, PA | 1 |
| Mirabal, GS | 1 |
| Harthorne, JW | 1 |
| Hurvitz, RJ | 1 |
| Vlahakes, GJ | 1 |
| Jacobs, ML | 1 |
| Ilvento, JP | 1 |
| Buckley, MJ | 1 |
| Hyatt, RH | 1 |
| Sinha, B | 1 |
| Vallon, A | 1 |
| Bailey, RJ | 1 |
| Martin, A | 1 |
| Zhu, YY | 1 |
| Botvinick, E | 1 |
| Dae, M | 1 |
| Golden, J | 1 |
| Hattner, R | 1 |
| Gupta, RN | 1 |
| Hoffert, D | 1 |
| Roberts, RS | 1 |
| Giovannini, G | 1 |
| Giganti, M | 1 |
| Colamussi, V | 1 |
| Pichler, WJ | 1 |
| Schindler, L | 1 |
| Stadler, BM | 1 |
| de Weck, AL | 1 |
| Jones, DB | 1 |
| Mullick, FG | 1 |
| Hoofnagle, JH | 1 |
| Baranski, B | 1 |
| Schmidt, A | 1 |
| König, W | 1 |
| Binner, L | 1 |
| Mayer, U | 1 |
| Stauch, M | 1 |
| Helmy, I | 1 |
| Gee, G | 1 |
| Sharkey, H | 1 |
| Malone, P | 1 |
| Sauve, MJ | 2 |
| Carella, F | 1 |
| Morandi, L | 1 |
| Cappiello, E | 1 |
| Mangoni, A | 1 |
| Xaubet, A | 1 |
| Roca, J | 1 |
| Rodriguez-Roisin, R | 1 |
| Herranz, J | 1 |
| Marin, A | 1 |
| Lomeña, F | 1 |
| Montserrat, JM | 1 |
| Agustí-Vidal, A | 1 |
| Hwang, YS | 1 |
| Lo, HM | 1 |
| Lin, FY | 1 |
| Chiang, FT | 1 |
| Tseng, CD | 1 |
| Tseng, YZ | 1 |
| Wu, TL | 1 |
| Perelman, MS | 1 |
| Miani, D | 1 |
| Neri, R | 2 |
| Di Lenarda, A | 1 |
| Depelchin, P | 1 |
| Schoenfeld, P | 1 |
| Stoupel, E | 1 |
| Degré, S | 1 |
| Tomaszewski, R | 1 |
| Klein, HO | 1 |
| Beker, B | 1 |
| DiSegni, E | 1 |
| Kaplinsky, E | 1 |
| Moura, A | 1 |
| Moura, AV | 1 |
| Beckers, J | 1 |
| Bolińska, H | 1 |
| Musiał, WJ | 1 |
| Ruta, J | 1 |
| Benharkate, M | 1 |
| Plassard, G | 1 |
| Legeai, J | 1 |
| Worcel, M | 1 |
| Greenberg, ML | 1 |
| Lerman, BB | 2 |
| Shipe, JR | 1 |
| Kaiser, DL | 1 |
| Nalos, PC | 1 |
| Kass, RM | 1 |
| Gang, ES | 2 |
| Fishbein, MC | 1 |
| López, AM | 1 |
| Sánchez, C | 1 |
| Palazzo, JP | 1 |
| Visconti, RJ | 1 |
| Liberatore, MA | 1 |
| Low, RB | 1 |
| Grogan, WA | 1 |
| Narkun, DM | 1 |
| Massari, D | 1 |
| Cavagnini, F | 1 |
| Dubini, D | 1 |
| Kadish, AH | 1 |
| Buxton, AE | 3 |
| Flores, B | 1 |
| Eldar, M | 1 |
| Falik, R | 1 |
| Flores, BT | 2 |
| Shaw, L | 1 |
| Gibson, GA | 1 |
| Palakurthy, PR | 1 |
| Iyer, V | 1 |
| Klein, J | 1 |
| Nicolai, Y | 1 |
| Zhu, J | 1 |
| Haines, DE | 1 |
| Proclemer, A | 1 |
| Gianfagna, P | 1 |
| Fontanelli, A | 1 |
| Bernardi, G | 1 |
| Feruglio, GA | 1 |
| Hockings, BE | 1 |
| George, T | 1 |
| Mahrous, F | 1 |
| Taylor, RR | 1 |
| Hajar, HA | 1 |
| Shackleford, EJ | 1 |
| Watson, FT | 1 |
| Wójcik, J | 1 |
| Florkiewicz, H | 1 |
| Markiewicz, M | 1 |
| Rosenfeld, LF | 1 |
| Perlmutter, RA | 1 |
| Bookbinder, MJ | 1 |
| McPherson, CA | 1 |
| Burgess, CD | 1 |
| Siebers, RW | 1 |
| Purdie, GL | 1 |
| Taylor, C | 1 |
| Maling, TJ | 1 |
| Costigan, DC | 1 |
| Holland, FJ | 1 |
| Daneman, D | 1 |
| Hesslein, PS | 1 |
| Vogel, M | 1 |
| Ellis, G | 1 |
| Lupon-Rosés, J | 1 |
| Simó-Canonge, R | 1 |
| Lu-Cortez, L | 1 |
| Permanyer-Miralda, G | 1 |
| Allende-Monclús, H | 1 |
| Brown, MA | 1 |
| Norris, RM | 1 |
| Barbieri, E | 1 |
| Conti, F | 1 |
| Zampieri, P | 1 |
| Trevi, GP | 1 |
| Zardini, P | 1 |
| Mercer, J | 1 |
| Rutherford, JD | 1 |
| Vanoli, E | 2 |
| Abildgaard, U | 1 |
| Hansen, PF | 1 |
| Purcaro, A | 1 |
| Massacci, C | 1 |
| Curzi, G | 1 |
| Pigini, G | 1 |
| Costantini, C | 1 |
| Bilancini, A | 1 |
| Blandini, A | 1 |
| Beck-Peccoz, P | 1 |
| Cattaneo, MG | 1 |
| Faglia, G | 1 |
| Chen, WC | 1 |
| Zeng, ZR | 1 |
| Wu, CF | 1 |
| Pepper, GA | 1 |
| Tynan, MJ | 1 |
| Tao, GS | 1 |
| Zhao, CY | 1 |
| Wang, XS | 1 |
| Szekeres, L | 1 |
| Callahan, B | 1 |
| James, MA | 1 |
| Papouchado, M | 1 |
| Vann Jones, J | 1 |
| Kienzle, MG | 1 |
| Salvi, A | 1 |
| Pandullo, C | 1 |
| Gittinger, JW | 1 |
| Simon, VA | 1 |
| McManus, K | 1 |
| Kuo, CS | 1 |
| Paciotti, MV | 1 |
| Dubner, SJ | 1 |
| Elencwajg, BD | 1 |
| Palma, S | 1 |
| Mendelzon, R | 1 |
| Ramos, A | 1 |
| Bertolasi, CA | 1 |
| Dunn, M | 1 |
| Wladimiroff, JW | 1 |
| Stewart, PA | 1 |
| Carrasco, HA | 1 |
| Vicuña, AV | 1 |
| Molina, C | 1 |
| Landaeta, A | 1 |
| Reynosa, J | 1 |
| Vicuña, N | 1 |
| Fuenmayor, A | 1 |
| López, F | 1 |
| Popiliev, I | 1 |
| Donaghue, KC | 1 |
| Clarke, P | 1 |
| Hooper, MJ | 1 |
| Kushakovskiĭ, MS | 1 |
| Uzilevskaia, RA | 1 |
| Escoubet, B | 3 |
| Maison-Blanche, P | 2 |
| Adams, PC | 1 |
| Morley, AR | 1 |
| Callaghan, J | 1 |
| Torres, V | 1 |
| Tepper, D | 1 |
| Flowers, D | 1 |
| Wynn, J | 1 |
| Lam, S | 1 |
| Keefe, D | 1 |
| Miura, DS | 1 |
| Berger, Y | 1 |
| Commin, P | 1 |
| Menasché, P | 2 |
| Piwnica, A | 2 |
| Echter, E | 1 |
| Sugawara, M | 1 |
| Pekary, AE | 1 |
| Ross, R | 1 |
| DiStefano, JJ | 1 |
| Baerman, JM | 1 |
| Annesley, T | 1 |
| DiCarlo, LA | 1 |
| Foley, MK | 1 |
| Crevey, BJ | 1 |
| Solares, G | 1 |
| Ramos, F | 1 |
| Martín-Durán, R | 1 |
| San-José, JM | 1 |
| Buitrago, M | 1 |
| Haedo, AH | 1 |
| Bandieri, JD | 1 |
| Shea, P | 1 |
| Lal, R | 1 |
| Kim, SS | 1 |
| Schechtman, K | 1 |
| Ruffy, R | 1 |
| Doherty, JU | 1 |
| Cheymol, G | 1 |
| Lagier, G | 1 |
| Meese, R | 1 |
| Smitherman, TC | 1 |
| Croft, CH | 1 |
| Burger, A | 1 |
| Nicod, P | 1 |
| Borowski, GD | 1 |
| Garofano, CD | 1 |
| Rose, LI | 1 |
| Rotmensch, HR | 1 |
| Davis, JR | 1 |
| Littler, WA | 1 |
| Ramsden, DB | 1 |
| Robson, DJ | 1 |
| Jeeva Raj, MV | 1 |
| Zaza, A | 1 |
| Kruyssen, DA | 1 |
| Krauss, XH | 1 |
| Storm, CJ | 1 |
| Jahns, G | 1 |
| Linné, R | 1 |
| Schaudig, U | 1 |
| Kein, G | 1 |
| Wirtzfeld, A | 1 |
| Komajda, M | 1 |
| Farges, D | 1 |
| Standertskjöld-Nordenstam, CG | 1 |
| Wandtke, JC | 1 |
| Hood, WB | 1 |
| Zugibe, FT | 1 |
| Butler, L | 1 |
| Xu, ML | 1 |
| Tao, SQ | 1 |
| Yu, YW | 1 |
| Zhou, YF | 1 |
| Huang, DX | 1 |
| Li, ZJ | 1 |
| Kumana, CR | 1 |
| Tanser, P | 1 |
| Markos, J | 1 |
| Veronese, ME | 1 |
| Nicholson, MR | 1 |
| McLean, S | 1 |
| Shevland, JE | 1 |
| Capucci, A | 1 |
| Melandri, G | 1 |
| Mantovani, B | 1 |
| Maresta, A | 1 |
| Rae, AP | 1 |
| Sokoloff, NM | 1 |
| O'Callaghan, WG | 1 |
| Colavita, PG | 1 |
| Smith, MS | 1 |
| German, LD | 1 |
| Cahill, TB | 1 |
| Paciaroni, E | 1 |
| Ferroni, C | 1 |
| Marini, M | 1 |
| Campanari, G | 1 |
| Rosenthal, ME | 1 |
| Oseran, DS | 1 |
| Vitola, D | 1 |
| Guillermo-Cal, L | 1 |
| Daudt, NS | 1 |
| Zielinsky, P | 1 |
| Bertoletti, JC | 1 |
| Wagner, EM | 1 |
| Moura, MR | 1 |
| Firpo, CM | 1 |
| Troendle, A | 1 |
| Schmid, B | 1 |
| Balmer, P | 1 |
| Kohler, B | 1 |
| Jaillard, J | 1 |
| De Thomatis, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multi-center, Open Label, Randomised Parallel- Group Study to Compare the Efficacy of Cholestyramine Plus Standard Treatment Versus Prednisolone Plus Standard Treatment Versus Standard Treatment Alone in Treatment of Overt Hyperthyroidism[NCT03303053] | Phase 3 | 135 participants (Anticipated) | Interventional | 2017-05-11 | Recruiting | ||
| Development of a Mathematical Model for the Evaluation of the Potassium Kinetic During and After Hemodialysis for the Potassium Profiling in the Dialysate to Prevent Arrhythmias[NCT04563091] | 6 participants (Anticipated) | Interventional | 2018-11-15 | Recruiting | |||
| Cardiac Resynchronization Therapy With Synchronized RV Pacing to Improve Cardiac Function in Patients With Right Bundle Branch Block and Systolic LV Dysfunction[NCT05936294] | 5 participants (Actual) | Interventional | 2017-09-15 | Terminated (stopped due to Low enrollment) | |||
| CRM and Fusion Beats: Effects of Progressive Fusion on Intra-left Ventricular Mechanical Function[NCT00610896] | 25 participants (Actual) | Observational | 2008-01-31 | Completed | |||
| A Randomized, Prospective Multicenter Study to Determine the Incidence of Atrial Fibrillation and Heart Failure in Correlation to Stimulation Modes of Pacemakers[NCT00161551] | Phase 4 | 402 participants (Anticipated) | Interventional | 2004-11-30 | Recruiting | ||
| IntAct, Study on Promotion of Intrinsic Activity.[NCT00156741] | Phase 4 | 150 participants | Interventional | 2004-04-30 | Active, not recruiting | ||
| A Single Center Prospective, Pilot Study Examining the Non-invasive Evaluation of Ventricular Synchrony in Pediatric Patients[NCT00165932] | 145 participants (Actual) | Observational | 2004-06-30 | Completed | |||
| Left Ventricular Septum Pacing in Patients by Transvenous Approach Through the Inter-ventricular Septum - Feasibility, Long-term Lead Stability and Safety[NCT01609738] | 12 participants (Actual) | Observational | 2012-11-30 | Completed | |||
| Impact of Atrio-ventricular Optimization With His Bundle Pacing on Treatment of Atrio-ventricular Dromotropathy[NCT04544345] | 17 participants (Actual) | Interventional | 2019-12-23 | Completed | |||
| PReventive Effect Of Left Bundle Branch Area Pacing Versus righT vEntricular paCing on All Cause deaTh, Heart Failure Progression, and Ventricular dysSYNChrony in Patients With Substantial Ventricular Pacing (PROTECT-SYNC): Multicenter Prospective Randomi[NCT05585411] | 450 participants (Anticipated) | Interventional | 2023-12-31 | Not yet recruiting | |||
| Comparison of Right Ventricular Septal Pacing to Minimized Right Ventricular Septal Stimulation in Patients With Sick Sinus Syndrome[NCT01477138] | 126 participants (Anticipated) | Observational | 2011-07-31 | Recruiting | |||
| Using Time-dependent Intravenous Infusions of Amiodarone for Conversions to Sinus Rhythms in Patients With Paroxysmal Atrial Fibrillation[NCT03432663] | Phase 4 | 60 participants (Actual) | Interventional | 2008-08-01 | Completed | ||
| Pre-Operative Stellate Ganglion to Prevent Post-Operative Atrial Fibrillation[NCT05656170] | 0 participants (Actual) | Interventional | 2023-10-01 | Withdrawn (stopped due to Unable to begin study) | |||
| Prophylactic Amiodarone for the Prevention of Arrhythmias That Begin Early After Revascularization, Valve Replacement, or Repair - PAPABEAR[NCT00251706] | Phase 3 | 600 participants | Interventional | 1999-02-28 | Completed | ||
| Multi-catheter Cryotherapy Versus Radiofrequency Catheter Ablation for the Treatment of Standard and Resistant Arrhythmias[NCT03816033] | 600 participants (Anticipated) | Interventional | 2018-06-01 | Recruiting | |||
| Reveal® In-Office Implants Study[NCT01168427] | 66 participants (Actual) | Observational | 2010-08-31 | Completed | |||
| aMsa and amiOdarone Study in cArdiaC Arrest[NCT04997980] | 500 participants (Anticipated) | Observational | 2015-01-01 | Recruiting | |||
| Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients With Atrial Tachyarrhythmias[NCT03413150] | 80 participants (Actual) | Observational | 2007-01-31 | Completed | |||
| "Population Pharmacokinetics and Pharmacodynamics of Amiodarone in Children: PK-AMIO"[NCT03842020] | 57 participants (Actual) | Interventional | 2019-02-13 | Completed | |||
| [NCT00000531] | Phase 3 | 0 participants | Interventional | 1992-09-30 | Completed | ||
| Catheter Ablation for Ventricular Tachycardia in Patients With an Implantable Cardioverter Defibrillator (CALYPSO) PILOT TRIAL[NCT01576042] | 27 participants (Actual) | Interventional | 2012-05-31 | Terminated (stopped due to Main objectives of the study were met; consensus among investigators that continuing the study would not add new information beyond that already learned.) | |||
| Congestive Heart Failure Atrial Arrhythmia Monitoring and Pacing (CHAMP)[NCT00156728] | Phase 4 | 172 participants | Interventional | 2003-10-31 | Completed | ||
| Acute Mechanical Response to Anti-arrhythmic Drug Therapy[NCT02575534] | 0 participants (Actual) | Interventional | 2015-10-31 | Withdrawn (stopped due to No enrollment in study.) | |||
| Pragmatic Randomized Clinical Trial of Early Dronedarone Versus Usual Care to Change and Improve Outcomes in Persons With First-Detected Atrial Fibrillation[NCT05130268] | Phase 4 | 3,000 participants (Anticipated) | Interventional | 2021-10-29 | Active, not recruiting | ||
| Effect of Levothyroxine on Serum Adiponectin, Insulin Resistance and Cardiovascular Risk in Patients With Hypothyroidism[NCT02467244] | 120 participants (Actual) | Observational | 2017-02-01 | Completed | |||
| Characterization of Cardiac Arrhythmias in End Stage Kidney Disease Patients on Hemodialysis Using an Implantable Continuous Cardiac Rhythm Monitoring Device: A Pilot Study[NCT00932659] | 8 participants (Actual) | Observational | 2009-06-30 | Completed | |||
| Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in Europe[NCT02064192] | 2,285 participants (Actual) | Observational | 2014-05-31 | Completed | |||
| A Pilot Trial of Patient Decision Aids for Implantable Cardioverter-Defibrillators (ICDs)[NCT02026102] | 15 participants (Actual) | Interventional | 2014-09-30 | Completed | |||
| STereotactic Ablative Radiosurgery of Recurrent Ventricular Tachycardia in Structural Heart Disease[NCT03819504] | 0 participants (Actual) | Interventional | 2018-08-01 | Withdrawn (stopped due to Change in the design of the study) | |||
| Phase I/II Study of 4-D Navigated Non-invasive Radiosurgical Ablation of Ventricular Tachycardia[NCT03601832] | 10 participants (Actual) | Interventional | 2018-08-01 | Completed | |||
| VOYAGE- Ventricular Tachycardia Ablation and Myocardial Scar Characterization With Magnetic Resonance[NCT04694079] | Phase 3 | 103 participants (Anticipated) | Interventional | 2020-08-03 | Recruiting | ||
| STereotactic Ablative Radiosurgery of Recurrent Ventricular Tachycardia in Structural Heart Disease[NCT04612140] | 100 participants (Actual) | Interventional | 2020-10-01 | Completed | |||
| A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart[NCT00326690] | 0 participants (Actual) | Interventional | 2005-11-30 | Withdrawn (stopped due to Unable to recruit and enroll patients) | |||
| Arrhythmia Prediction Trial and Risk Stratification in Heart Failure Patients - Athens.[NCT02175836] | 500 participants (Anticipated) | Observational | 2007-10-31 | Recruiting | |||
| CMR Based Prediction of Ventricular Tachycardia Events in Healed Myocardial Infarction (DEVELOP-VT)[NCT04599439] | 1,000 participants (Anticipated) | Observational [Patient Registry] | 2020-08-01 | Recruiting | |||
| An Intervention to Improve ICD Deactivation Conversations (WISDOM - Working to Improve discuSsions About DefibrillatOr Management)[NCT01459744] | 562 participants (Actual) | Interventional | 2011-09-30 | Completed | |||
| Preventive VT Substrate Ablation in Patients With Chronic Post-MI Scar Showing Arrhythmogenic Characteristics[NCT04675073] | Phase 3 | 58 participants (Anticipated) | Interventional | 2021-06-01 | Recruiting | ||
| Effects of Surgical Monopolar Electrocautery and Optimal Electrosurgery Unit Return Pad Placement on Implantable Cardioverter Defibrillators Protocol[NCT01572246] | 167 participants (Actual) | Observational | 2012-05-31 | Completed | |||
| Nursing Therapeutics Education and Heart Failure (HF): an Experimental Study[NCT02425488] | 30 participants (Actual) | Interventional | 2015-04-30 | Terminated (stopped due to Feasability phase completed: Cost Evaluation) | |||
| Non-invasive Programmed Stimulation to Identify High-risk Patients With Implanted Cardioverter-defibrillator[NCT02373306] | 150 participants (Anticipated) | Interventional | 2013-11-30 | Completed | |||
| Safety Assessment for Sotalol Protocol in Outpatient Unit[NCT05418036] | Phase 4 | 110 participants (Anticipated) | Interventional | 2020-10-26 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
This objective estimates the proportion of patients having procedure-related complication requiring resolution by surgical intervention at 90 days post-implant procedure using Kaplan-Meier method. (NCT01168427)
Timeframe: From Implant to 90 days post-implant procedure
| Intervention | participants (Number) |
|---|---|
| Implant Cohort | 2 |
Report number of participants having procedure-related adverse events that meet the primary endpoint (requiring surgical intervention), and number of participants having other procedure-related adverse events (not requiring surgical intervention). (NCT01168427)
Timeframe: From Implant to 90 days post-implant procedure
| Intervention | participants (Number) | |
|---|---|---|
| AEs that meet the primary endpoint | Other procedure-related AEs | |
| Implant Cohort | 2 | 4 |
Records participants hospitalized for VT during the study (NCT01576042)
Timeframe: Baseline, 6 months
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 5 |
| Antiarrhythmic Medication | 7 |
Records participants who completed Month 3 Follow-Up Visit (NCT01576042)
Timeframe: 3 months
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 11 |
| Antiarrhythmic Medication | 12 |
Records participants who completed Month 6 Follow-Up Visit (NCT01576042)
Timeframe: 6 Months
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 7 |
| Antiarrhythmic Medication | 10 |
Records participants who had at least one of the efficacy outcome measurement (including death, hospitalization due to VT) (NCT01576042)
Timeframe: 6 Months
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 11 |
| Antiarrhythmic Medication | 14 |
Records participants who received study randomized treatment during the study (NCT01576042)
Timeframe: 6 months
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 11 |
| Antiarrhythmic Medication | 14 |
Records participants who only received study treatment as randomized during the entire study (NCT01576042)
Timeframe: 6 month
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 6 |
| Antiarrhythmic Medication | 13 |
Records participants who received study treatment as randomized and later switched to other treatment arm during the study (NCT01576042)
Timeframe: 6 months
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 5 |
| Antiarrhythmic Medication | 1 |
Days from the date of the first study treatment to the date of first ICD recurrent therapy for VT. (NCT01576042)
Timeframe: Baseline, 6 months
| Intervention | Days (Mean) |
|---|---|
| Catheter Ablation | 70.1 |
| Antiarrhythmic Medication | 78.7 |
(NCT00932659)
Timeframe: 6 months
| Intervention | participants (Number) |
|---|---|
| Single Arm: Hemodialysis Patients Implanted With REVEAL Device | 0 |
(NCT00932659)
Timeframe: 6 months
| Intervention | participants (Number) |
|---|---|
| Single Arm: Hemodialysis Patients Implanted With REVEAL Device | 0 |
209 reviews available for amiodarone and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Amiodarone in ventricular arrhythmias: still a valuable resource?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Defibrillators, Im | 2021 |
Amiodarone in ventricular arrhythmias: still a valuable resource?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Defibrillators, Im | 2021 |
Drug Interactions Affecting Antiarrhythmic Drug Use.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Arrhythmias, Cardiac; Drug Interactions; | 2022 |
Drug Interactions Affecting Antiarrhythmic Drug Use.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Arrhythmias, Cardiac; Drug Interactions; | 2022 |
Amiodarone-induced cutaneous leukocytoclastic vasculitis: a case report and a review of the literature.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Leg; Skin; Vasculitis, Leukocytoclastic, Cutaneous | 2022 |
Amiodarone-induced cutaneous leukocytoclastic vasculitis: a case report and a review of the literature.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Leg; Skin; Vasculitis, Leukocytoclastic, Cutaneous | 2022 |
Prevalence of Amiodarone Induced Hypothyroidism and Hyperthyroidism in Patients with Heart Diseases: A Systematic Review and Meta-Analysis.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Hyperthyroidism; Hypothyroidism; Prevalence | 2023 |
Prevalence of Amiodarone Induced Hypothyroidism and Hyperthyroidism in Patients with Heart Diseases: A Systematic Review and Meta-Analysis.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Hyperthyroidism; Hypothyroidism; Prevalence | 2023 |
Atrial Flutter in Pediatric Patients.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Flutter; Child; Child, Preschool; D | 2022 |
Atrial Flutter in Pediatric Patients.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Flutter; Child; Child, Preschool; D | 2022 |
Meta-Analysis Comparing the Relative Risk of Adverse Events for Amiodarone Versus Placebo.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug-Related Side Effects and Adverse Reac | 2019 |
Meta-Analysis Comparing the Relative Risk of Adverse Events for Amiodarone Versus Placebo.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug-Related Side Effects and Adverse Reac | 2019 |
The role of amiodarone in contemporary management of complex cardiac arrhythmias.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart; Heart Rate; Humans | 2020 |
The role of amiodarone in contemporary management of complex cardiac arrhythmias.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart; Heart Rate; Humans | 2020 |
Amiodarone: A Comprehensive Guide for Clinicians.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Drug Int | 2020 |
Amiodarone: A Comprehensive Guide for Clinicians.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Drug Int | 2020 |
Evaluation and Treatment of Amiodarone-Induced Thyroid Disorders.
Topics: Albania; Amiodarone; Arrhythmias, Cardiac; Coronary Artery Disease; Humans; Male; Middle Aged; Myoca | 2021 |
Evaluation and Treatment of Amiodarone-Induced Thyroid Disorders.
Topics: Albania; Amiodarone; Arrhythmias, Cardiac; Coronary Artery Disease; Humans; Male; Middle Aged; Myoca | 2021 |
The Role of Radiopharmaceuticals in Amiodarone-Induced Thyroid Pathology.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Biomarkers; Diagnosis, Differential; Early | 2017 |
The Role of Radiopharmaceuticals in Amiodarone-Induced Thyroid Pathology.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Biomarkers; Diagnosis, Differential; Early | 2017 |
Antiarrhythmic drug therapy during cardiopulmonary resuscitation: should we use it?
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiopulm | 2018 |
Antiarrhythmic drug therapy during cardiopulmonary resuscitation: should we use it?
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiopulm | 2018 |
Amiodarone Refractory Electrical Storm Post-Revascularization for Anterior ST Elevation Myocardial Infarction: A Case Report and Brief Review of the Literature.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catheter Ablation; Drug Resistance; Humans | 2018 |
Amiodarone Refractory Electrical Storm Post-Revascularization for Anterior ST Elevation Myocardial Infarction: A Case Report and Brief Review of the Literature.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catheter Ablation; Drug Resistance; Humans | 2018 |
Intravenous Sotalol: An Under Used Treatment Strategy.
Topics: Administration, Intravenous; Adrenergic beta-Antagonists; Amiodarone; Arrhythmias, Cardiac; Dose-Res | 2018 |
Intravenous Sotalol: An Under Used Treatment Strategy.
Topics: Administration, Intravenous; Adrenergic beta-Antagonists; Amiodarone; Arrhythmias, Cardiac; Dose-Res | 2018 |
Antiarrhythmic drug-induced smell and taste disturbances: A case report and literature review.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dysgeusia; Female; Humans; Metoprolo | 2018 |
Antiarrhythmic drug-induced smell and taste disturbances: A case report and literature review.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dysgeusia; Female; Humans; Metoprolo | 2018 |
Amiodarone for arrhythmia in patients with Chagas disease: A systematic review and individual patient data meta-analysis.
Topics: Amiodarone; Arrhythmias, Cardiac; Chagas Cardiomyopathy | 2018 |
Amiodarone for arrhythmia in patients with Chagas disease: A systematic review and individual patient data meta-analysis.
Topics: Amiodarone; Arrhythmias, Cardiac; Chagas Cardiomyopathy | 2018 |
Amiodarone and acupuncture for cardiac arrhythmia: Study protocol for a systematic review.
Topics: Acupuncture Therapy; Age Factors; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Combined | 2019 |
Amiodarone and acupuncture for cardiac arrhythmia: Study protocol for a systematic review.
Topics: Acupuncture Therapy; Age Factors; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Combined | 2019 |
[Effect of amiodarone on the thyroid function and safety of the therapy--what's new].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Causality; Comorbidity; Dronedarone; Human | 2012 |
[Effect of amiodarone on the thyroid function and safety of the therapy--what's new].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Causality; Comorbidity; Dronedarone; Human | 2012 |
Antiarrhythmic drugs 2013: state of the art.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Discovery; Drug Synergism; Humans; Mo | 2013 |
Antiarrhythmic drugs 2013: state of the art.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Discovery; Drug Synergism; Humans; Mo | 2013 |
Amiodarone and concurrent antiretroviral therapy: a case report and review of the literature.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Anti-Retroviral Agents; Antiretroviral Therap | 2014 |
Amiodarone and concurrent antiretroviral therapy: a case report and review of the literature.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Anti-Retroviral Agents; Antiretroviral Therap | 2014 |
[Anesthetic management of patients with arrhythmogenic right ventricular cardiomyopathy].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Amiodarone; Anesthesia, General; Anesthesia, | 2014 |
[Anesthetic management of patients with arrhythmogenic right ventricular cardiomyopathy].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Amiodarone; Anesthesia, General; Anesthesia, | 2014 |
[Treatment with amiodarone].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Interactions; Drug Monitoring; Humans | 2014 |
[Treatment with amiodarone].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Interactions; Drug Monitoring; Humans | 2014 |
Practical Management Guide for Clinicians Who Treat Patients with Amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans | 2016 |
Practical Management Guide for Clinicians Who Treat Patients with Amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans | 2016 |
[Treatment with amiodarone].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Interactions; Drug Monitoring; Humans | 2015 |
[Treatment with amiodarone].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Interactions; Drug Monitoring; Humans | 2015 |
[Amiodaron for treatment of perioperative cardiac arrythmia: a broad spectrum antiarrythmetic agent?].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Therapy, Combination; Humans; Periope | 2008 |
[Amiodaron for treatment of perioperative cardiac arrythmia: a broad spectrum antiarrythmetic agent?].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Therapy, Combination; Humans; Periope | 2008 |
Thyrotoxic cardiac disease.
Topics: Adrenergic Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Di | 2008 |
Thyrotoxic cardiac disease.
Topics: Adrenergic Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Di | 2008 |
[Arrhythmias during pregnancy].
Topics: Adenosine; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Impla | 2008 |
[Arrhythmias during pregnancy].
Topics: Adenosine; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Impla | 2008 |
Amiodarone as paradigm for developing new drugs for atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibril | 2008 |
Amiodarone as paradigm for developing new drugs for atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibril | 2008 |
Dronedarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dronedarone; Drug Interactions; Humans; In | 2009 |
Dronedarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dronedarone; Drug Interactions; Humans; In | 2009 |
New pharmacological agents for arrhythmias.
Topics: Acetanilides; Adenosine A1 Receptor Agonists; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Arrhythm | 2009 |
New pharmacological agents for arrhythmias.
Topics: Acetanilides; Adenosine A1 Receptor Agonists; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Arrhythm | 2009 |
PM101: intravenous amiodarone formulation changes can improve medication safety.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chemistry, Pharmaceutical; Humans | 2010 |
PM101: intravenous amiodarone formulation changes can improve medication safety.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chemistry, Pharmaceutical; Humans | 2010 |
Amiodarone for the emergency care of children.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Dose-Response Relationship, Drug; H | 2010 |
Amiodarone for the emergency care of children.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Dose-Response Relationship, Drug; H | 2010 |
Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug-Related Side Effects and Adverse Reac | 2010 |
Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug-Related Side Effects and Adverse Reac | 2010 |
[Ionic mechanisms of action of class III antiarrhythmic drugs].
Topics: Amiodarone; Animals; Anisoles; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Dronedarone; Elec | 2010 |
[Ionic mechanisms of action of class III antiarrhythmic drugs].
Topics: Amiodarone; Animals; Anisoles; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Dronedarone; Elec | 2010 |
Dronedarone: a new antiarrhythmic agent.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Dronedarone; Fem | 2010 |
Dronedarone: a new antiarrhythmic agent.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Dronedarone; Fem | 2010 |
[The research practice of anti-arrhythmic agents targeting on potassium ion channel].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dronedarone; Humans; Hydantoins; | 2011 |
[The research practice of anti-arrhythmic agents targeting on potassium ion channel].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dronedarone; Humans; Hydantoins; | 2011 |
Dronedarone: an overview.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Dronedarone; Heart Ra | 2012 |
Dronedarone: an overview.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Dronedarone; Heart Ra | 2012 |
Examining the safety of amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Evidence-Based Med | 2012 |
Examining the safety of amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Evidence-Based Med | 2012 |
[Arrhythmias in cardiomyopathies].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Death, Sudden, Cardiac; | 2002 |
[Arrhythmias in cardiomyopathies].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Death, Sudden, Cardiac; | 2002 |
Amiodarone in the prevention and treatment of arrhythmia.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans | 2002 |
Amiodarone in the prevention and treatment of arrhythmia.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans | 2002 |
Visual changes secondary to initiation of amiodarone: a case report and review involving ocular management in cardiac polypharmacy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Male; Polypharmacy; Vision D | 2002 |
Visual changes secondary to initiation of amiodarone: a case report and review involving ocular management in cardiac polypharmacy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Male; Polypharmacy; Vision D | 2002 |
[Drug therapy of ventricular arrhythmias - a contemporary perspective].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Clinical Trials | 2002 |
[Drug therapy of ventricular arrhythmias - a contemporary perspective].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Clinical Trials | 2002 |
Using oral amiodarone safely.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Eruptions; Drug | 2003 |
Using oral amiodarone safely.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Eruptions; Drug | 2003 |
Antiarrhythmic therapy in heart failure.
Topics: Algorithms; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Arrhythmia | 2002 |
Antiarrhythmic therapy in heart failure.
Topics: Algorithms; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Arrhythmia | 2002 |
Potentially significant drug interactions of class III antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Drug Interactions; Hu | 2003 |
Potentially significant drug interactions of class III antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Drug Interactions; Hu | 2003 |
Role of amiodarone in the era of the implantable cardioverter defibrillator.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Combined Modalit | 2003 |
Role of amiodarone in the era of the implantable cardioverter defibrillator.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Combined Modalit | 2003 |
Arrhythmias in the intensive care patient.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; | 2003 |
Arrhythmias in the intensive care patient.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; | 2003 |
Management of hypertrophic cardiomyopathy in children.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Chann | 2003 |
Management of hypertrophic cardiomyopathy in children.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Chann | 2003 |
Sudden cardiac death: prevention and treatment.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Contraindicat | 2003 |
Sudden cardiac death: prevention and treatment.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Contraindicat | 2003 |
Surgical management of amiodarone-induced thyrotoxicosis.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Female; Humans; M | 2003 |
Surgical management of amiodarone-induced thyrotoxicosis.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Female; Humans; M | 2003 |
Are implantable cardioverter-defribrillators always superior to amiodarone?
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Cost-Benefi | 2003 |
Are implantable cardioverter-defribrillators always superior to amiodarone?
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Cost-Benefi | 2003 |
[Cardiopulmonary resuscitation. Simpler is more effective: the current guidelines].
Topics: Adult; Advanced Cardiac Life Support; Aged; Algorithms; Amiodarone; Anti-Arrhythmia Agents; Arrhythm | 2003 |
[Cardiopulmonary resuscitation. Simpler is more effective: the current guidelines].
Topics: Adult; Advanced Cardiac Life Support; Aged; Algorithms; Amiodarone; Anti-Arrhythmia Agents; Arrhythm | 2003 |
Complex drug-drug-disease interactions between amiodarone, warfarin, and the thyroid gland.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Arrhythmias, Cardiac; Drug Interactions; | 2004 |
Complex drug-drug-disease interactions between amiodarone, warfarin, and the thyroid gland.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Arrhythmias, Cardiac; Drug Interactions; | 2004 |
Dronedarone: an amiodarone analogue.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Droneda | 2004 |
Dronedarone: an amiodarone analogue.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Droneda | 2004 |
A benefit-risk assessment of class III antiarrhythmic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Combined Modalit | 2004 |
A benefit-risk assessment of class III antiarrhythmic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Combined Modalit | 2004 |
[Thyroid and cardiovascular disorders].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiovascular Diseases; Coronary Artery B | 2004 |
[Thyroid and cardiovascular disorders].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiovascular Diseases; Coronary Artery B | 2004 |
[Ocular side-effects associated with amiodarone therapy].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Corneal Opacity; Dose-Response Re | 2005 |
[Ocular side-effects associated with amiodarone therapy].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Corneal Opacity; Dose-Response Re | 2005 |
Thyrotoxicosis and the cardiovascular system.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiovascula | 2005 |
Thyrotoxicosis and the cardiovascular system.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiovascula | 2005 |
Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: a meta-analysis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardi | 2005 |
Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: a meta-analysis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardi | 2005 |
[Fundamental principle in therapy for arrhythmia].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catheter Abla | 2006 |
[Fundamental principle in therapy for arrhythmia].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catheter Abla | 2006 |
[Clinical therapy for arrhythmias and EBM].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Arrhythmias, Cardia | 2006 |
[Clinical therapy for arrhythmias and EBM].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Arrhythmias, Cardia | 2006 |
[Present status in and prospects for anti-arrhythmic drug therapy: How to use type III anti-arrhythmic agents].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bepridil; Drug Therapy, Combination; Human | 2006 |
[Present status in and prospects for anti-arrhythmic drug therapy: How to use type III anti-arrhythmic agents].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bepridil; Drug Therapy, Combination; Human | 2006 |
Is there a role for amiodarone in the era of the implantable cardioverter-defibrillator?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Combined Modality Therapy; Defibrillators, | 2006 |
Is there a role for amiodarone in the era of the implantable cardioverter-defibrillator?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Combined Modality Therapy; Defibrillators, | 2006 |
Short QT syndrome: a case report and review of literature.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Arrhythmias, Cardiac; Electrocardiography; ERG1 Pota | 2006 |
Short QT syndrome: a case report and review of literature.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Arrhythmias, Cardiac; Electrocardiography; ERG1 Pota | 2006 |
Amiodarone: a multifaceted antiarrhythmic drug.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibril | 2006 |
Amiodarone: a multifaceted antiarrhythmic drug.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibril | 2006 |
Drug evaluation: dronedarone, a novel non-iodinated anti-arrhythmic agent.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Clinical Tri | 2006 |
Drug evaluation: dronedarone, a novel non-iodinated anti-arrhythmic agent.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Clinical Tri | 2006 |
Clinical considerations for the allied professional: translating knowledge about amiodarone into education for the patient.
Topics: Allied Health Personnel; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Health Knowledge, | 2006 |
Clinical considerations for the allied professional: translating knowledge about amiodarone into education for the patient.
Topics: Allied Health Personnel; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Health Knowledge, | 2006 |
Total thyroidectomy for amiodarone-associated thyrotoxicosis in patients with severe cardiac disease.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Hu | 2006 |
Total thyroidectomy for amiodarone-associated thyrotoxicosis in patients with severe cardiac disease.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Hu | 2006 |
Prophylactic therapy to prevent atrial arrhythmia after cardiac surgery.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cardiac Surgic | 2007 |
Prophylactic therapy to prevent atrial arrhythmia after cardiac surgery.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cardiac Surgic | 2007 |
[Lethal arrhythmia associated with heart failure].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Defibrillators, Im | 2007 |
[Lethal arrhythmia associated with heart failure].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Defibrillators, Im | 2007 |
[Antiarrhythmic drug therapy in patients with heart failure].
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Conver | 2007 |
[Antiarrhythmic drug therapy in patients with heart failure].
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Conver | 2007 |
Prescribing amiodarone: an evidence-based review of clinical indications.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Interactions; Humans | 2007 |
Prescribing amiodarone: an evidence-based review of clinical indications.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Interactions; Humans | 2007 |
Antiarrhythmic drugs: present and future.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Design; Humans; Hydantoins; Imidazoli | 2007 |
Antiarrhythmic drugs: present and future.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Design; Humans; Hydantoins; Imidazoli | 2007 |
Effects of antiarrhythmic agents on cardiac function.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Car | 1982 |
Effects of antiarrhythmic agents on cardiac function.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Car | 1982 |
[Idiopathic mitral valve prolapse].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anticoagulants; Arrhythmias, Cardiac; Diagnosis, Differenti | 1983 |
[Idiopathic mitral valve prolapse].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anticoagulants; Arrhythmias, Cardiac; Diagnosis, Differenti | 1983 |
Is amiodarone an ideal antiarrhythmic drug?
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Drug; Drug Interactions; | 1984 |
Is amiodarone an ideal antiarrhythmic drug?
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Drug; Drug Interactions; | 1984 |
Arrhythmias in dilated and hypertrophic cardiomyopathy.
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiomegaly; Cardiomyopathy, Hypertrophic; Death, Sudden; Electro | 1984 |
Arrhythmias in dilated and hypertrophic cardiomyopathy.
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiomegaly; Cardiomyopathy, Hypertrophic; Death, Sudden; Electro | 1984 |
Amiodarone: historical development and pharmacologic profile.
Topics: Action Potentials; Amiodarone; Angina Pectoris; Animals; Arrhythmias, Cardiac; Benzofurans; Electrop | 1983 |
Amiodarone: historical development and pharmacologic profile.
Topics: Action Potentials; Amiodarone; Angina Pectoris; Animals; Arrhythmias, Cardiac; Benzofurans; Electrop | 1983 |
Serious adverse effects of amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Heart; Heart Conduction System; Humans; Hyperthyroidi | 1984 |
Serious adverse effects of amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Heart; Heart Conduction System; Humans; Hyperthyroidi | 1984 |
Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects.
Topics: Administration, Oral; Amiodarone; Animals; Arrhythmias, Cardiac; Atrioventricular Node; Benzofurans; | 1984 |
Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects.
Topics: Administration, Oral; Amiodarone; Animals; Arrhythmias, Cardiac; Atrioventricular Node; Benzofurans; | 1984 |
Clinical pharmacology of amiodarone.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Drug Interactions; Heart Ventricles; Humans; | 1984 |
Clinical pharmacology of amiodarone.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Drug Interactions; Heart Ventricles; Humans; | 1984 |
Clinical use and pharmacology of amiodarone.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Autonomic Ne | 1984 |
Clinical use and pharmacology of amiodarone.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Autonomic Ne | 1984 |
The electrophysiology and pharmacology of verapamil, flecainide, and amiodarone: correlations with clinical effects and antiarrhythmic actions.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Drug Interactions; F | 1984 |
The electrophysiology and pharmacology of verapamil, flecainide, and amiodarone: correlations with clinical effects and antiarrhythmic actions.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Drug Interactions; F | 1984 |
Electropharmacology of antiarrhythmic drugs.
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide | 1983 |
Electropharmacology of antiarrhythmic drugs.
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide | 1983 |
Amiodarone: the experience of the past decade.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Drug; Drug Interactions; | 1983 |
Amiodarone: the experience of the past decade.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Drug; Drug Interactions; | 1983 |
Therapy with investigational antiarrhythmic drugs.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Encainide; Fl | 1984 |
Therapy with investigational antiarrhythmic drugs.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Encainide; Fl | 1984 |
Investigational antiarrhythmic drugs for the treatment of ventricular rhythm disturbances.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Encainide; Flecainide | 1984 |
Investigational antiarrhythmic drugs for the treatment of ventricular rhythm disturbances.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Encainide; Flecainide | 1984 |
New antiarrhythmic drugs: their place in therapy.
Topics: Action Potentials; Ajmaline; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhy | 1981 |
New antiarrhythmic drugs: their place in therapy.
Topics: Action Potentials; Ajmaline; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhy | 1981 |
Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone.
Topics: Acute Disease; Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atria | 1981 |
Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone.
Topics: Acute Disease; Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atria | 1981 |
The natural history of hypertrophic cardiomyopathy.
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Death, Sudden; Humans; Nifedipine; P | 1981 |
The natural history of hypertrophic cardiomyopathy.
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Death, Sudden; Humans; Nifedipine; P | 1981 |
Antiarrhythmic agents in older patients. Current state of knowledge.
Topics: Aged; Aging; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; | 1994 |
Antiarrhythmic agents in older patients. Current state of knowledge.
Topics: Aged; Aging; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; | 1994 |
[Long-term efficacy and tolerability of amiodarone in children].
Topics: Administration, Oral; Adolescent; Age Factors; Amiodarone; Arrhythmias, Cardiac; Child; Child, Presc | 1995 |
[Long-term efficacy and tolerability of amiodarone in children].
Topics: Administration, Oral; Adolescent; Age Factors; Amiodarone; Arrhythmias, Cardiac; Child; Child, Presc | 1995 |
Amiodarone and post-MI patients.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Death, Sudden, Cardiac; | 1993 |
Amiodarone and post-MI patients.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Death, Sudden, Cardiac; | 1993 |
Amiodarone: reevaluation of an old drug.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Electrophysiology; Heart; Hemodynamics; Humans | 1995 |
Amiodarone: reevaluation of an old drug.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Electrophysiology; Heart; Hemodynamics; Humans | 1995 |
[Amiodarone in the nineties: to whom and what dosage?].
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Clinical Trials | 1995 |
[Amiodarone in the nineties: to whom and what dosage?].
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Clinical Trials | 1995 |
[Ventricular arrhythmias after myocardial infarction: risk classification and treatment concepts].
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia A | 1995 |
[Ventricular arrhythmias after myocardial infarction: risk classification and treatment concepts].
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia A | 1995 |
Cardiology--II: Treatment of heart failure and atrial fibrillation and arrhythmias.
Topics: Adrenergic beta-Antagonists; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Catheter Ablatio | 1994 |
Cardiology--II: Treatment of heart failure and atrial fibrillation and arrhythmias.
Topics: Adrenergic beta-Antagonists; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Catheter Ablatio | 1994 |
Arrhythmia control by prolonging repolarization: the concept and its potential therapeutic impact.
Topics: Action Potentials; Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhyth | 1993 |
Arrhythmia control by prolonging repolarization: the concept and its potential therapeutic impact.
Topics: Action Potentials; Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhyth | 1993 |
[Management of patients with risk of sudden death. The amiodarone example].
Topics: Amiodarone; Arrhythmias, Cardiac; Canada; Cardiomyopathy, Dilated; Death, Sudden, Cardiac; Europe; H | 1994 |
[Management of patients with risk of sudden death. The amiodarone example].
Topics: Amiodarone; Arrhythmias, Cardiac; Canada; Cardiomyopathy, Dilated; Death, Sudden, Cardiac; Europe; H | 1994 |
Class III antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Electrocardiogra | 1994 |
Class III antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Electrocardiogra | 1994 |
[Amiodarone].
Topics: Amiodarone; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Electrocardiography; Hemodynamic | 1993 |
[Amiodarone].
Topics: Amiodarone; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Electrocardiography; Hemodynamic | 1993 |
Secondary prevention after myocardial infarction with class III antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudden, C | 1993 |
Secondary prevention after myocardial infarction with class III antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudden, C | 1993 |
Sudden death prevention in patients with advanced ventricular dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Death, Su | 1993 |
Sudden death prevention in patients with advanced ventricular dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Death, Su | 1993 |
Should post-infarction asymptomatic ventricular arrhythmias be treated? The need for caution.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Heart Ventricles; | 1995 |
Should post-infarction asymptomatic ventricular arrhythmias be treated? The need for caution.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Heart Ventricles; | 1995 |
Proarrhythmia with class III antiarrhythmic drugs: definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implications.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrophysiology; Forecasting; Humans; In | 1995 |
Proarrhythmia with class III antiarrhythmic drugs: definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implications.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrophysiology; Forecasting; Humans; In | 1995 |
What have clinical trials taught us about proarrhythmia?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Electrocardiogra | 1996 |
What have clinical trials taught us about proarrhythmia?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Electrocardiogra | 1996 |
Assessment of arrhythmias after myocardial infarction in the post-CAST era.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Electrocardiogra | 1996 |
Assessment of arrhythmias after myocardial infarction in the post-CAST era.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Electrocardiogra | 1996 |
Drug therapy versus implantation of a cardiac defibrillator for the treatment of malignant arrhythmias in left ventricular dysfunction.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Female; Human | 1996 |
Drug therapy versus implantation of a cardiac defibrillator for the treatment of malignant arrhythmias in left ventricular dysfunction.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Female; Human | 1996 |
[Clinical use of intravenous amiodarone for supraventricular arrhythmias].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Humans; Infusions, In | 1995 |
[Clinical use of intravenous amiodarone for supraventricular arrhythmias].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Humans; Infusions, In | 1995 |
[Stratification of arrhythmia risk and therapeutic options in survivors of acute myocardial infarction].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Tria | 1996 |
[Stratification of arrhythmia risk and therapeutic options in survivors of acute myocardial infarction].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Tria | 1996 |
[Assessment of ventricular arrhythmias].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catheter Abla | 1996 |
[Assessment of ventricular arrhythmias].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catheter Abla | 1996 |
[Anti-arrhythmic therapy and cardiac failure].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden | 1995 |
[Anti-arrhythmic therapy and cardiac failure].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden | 1995 |
Is there a need for new antiarrhythmic drugs?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Conduction System; Humans; Propafeno | 1996 |
Is there a need for new antiarrhythmic drugs?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Conduction System; Humans; Propafeno | 1996 |
Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cardiomyopathy | 1996 |
Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cardiomyopathy | 1996 |
Intravenous amiodarone: pharmacology, pharmacokinetics, and clinical use.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Humans; | 1996 |
Intravenous amiodarone: pharmacology, pharmacokinetics, and clinical use.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Humans; | 1996 |
[Class III antiarrhythmic drugs].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Humans; Sotalol | 1996 |
[Class III antiarrhythmic drugs].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Humans; Sotalol | 1996 |
[Arrhythmias with normal heart rate].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Premature Complexes; Death, Sudden, | 1996 |
[Arrhythmias with normal heart rate].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Premature Complexes; Death, Sudden, | 1996 |
The rational use of intravenous amiodarone in the perioperative period.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Hemodynamics; Humans | 1997 |
The rational use of intravenous amiodarone in the perioperative period.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Hemodynamics; Humans | 1997 |
Amiodarone: a late comer.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Failure; Heart Ventricles; Humans; M | 1997 |
Amiodarone: a late comer.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Failure; Heart Ventricles; Humans; M | 1997 |
Amiodarone: the expanding antiarrhythmic role and how to follow a patient on chronic therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Chronic Disease; Cont | 1997 |
Amiodarone: the expanding antiarrhythmic role and how to follow a patient on chronic therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Chronic Disease; Cont | 1997 |
[Pharmacological treatment of atrial fibrillation].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibril | 1997 |
[Pharmacological treatment of atrial fibrillation].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibril | 1997 |
Antiarrhythmic therapies for the prevention of sudden cardiac death.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Artery Bypass; Death, Sudden, Car | 1997 |
Antiarrhythmic therapies for the prevention of sudden cardiac death.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Artery Bypass; Death, Sudden, Car | 1997 |
Drug-induced cardiac arrhythmias: incidence, prevention and management.
Topics: Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Anti-Infective Agents; | 1997 |
Drug-induced cardiac arrhythmias: incidence, prevention and management.
Topics: Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Anti-Infective Agents; | 1997 |
Controlling cardiac arrhythmias: an overview with a historical perspective.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Tria | 1997 |
Controlling cardiac arrhythmias: an overview with a historical perspective.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Tria | 1997 |
Pharmacologic and pharmacokinetic profile of class III antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Humans; Phenethylamin | 1997 |
Pharmacologic and pharmacokinetic profile of class III antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Humans; Phenethylamin | 1997 |
Proarrhythmia with class III antiarrhythmic drugs: types, risks, and management.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Conduction System; Humans; Myocardia | 1997 |
Proarrhythmia with class III antiarrhythmic drugs: types, risks, and management.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Conduction System; Humans; Myocardia | 1997 |
Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Female; Hear | 1997 |
Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Female; Hear | 1997 |
Interactions between implantable cardioverter-defibrillators and class III agents.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Dise | 1998 |
Interactions between implantable cardioverter-defibrillators and class III agents.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Dise | 1998 |
The current role of amiodarone in patients with congestive heart failure.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Clinical Trials as To | 1998 |
The current role of amiodarone in patients with congestive heart failure.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Clinical Trials as To | 1998 |
Antiarrhythmic therapy in the post-infarction setting: update from major amiodarone studies.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Myocard | 1998 |
Antiarrhythmic therapy in the post-infarction setting: update from major amiodarone studies.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Myocard | 1998 |
Prevention of sudden cardiac death: a current perspective.
Topics: Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; | 1998 |
Prevention of sudden cardiac death: a current perspective.
Topics: Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; | 1998 |
Sudden cardiac death prevention: antiarrhythmic drugs and the implantable cardioverter-defibrillator.
Topics: Actuarial Analysis; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Combined Modality Ther | 1995 |
Sudden cardiac death prevention: antiarrhythmic drugs and the implantable cardioverter-defibrillator.
Topics: Actuarial Analysis; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Combined Modality Ther | 1995 |
Mechanisms underlying variability in response to drug therapy: implications for amiodarone use.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Biological Availability; Biotransformation; Dose-Response | 1999 |
Mechanisms underlying variability in response to drug therapy: implications for amiodarone use.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Biological Availability; Biotransformation; Dose-Response | 1999 |
[Ocular findings associated to the use of amiodarone].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cornea; Eye Diseases; Female; | 1996 |
[Ocular findings associated to the use of amiodarone].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cornea; Eye Diseases; Female; | 1996 |
Arrhythmic risk stratification of post-myocardial infarction patients.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Electrophysiology; | 2000 |
Arrhythmic risk stratification of post-myocardial infarction patients.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Electrophysiology; | 2000 |
New advances in class III antiarrhythmic drug therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrophysiology; Humans; Hydantoins; Imi | 2000 |
New advances in class III antiarrhythmic drug therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrophysiology; Humans; Hydantoins; Imi | 2000 |
Amiodarone: clinical trials.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudden; D | 2000 |
Amiodarone: clinical trials.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudden; D | 2000 |
Optimizing oral dosing and monitoring of noncardiac toxicities with chronic amiodarone therapy.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as T | 2000 |
Optimizing oral dosing and monitoring of noncardiac toxicities with chronic amiodarone therapy.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as T | 2000 |
[Antiarrhythmic therapy in patients with heart failure].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacin | 2000 |
[Antiarrhythmic therapy in patients with heart failure].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacin | 2000 |
Combination ICD and drug treatments-best options.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Combined Modality Therapy; Death, Sudden, | 2000 |
Combination ICD and drug treatments-best options.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Combined Modality Therapy; Death, Sudden, | 2000 |
Revisiting established medical options - antiarrhythmic drugs and beta-blocker combinations.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Therapy, | 2000 |
Revisiting established medical options - antiarrhythmic drugs and beta-blocker combinations.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Therapy, | 2000 |
Drug-induced proarrhythmic effects: assessment of changes in QT interval.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Electrophysiology; He | 2000 |
Drug-induced proarrhythmic effects: assessment of changes in QT interval.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Electrophysiology; He | 2000 |
Management of malignant ventricular arrhythmias and cardiac arrest.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Defibrillators | 2000 |
Management of malignant ventricular arrhythmias and cardiac arrest.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Defibrillators | 2000 |
Antiarrhythmic drugs in pregnancy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Heart | 2001 |
Antiarrhythmic drugs in pregnancy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Heart | 2001 |
Thyroid hormone and the cardiovascular system.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Heart; Heart Diseases | 2001 |
Thyroid hormone and the cardiovascular system.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Heart; Heart Diseases | 2001 |
The role of class III antiarrhythmic agents in maintaining sinus rhythm.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Heart Conduction Syst | 2000 |
The role of class III antiarrhythmic agents in maintaining sinus rhythm.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Heart Conduction Syst | 2000 |
Clinical differences between the newer antiarrhythmic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bridged Bicyclo Compounds, Heterocyclic; C | 2000 |
Clinical differences between the newer antiarrhythmic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bridged Bicyclo Compounds, Heterocyclic; C | 2000 |
Intravenous amiodarone in intensive care. Time for a reappraisal?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Critical Care; Critical Illness; Drug Inte | 2000 |
Intravenous amiodarone in intensive care. Time for a reappraisal?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Critical Care; Critical Illness; Drug Inte | 2000 |
[Amiodarone].
Topics: Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Eye; Humans; Lung; Thyroi | 2001 |
[Amiodarone].
Topics: Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Eye; Humans; Lung; Thyroi | 2001 |
Mechanisms of action of antiarrhythmic drugs relative to the origin and perpetuation of cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Tria | 2001 |
Mechanisms of action of antiarrhythmic drugs relative to the origin and perpetuation of cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Tria | 2001 |
Postoperative arrhythmias and conduction disorders.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Surgical Procedures; | 2001 |
Postoperative arrhythmias and conduction disorders.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Surgical Procedures; | 2001 |
[Amiodarone in the treatment of arrhythmias].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Competence; Drug Interactions; He | 1998 |
[Amiodarone in the treatment of arrhythmias].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Competence; Drug Interactions; He | 1998 |
Sudden death due to cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Baroreflex; C | 2001 |
Sudden death due to cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Baroreflex; C | 2001 |
Sudden death due to cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Baroreflex; C | 2001 |
Sudden death due to cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Baroreflex; C | 2001 |
Sudden death due to cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Baroreflex; C | 2001 |
Sudden death due to cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Baroreflex; C | 2001 |
Sudden death due to cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Baroreflex; C | 2001 |
Sudden death due to cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Baroreflex; C | 2001 |
[Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; A | 2001 |
[Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; A | 2001 |
Review of common adverse effects of selected antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans | 2000 |
Review of common adverse effects of selected antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans | 2000 |
Management of common arrhythmias: Part I. Supraventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Echocardiography, Tra | 2002 |
Management of common arrhythmias: Part I. Supraventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Echocardiography, Tra | 2002 |
Limitations of present drug therapy of cardiac arrhythmias--a review.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Com | 1977 |
Limitations of present drug therapy of cardiac arrhythmias--a review.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Com | 1977 |
[Clinical use of Cordarone].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Anti-Arrhyth | 1979 |
[Clinical use of Cordarone].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Anti-Arrhyth | 1979 |
The utility of serum drug level monitoring during therapy with class III antiarrhythmic agents.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Sotalol | 1992 |
The utility of serum drug level monitoring during therapy with class III antiarrhythmic agents.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Sotalol | 1992 |
Therapy with and assessment of class III antiarrhythmic agents in different patient populations.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Evaluation; Electrocardiography, Ambu | 1992 |
Therapy with and assessment of class III antiarrhythmic agents in different patient populations.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Evaluation; Electrocardiography, Ambu | 1992 |
Clinical efficacy of long-term treatment with amiodarone for life-threatening arrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Prospective Studies; Randomized Controlled Trials as Topic | 1992 |
Clinical efficacy of long-term treatment with amiodarone for life-threatening arrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Prospective Studies; Randomized Controlled Trials as Topic | 1992 |
Efficacy of intravenously administered amiodarone for short-term control of serious arrhythmias.
Topics: Action Potentials; Amiodarone; Arrhythmias, Cardiac; Electrophysiology; Hemodynamics; Humans; Hypote | 1992 |
Efficacy of intravenously administered amiodarone for short-term control of serious arrhythmias.
Topics: Action Potentials; Amiodarone; Arrhythmias, Cardiac; Electrophysiology; Hemodynamics; Humans; Hypote | 1992 |
[Mishaps with anti-arrhythmic agents used to reduce mortality after infarction].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Myocardial Infarction | 1992 |
[Mishaps with anti-arrhythmic agents used to reduce mortality after infarction].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Myocardial Infarction | 1992 |
[New anti-arrhythmia agents].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardio | 1992 |
[New anti-arrhythmia agents].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardio | 1992 |
Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Cardiomyopathies; Drug Interactions; Heart Conduction Sys | 1992 |
Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Cardiomyopathies; Drug Interactions; Heart Conduction Sys | 1992 |
Clinical significance and management of arrhythmias in the heart failure patient.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cause of Death; Female; Heart | 1992 |
Clinical significance and management of arrhythmias in the heart failure patient.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cause of Death; Female; Heart | 1992 |
Use of amiodarone for elderly patients.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Drug Interactions; Electrocardiography, Ambulatory; Humans | 1992 |
Use of amiodarone for elderly patients.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Drug Interactions; Electrocardiography, Ambulatory; Humans | 1992 |
Class III drugs: their effects on arrhythmias and on the QT interval.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; | 1992 |
Class III drugs: their effects on arrhythmias and on the QT interval.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; | 1992 |
[Amiodarone: the most effective and the most problematic arrhythmia drug].
Topics: Amiodarone; Arrhythmias, Cardiac; Electrophysiology; Humans | 1990 |
[Amiodarone: the most effective and the most problematic arrhythmia drug].
Topics: Amiodarone; Arrhythmias, Cardiac; Electrophysiology; Humans | 1990 |
The value of oral amiodarone in the treatment of ventricular arrhythmias in heart disease.
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Death, Sudden; Heart Diseases; Humans | 1991 |
The value of oral amiodarone in the treatment of ventricular arrhythmias in heart disease.
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Death, Sudden; Heart Diseases; Humans | 1991 |
Practical aspects of the use of amiodarone.
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Contraindications; Death, Sudden; Electrocar | 1991 |
Practical aspects of the use of amiodarone.
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Contraindications; Death, Sudden; Electrocar | 1991 |
Amiodarone in long term prophylaxis.
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Death, Sudden; Electrophysiology; Heart Cond | 1991 |
Amiodarone in long term prophylaxis.
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Death, Sudden; Electrophysiology; Heart Cond | 1991 |
[What is the latest in anti-arrhythmia therapy?].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Tri | 1991 |
[What is the latest in anti-arrhythmia therapy?].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Tri | 1991 |
Pharmacology and pharmacokinetics of amiodarone.
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Biological Availability; Hemodynamics; Human | 1991 |
Pharmacology and pharmacokinetics of amiodarone.
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Biological Availability; Hemodynamics; Human | 1991 |
Amiodarone therapy guided by electrophysiologic testing: an update.
Topics: Amiodarone; Arrhythmias, Cardiac; Electric Countershock; Electric Stimulation; Electrophysiology; Hu | 1991 |
Amiodarone therapy guided by electrophysiologic testing: an update.
Topics: Amiodarone; Arrhythmias, Cardiac; Electric Countershock; Electric Stimulation; Electrophysiology; Hu | 1991 |
Ventricular arrhythmias associated with congestive heart failure: the role for amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Heart Failure; Heart Ventricles; Humans | 1991 |
Ventricular arrhythmias associated with congestive heart failure: the role for amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Heart Failure; Heart Ventricles; Humans | 1991 |
[Does amiodarone have a benefit effect on mortality?].
Topics: Amiodarone; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Eye Diseases; France; Heart Arrest; Humans | 1991 |
[Does amiodarone have a benefit effect on mortality?].
Topics: Amiodarone; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Eye Diseases; France; Heart Arrest; Humans | 1991 |
[Mechanisms of interactions of anti-arrhythmia agents during their combined use].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Digoxin; Drug Interactions; Drug Therapy, | 1991 |
[Mechanisms of interactions of anti-arrhythmia agents during their combined use].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Digoxin; Drug Interactions; Drug Therapy, | 1991 |
[Comparative characteristics of arrhythmogenic effects of anti-arrhythmia agents].
Topics: Aconitine; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Electrocardiograp | 1991 |
[Comparative characteristics of arrhythmogenic effects of anti-arrhythmia agents].
Topics: Aconitine; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Electrocardiograp | 1991 |
Hemodynamic profile of amiodarone during acute and long-term administration in patients with ventricular dysfunction.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Heart Failure; Hemodyna | 1990 |
Hemodynamic profile of amiodarone during acute and long-term administration in patients with ventricular dysfunction.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Heart Failure; Hemodyna | 1990 |
[Amiodarone: new concepts on its anti-arrhythmic effect].
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Calcium; Electrophysiology; Heart; Hemodynamics; Humans; | 1990 |
[Amiodarone: new concepts on its anti-arrhythmic effect].
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Calcium; Electrophysiology; Heart; Hemodynamics; Humans; | 1990 |
Clinical implications of new studies in the treatment of benign, potentially malignant and malignant ventricular arrhythmias.
Topics: Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Flecainide; | 1990 |
Clinical implications of new studies in the treatment of benign, potentially malignant and malignant ventricular arrhythmias.
Topics: Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Flecainide; | 1990 |
[Amiodarone: mechanisms of anti-arrhythmic action].
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Dogs; Electrocardiography; Guinea Pigs; Humans; Rabbits | 1990 |
[Amiodarone: mechanisms of anti-arrhythmic action].
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Dogs; Electrocardiography; Guinea Pigs; Humans; Rabbits | 1990 |
[Adverse and toxic reaction to amiodarone and its interaction with other drugs].
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Hyperthyroidism; Hypothyroidism; Pneumonia | 1990 |
[Adverse and toxic reaction to amiodarone and its interaction with other drugs].
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Hyperthyroidism; Hypothyroidism; Pneumonia | 1990 |
Amiodarone: value of programmed electrical stimulation and Holter monitoring.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Cardiac Pacing, Artificial; Clin | 1986 |
Amiodarone: value of programmed electrical stimulation and Holter monitoring.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Cardiac Pacing, Artificial; Clin | 1986 |
Update: cardiac antiarrhythmic drugs.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Encainide; Fl | 1989 |
Update: cardiac antiarrhythmic drugs.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Encainide; Fl | 1989 |
Ventricular arrhythmias. An assessment of newer therapeutic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Flecainide; Humans; Lidocaine; Mexiletine; | 1989 |
Ventricular arrhythmias. An assessment of newer therapeutic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Flecainide; Humans; Lidocaine; Mexiletine; | 1989 |
Hepatotoxicity associated with amiodarone therapy.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Biopsy; Chemical and Drug Induced Liver Injury; Half-Life; H | 1989 |
Hepatotoxicity associated with amiodarone therapy.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Biopsy; Chemical and Drug Induced Liver Injury; Half-Life; H | 1989 |
Amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Drug Interactions; Hemodynamics; Humans | 1989 |
Amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Drug Interactions; Hemodynamics; Humans | 1989 |
The role of electrophysiologic testing in the selection of amiodarone therapy.
Topics: Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Electrophysiology; Humans | 1989 |
The role of electrophysiologic testing in the selection of amiodarone therapy.
Topics: Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Electrophysiology; Humans | 1989 |
Low-dose amiodarone for the treatment of arrhythmias in hypertrophic cardiomyopathy.
Topics: Adolescent; Adult; Amiodarone; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Humans; Middle Ag | 1989 |
Low-dose amiodarone for the treatment of arrhythmias in hypertrophic cardiomyopathy.
Topics: Adolescent; Adult; Amiodarone; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Humans; Middle Ag | 1989 |
Amiodarone and torsade de pointes.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Humans; Long QT Syndr | 1989 |
Amiodarone and torsade de pointes.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Humans; Long QT Syndr | 1989 |
[Effects of amiodarone on thyroid gland function].
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Hyperthyroidism; Hypothyroidism; Thyroid Function Tests | 1989 |
[Effects of amiodarone on thyroid gland function].
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Hyperthyroidism; Hypothyroidism; Thyroid Function Tests | 1989 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrh | 1985 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrh | 1985 |
Many things are not found in books or journals ... but some things are! Value of electrophysiologic testing in patients with malignant ventricular arrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Humans | 1988 |
Many things are not found in books or journals ... but some things are! Value of electrophysiologic testing in patients with malignant ventricular arrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Humans | 1988 |
Indications for the use of amiodarone: a personal perspective.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Tachycardia; Ventricular Fibrillation | 1987 |
Indications for the use of amiodarone: a personal perspective.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Tachycardia; Ventricular Fibrillation | 1987 |
Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
Topics: Aged; Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Digox | 1986 |
Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
Topics: Aged; Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Digox | 1986 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecaini | 1986 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecaini | 1986 |
Antiarrhythmic agents for chronic ventricular arrhythmias.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Encainide; Flecain | 1987 |
Antiarrhythmic agents for chronic ventricular arrhythmias.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Encainide; Flecain | 1987 |
Amiodarone in the management of cardiac arrhythmias: current concepts.
Topics: Amiodarone; Arrhythmias, Cardiac; Hemodynamics; Humans | 1988 |
Amiodarone in the management of cardiac arrhythmias: current concepts.
Topics: Amiodarone; Arrhythmias, Cardiac; Hemodynamics; Humans | 1988 |
Amiodarone therapeutic plasma concentration monitoring. Is it practical?
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Child; Dose-Response Relationship, Drug; Humans; Monitoring | 1988 |
Amiodarone therapeutic plasma concentration monitoring. Is it practical?
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Child; Dose-Response Relationship, Drug; Humans; Monitoring | 1988 |
Amiodarone: current perspectives from Europe.
Topics: Absorption; Amiodarone; Arrhythmias, Cardiac; Drug Interactions; Europe; Humans; Time Factors | 1987 |
Amiodarone: current perspectives from Europe.
Topics: Absorption; Amiodarone; Arrhythmias, Cardiac; Drug Interactions; Europe; Humans; Time Factors | 1987 |
[Clinical use of kordaron: new possibilities and limits].
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Drug Evaluation; Drug Evaluation, Preclinical; Humans | 1987 |
[Clinical use of kordaron: new possibilities and limits].
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Drug Evaluation; Drug Evaluation, Preclinical; Humans | 1987 |
[Amiodarone, a class 3 antiarrhythmic agent: current electrophysiological and therapeutic aspects].
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiomyopathy, Hypertrophic; H | 1986 |
[Amiodarone, a class 3 antiarrhythmic agent: current electrophysiological and therapeutic aspects].
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiomyopathy, Hypertrophic; H | 1986 |
[Disorders of cardiac rhythm and conduction in Chagas cardiomyopathy].
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Chagas Cardiomyopathy; Humans | 1986 |
[Disorders of cardiac rhythm and conduction in Chagas cardiomyopathy].
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Chagas Cardiomyopathy; Humans | 1986 |
Amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Kinetics | 1987 |
Amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Kinetics | 1987 |
Class III drugs: amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans | 1987 |
Class III drugs: amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans | 1987 |
Clinical use of amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Electrophysiology; Heart; Humans; H | 1985 |
Clinical use of amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Electrophysiology; Heart; Humans; H | 1985 |
[Amiodarone: pharmacology, clinical use and side effects].
Topics: Amiodarone; Arrhythmias, Cardiac; Autonomic Nervous System; Benzofurans; Blood Coagulation; Digitali | 1985 |
[Amiodarone: pharmacology, clinical use and side effects].
Topics: Amiodarone; Arrhythmias, Cardiac; Autonomic Nervous System; Benzofurans; Blood Coagulation; Digitali | 1985 |
Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Encainide; Fl | 1985 |
Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Encainide; Fl | 1985 |
80 trials available for amiodarone and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Prophylactic amiodarone vs dronedarone for prevention of perioperative arrhythmias in offpump coronary artery bypass grafting: A pilot randomized controlled trial.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Artery Bypass; Dronedarone; Human | 2017 |
Prophylactic amiodarone vs dronedarone for prevention of perioperative arrhythmias in offpump coronary artery bypass grafting: A pilot randomized controlled trial.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Artery Bypass; Dronedarone; Human | 2017 |
The efficacy of amiodarone-propranolol combination for the management of childhood arrhythmias.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Child, Preschool; Drug | 2013 |
The efficacy of amiodarone-propranolol combination for the management of childhood arrhythmias.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Child, Preschool; Drug | 2013 |
SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sud | 2015 |
SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sud | 2015 |
Corneal Densitometry as a Novel Technique for Monitoring Amiodarone Therapy.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cornea; Co | 2016 |
Corneal Densitometry as a Novel Technique for Monitoring Amiodarone Therapy.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cornea; Co | 2016 |
Effects of injection-site splinting on the incidence of phlebitis in patients taking peripherally infused amiodarone: A randomized clinical trial.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Incidence; Infusions | 2017 |
Effects of injection-site splinting on the incidence of phlebitis in patients taking peripherally infused amiodarone: A randomized clinical trial.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Incidence; Infusions | 2017 |
Evaluation of the effects of PM101, a cyclodextrin-based formulation of intravenous amiodarone, on blood pressure in healthy humans.
Topics: Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; beta-Cyclodextrins; Blo | 2009 |
Evaluation of the effects of PM101, a cyclodextrin-based formulation of intravenous amiodarone, on blood pressure in healthy humans.
Topics: Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; beta-Cyclodextrins; Blo | 2009 |
Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cells, Cultured; Disease Prog | 2011 |
Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cells, Cultured; Disease Prog | 2011 |
Quality of life in the Canadian Implantable Defibrillator Study (CIDS).
Topics: Aged; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trial | 2002 |
Quality of life in the Canadian Implantable Defibrillator Study (CIDS).
Topics: Aged; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trial | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Antiarrhythmic effect of magnesium sulfate after open heart surgery: effect of blood levels.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Female; | 2003 |
Antiarrhythmic effect of magnesium sulfate after open heart surgery: effect of blood levels.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Female; | 2003 |
Are implantable cardioverter-defribrillators always superior to amiodarone?
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Cost-Benefi | 2003 |
Are implantable cardioverter-defribrillators always superior to amiodarone?
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Cost-Benefi | 2003 |
Amiodarone versus Implantable Defibrillator (AMIOVIRT): background, rationale, design, methods, results and implications.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Defibrillators, I | 2003 |
Amiodarone versus Implantable Defibrillator (AMIOVIRT): background, rationale, design, methods, results and implications.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Defibrillators, I | 2003 |
Individual patterns of dynamic QT/RR relationship in survivors of acute myocardial infarction and their relationship to antiarrhythmic efficacy of amiodarone.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiograp | 2004 |
Individual patterns of dynamic QT/RR relationship in survivors of acute myocardial infarction and their relationship to antiarrhythmic efficacy of amiodarone.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiograp | 2004 |
Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac S | 2005 |
Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac S | 2005 |
Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac S | 2005 |
Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac S | 2005 |
Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac S | 2005 |
Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac S | 2005 |
Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac S | 2005 |
Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac S | 2005 |
Decreased mortality in a rat model of acute postinfarction heart failure.
Topics: Amiodarone; Anesthesia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Critical Care; Diseas | 2006 |
Decreased mortality in a rat model of acute postinfarction heart failure.
Topics: Amiodarone; Anesthesia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Critical Care; Diseas | 2006 |
Effect of amiodarone on the serum concentration/dose ratio of metoprolol in patients with cardiac arrhythmia.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cytochrome P-450 CYP2D6; Cyto | 2006 |
Effect of amiodarone on the serum concentration/dose ratio of metoprolol in patients with cardiac arrhythmia.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cytochrome P-450 CYP2D6; Cyto | 2006 |
Selection of an antiarrhythmic drug for a sudden-death-prevention trial.
Topics: Acecainide; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneac | 1982 |
Selection of an antiarrhythmic drug for a sudden-death-prevention trial.
Topics: Acecainide; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneac | 1982 |
Amiodarone in the treatment of patients with refractory symptomatic ventricular and supraventricular arrhythmias. A long-term follow-up study.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Clinical Trials as To | 1983 |
Amiodarone in the treatment of patients with refractory symptomatic ventricular and supraventricular arrhythmias. A long-term follow-up study.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Clinical Trials as To | 1983 |
Amiodarone in the treatment of refractory ventricular arrhythmias. Importance and safety of initial high-dose therapy.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Clinical Trials as Topic; Half-Life; Heart Ventricles | 1983 |
Amiodarone in the treatment of refractory ventricular arrhythmias. Importance and safety of initial high-dose therapy.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Clinical Trials as Topic; Half-Life; Heart Ventricles | 1983 |
Multicenter controlled observation of a low-dose regimen of amiodarone for treatment of severe ventricular arrhythmias. Collaborative Group for Amiodarone Evaluation.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Clinical Trials as To | 1984 |
Multicenter controlled observation of a low-dose regimen of amiodarone for treatment of severe ventricular arrhythmias. Collaborative Group for Amiodarone Evaluation.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Clinical Trials as To | 1984 |
[Long-term drug therapy in ventricular cardiac arrhythmias. Is an improvement of the prognosis possible?].
Topics: Adult; Aged; Amiodarone; Aprindine; Arrhythmias, Cardiac; Disopyramide; Humans; Long-Term Care; Mexi | 1983 |
[Long-term drug therapy in ventricular cardiac arrhythmias. Is an improvement of the prognosis possible?].
Topics: Adult; Aged; Amiodarone; Aprindine; Arrhythmias, Cardiac; Disopyramide; Humans; Long-Term Care; Mexi | 1983 |
[Antiarrhythmic effects of amiodarone evaluated by dynamic electrocardiography].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Clinical Trials as Topic; El | 1981 |
[Antiarrhythmic effects of amiodarone evaluated by dynamic electrocardiography].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Clinical Trials as Topic; El | 1981 |
[Anti-arrhythmic and anti-anginal properties of amiodarone in ambulatory therapy].
Topics: Aged; Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Clinical Trials as Topic; Fema | 1981 |
[Anti-arrhythmic and anti-anginal properties of amiodarone in ambulatory therapy].
Topics: Aged; Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Clinical Trials as Topic; Fema | 1981 |
Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.
Topics: Actuarial Analysis; Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Death, Sud | 1995 |
Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.
Topics: Actuarial Analysis; Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Death, Sud | 1995 |
Acute electrophysiologic effects of amiodarone in patients with congestive heart failure.
Topics: Administration, Oral; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Function; Electrocardiography; | 1995 |
Acute electrophysiologic effects of amiodarone in patients with congestive heart failure.
Topics: Administration, Oral; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Function; Electrocardiography; | 1995 |
Sotalol in patients with implanted automatic defibrillators: effects on defibrillation and comparison with amiodarone.
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Combined Modality Therapy; Defibrillators, I | 1994 |
Sotalol in patients with implanted automatic defibrillators: effects on defibrillation and comparison with amiodarone.
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Combined Modality Therapy; Defibrillators, I | 1994 |
The European Myocardial Infarct Amiodarone Trial (EMIAT). EMIAT Investigators.
Topics: Amiodarone; Arrhythmias, Cardiac; Europe; Female; Humans; Male; Middle Aged; Myocardial Infarction; | 1993 |
The European Myocardial Infarct Amiodarone Trial (EMIAT). EMIAT Investigators.
Topics: Amiodarone; Arrhythmias, Cardiac; Europe; Female; Humans; Male; Middle Aged; Myocardial Infarction; | 1993 |
Usefulness of sotalol for life-threatening ventricular arrhythmias.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Hu | 1993 |
Usefulness of sotalol for life-threatening ventricular arrhythmias.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Hu | 1993 |
Long-term benefit of 1-year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction.
Topics: Amiodarone; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Follow-Up Studies; Heart Ventricles; Human | 1993 |
Long-term benefit of 1-year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction.
Topics: Amiodarone; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Follow-Up Studies; Heart Ventricles; Human | 1993 |
[Long-term effect of amiodarone therapy following myocardial infarct in patients with complex ventricular arrhythmias].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Female; Heart Ventricles; Humans; Ma | 1993 |
[Long-term effect of amiodarone therapy following myocardial infarct in patients with complex ventricular arrhythmias].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Female; Heart Ventricles; Humans; Ma | 1993 |
Pediatric use of intravenous amiodarone: efficacy and safety in critically ill patients from a multicenter protocol.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child, Preschool; Humans; Infant; Infusion | 1996 |
Pediatric use of intravenous amiodarone: efficacy and safety in critically ill patients from a multicenter protocol.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child, Preschool; Humans; Infant; Infusion | 1996 |
Interaction between amiodarone and lidocaine.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Proteins; Cytochrome P- | 1996 |
Interaction between amiodarone and lidocaine.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Proteins; Cytochrome P- | 1996 |
Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Double-Blind | 1997 |
Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Double-Blind | 1997 |
Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Double-Blind | 1997 |
Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Double-Blind | 1997 |
Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Double-Blind | 1997 |
Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Double-Blind | 1997 |
Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Double-Blind | 1997 |
Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Double-Blind | 1997 |
Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sud | 1997 |
Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sud | 1997 |
Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sud | 1997 |
Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sud | 1997 |
Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sud | 1997 |
Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sud | 1997 |
Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sud | 1997 |
Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sud | 1997 |
Mortality benefit of implantable cardioverter-defibrillator therapy in patients with persistent malignant ventricular arrhythmias despite amiodarone treatment.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Cohort Studies; Defibrillators, Implantable; Female; Follow- | 1997 |
Mortality benefit of implantable cardioverter-defibrillator therapy in patients with persistent malignant ventricular arrhythmias despite amiodarone treatment.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Cohort Studies; Defibrillators, Implantable; Female; Follow- | 1997 |
Clinical electrophysiologic effects of a single high oral dose of amiodarone.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia | 1997 |
Clinical electrophysiologic effects of a single high oral dose of amiodarone.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia | 1997 |
Interactions between implantable cardioverter-defibrillators and class III agents.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Dise | 1998 |
Interactions between implantable cardioverter-defibrillators and class III agents.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Dise | 1998 |
Potential impact of antiarrhythmic drugs versus implantable defibrillators on the management of ventricular arrhythmias: the Midlands trial of empirical amiodarone versus electrophysiologically guided intervention and cardioverter implant registry data.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Costs and Cost Analysis; Defibrillat | 1998 |
Potential impact of antiarrhythmic drugs versus implantable defibrillators on the management of ventricular arrhythmias: the Midlands trial of empirical amiodarone versus electrophysiologically guided intervention and cardioverter implant registry data.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Costs and Cost Analysis; Defibrillat | 1998 |
Elevation of high-density lipoprotein cholesterol in humans during long-term therapy with amiodarone.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cholesterol; Cholesterol, HDL | 1999 |
Elevation of high-density lipoprotein cholesterol in humans during long-term therapy with amiodarone.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cholesterol; Cholesterol, HDL | 1999 |
Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Defibrillators, Implantable; Female; Forecasting; Humans; Ma | 2000 |
Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Defibrillators, Implantable; Female; Forecasting; Humans; Ma | 2000 |
Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cause of Death; Electrocardiography, | 2000 |
Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cause of Death; Electrocardiography, | 2000 |
[Amiodarone for long term treatment of arrhythmia in children].
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Child, Preschool; Human | 2001 |
[Amiodarone for long term treatment of arrhythmia in children].
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Child, Preschool; Human | 2001 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
First clinical experience with the rapid-, short-acting amiodarone derivative E 047/1 after cardiac surgery.
Topics: Aged; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Area Under Curve; Arrhythmias, Cardi | 2002 |
First clinical experience with the rapid-, short-acting amiodarone derivative E 047/1 after cardiac surgery.
Topics: Aged; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Area Under Curve; Arrhythmias, Cardi | 2002 |
[Clinical use of Cordarone].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Anti-Arrhyth | 1979 |
[Clinical use of Cordarone].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Anti-Arrhyth | 1979 |
[Clinical evaluation of the use of i.v. amiodarone in the treatment of arrhythmias].
Topics: Acute Disease; Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Clinical Tria | 1979 |
[Clinical evaluation of the use of i.v. amiodarone in the treatment of arrhythmias].
Topics: Acute Disease; Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Clinical Tria | 1979 |
[Use of amiodarone in cardiac arrhythmias].
Topics: Adult; Aged; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Clinical Trials as Topic; Dogs; | 1975 |
[Use of amiodarone in cardiac arrhythmias].
Topics: Adult; Aged; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Clinical Trials as Topic; Dogs; | 1975 |
Clinical efficacy of amiodarone as an antiarrhythmic agent.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Clinical Trials as Topic; Cornea; Drug Evaluation; He | 1976 |
Clinical efficacy of amiodarone as an antiarrhythmic agent.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Clinical Trials as Topic; Cornea; Drug Evaluation; He | 1976 |
[Long-term clinical trial of amiodarone chlorhydrate as an antiarrhythmia agent].
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Clin | 1976 |
[Long-term clinical trial of amiodarone chlorhydrate as an antiarrhythmia agent].
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Clin | 1976 |
[Anti-arrhythmic effects of injectable amiodarone. Apropos of 100 cases].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Clinical Trials as Topi | 1976 |
[Anti-arrhythmic effects of injectable amiodarone. Apropos of 100 cases].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Clinical Trials as Topi | 1976 |
[Electrophysiologic basis of the anti-arrhythmic action of amiodarone in man].
Topics: Action Potentials; Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac | 1976 |
[Electrophysiologic basis of the anti-arrhythmic action of amiodarone in man].
Topics: Action Potentials; Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac | 1976 |
[Letter: The antiarrhythmic effects of injectable amiodarone].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Clinical Trials as Topic; Humans; Injections, Intrave | 1975 |
[Letter: The antiarrhythmic effects of injectable amiodarone].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Clinical Trials as Topic; Humans; Injections, Intrave | 1975 |
[New amiodarone protocol in the treatment of refractory arrhythmias].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; | 1992 |
[New amiodarone protocol in the treatment of refractory arrhythmias].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; | 1992 |
Amiodarone therapy does not compromise subsequent heart transplantation.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cardiotonic Agents; Feasibility | 1992 |
Amiodarone therapy does not compromise subsequent heart transplantation.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cardiotonic Agents; Feasibility | 1992 |
Beneficial effect of amiodarone on cardiac mortality in patients with asymptomatic complex ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular function.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Myocardial Infarction; St | 1992 |
Beneficial effect of amiodarone on cardiac mortality in patients with asymptomatic complex ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular function.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Myocardial Infarction; St | 1992 |
Intractable heart failure despite angiotensin-converting enzyme inhibitors, digoxin, and diuretics: long-term effectiveness of add-on therapy with pimobendan.
Topics: Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Digoxin; Diuretics | 1991 |
Intractable heart failure despite angiotensin-converting enzyme inhibitors, digoxin, and diuretics: long-term effectiveness of add-on therapy with pimobendan.
Topics: Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Digoxin; Diuretics | 1991 |
Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Double-Blind Method; Feasibil | 1991 |
Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Double-Blind Method; Feasibil | 1991 |
Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study.
Topics: Aged; Amiodarone; Analysis of Variance; Arrhythmias, Cardiac; Atrial Fibrillation; Chi-Square Distri | 1991 |
Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study.
Topics: Aged; Amiodarone; Analysis of Variance; Arrhythmias, Cardiac; Atrial Fibrillation; Chi-Square Distri | 1991 |
Relationship between preoperative amiodarone treatment and complications observed during anaesthesia for valvular cardiac surgery.
Topics: Adult; Aged; Amiodarone; Anesthesia, General; Aortic Valve; Arrhythmias, Cardiac; Depression, Chemic | 1990 |
Relationship between preoperative amiodarone treatment and complications observed during anaesthesia for valvular cardiac surgery.
Topics: Adult; Aged; Amiodarone; Anesthesia, General; Aortic Valve; Arrhythmias, Cardiac; Depression, Chemic | 1990 |
Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS)
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden; Female; Humans; Male; Middl | 1990 |
Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS)
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden; Female; Humans; Male; Middl | 1990 |
Antiarrhythmic treatment and myocardial infarction.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Myocardial Infarction; Research De | 1990 |
Antiarrhythmic treatment and myocardial infarction.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Myocardial Infarction; Research De | 1990 |
Amiodarone: value of programmed electrical stimulation and Holter monitoring.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Cardiac Pacing, Artificial; Clin | 1986 |
Amiodarone: value of programmed electrical stimulation and Holter monitoring.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Cardiac Pacing, Artificial; Clin | 1986 |
[Comparative efficacy of amiodarone and propranolol on ventricular arrhythmia in the post-infarction period].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Female; Follow-Up Studies; Humans; Male | 1989 |
[Comparative efficacy of amiodarone and propranolol on ventricular arrhythmia in the post-infarction period].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Female; Follow-Up Studies; Humans; Male | 1989 |
Multicentre randomized trial of sotalol vs amiodarone for chronic malignant ventricular tachyarrhythmias. Amiodarone vs Sotalol Study Group.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Blood Pressure; Electrocardiography; Electrocardiogra | 1989 |
Multicentre randomized trial of sotalol vs amiodarone for chronic malignant ventricular tachyarrhythmias. Amiodarone vs Sotalol Study Group.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Blood Pressure; Electrocardiography; Electrocardiogra | 1989 |
Beneficial effects of low dose amiodarone in patients with congestive cardiac failure: a placebo-controlled trial.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Clinical Trials as Topic; Follow-Up Studies; Heart Failure; | 1989 |
Beneficial effects of low dose amiodarone in patients with congestive cardiac failure: a placebo-controlled trial.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Clinical Trials as Topic; Follow-Up Studies; Heart Failure; | 1989 |
Comparison of the efficacy of propranolol and amiodarone in suppressing ventricular arrhythmias following myocardial infarction.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Female; Follow-Up Studies; Heart Ventricles; Humans; Male; M | 1989 |
Comparison of the efficacy of propranolol and amiodarone in suppressing ventricular arrhythmias following myocardial infarction.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Female; Follow-Up Studies; Heart Ventricles; Humans; Male; M | 1989 |
Ventricular arrhythmias in heart failure; their significance and modification by amiodarone (with notes on the safety of combined therapy with captopril).
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Captopril; Cardiomyopathy, Dilated; Clinical Tr | 1986 |
Ventricular arrhythmias in heart failure; their significance and modification by amiodarone (with notes on the safety of combined therapy with captopril).
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Captopril; Cardiomyopathy, Dilated; Clinical Tr | 1986 |
Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Topic; Depression, | 1987 |
Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Topic; Depression, | 1987 |
Work of cardiology community results in approval of amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Clinical Trials as Topic; Humans; Lung Diseases; Unit | 1986 |
Work of cardiology community results in approval of amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Clinical Trials as Topic; Humans; Lung Diseases; Unit | 1986 |
[Extracardiac side effects of Aminodarone].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Clinical Trials as Topic; Drug Evaluation; Eye Diseas | 1986 |
[Extracardiac side effects of Aminodarone].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Clinical Trials as Topic; Drug Evaluation; Eye Diseas | 1986 |
[Amiodarone in the treatment of cardiac arrhythmias].
Topics: Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Clinical Trials as Topic; Female; Heart R | 1986 |
[Amiodarone in the treatment of cardiac arrhythmias].
Topics: Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Clinical Trials as Topic; Female; Heart R | 1986 |
Effectiveness of amiodarone on ventricular arrhythmias during and after acute myocardial infarction.
Topics: Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Moni | 1987 |
Effectiveness of amiodarone on ventricular arrhythmias during and after acute myocardial infarction.
Topics: Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Moni | 1987 |
Ventricular arrhythmias during exercise in patients with heart failure: the effect of amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Double-Blind Method; Exercise Test; Female; Heart Failure; Heart V | 1987 |
Ventricular arrhythmias during exercise in patients with heart failure: the effect of amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Double-Blind Method; Exercise Test; Female; Heart Failure; Heart V | 1987 |
Multicenter low-dose amiodarone trial for "severe" ventricular arrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Clinical Trials as Topic; Humans | 1985 |
Multicenter low-dose amiodarone trial for "severe" ventricular arrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Clinical Trials as Topic; Humans | 1985 |
Efficacy of flecainide in the management of ventricular arrhythmias: comparative study with amiodarone.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Clinical Trials | 1985 |
Efficacy of flecainide in the management of ventricular arrhythmias: comparative study with amiodarone.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Clinical Trials | 1985 |
Effect of low oral doses of disopyramide and amiodarone on ventricular and atrial arrhythmias of chagasic patients with advanced myocardial damage.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Chagas Cardiomyopa | 1985 |
Effect of low oral doses of disopyramide and amiodarone on ventricular and atrial arrhythmias of chagasic patients with advanced myocardial damage.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Chagas Cardiomyopa | 1985 |
[Trial of the clinical use of Ritmilen].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyram | 1985 |
[Trial of the clinical use of Ritmilen].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyram | 1985 |
Amiodarone and N-desethylamiodarone concentrations in plasma, red blood cells, and myocardium after a single oral dose: relation to hemodynamic effects in surgical patients.
Topics: Administration, Oral; Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Blood Pressure; Erythroc | 1986 |
Amiodarone and N-desethylamiodarone concentrations in plasma, red blood cells, and myocardium after a single oral dose: relation to hemodynamic effects in surgical patients.
Topics: Administration, Oral; Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Blood Pressure; Erythroc | 1986 |
Long term efficacy of class I antiarrhythmic agents and amiodarone in patients with malignant ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Drug Administration Schedule; | 1985 |
Long term efficacy of class I antiarrhythmic agents and amiodarone in patients with malignant ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Drug Administration Schedule; | 1985 |
[Intravenous administration of lidocaine and amiodarone in patients with acute myocardial infarction].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Injections, Intravenous; Lidocaine; M | 1985 |
[Intravenous administration of lidocaine and amiodarone in patients with acute myocardial infarction].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Injections, Intravenous; Lidocaine; M | 1985 |
787 other studies available for amiodarone and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant | 2008 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant | 2008 |
Pharmacologic therapy for engraftment arrhythmia induced by transplantation of human cardiomyocytes.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cell Line; Cell- and Tissue-Based | 2021 |
Pharmacologic therapy for engraftment arrhythmia induced by transplantation of human cardiomyocytes.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cell Line; Cell- and Tissue-Based | 2021 |
Liver failure caused by intravenous amiodarone and effective intervention measures: A case report.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Critical Illness; Humans; Infusions, | 2022 |
Liver failure caused by intravenous amiodarone and effective intervention measures: A case report.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Critical Illness; Humans; Infusions, | 2022 |
Antiparasitic treatment with itraconazole and amiodarone in 2 dogs with severe, symptomatic Chagas cardiomyopathy.
Topics: Amiodarone; Animals; Anti-Infective Agents; Antiparasitic Agents; Arrhythmias, Cardiac; Chagas Cardi | 2022 |
Antiparasitic treatment with itraconazole and amiodarone in 2 dogs with severe, symptomatic Chagas cardiomyopathy.
Topics: Amiodarone; Animals; Anti-Infective Agents; Antiparasitic Agents; Arrhythmias, Cardiac; Chagas Cardi | 2022 |
Amiodarone induced pulmonary toxicity.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug-Related Side Effec | 2021 |
Amiodarone induced pulmonary toxicity.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug-Related Side Effec | 2021 |
Amiodarone Use and All-Cause Mortality in Patients With a Continuous-Flow Left Ventricular Assist Device.
Topics: Amiodarone; Arrhythmias, Cardiac; Female; Heart Failure; Heart-Assist Devices; Humans; Male; Retrosp | 2022 |
Amiodarone Use and All-Cause Mortality in Patients With a Continuous-Flow Left Ventricular Assist Device.
Topics: Amiodarone; Arrhythmias, Cardiac; Female; Heart Failure; Heart-Assist Devices; Humans; Male; Retrosp | 2022 |
Primary hypothyroidism with an episode of ventricular tachycardia in a patient with COVID-19: A case report.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; COVID-19; Electrocardiography; Human | 2022 |
Primary hypothyroidism with an episode of ventricular tachycardia in a patient with COVID-19: A case report.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; COVID-19; Electrocardiography; Human | 2022 |
Side Effects of Amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Drug-Related Side Effects and Adverse Reactions; Humans | 2022 |
Side Effects of Amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Drug-Related Side Effects and Adverse Reactions; Humans | 2022 |
Reply: Side Effects of Amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Drug-Related Side Effects and Adverse Reactions; Humans | 2022 |
Reply: Side Effects of Amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Drug-Related Side Effects and Adverse Reactions; Humans | 2022 |
Male infant with Noonan syndrome with
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Flecainide; Heart Failure; Humans; I | 2022 |
Male infant with Noonan syndrome with
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Flecainide; Heart Failure; Humans; I | 2022 |
Association between amiodarone and ventricular tachycardia after left ventricular assist device implant: a single-center experience.
Topics: Amiodarone; Arrhythmias, Cardiac; Heart Failure; Heart-Assist Devices; Humans; Tachycardia, Ventricu | 2023 |
Association between amiodarone and ventricular tachycardia after left ventricular assist device implant: a single-center experience.
Topics: Amiodarone; Arrhythmias, Cardiac; Heart Failure; Heart-Assist Devices; Humans; Tachycardia, Ventricu | 2023 |
Association between amiodarone and ventricular tachycardia after left ventricular assist device implant: a single-center experience.
Topics: Amiodarone; Arrhythmias, Cardiac; Heart Failure; Heart-Assist Devices; Humans; Tachycardia, Ventricu | 2023 |
Association between amiodarone and ventricular tachycardia after left ventricular assist device implant: a single-center experience.
Topics: Amiodarone; Arrhythmias, Cardiac; Heart Failure; Heart-Assist Devices; Humans; Tachycardia, Ventricu | 2023 |
Association between amiodarone and ventricular tachycardia after left ventricular assist device implant: a single-center experience.
Topics: Amiodarone; Arrhythmias, Cardiac; Heart Failure; Heart-Assist Devices; Humans; Tachycardia, Ventricu | 2023 |
Association between amiodarone and ventricular tachycardia after left ventricular assist device implant: a single-center experience.
Topics: Amiodarone; Arrhythmias, Cardiac; Heart Failure; Heart-Assist Devices; Humans; Tachycardia, Ventricu | 2023 |
Association between amiodarone and ventricular tachycardia after left ventricular assist device implant: a single-center experience.
Topics: Amiodarone; Arrhythmias, Cardiac; Heart Failure; Heart-Assist Devices; Humans; Tachycardia, Ventricu | 2023 |
Association between amiodarone and ventricular tachycardia after left ventricular assist device implant: a single-center experience.
Topics: Amiodarone; Arrhythmias, Cardiac; Heart Failure; Heart-Assist Devices; Humans; Tachycardia, Ventricu | 2023 |
Antiarrhythmic Drug Therapy for Ventricular Arrhythmias: The Changing Role in the Modern Era.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans | 2023 |
Antiarrhythmic Drug Therapy for Ventricular Arrhythmias: The Changing Role in the Modern Era.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans | 2023 |
Epicardial electrical heterogeneity after amiodarone treatment increases vulnerability to ventricular arrhythmias under therapeutic hypothermia.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Connexin 43; Heart Ventricles; Hypothermia, Induced; Swin | 2023 |
Epicardial electrical heterogeneity after amiodarone treatment increases vulnerability to ventricular arrhythmias under therapeutic hypothermia.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Connexin 43; Heart Ventricles; Hypothermia, Induced; Swin | 2023 |
Intravenous bolus potassium: Appropriate indication in recurrent ventricular fibrillation.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Humans; Infusions, Intravenous; Injections, I | 2023 |
Intravenous bolus potassium: Appropriate indication in recurrent ventricular fibrillation.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Humans; Infusions, Intravenous; Injections, I | 2023 |
Amiodarone-induced blue man syndrome: a case report.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Heart Disease | 2023 |
Amiodarone-induced blue man syndrome: a case report.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Heart Disease | 2023 |
Stable Ventricular Fibrillation: A Paradigm Rather Than Septal Shift?
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Lidocaine; Tachycardia, Ventricular; Ventricular Fibrillat | 2023 |
Stable Ventricular Fibrillation: A Paradigm Rather Than Septal Shift?
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Lidocaine; Tachycardia, Ventricular; Ventricular Fibrillat | 2023 |
Amiodarone prevents wave front-tail interactions in patients with heart failure: an in silico study.
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Failure; Humans; | 2023 |
Amiodarone prevents wave front-tail interactions in patients with heart failure: an in silico study.
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Failure; Humans; | 2023 |
Improved Survival in Hepatocellular Carcinoma Patients with Cardiac Arrhythmia by Amiodarone Treatment through Autophagy.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Autophagy; Carcinoma, Hepatocellular; Cell Survival; Female; | 2019 |
Improved Survival in Hepatocellular Carcinoma Patients with Cardiac Arrhythmia by Amiodarone Treatment through Autophagy.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Autophagy; Carcinoma, Hepatocellular; Cell Survival; Female; | 2019 |
Case Report: Malignant Ventricular Arrhythmias Mimicking Acute Coronary Syndrome in Chagas Disease.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chagas Cardiomyopathy; Clopidogrel; | 2020 |
Case Report: Malignant Ventricular Arrhythmias Mimicking Acute Coronary Syndrome in Chagas Disease.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chagas Cardiomyopathy; Clopidogrel; | 2020 |
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Amiodarone; Andersen Syndrome; Anti-Arrhythmia Agent | 2020 |
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Amiodarone; Andersen Syndrome; Anti-Arrhythmia Agent | 2020 |
Atrial Flutter-Unique Arrhythmia in Neonatal Population, Presentation of 3 Cases.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Flutter; Electrocardiography; Femal | 2020 |
Atrial Flutter-Unique Arrhythmia in Neonatal Population, Presentation of 3 Cases.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Flutter; Electrocardiography; Femal | 2020 |
Amiodarone disrupts cholesterol biosynthesis pathway and causes accumulation of circulating desmosterol by inhibiting 24-dehydrocholesterol reductase.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Case-Control Studies; Cells, Cultured; Cho | 2020 |
Amiodarone disrupts cholesterol biosynthesis pathway and causes accumulation of circulating desmosterol by inhibiting 24-dehydrocholesterol reductase.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Case-Control Studies; Cells, Cultured; Cho | 2020 |
Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
Topics: Amiodarone; Angiotensin-Converting Enzyme 2; Anti-Arrhythmia Agents; Antiviral Agents; Arrhythmias, | 2020 |
Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
Topics: Amiodarone; Angiotensin-Converting Enzyme 2; Anti-Arrhythmia Agents; Antiviral Agents; Arrhythmias, | 2020 |
Implementation of a Novel Order Set to Improve Baseline Pulmonary, Hepatic, and Thyroid Function Testing at Time of Inpatient Amiodarone Initiation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Liver Function Tests; Respiratory | 2020 |
Implementation of a Novel Order Set to Improve Baseline Pulmonary, Hepatic, and Thyroid Function Testing at Time of Inpatient Amiodarone Initiation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Liver Function Tests; Respiratory | 2020 |
Overdrive pacing of spiral waves in a model of human ventricular tissue.
Topics: Action Potentials; Amiodarone; Arrhythmias, Cardiac; Electrophysiology; Heart Conduction System; Hea | 2020 |
Overdrive pacing of spiral waves in a model of human ventricular tissue.
Topics: Action Potentials; Amiodarone; Arrhythmias, Cardiac; Electrophysiology; Heart Conduction System; Hea | 2020 |
Amiodarone inhibits arrhythmias in hypertensive rats by improving myocardial biomechanical properties.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Biomechanical Phenomena; Calcium; | 2020 |
Amiodarone inhibits arrhythmias in hypertensive rats by improving myocardial biomechanical properties.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Biomechanical Phenomena; Calcium; | 2020 |
Prognostic benefits of prior amiodarone or β-blocker use before the onset of ventricular arrhythmia with hemodynamic collapse.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Hemodynamics; | 2021 |
Prognostic benefits of prior amiodarone or β-blocker use before the onset of ventricular arrhythmia with hemodynamic collapse.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Hemodynamics; | 2021 |
Different voltage dependence of I
Topics: Action Potentials; Amiodarone; Arrhythmias, Cardiac; Bepridil; Calcium Channels, L-Type; Computer Si | 2021 |
Different voltage dependence of I
Topics: Action Potentials; Amiodarone; Arrhythmias, Cardiac; Bepridil; Calcium Channels, L-Type; Computer Si | 2021 |
COMBINED PHARMACOLOGICAL THERAPY INCLUDING SEVERAL ANTIARRHYTHMIC AGENTS FOR TREATMENT OF DIFFERENT DISORDERS OF CARDIAC RHYTHM.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Propafenone; Sotalol | 2021 |
COMBINED PHARMACOLOGICAL THERAPY INCLUDING SEVERAL ANTIARRHYTHMIC AGENTS FOR TREATMENT OF DIFFERENT DISORDERS OF CARDIAC RHYTHM.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Propafenone; Sotalol | 2021 |
Differential cytokine profiling in Chagasic patients according to their arrhythmogenic-status.
Topics: Adult; Aged; Amiodarone; Analysis of Variance; Arrhythmias, Cardiac; Biomarkers; Chagas Disease; Cyt | 2017 |
Differential cytokine profiling in Chagasic patients according to their arrhythmogenic-status.
Topics: Adult; Aged; Amiodarone; Analysis of Variance; Arrhythmias, Cardiac; Biomarkers; Chagas Disease; Cyt | 2017 |
Therapeutic monitoring of amiodarone: pharmacokinetics and evaluation of the relationship between effect and dose/concentration.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dose-Respo | 2017 |
Therapeutic monitoring of amiodarone: pharmacokinetics and evaluation of the relationship between effect and dose/concentration.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dose-Respo | 2017 |
The clinical value of regular thyroid function tests during amiodarone treatment.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Follow-Up Studies; Hu | 2017 |
The clinical value of regular thyroid function tests during amiodarone treatment.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Follow-Up Studies; Hu | 2017 |
Effects of amiodarone on short QT syndrome variant 3 in human ventricles: a simulation study.
Topics: Action Potentials; Amiodarone; Arrhythmias, Cardiac; Heart Ventricles; Humans; Ion Channels; Models, | 2017 |
Effects of amiodarone on short QT syndrome variant 3 in human ventricles: a simulation study.
Topics: Action Potentials; Amiodarone; Arrhythmias, Cardiac; Heart Ventricles; Humans; Ion Channels; Models, | 2017 |
THE SAFETY AND EFFICACY OF AMIODARONE AND CARVEDILOL COMBINATION IN TREATMENT OF PATIENTS WITH SEVERE CARDIAC RHYTHM DISORDERS.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibril | 2017 |
THE SAFETY AND EFFICACY OF AMIODARONE AND CARVEDILOL COMBINATION IN TREATMENT OF PATIENTS WITH SEVERE CARDIAC RHYTHM DISORDERS.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibril | 2017 |
[Severe ventricular arrhythmias in a patient with dilated cardiomyopathy and automated implantable defibrillator (AID)].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Death, Sudden, Ca | 2017 |
[Severe ventricular arrhythmias in a patient with dilated cardiomyopathy and automated implantable defibrillator (AID)].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Death, Sudden, Ca | 2017 |
[Amiodarone-induced immune complex cutaneous vasculitis].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Back; Diabetes Mellitus, Type 2; Humans; H | 2017 |
[Amiodarone-induced immune complex cutaneous vasculitis].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Back; Diabetes Mellitus, Type 2; Humans; H | 2017 |
Right ventricular tuberculous granuloma.
Topics: Amiodarone; Antitubercular Agents; Arrhythmias, Cardiac; Granuloma; Heart Diseases; Heart Ventricles | 2017 |
Right ventricular tuberculous granuloma.
Topics: Amiodarone; Antitubercular Agents; Arrhythmias, Cardiac; Granuloma; Heart Diseases; Heart Ventricles | 2017 |
Modeling the effects of amiodarone on short QT syndrome variant 2 in the human ventricles.
Topics: Action Potentials; Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Heart Conduction System; H | 2017 |
Modeling the effects of amiodarone on short QT syndrome variant 2 in the human ventricles.
Topics: Action Potentials; Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Heart Conduction System; H | 2017 |
Reply.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Metoprolol; Propafenone; Shock, Septic | 2018 |
Reply.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Metoprolol; Propafenone; Shock, Septic | 2018 |
[Update Ventricular Tachycardia].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catheter Ablation; Defibrillators; Humans; | 2018 |
[Update Ventricular Tachycardia].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catheter Ablation; Defibrillators; Humans; | 2018 |
Propafenone for supraventricular arrhythmias in septic shock-Comparison to amiodarone and metoprolol.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Metoprolol; Propafenone; Shock, Se | 2018 |
Propafenone for supraventricular arrhythmias in septic shock-Comparison to amiodarone and metoprolol.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Metoprolol; Propafenone; Shock, Se | 2018 |
Bizarre and scary ECG in yew leaves poisoning: Report of successful treatment.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Ca | 2018 |
Bizarre and scary ECG in yew leaves poisoning: Report of successful treatment.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Ca | 2018 |
Left Ventricular Assist Device Thrombosis-Amiodarone-Induced Hyperthyroidism: Causal Link?
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Failure; Heart-Assist D | 2019 |
Left Ventricular Assist Device Thrombosis-Amiodarone-Induced Hyperthyroidism: Causal Link?
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Failure; Heart-Assist D | 2019 |
Efficacy and Safety of Low-Dose Amiodarone Therapy for Tachyarrhythmia in Congenital Heart Disease.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Follow-Up Studies; Heart De | 2018 |
Efficacy and Safety of Low-Dose Amiodarone Therapy for Tachyarrhythmia in Congenital Heart Disease.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Follow-Up Studies; Heart De | 2018 |
Cardiac autonomic modulation and long-term use of amiodarone in patients with chronic Chagasic cardiopathy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Autonomic Nervous System; Chagas Car | 2018 |
Cardiac autonomic modulation and long-term use of amiodarone in patients with chronic Chagasic cardiopathy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Autonomic Nervous System; Chagas Car | 2018 |
Nonreentrant atrial tachycardia occurs independently of hypertrophic cardiomyopathy in RASopathy patients.
Topics: Amiodarone; Arrhythmias, Cardiac; Calcium; Cardiomyopathy, Hypertrophic; Costello Syndrome; Digoxin; | 2018 |
Nonreentrant atrial tachycardia occurs independently of hypertrophic cardiomyopathy in RASopathy patients.
Topics: Amiodarone; Arrhythmias, Cardiac; Calcium; Cardiomyopathy, Hypertrophic; Costello Syndrome; Digoxin; | 2018 |
Ventricular repolarization wave variations during the amiodarone treatment course.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Aged, 80 and over; Amiodarone; Arrhy | 2018 |
Ventricular repolarization wave variations during the amiodarone treatment course.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Aged, 80 and over; Amiodarone; Arrhy | 2018 |
Adverse effects of amiodarone therapy in adults with congenital heart disease.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Comorbidity; Drug | 2018 |
Adverse effects of amiodarone therapy in adults with congenital heart disease.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Comorbidity; Drug | 2018 |
Diagnosis and Clinical Course of Three Adolescents with Amiodarone-Induced Hyperthyroidism.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Arrhythmias, Cardiac; Female; Gl | 2018 |
Diagnosis and Clinical Course of Three Adolescents with Amiodarone-Induced Hyperthyroidism.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Arrhythmias, Cardiac; Female; Gl | 2018 |
The risk of cardiac events in patients who received concomitant levofloxacin and amiodarone.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Body Mass Index; Death; Drug Thera | 2019 |
The risk of cardiac events in patients who received concomitant levofloxacin and amiodarone.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Body Mass Index; Death; Drug Thera | 2019 |
Amiodarone is associated with adverse outcomes in patients with sustained ventricular arrhythmias upgraded to cardiac resynchronization therapy-defibrillators.
Topics: Action Potentials; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Resynchro | 2019 |
Amiodarone is associated with adverse outcomes in patients with sustained ventricular arrhythmias upgraded to cardiac resynchronization therapy-defibrillators.
Topics: Action Potentials; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Resynchro | 2019 |
Impact of Different Pharmacotherapies on Long-Term Outcomes in Patients with Electrical Storm.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amiodarone; Angiotensin II Type 1 Recep | 2019 |
Impact of Different Pharmacotherapies on Long-Term Outcomes in Patients with Electrical Storm.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amiodarone; Angiotensin II Type 1 Recep | 2019 |
Aggravation of atrial arrhythmia by amiodarone during the perinatal period: A case report.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Heart Failure; Humans; Pre- | 2019 |
Aggravation of atrial arrhythmia by amiodarone during the perinatal period: A case report.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Heart Failure; Humans; Pre- | 2019 |
Patterns of amiodarone-induced thyroid dysfunction in infants and children.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Developmental Disabilities; Early D | 2019 |
Patterns of amiodarone-induced thyroid dysfunction in infants and children.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Developmental Disabilities; Early D | 2019 |
[Experts' suggestions of normative application of amiodarone].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans | 2019 |
[Experts' suggestions of normative application of amiodarone].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans | 2019 |
Transient neonatal hypothyroidism following a short course of maternal amiodarone therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Hypothyroidism; Infant, Ne | 2019 |
Transient neonatal hypothyroidism following a short course of maternal amiodarone therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Hypothyroidism; Infant, Ne | 2019 |
The Effects of Amiodarone on Thyroid Function in Pediatric and Young Adult Patients.
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Child; Child, Preschool; Female; Humans; Incidence; In | 2019 |
The Effects of Amiodarone on Thyroid Function in Pediatric and Young Adult Patients.
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Child; Child, Preschool; Female; Humans; Incidence; In | 2019 |
Amiodarone monitoring practices in pediatric hospitals in the United States.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Child, Preschool; Drug | 2013 |
Amiodarone monitoring practices in pediatric hospitals in the United States.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Child, Preschool; Drug | 2013 |
Prophylactic amiodarone and lidocaine improve survival in an ovine model of large size myocardial infarction.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Disease Mode | 2013 |
Prophylactic amiodarone and lidocaine improve survival in an ovine model of large size myocardial infarction.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Disease Mode | 2013 |
Benefits of standardizing the treatment of arrhythmias in the sheep (Ovis aries) model of chronic heart failure after myocardial infarction.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catheters; Disease Models, Animal | 2013 |
Benefits of standardizing the treatment of arrhythmias in the sheep (Ovis aries) model of chronic heart failure after myocardial infarction.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catheters; Disease Models, Animal | 2013 |
Exercise intolerance in patients on dronedarone. What is the underlying mechanism?
Topics: Amiodarone; Arrhythmias, Cardiac; Dronedarone; Dyspnea; Exercise Tolerance; Female; Humans; Male; Mi | 2013 |
Exercise intolerance in patients on dronedarone. What is the underlying mechanism?
Topics: Amiodarone; Arrhythmias, Cardiac; Dronedarone; Dyspnea; Exercise Tolerance; Female; Humans; Male; Mi | 2013 |
[A case of simultaneously occurred amiodarone-induced hepatitis and hypothyroidism].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Chemical and Drug Induced Liver Injury; Female; Fibrosis; Hu | 2013 |
[A case of simultaneously occurred amiodarone-induced hepatitis and hypothyroidism].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Chemical and Drug Induced Liver Injury; Female; Fibrosis; Hu | 2013 |
Pharmacokinetics of intravenous amiodarone in children.
Topics: Administration, Intravenous; Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Car | 2013 |
Pharmacokinetics of intravenous amiodarone in children.
Topics: Administration, Intravenous; Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Car | 2013 |
[Amiodarone-induced pneumonia].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bronchoalveolar Lavage Fluid; Diagno | 2013 |
[Amiodarone-induced pneumonia].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bronchoalveolar Lavage Fluid; Diagno | 2013 |
Vortex punctate keratopathy resulting from amiodarone in a Chinese patient.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Corneal Diseases; Humans; Male; Middle Age | 2014 |
Vortex punctate keratopathy resulting from amiodarone in a Chinese patient.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Corneal Diseases; Humans; Male; Middle Age | 2014 |
Amiodarone-induced SIADH: two cases report.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Humans; Inappropriate ADH | 2014 |
Amiodarone-induced SIADH: two cases report.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Humans; Inappropriate ADH | 2014 |
Efficacy of Melissa officinalis in suppressing ventricular arrhythmias following ischemia-reperfusion of the heart: a comparison with amiodarone.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Disease Models, A | 2014 |
Efficacy of Melissa officinalis in suppressing ventricular arrhythmias following ischemia-reperfusion of the heart: a comparison with amiodarone.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Disease Models, A | 2014 |
Amiodarone use and risk of acute pancreatitis: A population-based case-control study.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Card | 2015 |
Amiodarone use and risk of acute pancreatitis: A population-based case-control study.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Card | 2015 |
Warning: Acute pancreatitis is associated with slightly higher current amiodarone use.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Male; Pancreatitis | 2015 |
Warning: Acute pancreatitis is associated with slightly higher current amiodarone use.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Male; Pancreatitis | 2015 |
The incidence and predictors of overall adverse effects caused by low dose amiodarone in real-world clinical practice.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrioventricular Block; Bradycardia; | 2014 |
The incidence and predictors of overall adverse effects caused by low dose amiodarone in real-world clinical practice.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrioventricular Block; Bradycardia; | 2014 |
Letter to the Editor--Amiodarone and risk of acute pancreatitis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Male; Pancreatitis | 2015 |
Letter to the Editor--Amiodarone and risk of acute pancreatitis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Male; Pancreatitis | 2015 |
Reply to the editor--amiodarone and risk of acute pancreatitis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Male; Pancreatitis | 2015 |
Reply to the editor--amiodarone and risk of acute pancreatitis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Male; Pancreatitis | 2015 |
Flexible and waterproof micro-sensors to uncover zebrafish circadian rhythms: The next generation of cardiac monitoring for drug screening.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Biosensing Techniques; Brugada Sy | 2015 |
Flexible and waterproof micro-sensors to uncover zebrafish circadian rhythms: The next generation of cardiac monitoring for drug screening.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Biosensing Techniques; Brugada Sy | 2015 |
Evaluating the Safety of Intraoperative Antiarrhythmics in Pediatric Cardiac Surgery Patients.
Topics: Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Surgical Proced | 2015 |
Evaluating the Safety of Intraoperative Antiarrhythmics in Pediatric Cardiac Surgery Patients.
Topics: Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Surgical Proced | 2015 |
Where to go in risk stratification for sudden cardiac death: Are P values enough?
Topics: Amiodarone; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Electrocardiography, Ambulatory; Female; H | 2015 |
Where to go in risk stratification for sudden cardiac death: Are P values enough?
Topics: Amiodarone; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Electrocardiography, Ambulatory; Female; H | 2015 |
Long-term pretreatment with desethylamiodarone (DEA) or amiodarone (AMIO) protects against coronary artery occlusion induced ventricular arrhythmias in conscious rats.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiotonic Agents; Consciousness | 2015 |
Long-term pretreatment with desethylamiodarone (DEA) or amiodarone (AMIO) protects against coronary artery occlusion induced ventricular arrhythmias in conscious rats.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiotonic Agents; Consciousness | 2015 |
Investigation of the antifibrillatory drug interactions between Amiodarone and Ibutilide in isolated, perfused Rabbit hearts.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Interactions; Heart; Lidocai | 2015 |
Investigation of the antifibrillatory drug interactions between Amiodarone and Ibutilide in isolated, perfused Rabbit hearts.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Interactions; Heart; Lidocai | 2015 |
Sofosbuvir + amiodarone: bradycardia and conduction disturbances.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antiviral Agents; Arrhythmias, Cardiac; Bradycardia; Brugada Syn | 2015 |
Sofosbuvir + amiodarone: bradycardia and conduction disturbances.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antiviral Agents; Arrhythmias, Cardiac; Bradycardia; Brugada Syn | 2015 |
Retrospective evaluation of intravenous premixed amiodarone use and adverse effects in dogs (17 cases: 2011-2014).
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Female; Male; Retrospective | 2016 |
Retrospective evaluation of intravenous premixed amiodarone use and adverse effects in dogs (17 cases: 2011-2014).
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Female; Male; Retrospective | 2016 |
Amiodarone-Induced Thyrotoxicosis Recurrence After Amiodarone Reintroduction.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Male; Middle | 2016 |
Amiodarone-Induced Thyrotoxicosis Recurrence After Amiodarone Reintroduction.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Male; Middle | 2016 |
Hyperpigmentation on face and arms and thyrotoxicosis induced by amiodarone treatment.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arm; Arrhythmias, Cardiac; Face; Humans; Hyperpigmentation | 2017 |
Hyperpigmentation on face and arms and thyrotoxicosis induced by amiodarone treatment.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arm; Arrhythmias, Cardiac; Face; Humans; Hyperpigmentation | 2017 |
Sex differences in the prehospital management of out-of-hospital cardiac arrest.
Topics: Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Atropine; Cardiopulmonary Resuscitation; | 2016 |
Sex differences in the prehospital management of out-of-hospital cardiac arrest.
Topics: Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Atropine; Cardiopulmonary Resuscitation; | 2016 |
Left-dominant Arrhythmogenic Cardiomyopathy: A Case Misdiagnosed as Pseudoaneurysm.
Topics: Amiodarone; Aneurysm, False; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Humans; | 2016 |
Left-dominant Arrhythmogenic Cardiomyopathy: A Case Misdiagnosed as Pseudoaneurysm.
Topics: Amiodarone; Aneurysm, False; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Humans; | 2016 |
Bradyarrhythmia induced by amiodarone-sofosbuvir co-administration.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bradycardia; Drug Interactions; Drug Thera | 2016 |
Bradyarrhythmia induced by amiodarone-sofosbuvir co-administration.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bradycardia; Drug Interactions; Drug Thera | 2016 |
Long-term adherence to dronedarone in patients with atrial arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dronedarone; Female; Follow-Up Studi | 2016 |
Long-term adherence to dronedarone in patients with atrial arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dronedarone; Female; Follow-Up Studi | 2016 |
Intra-Articular Pigmentation of Synovium: An Unusual Cause.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Arthroscopy; Diagnosis, Differential | 2016 |
Intra-Articular Pigmentation of Synovium: An Unusual Cause.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Arthroscopy; Diagnosis, Differential | 2016 |
Reply.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans | 2017 |
Reply.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans | 2017 |
New Recommendation for Amiodarone in Treatment of Symptomatic Arrhythmias Associated With Atrioventricular Bypass Tracts.
Topics: Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Humans; Tachycardia | 2017 |
New Recommendation for Amiodarone in Treatment of Symptomatic Arrhythmias Associated With Atrioventricular Bypass Tracts.
Topics: Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Humans; Tachycardia | 2017 |
Amiodarone for the Prevention of Sudden Cardiac Death.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Combined Modality Therapy; Death, Sudden, | 2016 |
Amiodarone for the Prevention of Sudden Cardiac Death.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Combined Modality Therapy; Death, Sudden, | 2016 |
ECG of the Month.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Electric Cou | 2017 |
ECG of the Month.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Electric Cou | 2017 |
[Predictive parameters of occurrence of adequate interventions in patients with implanted cardioverter-defibrillators with or without resynchronisation therapy in primary prevention of sudden cardiac death in dilated cardiomyopathy].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Resynchronization Therapy; C | 2017 |
[Predictive parameters of occurrence of adequate interventions in patients with implanted cardioverter-defibrillators with or without resynchronisation therapy in primary prevention of sudden cardiac death in dilated cardiomyopathy].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Resynchronization Therapy; C | 2017 |
Trace amine-associated receptor 1 (TAAR1) is activated by amiodarone metabolites.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Combinatorial Chemistry Technique | 2008 |
Trace amine-associated receptor 1 (TAAR1) is activated by amiodarone metabolites.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Combinatorial Chemistry Technique | 2008 |
Clinical criteria for predicting benefit of ICD/PM in post myocardial infarction patients: an AVID and CAST analysis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudden, C | 2008 |
Clinical criteria for predicting benefit of ICD/PM in post myocardial infarction patients: an AVID and CAST analysis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudden, C | 2008 |
Case files of the medical toxicology fellowship at the toxikon consortium in Chicago: cocaine-associated wide-complex dysrhythmias and cardiac arrest - treatment nuances and controversies.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticonvulsants; Antidotes; Arrhythmias, Cardiac; Charcoal; Coca | 2008 |
Case files of the medical toxicology fellowship at the toxikon consortium in Chicago: cocaine-associated wide-complex dysrhythmias and cardiac arrest - treatment nuances and controversies.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticonvulsants; Antidotes; Arrhythmias, Cardiac; Charcoal; Coca | 2008 |
[2008 Task force guidelines for amiodarone use in the treatment of arrhythmias (no abstract)].
Topics: Advisory Committees; Amiodarone; Arrhythmias, Cardiac; Guidelines as Topic; Humans | 2008 |
[2008 Task force guidelines for amiodarone use in the treatment of arrhythmias (no abstract)].
Topics: Advisory Committees; Amiodarone; Arrhythmias, Cardiac; Guidelines as Topic; Humans | 2008 |
[Glass of water or ablation? - episodes of malignant atrial tachyarrhythmias during swimming in a lake in a woman with overt Wolff-Parkinson-White syndrome and benign palpitations for several decades of life].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter | 2008 |
[Glass of water or ablation? - episodes of malignant atrial tachyarrhythmias during swimming in a lake in a woman with overt Wolff-Parkinson-White syndrome and benign palpitations for several decades of life].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter | 2008 |
Magnesium sulphate and amiodarone prophylaxis for prevention of postoperative arrhythmia in coronary by-pass operations.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Artery Bypass; Creatine Kinase, M | 2009 |
Magnesium sulphate and amiodarone prophylaxis for prevention of postoperative arrhythmia in coronary by-pass operations.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Artery Bypass; Creatine Kinase, M | 2009 |
Long-term neurodevelopmental outcome after fetal arrhythmia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrioventricular Block; Child, Preschool; | 2009 |
Long-term neurodevelopmental outcome after fetal arrhythmia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrioventricular Block; Child, Preschool; | 2009 |
Determination of the class III antiarrhythmic drugs dronedarone and amiodarone, and their principal metabolites in plasma and myocardium by high-performance liquid chromatography and UV-detection.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chromatography, High Pressure Liquid; Dron | 2009 |
Determination of the class III antiarrhythmic drugs dronedarone and amiodarone, and their principal metabolites in plasma and myocardium by high-performance liquid chromatography and UV-detection.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chromatography, High Pressure Liquid; Dron | 2009 |
[How did ATHENA win ANDROMEDA? Results of the ATHENA].
Topics: Amiodarone; Arrhythmias, Cardiac; Dronedarone; Electrocardiography; Heart Rate; Humans; Randomized C | 2009 |
[How did ATHENA win ANDROMEDA? Results of the ATHENA].
Topics: Amiodarone; Arrhythmias, Cardiac; Dronedarone; Electrocardiography; Heart Rate; Humans; Randomized C | 2009 |
[Possible role of sarcoplasmatic reticulum in anti-arrhythmic effects of the class III agent amiodarone].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Male; Myo | 2009 |
[Possible role of sarcoplasmatic reticulum in anti-arrhythmic effects of the class III agent amiodarone].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Male; Myo | 2009 |
How frequently should a patient taking amiodarone be screened for thyroid dysfunction?
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Follow-Up Studies; Humans; Hyperthyr | 2009 |
How frequently should a patient taking amiodarone be screened for thyroid dysfunction?
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Follow-Up Studies; Humans; Hyperthyr | 2009 |
Dronedarone approved for atrial arrhythmias.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dronedarone; Drug Ap | 2009 |
Dronedarone approved for atrial arrhythmias.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dronedarone; Drug Ap | 2009 |
[Cardiac symptoms in endocrinologic disorders. Heart illness caused by the thyroid gland].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Arrhythmias, Cardiac; Atrial Fi | 2009 |
[Cardiac symptoms in endocrinologic disorders. Heart illness caused by the thyroid gland].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Arrhythmias, Cardiac; Atrial Fi | 2009 |
Implementation of an amiodarone ambulatory care clinic.
Topics: Ambulatory Care Facilities; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Pharma | 2009 |
Implementation of an amiodarone ambulatory care clinic.
Topics: Ambulatory Care Facilities; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Pharma | 2009 |
Amiodarone-induced alveolar haemorrhage: a rare complication of a common medication.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Fatal Outcome; Hemorrhage; Humans; Lung Di | 2010 |
Amiodarone-induced alveolar haemorrhage: a rare complication of a common medication.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Fatal Outcome; Hemorrhage; Humans; Lung Di | 2010 |
Multifactorial QT interval prolongation.
Topics: Alcoholism; Amiodarone; Antipsychotic Agents; Arrhythmias, Cardiac; Biomarkers; Citalopram; Cyclohex | 2010 |
Multifactorial QT interval prolongation.
Topics: Alcoholism; Amiodarone; Antipsychotic Agents; Arrhythmias, Cardiac; Biomarkers; Citalopram; Cyclohex | 2010 |
Dronedarone: NICE enough?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Dronedarone; Hum | 2010 |
Dronedarone: NICE enough?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Dronedarone; Hum | 2010 |
[A rare cause of thyreotoxicosis].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Arrhythmias, Cardiac; Dyspnea; Glucoco | 2010 |
[A rare cause of thyreotoxicosis].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Arrhythmias, Cardiac; Dyspnea; Glucoco | 2010 |
Amiodarone: an effective antiarrhythmic drug with unusual side effects.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Administration Schedule; Drug Eruptio | 2010 |
Amiodarone: an effective antiarrhythmic drug with unusual side effects.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Administration Schedule; Drug Eruptio | 2010 |
Homozygous mutation in SCN5A associated with atrial quiescence, recalcitrant arrhythmias, and poor capture thresholds.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cardiopulmonar | 2011 |
Homozygous mutation in SCN5A associated with atrial quiescence, recalcitrant arrhythmias, and poor capture thresholds.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cardiopulmonar | 2011 |
Evolving cardiac conduction phenotypes in developing zebrafish larvae: implications to drug sensitivity.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Electroca | 2010 |
Evolving cardiac conduction phenotypes in developing zebrafish larvae: implications to drug sensitivity.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Electroca | 2010 |
A dangerous fruit juice.
Topics: Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Beverages; Citrus paradisi; Electric Countersho | 2012 |
A dangerous fruit juice.
Topics: Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Beverages; Citrus paradisi; Electric Countersho | 2012 |
Thyroid hormone, amiodarone therapy, and prognosis in left ventricular systolic dysfunction.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Case-Control Studies; Female; Follow | 2011 |
Thyroid hormone, amiodarone therapy, and prognosis in left ventricular systolic dysfunction.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Case-Control Studies; Female; Follow | 2011 |
[Effects of combined amiodarone and antiarrhythmic peptide use on the cardiac gap junctions and incidence of induced ventricular arrhythmias in healed myocardial infarction rabbit models].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Connexin 43; Male; Myocardial Inf | 2010 |
[Effects of combined amiodarone and antiarrhythmic peptide use on the cardiac gap junctions and incidence of induced ventricular arrhythmias in healed myocardial infarction rabbit models].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Connexin 43; Male; Myocardial Inf | 2010 |
Determinants and outcome of amiodarone-associated thyroid dysfunction.
Topics: Adult; Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Databases, Factu | 2011 |
Determinants and outcome of amiodarone-associated thyroid dysfunction.
Topics: Adult; Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Databases, Factu | 2011 |
Transseptal left ventricular endocardial pacing reduces dispersion of ventricular repolarization.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia | 2011 |
Transseptal left ventricular endocardial pacing reduces dispersion of ventricular repolarization.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia | 2011 |
Proarrhythmic potential of amiodarone: an underestimated risk?
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Dilated | 2012 |
Proarrhythmic potential of amiodarone: an underestimated risk?
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Dilated | 2012 |
The effects of allitridi and amiodarone on the conduction system and reverse use-dependence in the isolated hearts of rats with myocardial infarction.
Topics: Action Potentials; Allyl Compounds; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardia | 2012 |
The effects of allitridi and amiodarone on the conduction system and reverse use-dependence in the isolated hearts of rats with myocardial infarction.
Topics: Action Potentials; Allyl Compounds; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardia | 2012 |
Incessant monomorphic ventricular tachycardia induced by the proarrhythmic effect of amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Injections, Intravenous; Midd | 2011 |
Incessant monomorphic ventricular tachycardia induced by the proarrhythmic effect of amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Injections, Intravenous; Midd | 2011 |
Evaluation of defibrillation safety margin in modern implantable cardioverter defibrillators after administration of amiodarone.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrilla | 2012 |
Evaluation of defibrillation safety margin in modern implantable cardioverter defibrillators after administration of amiodarone.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrilla | 2012 |
Retrospective evaluation of the use of amiodarone in dogs with arrhythmias (from 2003 to 2010).
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dog Diseases; Dogs; Female; Follo | 2012 |
Retrospective evaluation of the use of amiodarone in dogs with arrhythmias (from 2003 to 2010).
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dog Diseases; Dogs; Female; Follo | 2012 |
Population pharmacokinetic investigation for optimization of amiodarone therapy in Japanese patients.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Body Mass | 2011 |
Population pharmacokinetic investigation for optimization of amiodarone therapy in Japanese patients.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Body Mass | 2011 |
Amiodarone-induced T-U fusion.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; El | 2012 |
Amiodarone-induced T-U fusion.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; El | 2012 |
[Effect of anti-arrhythmia drugs on mouse arrhythmia induced by Bufonis Venenum].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bufanolides; Electrocardiography; | 2011 |
[Effect of anti-arrhythmia drugs on mouse arrhythmia induced by Bufonis Venenum].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bufanolides; Electrocardiography; | 2011 |
Modifiable practices associated with sudden death among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Dialysis Sol | 2012 |
Modifiable practices associated with sudden death among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Dialysis Sol | 2012 |
Efficacy and safety profile of dronedarone in clinical practice. Preliminary results of the Magdeburg Dronedarone Registry.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Cohort Studies; Dronedarone; Female; Follow-Up Studies; Gast | 2012 |
Efficacy and safety profile of dronedarone in clinical practice. Preliminary results of the Magdeburg Dronedarone Registry.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Cohort Studies; Dronedarone; Female; Follow-Up Studies; Gast | 2012 |
Amiodarone-associated neuromyopathy: a report of four cases.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electromyography; Female; Follow-Up | 2012 |
Amiodarone-associated neuromyopathy: a report of four cases.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electromyography; Female; Follow-Up | 2012 |
Total thyroidectomy for amiodarone-associated thyrotoxicosis: should surgery always be delayed for pre-operative medical preparation?
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Arrhythmias, | 2012 |
Total thyroidectomy for amiodarone-associated thyrotoxicosis: should surgery always be delayed for pre-operative medical preparation?
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Arrhythmias, | 2012 |
Hemodynamically compromising cardiac arrhythmia during surgery for acute traumatic brain injury: management and outcome.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Brain Injuries; Drainage; Electrocardiogra | 2012 |
Hemodynamically compromising cardiac arrhythmia during surgery for acute traumatic brain injury: management and outcome.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Brain Injuries; Drainage; Electrocardiogra | 2012 |
Proarrhythmic potential of dronedarone: emerging evidence from spontaneous adverse event reporting.
Topics: Adverse Drug Reaction Reporting Systems; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; D | 2012 |
Proarrhythmic potential of dronedarone: emerging evidence from spontaneous adverse event reporting.
Topics: Adverse Drug Reaction Reporting Systems; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; D | 2012 |
[Optimum heart rate - the current goal of cardiovascular therapy. Position statement of the Polish Cardiac Society Working Group on Cardiovascular Drug Therapy].
Topics: Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Di | 2012 |
[Optimum heart rate - the current goal of cardiovascular therapy. Position statement of the Polish Cardiac Society Working Group on Cardiovascular Drug Therapy].
Topics: Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Di | 2012 |
Impact of amiodarone and cisapride on simulated human ventricular electrophysiology and electrocardiograms.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cisapride; Computer Simulation; Drug Thera | 2012 |
Impact of amiodarone and cisapride on simulated human ventricular electrophysiology and electrocardiograms.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cisapride; Computer Simulation; Drug Thera | 2012 |
Torsade de pointes due to dronedarone: déjà vu?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dronedarone; Humans | 2012 |
Torsade de pointes due to dronedarone: déjà vu?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dronedarone; Humans | 2012 |
Liposomal amiodarone augments anti-arrhythmic effects and reduces hemodynamic adverse effects in an ischemia/reperfusion rat model.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Hemodynam | 2013 |
Liposomal amiodarone augments anti-arrhythmic effects and reduces hemodynamic adverse effects in an ischemia/reperfusion rat model.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Hemodynam | 2013 |
Different effects of dronedarone and amiodarone on pulmonary vein electrophysiology, mechanical properties and H2O2-induced arrhythmogenicity.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dronedarone; Electrophysiological | 2013 |
Different effects of dronedarone and amiodarone on pulmonary vein electrophysiology, mechanical properties and H2O2-induced arrhythmogenicity.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dronedarone; Electrophysiological | 2013 |
[First unilateral, later bilateral optic neuropathy. Amiodarone as the cause?].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blindness; Dose-Response Relationshi | 2002 |
[First unilateral, later bilateral optic neuropathy. Amiodarone as the cause?].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blindness; Dose-Response Relationshi | 2002 |
Comparison of the in vivo electrophysiological and proarrhythmic effects of amiodarone with those of a selective class III drug, sematilide, using a canine chronic atrioventricular block model.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disease; Dogs; Dose-Respo | 2002 |
Comparison of the in vivo electrophysiological and proarrhythmic effects of amiodarone with those of a selective class III drug, sematilide, using a canine chronic atrioventricular block model.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disease; Dogs; Dose-Respo | 2002 |
Comparison of plasma concentrations for two amiodarone products.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Male; Medical | 2002 |
Comparison of plasma concentrations for two amiodarone products.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Male; Medical | 2002 |
Amiodarone for cardiac arrhythmias. Key management issues for NPs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Databases, Factual; Drug Interactions; Hum | 2001 |
Amiodarone for cardiac arrhythmias. Key management issues for NPs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Databases, Factual; Drug Interactions; Hum | 2001 |
A better control for ICD patients?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Humans | 2002 |
A better control for ICD patients?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Humans | 2002 |
[Arrhythmias after surgery for congenital heart disease].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electroencephalography; Exercise Test; Hea | 2002 |
[Arrhythmias after surgery for congenital heart disease].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electroencephalography; Exercise Test; Hea | 2002 |
[Atrial flutter with 1/1 nodo-ventricular conduction with amiodarone. From physiopathology to diagnosis].
Topics: Administration, Oral; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial | 2002 |
[Atrial flutter with 1/1 nodo-ventricular conduction with amiodarone. From physiopathology to diagnosis].
Topics: Administration, Oral; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial | 2002 |
Amiodarone-induced postrepolarization refractoriness suppresses induction of ventricular fibrillation.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models | 2003 |
Amiodarone-induced postrepolarization refractoriness suppresses induction of ventricular fibrillation.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models | 2003 |
Is prophylaxis the best use of the ICD? Response to the letter to the editor (Sharma et al.).
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Humans; Rando | 2003 |
Is prophylaxis the best use of the ICD? Response to the letter to the editor (Sharma et al.).
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Humans; Rando | 2003 |
Improved survival of cardiac transplantation candidates with implantable cardioverter defibrillator therapy: role of beta-blocker or amiodarone treatment.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardio | 2003 |
Improved survival of cardiac transplantation candidates with implantable cardioverter defibrillator therapy: role of beta-blocker or amiodarone treatment.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardio | 2003 |
A bridge, but to where?
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopath | 2003 |
A bridge, but to where?
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopath | 2003 |
[Anti-arrhythmic therapy: diagnostic possibilities of signal-averaged electrocardiography and heart rate variability].
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Data I | 2003 |
[Anti-arrhythmic therapy: diagnostic possibilities of signal-averaged electrocardiography and heart rate variability].
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Data I | 2003 |
[Effect of drug therapy on frequency of adequate discharges of implanted cardioverter defibrillator].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Chann | 2003 |
[Effect of drug therapy on frequency of adequate discharges of implanted cardioverter defibrillator].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Chann | 2003 |
Effect of two new PBN-derived phosphorylated nitrones against postischaemic ventricular dysrhythmias.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cyclic N-Oxides; Dose-Response Re | 2003 |
Effect of two new PBN-derived phosphorylated nitrones against postischaemic ventricular dysrhythmias.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cyclic N-Oxides; Dose-Response Re | 2003 |
[Effect of cordaron on systolic and diastolic functions of the left ventricle in patients with a mixed form of chronic low cardiac output and cardiac arrhythmias].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Ou | 2003 |
[Effect of cordaron on systolic and diastolic functions of the left ventricle in patients with a mixed form of chronic low cardiac output and cardiac arrhythmias].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Ou | 2003 |
Living with amiodarone. The story behind this effective heart-rhythm drug, the way it acts in the body, and even its side effects are on the strange side. Understanding its idiosyncrasies can help you use it safely.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Communication; Humans; Physician-Patient R | 2003 |
Living with amiodarone. The story behind this effective heart-rhythm drug, the way it acts in the body, and even its side effects are on the strange side. Understanding its idiosyncrasies can help you use it safely.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Communication; Humans; Physician-Patient R | 2003 |
[The development and clinical testing of antiarrhythmia drugs of a new chemical class].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac | 2003 |
[The development and clinical testing of antiarrhythmia drugs of a new chemical class].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac | 2003 |
[Progress in the clinical use of anti-arrhythmic drugs (I)].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Clinical Trials as Topic; Humans; H | 2003 |
[Progress in the clinical use of anti-arrhythmic drugs (I)].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Clinical Trials as Topic; Humans; H | 2003 |
[Correction of rate and structure of ventricular rhythm in permanent atrial fibrillation: a novel pathogenetic approach].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Digoxin; Electrocardi | 2004 |
[Correction of rate and structure of ventricular rhythm in permanent atrial fibrillation: a novel pathogenetic approach].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Digoxin; Electrocardi | 2004 |
Use of population modeling to define rational monitoring of amiodarone hepatic effects.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Biomarkers; Chemical and Drug Induce | 2004 |
Use of population modeling to define rational monitoring of amiodarone hepatic effects.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Biomarkers; Chemical and Drug Induce | 2004 |
Clinical trials of prophylactic implantable defibrillator therapy in patients with nonischemic cardiomyopathy: what have we learned and what can we expect from future trials?
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia A | 2003 |
Clinical trials of prophylactic implantable defibrillator therapy in patients with nonischemic cardiomyopathy: what have we learned and what can we expect from future trials?
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia A | 2003 |
Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flutter.
Topics: Age Factors; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atri | 2004 |
Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flutter.
Topics: Age Factors; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atri | 2004 |
Several new considerations in mitral valve repair.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Chordae | 2004 |
Several new considerations in mitral valve repair.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Chordae | 2004 |
Different predictive values of electrophysiological testing and autonomic assessment in patients surviving a sustained arrhythmic episode.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Baroreflex; D | 2004 |
Different predictive values of electrophysiological testing and autonomic assessment in patients surviving a sustained arrhythmic episode.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Baroreflex; D | 2004 |
Randomized clinical trials: how long should they last?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cost-Benefit Analysis; Death, Sudden, Card | 2004 |
Randomized clinical trials: how long should they last?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cost-Benefit Analysis; Death, Sudden, Card | 2004 |
[Pacemaker syndrome in the absence of artificial pacemaker (pseudopacemaker syndrome)].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Diagnosis, Differential; Echocar | 2004 |
[Pacemaker syndrome in the absence of artificial pacemaker (pseudopacemaker syndrome)].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Diagnosis, Differential; Echocar | 2004 |
[Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti | 2004 |
[Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti | 2004 |
Surgical management of amiodarone-associated thyrotoxicosis: Mayo Clinic experience.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Fatal Outc | 2004 |
Surgical management of amiodarone-associated thyrotoxicosis: Mayo Clinic experience.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Fatal Outc | 2004 |
[Comparison of the anti-arrhythmic effects of matrine and berbamine with amiodarone and RP58866].
Topics: Aconitine; Alkaloids; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzylisoqu | 2004 |
[Comparison of the anti-arrhythmic effects of matrine and berbamine with amiodarone and RP58866].
Topics: Aconitine; Alkaloids; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzylisoqu | 2004 |
[The specific features of thyrotoxicosis and euthyroid hyperthyroxinemia developed due to the use of cordarone].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Autoantibodies; Blood Flow Velocity; Elect | 2004 |
[The specific features of thyrotoxicosis and euthyroid hyperthyroxinemia developed due to the use of cordarone].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Autoantibodies; Blood Flow Velocity; Elect | 2004 |
Antiarrhythmic properties of a prior oral loading of amiodarone in in vivo canine coronary ligation/reperfusion-induced arrhythmia model: comparison with other class III antiarrhythmic drugs.
Topics: Administration, Oral; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Ve | 2005 |
Antiarrhythmic properties of a prior oral loading of amiodarone in in vivo canine coronary ligation/reperfusion-induced arrhythmia model: comparison with other class III antiarrhythmic drugs.
Topics: Administration, Oral; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Ve | 2005 |
Usefulness of ventricular repolarization dynamicity in predicting arrhythmic deaths in patients with ischemic cardiomyopathy (from the European Myocardial Infarct Amiodarone Trial).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Death; Electrocard | 2005 |
Usefulness of ventricular repolarization dynamicity in predicting arrhythmic deaths in patients with ischemic cardiomyopathy (from the European Myocardial Infarct Amiodarone Trial).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Death; Electrocard | 2005 |
Endothelin-1 gene polymorphism in patients with malignant arrhythmias.
Topics: Aged; Amino Acid Sequence; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, | 2004 |
Endothelin-1 gene polymorphism in patients with malignant arrhythmias.
Topics: Aged; Amino Acid Sequence; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, | 2004 |
[Dermatological adverse reactions of amiodarone].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac | 2005 |
[Dermatological adverse reactions of amiodarone].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac | 2005 |
[Possibility of differentiated treatment of ventricular heart rate disturbances based on mechanism of their development].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Sotalol; Ventricular Dysfunction | 2005 |
[Possibility of differentiated treatment of ventricular heart rate disturbances based on mechanism of their development].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Sotalol; Ventricular Dysfunction | 2005 |
Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Combined Moda | 2005 |
Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Combined Moda | 2005 |
Safe and effective pharmacologic management of arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Flecainide; Humans; P | 2005 |
Safe and effective pharmacologic management of arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Flecainide; Humans; P | 2005 |
Summaries for patients. Potential benefits of amiodarone for patients undergoing open-heart surgery.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardi | 2005 |
Summaries for patients. Potential benefits of amiodarone for patients undergoing open-heart surgery.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardi | 2005 |
[Establishment of a novel arrhythmia model in rats].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Disease Models, | 2005 |
[Establishment of a novel arrhythmia model in rats].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Disease Models, | 2005 |
Tolvaptan administration does not affect steady state amiodarone concentrations in patients with cardiac arrhythmias.
Topics: Aged; Aged, 80 and over; Amiodarone; Antidiuretic Hormone Receptor Antagonists; Arrhythmias, Cardiac | 2005 |
Tolvaptan administration does not affect steady state amiodarone concentrations in patients with cardiac arrhythmias.
Topics: Aged; Aged, 80 and over; Amiodarone; Antidiuretic Hormone Receptor Antagonists; Arrhythmias, Cardiac | 2005 |
Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Hu | 2004 |
Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Hu | 2004 |
Prophylaxis against postoperative atrial fibrillation: current progress and future directions.
Topics: Adrenergic beta-Antagonists; Amiodarone; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Humans; | 2005 |
Prophylaxis against postoperative atrial fibrillation: current progress and future directions.
Topics: Adrenergic beta-Antagonists; Amiodarone; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Humans; | 2005 |
Localized sources maintaining atrial fibrillation organized by prior ablation.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Body Surface Potential Mapping; Cathete | 2006 |
Localized sources maintaining atrial fibrillation organized by prior ablation.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Body Surface Potential Mapping; Cathete | 2006 |
Clinical significance of the electrophysiologic study (EPS)-guided therapy for the secondary prevention of ventricular tachycardia.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catheter Ablation; Defibrilla | 2006 |
Clinical significance of the electrophysiologic study (EPS)-guided therapy for the secondary prevention of ventricular tachycardia.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catheter Ablation; Defibrilla | 2006 |
[Ocular manifestation in amiodarone toxicity--case report].
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chorioretinitis; Female | 2005 |
[Ocular manifestation in amiodarone toxicity--case report].
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chorioretinitis; Female | 2005 |
[Diagnostics, treatment, and prevention of iatrogenic iodine-induced thyroid gland diseases].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Follow-Up Studies; Humans; Iatroge | 2006 |
[Diagnostics, treatment, and prevention of iatrogenic iodine-induced thyroid gland diseases].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Follow-Up Studies; Humans; Iatroge | 2006 |
Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Female; Goiter, Nodular; Graves Disease; Humans; Male | 2006 |
Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Female; Goiter, Nodular; Graves Disease; Humans; Male | 2006 |
Drug-induced T wave alternans.
Topics: Amiodarone; Anti-Arrhythmia Agents; Aortic Diseases; Arrhythmias, Cardiac; Atrial Fibrillation; Elec | 2006 |
Drug-induced T wave alternans.
Topics: Amiodarone; Anti-Arrhythmia Agents; Aortic Diseases; Arrhythmias, Cardiac; Atrial Fibrillation; Elec | 2006 |
Monitoring the use of amiodarone: compliance with guidelines.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Monitoring; Female; Guideline A | 2006 |
Monitoring the use of amiodarone: compliance with guidelines.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Monitoring; Female; Guideline A | 2006 |
Pro-arrhythmic effects of amiodarone and concomitant rate-control medication.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Arrhythmia | 2006 |
Pro-arrhythmic effects of amiodarone and concomitant rate-control medication.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Arrhythmia | 2006 |
The utility of implantable loop recorders for diagnosing unexplained syncope in 100 consecutive patients: five-year, single-center experience.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia | 2006 |
The utility of implantable loop recorders for diagnosing unexplained syncope in 100 consecutive patients: five-year, single-center experience.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia | 2006 |
Amiodarone therapy in patients implanted with cardioverter-defibrillator for life-threatening ventricular arrhythmias.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia | 2006 |
Amiodarone therapy in patients implanted with cardioverter-defibrillator for life-threatening ventricular arrhythmias.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia | 2006 |
Unmasking of the Brugada syndrome phenotype during the acute phase of amiodarone infusion.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Electrocardiography; | 2006 |
Unmasking of the Brugada syndrome phenotype during the acute phase of amiodarone infusion.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Electrocardiography; | 2006 |
Amiodarone induced skin necrosis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Eruptions; Humans; Male; Middle Aged; | 2006 |
Amiodarone induced skin necrosis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Eruptions; Humans; Male; Middle Aged; | 2006 |
Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Arrhythmias, Cardiac; Drug Administration Sc | 2006 |
Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Arrhythmias, Cardiac; Drug Administration Sc | 2006 |
A history of heart failure predicts arrhythmia treatment efficacy: data from the Antiarrythmics versus Implantable Defibrillators (AVID) study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Female; | 2006 |
A history of heart failure predicts arrhythmia treatment efficacy: data from the Antiarrythmics versus Implantable Defibrillators (AVID) study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Female; | 2006 |
QT prolongation due to aortic aneurysm rupture and amiodarone in a patient with a H558R polymorphism in the cardiac sodium channel gene SCN5A.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Aortic Aneurysm, Abdominal; Aortic Rupture; Arrhythmias, C | 2006 |
QT prolongation due to aortic aneurysm rupture and amiodarone in a patient with a H558R polymorphism in the cardiac sodium channel gene SCN5A.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Aortic Aneurysm, Abdominal; Aortic Rupture; Arrhythmias, C | 2006 |
[Amiodaron effects on atrioventricular conduction].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bundle of His; Coronary Disease; Dose-Resp | 2006 |
[Amiodaron effects on atrioventricular conduction].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bundle of His; Coronary Disease; Dose-Resp | 2006 |
Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case-control study.
Topics: Adult; Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillat | 2007 |
Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case-control study.
Topics: Adult; Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillat | 2007 |
Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study.
Topics: Aged; Amiodarone; Anesthesia, Local; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Autonomic Nerve B | 2007 |
Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study.
Topics: Aged; Amiodarone; Anesthesia, Local; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Autonomic Nerve B | 2007 |
Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Defibrillators, I | 2006 |
Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Defibrillators, I | 2006 |
Antiarrhythmic activity of a membrane-protecting agent Sal'magin in rats with aconitine-induced arrhythmias.
Topics: Aconitine; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Male; Rats; Sa | 2006 |
Antiarrhythmic activity of a membrane-protecting agent Sal'magin in rats with aconitine-induced arrhythmias.
Topics: Aconitine; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Male; Rats; Sa | 2006 |
Comparison of noncontact and electroanatomic mapping to identify scar and arrhythmia late after the Fontan procedure.
Topics: Adolescent; Adult; Aging; Amiodarone; Arrhythmias, Cardiac; Atrial Function, Right; Cardiac Catheter | 2007 |
Comparison of noncontact and electroanatomic mapping to identify scar and arrhythmia late after the Fontan procedure.
Topics: Adolescent; Adult; Aging; Amiodarone; Arrhythmias, Cardiac; Atrial Function, Right; Cardiac Catheter | 2007 |
Amiodarone and ischemic optic neuropathy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Optic Neuropathy, Ischemic; Risk F | 2007 |
Amiodarone and ischemic optic neuropathy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Optic Neuropathy, Ischemic; Risk F | 2007 |
Amiodarone and cardiac surgery.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Surgical Pro | 2007 |
Amiodarone and cardiac surgery.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Surgical Pro | 2007 |
Simulation of cardiac hypopolarization arrhythmias and evaluation of cardiomyocyte membrane hypopolarization in experimental animals.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrioventricular Node; Blood Pres | 2006 |
Simulation of cardiac hypopolarization arrhythmias and evaluation of cardiomyocyte membrane hypopolarization in experimental animals.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrioventricular Node; Blood Pres | 2006 |
Prevention of atrial fibrillation with moderate doses of amiodarone in the postoperative period of cardiac surgery is safe and effective in patients with high risk for developing this arrhythmia.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillati | 2007 |
Prevention of atrial fibrillation with moderate doses of amiodarone in the postoperative period of cardiac surgery is safe and effective in patients with high risk for developing this arrhythmia.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillati | 2007 |
Augmentation of late sodium current unmasks the proarrhythmic effects of amiodarone.
Topics: Action Potentials; Amiodarone; Animals; Arrhythmias, Cardiac; Cnidarian Venoms; Dose-Response Relati | 2008 |
Augmentation of late sodium current unmasks the proarrhythmic effects of amiodarone.
Topics: Action Potentials; Amiodarone; Animals; Arrhythmias, Cardiac; Cnidarian Venoms; Dose-Response Relati | 2008 |
Use of amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Risk | 2007 |
Use of amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Risk | 2007 |
Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia | 2008 |
Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia | 2008 |
ICD patients with elevated defibrillation threshold: clinical behavior and therapeutic alternatives.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Defibrillators, Im | 2008 |
ICD patients with elevated defibrillation threshold: clinical behavior and therapeutic alternatives.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Defibrillators, Im | 2008 |
Differential diagnosis and appropriate treatment of four thyrotoxic patients with Graves' disease required to take amiodarone due to life-threatening arrhythmia.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Arrhythmias, Cardiac; Diagnosis, Diff | 2008 |
Differential diagnosis and appropriate treatment of four thyrotoxic patients with Graves' disease required to take amiodarone due to life-threatening arrhythmia.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Arrhythmias, Cardiac; Diagnosis, Diff | 2008 |
Characteristics of the amiodarone-warfarin interaction during long-term follow-up.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Arrhythmias, Cardiac; Dose-Response | 2008 |
Characteristics of the amiodarone-warfarin interaction during long-term follow-up.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Arrhythmias, Cardiac; Dose-Response | 2008 |
New drugs in the management of ventricular arrhythmias.
Topics: Acecainide; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneac | 1984 |
New drugs in the management of ventricular arrhythmias.
Topics: Acecainide; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneac | 1984 |
Amiodarone pulmonary toxicity.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Therapy, Combination; Heart Ventricles; Humans; | 1984 |
Amiodarone pulmonary toxicity.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Therapy, Combination; Heart Ventricles; Humans; | 1984 |
Drugs and the heart. IV. Antiarrhythmic agents.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Br | 1980 |
Drugs and the heart. IV. Antiarrhythmic agents.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Br | 1980 |
[Effects of anti-arrhythmia agents on heart rate. Significance and importance].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibril | 1981 |
[Effects of anti-arrhythmia agents on heart rate. Significance and importance].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibril | 1981 |
Dangerous interaction between amiodarone and quinidine.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Interactions; Drug Therapy, Combination; Electro | 1982 |
Dangerous interaction between amiodarone and quinidine.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Interactions; Drug Therapy, Combination; Electro | 1982 |
Ventricular ectopy: etiology, evaluation, and therapy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Aprindine; Arrhyth | 1982 |
Ventricular ectopy: etiology, evaluation, and therapy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Aprindine; Arrhyth | 1982 |
Safe treatment of resistant ventricular arrhythmias with a combination of amiodarone and quinidine or mexiletine.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Therapy, Combination; Female; Heart | 1983 |
Safe treatment of resistant ventricular arrhythmias with a combination of amiodarone and quinidine or mexiletine.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Therapy, Combination; Female; Heart | 1983 |
Amiodarone--when and for whom?
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans | 1983 |
Amiodarone--when and for whom?
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans | 1983 |
Amiodarone and lung function.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Pneumonia | 1983 |
Amiodarone and lung function.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Pneumonia | 1983 |
[Treatment of parasystole and the problems of diagnosis of parasystole of the interlinked type].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Diagn | 1980 |
[Treatment of parasystole and the problems of diagnosis of parasystole of the interlinked type].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Diagn | 1980 |
[Effect of amiodarone on ventricular arrhythmias evaluated by serial exercise testing (author's transl)].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Complexes, Premature; Exercise T | 1981 |
[Effect of amiodarone on ventricular arrhythmias evaluated by serial exercise testing (author's transl)].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Complexes, Premature; Exercise T | 1981 |
[Is the revival of amiodarone (cordarone) justified? Testing of its anti-arrhythmic effect with long-term (24 hrs.) electrocardiography].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Complexes, Premature; Electrocar | 1981 |
[Is the revival of amiodarone (cordarone) justified? Testing of its anti-arrhythmic effect with long-term (24 hrs.) electrocardiography].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Complexes, Premature; Electrocar | 1981 |
[Drug therapy of arrhythmia in coronary cardiopathy].
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Cardiac Comp | 1983 |
[Drug therapy of arrhythmia in coronary cardiopathy].
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Cardiac Comp | 1983 |
The electrophysiologic basis for the use of amiodarone for treatment of cardiac arrhythmias.
Topics: Action Potentials; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Dogs; Electrocardiography | 1983 |
The electrophysiologic basis for the use of amiodarone for treatment of cardiac arrhythmias.
Topics: Action Potentials; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Dogs; Electrocardiography | 1983 |
The use of amiodarone in children.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Benzofurans; Bundle-Branch Bl | 1983 |
The use of amiodarone in children.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Benzofurans; Bundle-Branch Bl | 1983 |
The clinical results of amiodarone in cardiac arrhythmias: optimal dosing.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Drug; Heart Conduction Sy | 1984 |
The clinical results of amiodarone in cardiac arrhythmias: optimal dosing.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Drug; Heart Conduction Sy | 1984 |
European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillati | 1984 |
European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillati | 1984 |
[Cellular effects of anti-arrhythmia drugs. Their predictive value of therapeutic effects].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catecholamines; Electrolytes; Hea | 1981 |
[Cellular effects of anti-arrhythmia drugs. Their predictive value of therapeutic effects].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catecholamines; Electrolytes; Hea | 1981 |
Side effects of long-term amiodarone therapy.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Dose-Response Relation | 1983 |
Side effects of long-term amiodarone therapy.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Dose-Response Relation | 1983 |
Amiodarone neuropathy.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle Aged; Nervous Syst | 1983 |
Amiodarone neuropathy.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle Aged; Nervous Syst | 1983 |
Neuropathy and fatal hepatitis in a patient receiving amiodarone.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Chemical and Drug Induced Liver Injury; Humans; | 1984 |
Neuropathy and fatal hepatitis in a patient receiving amiodarone.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Chemical and Drug Induced Liver Injury; Humans; | 1984 |
Adverse reactions during treatment with amiodarone hydrochloride.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Digoxin; Drug Interactions; Female; Huma | 1983 |
Adverse reactions during treatment with amiodarone hydrochloride.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Digoxin; Drug Interactions; Female; Huma | 1983 |
Adverse reactions during treatment with amiodarone hydrochloride.
Topics: Alopecia; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Middle Aged | 1983 |
Adverse reactions during treatment with amiodarone hydrochloride.
Topics: Alopecia; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Middle Aged | 1983 |
Amiodarone and thyroid function: clinical implications during antiarrhythmic therapy.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Hyperthyroidism; Hypothyroidism; Iodides; Mal | 1983 |
Amiodarone and thyroid function: clinical implications during antiarrhythmic therapy.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Hyperthyroidism; Hypothyroidism; Iodides; Mal | 1983 |
[Control of anti-arrhythmia therapy with amiodarone. Value of the determination of blood levels].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Erythrocytes; Humans; Long-Term Care; Mi | 1984 |
[Control of anti-arrhythmia therapy with amiodarone. Value of the determination of blood levels].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Erythrocytes; Humans; Long-Term Care; Mi | 1984 |
Effect of amiodarone on thyroid hormone economy.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Hyperthyroidism; Hypothy | 1984 |
Effect of amiodarone on thyroid hormone economy.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Hyperthyroidism; Hypothy | 1984 |
Nursing care for survivors of sudden cardiac death.
Topics: Adaptation, Psychological; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Arrest; H | 1984 |
Nursing care for survivors of sudden cardiac death.
Topics: Adaptation, Psychological; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Arrest; H | 1984 |
[Amiodarone-flecainide combination in the treatment of severe ventricular arrhythmia].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Drug Therapy, Combination; Fl | 1984 |
[Amiodarone-flecainide combination in the treatment of severe ventricular arrhythmia].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Drug Therapy, Combination; Fl | 1984 |
Worsening of arrhythmias during pharmacological treatment.
Topics: Adolescent; Adult; Aged; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzene | 1984 |
Worsening of arrhythmias during pharmacological treatment.
Topics: Adolescent; Adult; Aged; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzene | 1984 |
Drug therapy of cardiac arrhythmias.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Biological Availabili | 1983 |
Drug therapy of cardiac arrhythmias.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Biological Availabili | 1983 |
Antiarrhythmic actions of amiodarone.
Topics: Adult; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Dose-Response Relat | 1982 |
Antiarrhythmic actions of amiodarone.
Topics: Adult; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Dose-Response Relat | 1982 |
[Amiodarone in the treatment of dysrhythmia].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle Aged | 1984 |
[Amiodarone in the treatment of dysrhythmia].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle Aged | 1984 |
Hemodynamic effects of intravenous amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Blood Pressure; Cardiac Output; Female; Hemodynamics; | 1984 |
Hemodynamic effects of intravenous amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Blood Pressure; Cardiac Output; Female; Hemodynamics; | 1984 |
[Usefulness of the reverse T3 (rT3) determination in patients under chronic treatment with amiodarone].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle Aged; Thyro | 1984 |
[Usefulness of the reverse T3 (rT3) determination in patients under chronic treatment with amiodarone].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle Aged; Thyro | 1984 |
[Thyroid functional parameters during anti-arrhythmia therapy with amiodarone].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Hyperthyroid | 1984 |
[Thyroid functional parameters during anti-arrhythmia therapy with amiodarone].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Hyperthyroid | 1984 |
Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Drug; Female | 1984 |
Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Drug; Female | 1984 |
Atrial parasystole and amiodarone.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Female; Heart Atria; Huma | 1984 |
Atrial parasystole and amiodarone.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Female; Heart Atria; Huma | 1984 |
Electrophysiologic effects of amiodarone: experimental and clinical observation relative to serum and tissue drug concentrations.
Topics: Action Potentials; Aged; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Electrocardiography | 1984 |
Electrophysiologic effects of amiodarone: experimental and clinical observation relative to serum and tissue drug concentrations.
Topics: Action Potentials; Aged; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Electrocardiography | 1984 |
Advances in the management of cardiac arrhythmias in children.
Topics: Adolescent; Adult; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Pa | 1984 |
Advances in the management of cardiac arrhythmias in children.
Topics: Adolescent; Adult; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Pa | 1984 |
Effect of amiodarone on ventricular function as measured by gated radionuclide angiography.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Output; Female; Heart; Heart Diseases; | 1984 |
Effect of amiodarone on ventricular function as measured by gated radionuclide angiography.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Output; Female; Heart; Heart Diseases; | 1984 |
Amiodarone photosensitivity.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Erythema; Humans; Male; Photosensitivity Disord | 1984 |
Amiodarone photosensitivity.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Erythema; Humans; Male; Photosensitivity Disord | 1984 |
Side effects during therapy with low dosage amiodarone.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Female; Humans; Male; | 1984 |
Side effects during therapy with low dosage amiodarone.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Female; Humans; Male; | 1984 |
[Pneumonitis due to amiodarone].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Drug; Humans; Male | 1984 |
[Pneumonitis due to amiodarone].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Drug; Humans; Male | 1984 |
Hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Central Ve | 1984 |
Hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Central Ve | 1984 |
[Antiarrhythmic effect and side effects of amiodarone].
Topics: Adult; Aged; Airway Resistance; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cornea; Corneal Opaci | 1984 |
[Antiarrhythmic effect and side effects of amiodarone].
Topics: Adult; Aged; Airway Resistance; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cornea; Corneal Opaci | 1984 |
[Clinical efficacy of intravenous amiodarone in the treatment of cardiac arrhythmia].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Injections, | 1984 |
[Clinical efficacy of intravenous amiodarone in the treatment of cardiac arrhythmia].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Injections, | 1984 |
[Amiodarone in the long-term treatment of arrhythmia].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Follow-Up Studies; Heart Rate; Humans; M | 1984 |
[Amiodarone in the long-term treatment of arrhythmia].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Follow-Up Studies; Heart Rate; Humans; M | 1984 |
Amiodarone keratopathy.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Dose-Response Relationship, D | 1984 |
Amiodarone keratopathy.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Dose-Response Relationship, D | 1984 |
[Pharmacological and clinical research on the interaction of digitalis and amiodarone in heart disease patients with varying degrees of cardiac insufficiency].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Digitalis Glycosides; Digoxin; Drug Inte | 1984 |
[Pharmacological and clinical research on the interaction of digitalis and amiodarone in heart disease patients with varying degrees of cardiac insufficiency].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Digitalis Glycosides; Digoxin; Drug Inte | 1984 |
Amiodarone: a new drug for the treatment of cardiac arrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Tachycardia | 1984 |
Amiodarone: a new drug for the treatment of cardiac arrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Tachycardia | 1984 |
Amiodarone for long-term management of patients with hypertrophic cardiomyopathy.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Cardiom | 1984 |
Amiodarone for long-term management of patients with hypertrophic cardiomyopathy.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Cardiom | 1984 |
Amiodarone: clinical consideration.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Humans | 1984 |
Amiodarone: clinical consideration.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Humans | 1984 |
Amiodarone--a drug for all seasons?
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans | 1983 |
Amiodarone--a drug for all seasons?
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans | 1983 |
Amiodarone therapy for life threatening or refractory cardiac arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Kinetics; Ma | 1983 |
Amiodarone therapy for life threatening or refractory cardiac arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Kinetics; Ma | 1983 |
Amiodarone keratopathy.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Opacity; Humans | 1984 |
Amiodarone keratopathy.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Opacity; Humans | 1984 |
Amiodarone: basic concepts and clinical applications. May 9-10, 1983 Bethesda, Maryland.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans | 1983 |
Amiodarone: basic concepts and clinical applications. May 9-10, 1983 Bethesda, Maryland.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans | 1983 |
Hemodynamic effects of intravenous amiodarone in patients with depressed left ventricular function and recurrent ventricular tachycardia.
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Blood Pressure; Cardiac Output; | 1983 |
Hemodynamic effects of intravenous amiodarone in patients with depressed left ventricular function and recurrent ventricular tachycardia.
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Blood Pressure; Cardiac Output; | 1983 |
Efficacy of amiodarone for refractory supraventricular tachyarrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillati | 1983 |
Efficacy of amiodarone for refractory supraventricular tachyarrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillati | 1983 |
Ventricular arrhythmias: use of electrophysiologic studies.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Electrophysiology; | 1983 |
Ventricular arrhythmias: use of electrophysiologic studies.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Electrophysiology; | 1983 |
Control of sudden recurrent arrhythmic deaths: role of amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Electric Stimulation; Electro | 1983 |
Control of sudden recurrent arrhythmic deaths: role of amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Electric Stimulation; Electro | 1983 |
Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Drug | 1983 |
Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Drug | 1983 |
Efficacy and safety of long-term amiodarone in treatment of cardiac arrhythmias: dosage experience.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Blood Coagulation Disorders; | 1983 |
Efficacy and safety of long-term amiodarone in treatment of cardiac arrhythmias: dosage experience.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Blood Coagulation Disorders; | 1983 |
Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long-term follow-up.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Digoxin; Dose-Response Relationship, Drug; Drug | 1983 |
Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long-term follow-up.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Digoxin; Dose-Response Relationship, Drug; Drug | 1983 |
Amiodarone dosing: a proposal based on its pharmacokinetics.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Half-Life; Humans; Kinetics; Models, Biological | 1983 |
Amiodarone dosing: a proposal based on its pharmacokinetics.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Half-Life; Humans; Kinetics; Models, Biological | 1983 |
Ten years of experience with amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Chagas Cardiomyopathy; Dose-Resp | 1983 |
Ten years of experience with amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Chagas Cardiomyopathy; Dose-Resp | 1983 |
Renal elimination of amiodarone and its desethyl metabolite.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Kidney; Kidney Failure, Chronic; Male | 1983 |
Renal elimination of amiodarone and its desethyl metabolite.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Kidney; Kidney Failure, Chronic; Male | 1983 |
Amiodarone in the treatment of patients with resistant arrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans | 1983 |
Amiodarone in the treatment of patients with resistant arrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans | 1983 |
[Changes in thyroid function during anti-arrhythmia therapy with amiodaron].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Hyperthyroidism | 1983 |
[Changes in thyroid function during anti-arrhythmia therapy with amiodaron].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Hyperthyroidism | 1983 |
[Influence of treatment with amiodarone in response to electric cardioversion in patients with complete arrhythmia caused by auricular fibrillation].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Electric Countersho | 1983 |
[Influence of treatment with amiodarone in response to electric cardioversion in patients with complete arrhythmia caused by auricular fibrillation].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Electric Countersho | 1983 |
[Intravenous amiodarone in supraventricular and ventricular hyperkinetic arrhythmias. Experience in 60 cases].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Electrocardiography; | 1983 |
[Intravenous amiodarone in supraventricular and ventricular hyperkinetic arrhythmias. Experience in 60 cases].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Electrocardiography; | 1983 |
[Amiodarone, a new anti-arrhythmia agent in arrhythmia associated with myocardial infarct].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Middle Aged; Myocardial Infarction | 1983 |
[Amiodarone, a new anti-arrhythmia agent in arrhythmia associated with myocardial infarct].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Middle Aged; Myocardial Infarction | 1983 |
[Clinical observation on 341 patients with arrhythmia treated with amiodarone].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Electrocardiography; | 1983 |
[Clinical observation on 341 patients with arrhythmia treated with amiodarone].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Electrocardiography; | 1983 |
Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Digitalis Glycosides; Drug Interact | 1983 |
Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Digitalis Glycosides; Drug Interact | 1983 |
Arrhythmia and prognosis in hypertrophic cardiomyopathy.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Death, Sudden; | 1983 |
Arrhythmia and prognosis in hypertrophic cardiomyopathy.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Death, Sudden; | 1983 |
[Amiodarone in the acute treatment of hyperkinetic arrhythmias in cardiosurgery].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Evaluation; Female; Heart Diseases; | 1983 |
[Amiodarone in the acute treatment of hyperkinetic arrhythmias in cardiosurgery].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Evaluation; Female; Heart Diseases; | 1983 |
Problems of antiarrhythmic treatment in children.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Electrocardiography; Humans; Propaf | 1983 |
Problems of antiarrhythmic treatment in children.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Electrocardiography; Humans; Propaf | 1983 |
Replacement of amiodarone by sotalol for repetitive ventricular premature beats.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle Aged; Myocardial I | 1984 |
Replacement of amiodarone by sotalol for repetitive ventricular premature beats.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle Aged; Myocardial I | 1984 |
Possible recurrence of amiodarone pulmonary toxicity following corticosteroid therapy.
Topics: Adrenal Cortex Hormones; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Biopsy; Humans; Lung; Male; | 1984 |
Possible recurrence of amiodarone pulmonary toxicity following corticosteroid therapy.
Topics: Adrenal Cortex Hormones; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Biopsy; Humans; Lung; Male; | 1984 |
Prognosis after sudden cardiac death without associated myocardial infarction: one year follow-up of empiric therapy with amiodarone.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Death, Sudden; Dose-Response Relationshi | 1984 |
Prognosis after sudden cardiac death without associated myocardial infarction: one year follow-up of empiric therapy with amiodarone.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Death, Sudden; Dose-Response Relationshi | 1984 |
Amiodarone-induced ventricular tachyarrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Heart Ventricles; Humans; Middle Aged | 1984 |
Amiodarone-induced ventricular tachyarrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Heart Ventricles; Humans; Middle Aged | 1984 |
Clinical evaluation of the efficacy of oral amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Drug; Humans | 1984 |
Clinical evaluation of the efficacy of oral amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Drug; Humans | 1984 |
Efficacy of amiodarone during long-term treatment of potentially dangerous ventricular arrhythmias in patients with chronic stable ischemic heart disease.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Coronary Disease; Electrocardiography; E | 1984 |
Efficacy of amiodarone during long-term treatment of potentially dangerous ventricular arrhythmias in patients with chronic stable ischemic heart disease.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Coronary Disease; Electrocardiography; E | 1984 |
Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Chagas Cardiomyopathy; Chronic Disease; | 1984 |
Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Chagas Cardiomyopathy; Chronic Disease; | 1984 |
Clinical and chemical assessment of thyroid function during therapy with amiodarone.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Hypothyroidism; Male; Mi | 1984 |
Clinical and chemical assessment of thyroid function during therapy with amiodarone.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Hypothyroidism; Male; Mi | 1984 |
[Formation of multiple round foci in the lung during amiodarone therapy].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Lung Diseases; Male; Radiography, Thora | 1984 |
[Formation of multiple round foci in the lung during amiodarone therapy].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Lung Diseases; Male; Radiography, Thora | 1984 |
Effect of amiodarone on serum quinidine and procainamide levels.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Interactions; Female; Humans; Male; | 1984 |
Effect of amiodarone on serum quinidine and procainamide levels.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Interactions; Female; Humans; Male; | 1984 |
[Effect of intravenous amiodarone on electrophysiological characteristics of the human heart].
Topics: Action Potentials; Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Heart Conduction Sy | 1984 |
[Effect of intravenous amiodarone on electrophysiological characteristics of the human heart].
Topics: Action Potentials; Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Heart Conduction Sy | 1984 |
[Complications of long-term treatment with amiodarone].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Female; Humans; Male; Middle | 1984 |
[Complications of long-term treatment with amiodarone].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Female; Humans; Male; Middle | 1984 |
[Use of a nomogram in treating cardiac arrhythmias with cordarone].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; M | 1984 |
[Use of a nomogram in treating cardiac arrhythmias with cordarone].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; M | 1984 |
Suppression of high-grade ventricular ectopic activity by antiarrhythmic drug treatment as a marker for survival in patients with chronic coronary artery disease.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Female; Hum | 1984 |
Suppression of high-grade ventricular ectopic activity by antiarrhythmic drug treatment as a marker for survival in patients with chronic coronary artery disease.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Female; Hum | 1984 |
Functional significance of chronotropic response during chronic amiodarone therapy.
Topics: Adult; Aged; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Blood Pressure; Depression, Che | 1984 |
Functional significance of chronotropic response during chronic amiodarone therapy.
Topics: Adult; Aged; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Blood Pressure; Depression, Che | 1984 |
Amiodarone-digoxin interaction. Clinical and experimental observations.
Topics: Adolescent; Adult; Aged; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Digoxin; Drug Inter | 1984 |
Amiodarone-digoxin interaction. Clinical and experimental observations.
Topics: Adolescent; Adult; Aged; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Digoxin; Drug Inter | 1984 |
Effect of amiodarone on conduction and refractoriness of the His-Purkinje system in the human heart.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Bundle of His; Cardiac Pacing, Artificia | 1984 |
Effect of amiodarone on conduction and refractoriness of the His-Purkinje system in the human heart.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Bundle of His; Cardiac Pacing, Artificia | 1984 |
Amiodarone-induced intra-His block.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Atrioventricular Node; Benzofurans; Bundle of His; Electroca | 1984 |
Amiodarone-induced intra-His block.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Atrioventricular Node; Benzofurans; Bundle of His; Electroca | 1984 |
[Electrophysiological studies on the effect of cordarone].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Atrioventricular Node; Benzofurans; Electrocardiography; Fe | 1984 |
[Electrophysiological studies on the effect of cordarone].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Atrioventricular Node; Benzofurans; Electrocardiography; Fe | 1984 |
Amiodarone hepatotoxicity simulating alcoholic liver disease.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Chemical and Drug Induced Liver Injury; Diagno | 1984 |
Amiodarone hepatotoxicity simulating alcoholic liver disease.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Chemical and Drug Induced Liver Injury; Diagno | 1984 |
Amiodarone--application and clinical pharmacology in atrial fibrillation and other arrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Electrocardiography | 1984 |
Amiodarone--application and clinical pharmacology in atrial fibrillation and other arrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Electrocardiography | 1984 |
[33-year-old patient with severe ventricular heart rhythm disorders].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Cardiomyopathies; Electroencephalography; Heart Failure; He | 1982 |
[33-year-old patient with severe ventricular heart rhythm disorders].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Cardiomyopathies; Electroencephalography; Heart Failure; He | 1982 |
[Amiodarone in the treatment of cardiac rhythm disturbances in children. Apropos of 135 cases].
Topics: Administration, Oral; Adolescent; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Child, Presc | 1980 |
[Amiodarone in the treatment of cardiac rhythm disturbances in children. Apropos of 135 cases].
Topics: Administration, Oral; Adolescent; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Child, Presc | 1980 |
Amiodarone increases plasma digoxin concentrations.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Digoxin; Drug Interactions; Humans | 1981 |
Amiodarone increases plasma digoxin concentrations.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Digoxin; Drug Interactions; Humans | 1981 |
New drugs for treating cardiac arrhythmias.
Topics: Acebutolol; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Encainide | 1981 |
New drugs for treating cardiac arrhythmias.
Topics: Acebutolol; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Encainide | 1981 |
Newer antiarrhythmic drugs.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Humans; Tocainide; Ve | 1981 |
Newer antiarrhythmic drugs.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Humans; Tocainide; Ve | 1981 |
Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Humans; | 1981 |
Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Humans; | 1981 |
Advances in antiarrhythmic therapy. The role of newer antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Atrioventricular Node; Humans; | 1982 |
Advances in antiarrhythmic therapy. The role of newer antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Atrioventricular Node; Humans; | 1982 |
Electrophysiologic testing of antiarrhythmic agents.
Topics: Administration, Oral; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, | 1982 |
Electrophysiologic testing of antiarrhythmic agents.
Topics: Administration, Oral; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, | 1982 |
[Corneal pigmentation due to amiodarone therapy (author's transl)].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Humans; Male; Middle Aged; Pi | 1981 |
[Corneal pigmentation due to amiodarone therapy (author's transl)].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Humans; Male; Middle Aged; Pi | 1981 |
[Clinical observation on ocular complications after administration of amiodarone in control of arrhythmias].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Eye Diseases; Female; Humans; Iodides; M | 1982 |
[Clinical observation on ocular complications after administration of amiodarone in control of arrhythmias].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Eye Diseases; Female; Humans; Iodides; M | 1982 |
Ventricular flutter during treatment with amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Female; Heart Ventricles; Humans | 1983 |
Ventricular flutter during treatment with amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Female; Heart Ventricles; Humans | 1983 |
[Amiodarone (Cordarex) in supraventricular and ventricular arrhythmias refractory to therapy].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Humans | 1983 |
[Amiodarone (Cordarex) in supraventricular and ventricular arrhythmias refractory to therapy].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Humans | 1983 |
Low-dose steroid therapy for prophylaxis of amiodarone-induced pulmonary infiltrates.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Male; Middle Aged; Pneumonia; Prednisone; Pul | 1983 |
Low-dose steroid therapy for prophylaxis of amiodarone-induced pulmonary infiltrates.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Male; Middle Aged; Pneumonia; Prednisone; Pul | 1983 |
[Amiodarone in the treatment of cardiac arrhythmias in children].
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Child, Preschool; Female; Humans; | 1983 |
[Amiodarone in the treatment of cardiac arrhythmias in children].
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Child, Preschool; Female; Humans; | 1983 |
Amiodarone therapy during pregnancy.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Infant, Newborn; Maternal-Feta | 1983 |
Amiodarone therapy during pregnancy.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Infant, Newborn; Maternal-Feta | 1983 |
Amiodarone in refractory life-threatening ventricular arrhythmias.
Topics: Acute Disease; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Fema | 1983 |
Amiodarone in refractory life-threatening ventricular arrhythmias.
Topics: Acute Disease; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Fema | 1983 |
Amiodarone-induced polymorphous ventricular tachycardia.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Pacing, Artificial; Electrocardiography | 1983 |
Amiodarone-induced polymorphous ventricular tachycardia.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Pacing, Artificial; Electrocardiography | 1983 |
[Low-dose amiodarone therapy in the treatment of therapy-refractory complex ventricular arrhythmias].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Evaluation; Drug Resistance; Electr | 1983 |
[Low-dose amiodarone therapy in the treatment of therapy-refractory complex ventricular arrhythmias].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Evaluation; Drug Resistance; Electr | 1983 |
Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Pacing, Artificial; Chromatograp | 1983 |
Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Pacing, Artificial; Chromatograp | 1983 |
Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle Aged; Tachy | 1983 |
Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle Aged; Tachy | 1983 |
The efficacy of amiodarone for ventricular arrhythmias cannot be predicted with clinical electrophysiological studies.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrophysiology; Heart Ventricles; Humans; Tachycar | 1983 |
The efficacy of amiodarone for ventricular arrhythmias cannot be predicted with clinical electrophysiological studies.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrophysiology; Heart Ventricles; Humans; Tachycar | 1983 |
Amiodarone distribution in human tissues after sudden death during Holter recording.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Death, Sudden; Electrocardiography; Humans; Male; Mid | 1983 |
Amiodarone distribution in human tissues after sudden death during Holter recording.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Death, Sudden; Electrocardiography; Humans; Male; Mid | 1983 |
Use of amiodarone in the therapy of primary ventricular arrhythmias in children.
Topics: Adolescent; Age Factors; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Corneal Diseases; Dru | 1983 |
Use of amiodarone in the therapy of primary ventricular arrhythmias in children.
Topics: Adolescent; Age Factors; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Corneal Diseases; Dru | 1983 |
Serum concentrations of amiodarone during long term therapy. Relation to dose, efficacy and toxicity.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Eye Diseases; Female; | 1983 |
Serum concentrations of amiodarone during long term therapy. Relation to dose, efficacy and toxicity.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Eye Diseases; Female; | 1983 |
Amiodarone pneumonitis.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Male; Middle Aged; Pneumonia; Tachycardia | 1983 |
Amiodarone pneumonitis.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Male; Middle Aged; Pneumonia; Tachycardia | 1983 |
Ventricular arrhythmias in congestive cardiomyopathy.
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiomyopathies; Heart Failure; Heart Ventricles; Humans | 1983 |
Ventricular arrhythmias in congestive cardiomyopathy.
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiomyopathies; Heart Failure; Heart Ventricles; Humans | 1983 |
[Clinical pharmacology of anti-arrhythmia agents].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Humans; Lidocaine; Qui | 1983 |
[Clinical pharmacology of anti-arrhythmia agents].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Humans; Lidocaine; Qui | 1983 |
[Highlights from the symposium on the treatment of arrhythmia].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Therapy, Combination; Fe | 1983 |
[Highlights from the symposium on the treatment of arrhythmia].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Therapy, Combination; Fe | 1983 |
[Validity and limits of invasive pharmacological tests in the treatment of malignant ventricular hyperkinetic arrhythmias].
Topics: Adult; Aged; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Evaluation; Fe | 1983 |
[Validity and limits of invasive pharmacological tests in the treatment of malignant ventricular hyperkinetic arrhythmias].
Topics: Adult; Aged; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Evaluation; Fe | 1983 |
Amiodarone in long term management of refractory cardiac tachyarrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Female; Heart Atria | 1981 |
Amiodarone in long term management of refractory cardiac tachyarrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Female; Heart Atria | 1981 |
Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Coronary Disease; Female; Heart Failure; | 1982 |
Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Coronary Disease; Female; Heart Failure; | 1982 |
Programmed ventricular stimulation in predicting vulnerability to ventricular arrhythmias and their response to antiarrhythmic therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Electrocardiog | 1982 |
Programmed ventricular stimulation in predicting vulnerability to ventricular arrhythmias and their response to antiarrhythmic therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Electrocardiog | 1982 |
More on amiodarone for ventricular tachyarrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Digoxin; Drug Interactions; Heart Ventricles; Humans | 1982 |
More on amiodarone for ventricular tachyarrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Digoxin; Drug Interactions; Heart Ventricles; Humans | 1982 |
Amiodarone keratopathy. Correlation to dosage and duration.
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Drug Administ | 1982 |
Amiodarone keratopathy. Correlation to dosage and duration.
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Drug Administ | 1982 |
The potentiation of warfarin anticoagulation by amiodarone.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Blood Coagulation; Blood Coagulation Factors; D | 1982 |
The potentiation of warfarin anticoagulation by amiodarone.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Blood Coagulation; Blood Coagulation Factors; D | 1982 |
Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Electrocardiogra | 1982 |
Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Electrocardiogra | 1982 |
QT and action potential duration.
Topics: Action Potentials; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Heart; Humans | 1982 |
QT and action potential duration.
Topics: Action Potentials; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Heart; Humans | 1982 |
Adverse effects of amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Drug; Humans; Ischemic At | 1982 |
Adverse effects of amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Drug; Humans; Ischemic At | 1982 |
Ocular changes resulting from therapy with amiodarone.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Dose-Response Relation | 1982 |
Ocular changes resulting from therapy with amiodarone.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Dose-Response Relation | 1982 |
Amiodarone--benefits and risks in perspective.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Risk | 1982 |
Amiodarone--benefits and risks in perspective.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Risk | 1982 |
Electrophysiologic effects of chronic amiodarone therapy in patients with ventricular arrhythmias.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Atrioventricular Node; Benzofurans; Bundle of His; Cardiac P | 1982 |
Electrophysiologic effects of chronic amiodarone therapy in patients with ventricular arrhythmias.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Atrioventricular Node; Benzofurans; Bundle of His; Cardiac P | 1982 |
New antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Conduction System; Humans; Mexiletin | 1982 |
New antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Conduction System; Humans; Mexiletin | 1982 |
[Amiodarone: review of its antianginal properties and analysis of side effects].
Topics: Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Coronary Vessels; | 1982 |
[Amiodarone: review of its antianginal properties and analysis of side effects].
Topics: Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Coronary Vessels; | 1982 |
[Harmful interactions of amiodarone and class I anti-arrhythmia agents].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Drug Interaction | 1982 |
[Harmful interactions of amiodarone and class I anti-arrhythmia agents].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Drug Interaction | 1982 |
[Intravenous amiodarone in the treatment of supraventricular arrhythmias: immediate results].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Injections, | 1982 |
[Intravenous amiodarone in the treatment of supraventricular arrhythmias: immediate results].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Injections, | 1982 |
Oral amiodarone in high-risk ventricular arrhythmias.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Coronary Disease; | 1982 |
Oral amiodarone in high-risk ventricular arrhythmias.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Coronary Disease; | 1982 |
Amiodarone--an effective antiarrhythmic agent.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle Aged | 1982 |
Amiodarone--an effective antiarrhythmic agent.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle Aged | 1982 |
[Amiodarone: clinical pharmacology, therapeutic indications and limitations].
Topics: Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Heart; Humans; Membrane Potentials | 1982 |
[Amiodarone: clinical pharmacology, therapeutic indications and limitations].
Topics: Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Heart; Humans; Membrane Potentials | 1982 |
Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiomyopathy, Hypertrophic; Female; Hu | 1981 |
Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiomyopathy, Hypertrophic; Female; Hu | 1981 |
Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle | 1981 |
Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle | 1981 |
[Amiodarone in ventricular arrhythmias of chronic Chagas cardiopathy].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Chagas Cardiomyopathy; Female; Humans; M | 1980 |
[Amiodarone in ventricular arrhythmias of chronic Chagas cardiopathy].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Chagas Cardiomyopathy; Female; Humans; M | 1980 |
[Amiodarone as an antiarrhythmia drug - study using the exercise test].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Exercise Test; Female; Human | 1980 |
[Amiodarone as an antiarrhythmia drug - study using the exercise test].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Exercise Test; Female; Human | 1980 |
[Anti-arrhythmic effect of amiodarone - analysis through quantitative dynamic electrocardiography (the Holter system)].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Female; Heart Rate; Human | 1980 |
[Anti-arrhythmic effect of amiodarone - analysis through quantitative dynamic electrocardiography (the Holter system)].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Female; Heart Rate; Human | 1980 |
Effective management of the long q-t syndrome with amiodarone.
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Heart Ventricles; Hu | 1981 |
Effective management of the long q-t syndrome with amiodarone.
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Heart Ventricles; Hu | 1981 |
[The treatment of arrhythmias with amiodarone].
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Humans; In | 1981 |
[The treatment of arrhythmias with amiodarone].
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Humans; In | 1981 |
Control of refractory life-threatening ventricular tachyarrhythmias by amiodarone.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Electrocardiogra | 1981 |
Control of refractory life-threatening ventricular tachyarrhythmias by amiodarone.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Electrocardiogra | 1981 |
[Amiodarone pigmentation. A rare, but typical drug side-effect].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Drug; Humans; Male | 1981 |
[Amiodarone pigmentation. A rare, but typical drug side-effect].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Drug; Humans; Male | 1981 |
[Effectiveness of amiodarone in the treatment of arrhythmia].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Evaluation; Humans; Mid | 1981 |
[Effectiveness of amiodarone in the treatment of arrhythmia].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Evaluation; Humans; Mid | 1981 |
[Comparison of the effectiveness of amiodarone and quinidine in the prevention of arrhythmia].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Cardiomyopathies; Female; | 1980 |
[Comparison of the effectiveness of amiodarone and quinidine in the prevention of arrhythmia].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Cardiomyopathies; Female; | 1980 |
Amiodarone--a new type of antiarrhythmic drug.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans | 1981 |
Amiodarone--a new type of antiarrhythmic drug.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans | 1981 |
Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Heart Rate; Humans; Male; Middle Aged; Thyroid | 1981 |
Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Heart Rate; Humans; Male; Middle Aged; Thyroid | 1981 |
[Amiodarone and the thyroid gland].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Hyperthyroidism; Hypothy | 1981 |
[Amiodarone and the thyroid gland].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Hyperthyroidism; Hypothy | 1981 |
Amiodarone for ventricular arrhythmias.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Heart; Heart Ventricles; Huma | 1981 |
Amiodarone for ventricular arrhythmias.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Heart; Heart Ventricles; Huma | 1981 |
Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Cardiac Pacing, Artific | 1981 |
Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Cardiac Pacing, Artific | 1981 |
[Prajmalium bitartrate in hyperkinetic ventricular arrhythmias in infarct patients during rehabilitation].
Topics: Adult; Aged; Ajmaline; Ambulatory Care; Amiodarone; Arrhythmias, Cardiac; Drug Therapy, Combination; | 1981 |
[Prajmalium bitartrate in hyperkinetic ventricular arrhythmias in infarct patients during rehabilitation].
Topics: Adult; Aged; Ajmaline; Ambulatory Care; Amiodarone; Arrhythmias, Cardiac; Drug Therapy, Combination; | 1981 |
[Experience with intravenous amiodarone in hyperkinetic supraventricular arrhythmias].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Benzofurans; Fem | 1981 |
[Experience with intravenous amiodarone in hyperkinetic supraventricular arrhythmias].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Benzofurans; Fem | 1981 |
[Longterm effects of amiodarone in supraventricular tachyarrhythmias (author's transl)].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Female; Humans; Longi | 1981 |
[Longterm effects of amiodarone in supraventricular tachyarrhythmias (author's transl)].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Female; Humans; Longi | 1981 |
Antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Therapy, Combination; Humans; Lidocai | 1981 |
Antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Therapy, Combination; Humans; Lidocai | 1981 |
[Another type of interaction between blood levels of digitalis and anti-arrhythmic drugs: digoxin and amiodarone. Experience with long-term therapy].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Digoxin; Drug Interactions; Female; Humans; Mal | 1981 |
[Another type of interaction between blood levels of digitalis and anti-arrhythmic drugs: digoxin and amiodarone. Experience with long-term therapy].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Digoxin; Drug Interactions; Female; Humans; Mal | 1981 |
[Clinical experience with the efficacy of amiodarone in hyperkinetic supraventricular arrhythmias].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle Aged | 1981 |
[Clinical experience with the efficacy of amiodarone in hyperkinetic supraventricular arrhythmias].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle Aged | 1981 |
[Cordarone treatment of parasystole].
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Drug | 1980 |
[Cordarone treatment of parasystole].
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Drug | 1980 |
Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Benzofurans; Ele | 1980 |
Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Benzofurans; Ele | 1980 |
Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases.
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Child, Preschool; Drug Tolerance; | 1980 |
Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases.
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Child, Preschool; Drug Tolerance; | 1980 |
Effectiveness of amiodarone in resistant arrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Drug Resistance; Drug | 1980 |
Effectiveness of amiodarone in resistant arrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Drug Resistance; Drug | 1980 |
Intravenous amiodarone in the treatment of various arrhythmias following cardiac operations.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Surgical Procedures; Female; Hum | 1981 |
Intravenous amiodarone in the treatment of various arrhythmias following cardiac operations.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Surgical Procedures; Female; Hum | 1981 |
New approaches to antiarrhythmic therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Heart Conduction System; Humans | 1981 |
New approaches to antiarrhythmic therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Heart Conduction System; Humans | 1981 |
[Action of amiodarone hydrochloride in ventricular arrhythmias induced by barium chloride].
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Barium; Benzofurans; Chlorides; Dogs; Electrocardiography | 1980 |
[Action of amiodarone hydrochloride in ventricular arrhythmias induced by barium chloride].
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Barium; Benzofurans; Chlorides; Dogs; Electrocardiography | 1980 |
[Importance of programmed ventricular stimulation in the evaluation of proarrhythmic effects of orally administered anti-arrhythmia agents].
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Arti | 1995 |
[Importance of programmed ventricular stimulation in the evaluation of proarrhythmic effects of orally administered anti-arrhythmia agents].
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Arti | 1995 |
Amiodarone and sexual dysfunction.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Erectile Dysfunction; Humans; Libid | 1995 |
Amiodarone and sexual dysfunction.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Erectile Dysfunction; Humans; Libid | 1995 |
Can amiodarone pulmonary toxicity be predicted in patients undergoing implantable cardioverter defibrillator implantation?
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Defibrillators, Implantable; Female; Humans; Intensive Care | 1993 |
Can amiodarone pulmonary toxicity be predicted in patients undergoing implantable cardioverter defibrillator implantation?
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Defibrillators, Implantable; Female; Humans; Intensive Care | 1993 |
AVID necessity.
Topics: Amiodarone; Arrhythmias, Cardiac; Bias; Clinical Trials as Topic; Defibrillators, Implantable; Ethic | 1994 |
AVID necessity.
Topics: Amiodarone; Arrhythmias, Cardiac; Bias; Clinical Trials as Topic; Defibrillators, Implantable; Ethic | 1994 |
The quality of life of patients with life-threatening arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Electri | 1995 |
The quality of life of patients with life-threatening arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Electri | 1995 |
[Cerebellar syndrome caused by amiodarone].
Topics: Amiodarone; Arrhythmias, Cardiac; Cerebellar Ataxia; Evoked Potentials, Auditory; Humans; Male; Midd | 1994 |
[Cerebellar syndrome caused by amiodarone].
Topics: Amiodarone; Arrhythmias, Cardiac; Cerebellar Ataxia; Evoked Potentials, Auditory; Humans; Male; Midd | 1994 |
[Arrhythmia and conduction defects in polymyositis].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Dermatomyositis; Electrocardiography; Electrophysiology; Fo | 1994 |
[Arrhythmia and conduction defects in polymyositis].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Dermatomyositis; Electrocardiography; Electrophysiology; Fo | 1994 |
Risk factors for the development of specific noncardiovascular adverse effects associated with amiodarone.
Topics: Adult; Age Factors; Aged; Amiodarone; Arrhythmias, Cardiac; Chemical and Drug Induced Liver Injury; | 1995 |
Risk factors for the development of specific noncardiovascular adverse effects associated with amiodarone.
Topics: Adult; Age Factors; Aged; Amiodarone; Arrhythmias, Cardiac; Chemical and Drug Induced Liver Injury; | 1995 |
Amiodarone and torsades de pointes in patients with advanced heart failure.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chi-Square Distribution; Deat | 1995 |
Amiodarone and torsades de pointes in patients with advanced heart failure.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chi-Square Distribution; Deat | 1995 |
Amiodarone: should we use it more than we do?
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, Premature; Death, Sudden, | 1993 |
Amiodarone: should we use it more than we do?
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, Premature; Death, Sudden, | 1993 |
AVID necessity.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Heart Ventric | 1993 |
AVID necessity.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Heart Ventric | 1993 |
Pregnancy outcome after gestational exposure to amiodarone in Canada.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Arrhythmias, Cardiac; Bradycardia; Canada; Cohort St | 1995 |
Pregnancy outcome after gestational exposure to amiodarone in Canada.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Arrhythmias, Cardiac; Bradycardia; Canada; Cohort St | 1995 |
Chaotic atrial rhythm in children.
Topics: Amiodarone; Arrhythmias, Cardiac; Drug Evaluation; Electrocardiography; Electrocardiography, Ambulat | 1995 |
Chaotic atrial rhythm in children.
Topics: Amiodarone; Arrhythmias, Cardiac; Drug Evaluation; Electrocardiography; Electrocardiography, Ambulat | 1995 |
Amiodarone-induced parkinsonism: a case report and pathogenetic discussion.
Topics: Amiodarone; Arrhythmias, Cardiac; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson | 1995 |
Amiodarone-induced parkinsonism: a case report and pathogenetic discussion.
Topics: Amiodarone; Arrhythmias, Cardiac; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson | 1995 |
Amiodarone in patients with heart failure.
Topics: Amiodarone; Arrhythmias, Cardiac; Heart Failure; Humans; Survival Rate | 1995 |
Amiodarone in patients with heart failure.
Topics: Amiodarone; Arrhythmias, Cardiac; Heart Failure; Humans; Survival Rate | 1995 |
Bronchiolitis obliterans organizing pneumonia secondary to amiodarone: a rare aetiology.
Topics: Amiodarone; Arrhythmias, Cardiac; Biopsy; Cryptogenic Organizing Pneumonia; Female; Humans; Lung; Mi | 1995 |
Bronchiolitis obliterans organizing pneumonia secondary to amiodarone: a rare aetiology.
Topics: Amiodarone; Arrhythmias, Cardiac; Biopsy; Cryptogenic Organizing Pneumonia; Female; Humans; Lung; Mi | 1995 |
[The effect of kordaron on thyroid function in patients with ischemic heart disease].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Hypothyroidism; Male; Middle Aged; Myocardia | 1995 |
[The effect of kordaron on thyroid function in patients with ischemic heart disease].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Hypothyroidism; Male; Middle Aged; Myocardia | 1995 |
[Cardiac decompensation and syncope].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Heart Failure; Humans | 1994 |
[Cardiac decompensation and syncope].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Heart Failure; Humans | 1994 |
[Complex and asymptomatic hyperkinetic ventricular arrhythmias: a daily difficult decision problem].
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Card | 1994 |
[Complex and asymptomatic hyperkinetic ventricular arrhythmias: a daily difficult decision problem].
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Card | 1994 |
Amiodarone and the development of ARDS after lung surgery.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Pneumonectomy; Postoperative Complications; Respiratory Di | 1995 |
Amiodarone and the development of ARDS after lung surgery.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Pneumonectomy; Postoperative Complications; Respiratory Di | 1995 |
[Role of cordarone in the treatment of paroxysmal supraventricular tachyarrhythmia in pre-excitation syndrome].
Topics: Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Humans; Pre-Excitation Syndromes; Tachycardia | 1994 |
[Role of cordarone in the treatment of paroxysmal supraventricular tachyarrhythmia in pre-excitation syndrome].
Topics: Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Humans; Pre-Excitation Syndromes; Tachycardia | 1994 |
[Current Trends in the Therapy of Arrhythmia. Amiodarone, an evermore important anti-arrhythmia agent. Proceedings of a symposium. Nizza, 28 August 1993].
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Humans | 1993 |
[Current Trends in the Therapy of Arrhythmia. Amiodarone, an evermore important anti-arrhythmia agent. Proceedings of a symposium. Nizza, 28 August 1993].
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Humans | 1993 |
[Comments on the contribution by B.-D. Gonska (drug therapy). Amiodarone].
Topics: Amiodarone; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Drug Administration Schedule; El | 1994 |
[Comments on the contribution by B.-D. Gonska (drug therapy). Amiodarone].
Topics: Amiodarone; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Drug Administration Schedule; El | 1994 |
Ventricular ectopic beats and non-sustained ventricular tachycardia.
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Humans | 1993 |
Ventricular ectopic beats and non-sustained ventricular tachycardia.
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Humans | 1993 |
Arrhythmogenic actions of class III antiarrhythmic drugs in spontaneously beating rabbit sino-atrial node cells.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Comp | 1993 |
Arrhythmogenic actions of class III antiarrhythmic drugs in spontaneously beating rabbit sino-atrial node cells.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Comp | 1993 |
Orthodeoxia in amiodarone-induced acute reversible pulmonary damage.
Topics: Amiodarone; Arrhythmias, Cardiac; Blood Gas Analysis; Humans; Lung Diseases; Male; Middle Aged; Oxyg | 1994 |
Orthodeoxia in amiodarone-induced acute reversible pulmonary damage.
Topics: Amiodarone; Arrhythmias, Cardiac; Blood Gas Analysis; Humans; Lung Diseases; Male; Middle Aged; Oxyg | 1994 |
[Subclinical hypothyroidism in patients with ischemic heart disease].
Topics: Achilles Tendon; Aged; Amiodarone; Angina, Unstable; Arrhythmias, Cardiac; Euthyroid Sick Syndromes; | 1993 |
[Subclinical hypothyroidism in patients with ischemic heart disease].
Topics: Achilles Tendon; Aged; Amiodarone; Angina, Unstable; Arrhythmias, Cardiac; Euthyroid Sick Syndromes; | 1993 |
Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathy, Dilated; Drug Combinati | 1994 |
Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathy, Dilated; Drug Combinati | 1994 |
Progression of amiodarone induced cataracts.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Cataract; Contrast Sensitivity; Follow-Up Studies; Humans; L | 1993 |
Progression of amiodarone induced cataracts.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Cataract; Contrast Sensitivity; Follow-Up Studies; Humans; L | 1993 |
The impact of age on risk of adverse drug reactions to digoxin. For The Gruppo Italiano di Farmacovigilanza nell' Anziano.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amiodarone; Analysis of Variance; Arrhythmi | 1993 |
The impact of age on risk of adverse drug reactions to digoxin. For The Gruppo Italiano di Farmacovigilanza nell' Anziano.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amiodarone; Analysis of Variance; Arrhythmi | 1993 |
[Amiodarone in cardiac failure].
Topics: Amiodarone; Arrhythmias, Cardiac; Heart Failure; Humans; Prospective Studies | 1993 |
[Amiodarone in cardiac failure].
Topics: Amiodarone; Arrhythmias, Cardiac; Heart Failure; Humans; Prospective Studies | 1993 |
The implantable defibrillator and antiarrhythmic drugs--competitive and complementary treatment for severe ventricular arrhythmia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Combined Modality Therapy; Defibrillators, | 1993 |
The implantable defibrillator and antiarrhythmic drugs--competitive and complementary treatment for severe ventricular arrhythmia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Combined Modality Therapy; Defibrillators, | 1993 |
[Efficacy and secondary effects of chronic treatment with amiodarone].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Female; Follow-Up Studies; Humans; | 1993 |
[Efficacy and secondary effects of chronic treatment with amiodarone].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Female; Follow-Up Studies; Humans; | 1993 |
Absence of pharmacokinetic interaction between amiodarone and lidocaine.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Drug Interactions; Female; Humans; Lidocaine; Male; Middle A | 1994 |
Absence of pharmacokinetic interaction between amiodarone and lidocaine.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Drug Interactions; Female; Humans; Lidocaine; Male; Middle A | 1994 |
Measurement of tissue-bound amiodarone and its metabolites by computed tomography.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Iodine; Liver; Male; Middle Aged; Models, St | 1994 |
Measurement of tissue-bound amiodarone and its metabolites by computed tomography.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Iodine; Liver; Male; Middle Aged; Models, St | 1994 |
[Pulmonary toxicity due to amiodarone].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Humans; Lung; Male; Middle Aged; Myocardial Infarction; Myoc | 1993 |
[Pulmonary toxicity due to amiodarone].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Humans; Lung; Male; Middle Aged; Myocardial Infarction; Myoc | 1993 |
Class III antiarrhythmic action: the way forward?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Sotalol | 1993 |
Class III antiarrhythmic action: the way forward?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Sotalol | 1993 |
Comparative efficacy of antiarrhythmic agents in preventing halothane-epinephrine arrhythmias in rats.
Topics: Amiodarone; Anesthesia, Inhalation; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Epinephri | 1993 |
Comparative efficacy of antiarrhythmic agents in preventing halothane-epinephrine arrhythmias in rats.
Topics: Amiodarone; Anesthesia, Inhalation; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Epinephri | 1993 |
Creatinine elevation in patients receiving amiodarone correlates with serum amiodarone concentration.
Topics: Amiodarone; Arrhythmias, Cardiac; Chromatography, High Pressure Liquid; Creatinine; Female; Humans; | 1993 |
Creatinine elevation in patients receiving amiodarone correlates with serum amiodarone concentration.
Topics: Amiodarone; Arrhythmias, Cardiac; Chromatography, High Pressure Liquid; Creatinine; Female; Humans; | 1993 |
Five-year follow-up of 589 patients treated with amiodarone.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Electrophysiology; Female; Follow-Up | 1993 |
Five-year follow-up of 589 patients treated with amiodarone.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Electrophysiology; Female; Follow-Up | 1993 |
Amiodarone and ventricular arrhythmia suppression.
Topics: Amiodarone; Arrhythmias, Cardiac; Data Interpretation, Statistical; Humans | 1993 |
Amiodarone and ventricular arrhythmia suppression.
Topics: Amiodarone; Arrhythmias, Cardiac; Data Interpretation, Statistical; Humans | 1993 |
Risks of developing supraventricular and ventricular tachyarrhythmias after implantation of a cardioverter-defibrillator, and timing the activation of arrhythmia termination therapies.
Topics: Age Factors; Aged; Amiodarone; Arrhythmias, Cardiac; Defibrillators, Implantable; Female; Humans; In | 1993 |
Risks of developing supraventricular and ventricular tachyarrhythmias after implantation of a cardioverter-defibrillator, and timing the activation of arrhythmia termination therapies.
Topics: Age Factors; Aged; Amiodarone; Arrhythmias, Cardiac; Defibrillators, Implantable; Female; Humans; In | 1993 |
Efficacy and safety of amiodarone in infants.
Topics: Amiodarone; Arrhythmias, Cardiac; Female; Humans; Infant; Infant, Newborn; Male; Treatment Outcome | 1993 |
Efficacy and safety of amiodarone in infants.
Topics: Amiodarone; Arrhythmias, Cardiac; Female; Humans; Infant; Infant, Newborn; Male; Treatment Outcome | 1993 |
T wave alternans associated with amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Humans; Male; Middle Aged | 1993 |
T wave alternans associated with amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Humans; Male; Middle Aged | 1993 |
[The effect of treatment with propafenone, metoprolol and amiodarone on lymphocyte sodium efflux and level of cAMP in serum].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cyclic AMP; Female; Heart Dis | 1995 |
[The effect of treatment with propafenone, metoprolol and amiodarone on lymphocyte sodium efflux and level of cAMP in serum].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cyclic AMP; Female; Heart Dis | 1995 |
[Dispersion of ventricular recovery time as a new marker of arrhythmogenic risk].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Dise | 1995 |
[Dispersion of ventricular recovery time as a new marker of arrhythmogenic risk].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Dise | 1995 |
Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs.
Topics: Amiodarone; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans | 1995 |
Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs.
Topics: Amiodarone; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans | 1995 |
SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats.
Topics: Administration, Oral; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans | 1995 |
SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats.
Topics: Administration, Oral; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans | 1995 |
Measurement of serum amiodarone and desethylamiodarone by HPLC: its usefulness in the follow-up of arrhythmic patients treated with amiodarone.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chromatography, High Pressure | 1995 |
Measurement of serum amiodarone and desethylamiodarone by HPLC: its usefulness in the follow-up of arrhythmic patients treated with amiodarone.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chromatography, High Pressure | 1995 |
Acute antiarrhythmic effects of intravenously administered amiodarone on canine ventricular arrhythmia.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Digitalis; Dogs | 1995 |
Acute antiarrhythmic effects of intravenously administered amiodarone on canine ventricular arrhythmia.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Digitalis; Dogs | 1995 |
[Heart failure: causes and therapy of unstableness].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiotonic Agents; Digitalis Glycos | 1995 |
[Heart failure: causes and therapy of unstableness].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiotonic Agents; Digitalis Glycos | 1995 |
[Therapy of arrhythmias in hypertrophic cardiomyopathy].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomy | 1995 |
[Therapy of arrhythmias in hypertrophic cardiomyopathy].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomy | 1995 |
Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Defibrillators, Im | 1996 |
Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Defibrillators, Im | 1996 |
The SWORD of Damocles.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Myocardial Infarction; Randomized | 1996 |
The SWORD of Damocles.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Myocardial Infarction; Randomized | 1996 |
[Plasma concentrations and amiodarone/desethylamiodarone relations in patients subjected to chronic treatment].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Chromatography, High Pressure Liquid; Chronic Disease | 1996 |
[Plasma concentrations and amiodarone/desethylamiodarone relations in patients subjected to chronic treatment].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Chromatography, High Pressure Liquid; Chronic Disease | 1996 |
The coming of age of the class III antiarrhythmic principle: retrospective and future trends.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Electrophysiolog | 1996 |
The coming of age of the class III antiarrhythmic principle: retrospective and future trends.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Electrophysiolog | 1996 |
From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Conduct | 1996 |
From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Conduct | 1996 |
Amiodarone-induced epididymitis. Report of 2 cases.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Epididymitis; Humans; Male; Middle | 1996 |
Amiodarone-induced epididymitis. Report of 2 cases.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Epididymitis; Humans; Male; Middle | 1996 |
Survival analysis and clinical medicine. An observational comparison of the implantable cardioverter defibrillator, amiodarone treatment, and heart transplantation.
Topics: Age Distribution; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as | 1996 |
Survival analysis and clinical medicine. An observational comparison of the implantable cardioverter defibrillator, amiodarone treatment, and heart transplantation.
Topics: Age Distribution; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as | 1996 |
Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Kinetics; Male; Middle Aged; Thyroid Disease | 1997 |
Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Kinetics; Male; Middle Aged; Thyroid Disease | 1997 |
[Amiodarone in arrhythmia].
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Myocardial Infarction | 1996 |
[Amiodarone in arrhythmia].
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Myocardial Infarction | 1996 |
[Increased liver density in computed tomography as a result of anti-arrhythmia therapy with amiodarone].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Diagnosis, Differential; Fema | 1997 |
[Increased liver density in computed tomography as a result of anti-arrhythmia therapy with amiodarone].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Diagnosis, Differential; Fema | 1997 |
Do MADIT results apply only to "MADIT patients"? Multicenter Automatic Defibrillator Implantation Trial.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Humans; Multi | 1997 |
Do MADIT results apply only to "MADIT patients"? Multicenter Automatic Defibrillator Implantation Trial.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Humans; Multi | 1997 |
Determinants of nonthoracotomy biphasic defibrillation.
Topics: Age Factors; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Body Surface Area; Defibrilla | 1997 |
Determinants of nonthoracotomy biphasic defibrillation.
Topics: Age Factors; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Body Surface Area; Defibrilla | 1997 |
Assessment of the cardiac patient for fitness to drive: 1996 update.
Topics: Amiodarone; Arrhythmias, Cardiac; Automobile Driving; Defibrillators, Implantable; Electrocardiograp | 1996 |
Assessment of the cardiac patient for fitness to drive: 1996 update.
Topics: Amiodarone; Arrhythmias, Cardiac; Automobile Driving; Defibrillators, Implantable; Electrocardiograp | 1996 |
Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Humans; Myocardi | 1997 |
Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Humans; Myocardi | 1997 |
201Tl scintigraphy does not allow visualization of the thyroid in euthyroid and hyperthyroid patients treated with amiodarone.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Hu | 1997 |
201Tl scintigraphy does not allow visualization of the thyroid in euthyroid and hyperthyroid patients treated with amiodarone.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Hu | 1997 |
[Arrhythmia as risk factor].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Myocardial Infarction; Risk Factor | 1997 |
[Arrhythmia as risk factor].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Myocardial Infarction; Risk Factor | 1997 |
A pulse of 27 in a man with chronic heart disease.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disease; Drug Overdose; Drug Thera | 1997 |
A pulse of 27 in a man with chronic heart disease.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disease; Drug Overdose; Drug Thera | 1997 |
Beta-blocker prevention of proarrhythmia and proischemia: clues from CAST, CAMIAT, and EMIAT. Cardiac Arrhythmia Suppression Trial. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. European Myocardial Infarct Amiodarone Trial.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Multi | 1997 |
Beta-blocker prevention of proarrhythmia and proischemia: clues from CAST, CAMIAT, and EMIAT. Cardiac Arrhythmia Suppression Trial. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. European Myocardial Infarct Amiodarone Trial.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Multi | 1997 |
Clinical trials of implantable defibrillators.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Artery Bypass; Coronary Disease; | 1997 |
Clinical trials of implantable defibrillators.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Artery Bypass; Coronary Disease; | 1997 |
The amiodarone trials.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Humans; Myocardi | 1997 |
The amiodarone trials.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Humans; Myocardi | 1997 |
[Amiodarone toxicity in a patient with at-risk ventricular arrhythmia].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chemical and Drug Induced Liver Injury; He | 1997 |
[Amiodarone toxicity in a patient with at-risk ventricular arrhythmia].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chemical and Drug Induced Liver Injury; He | 1997 |
[Death is still a death. Does it matter if the cause is myocardial infarction or arrhythmia?].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cause of Death; Follow-Up Studies; Humans; | 1998 |
[Death is still a death. Does it matter if the cause is myocardial infarction or arrhythmia?].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cause of Death; Follow-Up Studies; Humans; | 1998 |
[Cardioprotective effects of the cyclic derivative of gamma-aminobutyric acid T3-146 during reperfusion].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cats; Electr | 1997 |
[Cardioprotective effects of the cyclic derivative of gamma-aminobutyric acid T3-146 during reperfusion].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cats; Electr | 1997 |
Dispersion of ventricular repolarization in the voltage domain.
Topics: Action Potentials; Amiodarone; Animals; Arrhythmias, Cardiac; Electrocardiography; Heart Conduction | 1998 |
Dispersion of ventricular repolarization in the voltage domain.
Topics: Action Potentials; Amiodarone; Animals; Arrhythmias, Cardiac; Electrocardiography; Heart Conduction | 1998 |
Acute effects of intravenous amiodarone on sulphate metabolites of thyroid hormones in arrhythmic patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia | 1997 |
Acute effects of intravenous amiodarone on sulphate metabolites of thyroid hormones in arrhythmic patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia | 1997 |
Intravenous amiodarone for arrythmia management.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Infusions, Intravenous | 1998 |
Intravenous amiodarone for arrythmia management.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Infusions, Intravenous | 1998 |
Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial).
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Tria | 1998 |
Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial).
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Tria | 1998 |
Amiodarone and mortality in CHF and post-MI.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden; Heart Failure; Human | 1998 |
Amiodarone and mortality in CHF and post-MI.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden; Heart Failure; Human | 1998 |
[Clinical tolerance of oral loading with elevated doses of amiodarone in a group of patients with heart failure].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia | 1997 |
[Clinical tolerance of oral loading with elevated doses of amiodarone in a group of patients with heart failure].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia | 1997 |
Cost-effectiveness analysis of invasive and noninvasive tests in high risk patients treated with amiodarone after acute myocardial infarction.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cost-Benefit Analysis; Decision Support Te | 1998 |
Cost-effectiveness analysis of invasive and noninvasive tests in high risk patients treated with amiodarone after acute myocardial infarction.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cost-Benefit Analysis; Decision Support Te | 1998 |
Cost-effectiveness of tests to assess the risk of sudden death after acute myocardial infarction.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cost-Benefit Analysis; Death, Sudden; Deci | 1998 |
Cost-effectiveness of tests to assess the risk of sudden death after acute myocardial infarction.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cost-Benefit Analysis; Death, Sudden; Deci | 1998 |
Effect of partial arrhythmia suppression with amiodarone on heart rate variability of patients with congestive heart failure.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Flow Velocity; Cardiac Output; Circa | 1998 |
Effect of partial arrhythmia suppression with amiodarone on heart rate variability of patients with congestive heart failure.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Flow Velocity; Cardiac Output; Circa | 1998 |
[Patients with structural heart disease, syncope of unknown etiology and inducible ventricular arrhythmias treated with implantable defibrillators].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia | 1998 |
[Patients with structural heart disease, syncope of unknown etiology and inducible ventricular arrhythmias treated with implantable defibrillators].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia | 1998 |
Influence of beta-blockers on the frequency of arrhythmia recurrences in patients with implantable cardioverter-defibrillator: an intraindividual comparison.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Arrhythmias, Cardiac; Atenolol; Defibrillators, Impla | 1998 |
Influence of beta-blockers on the frequency of arrhythmia recurrences in patients with implantable cardioverter-defibrillator: an intraindividual comparison.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Arrhythmias, Cardiac; Atenolol; Defibrillators, Impla | 1998 |
[Further data on amiodarone. Evidence based therapy of cardiac arrhythmias].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Humans; Ventricular D | 1998 |
[Further data on amiodarone. Evidence based therapy of cardiac arrhythmias].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Humans; Ventricular D | 1998 |
Implantable defibrillators and/or amiodarone: alternatives or complementary therapies.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Combined Modality Therapy; Defibrill | 1998 |
Implantable defibrillators and/or amiodarone: alternatives or complementary therapies.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Combined Modality Therapy; Defibrill | 1998 |
[Impaired left ventricular function in a patient with visual disturbance].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Female; Humans; Sa | 1998 |
[Impaired left ventricular function in a patient with visual disturbance].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Female; Humans; Sa | 1998 |
Impact of rifampin on serum amiodarone concentrations in a patient with congenital heart disease.
Topics: Adult; Amiodarone; Antibiotics, Antitubercular; Arrhythmias, Cardiac; Defibrillators, Implantable; F | 1999 |
Impact of rifampin on serum amiodarone concentrations in a patient with congenital heart disease.
Topics: Adult; Amiodarone; Antibiotics, Antitubercular; Arrhythmias, Cardiac; Defibrillators, Implantable; F | 1999 |
Progressive brown discoloration of silicone intraocular lenses after vitrectomy in a patient on amiodarone.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood-Aqueous Barrier; Color; Diseas | 1999 |
Progressive brown discoloration of silicone intraocular lenses after vitrectomy in a patient on amiodarone.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood-Aqueous Barrier; Color; Diseas | 1999 |
Effect of amiodarone and sotalol on the defibrillation threshold in comparison to patients without antiarrhythmic drug treatment.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Female; | 1999 |
Effect of amiodarone and sotalol on the defibrillation threshold in comparison to patients without antiarrhythmic drug treatment.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Female; | 1999 |
[Role of electrophysiology in the prognosis and therapy of cardiomyopathies].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopath | 1999 |
[Role of electrophysiology in the prognosis and therapy of cardiomyopathies].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopath | 1999 |
[Dyspnea and thoracic pain. A patient with recurring ventricular arrhythmia].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chest Pain; Dose-Response Relationsh | 1999 |
[Dyspnea and thoracic pain. A patient with recurring ventricular arrhythmia].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chest Pain; Dose-Response Relationsh | 1999 |
[Therapy of arrhythmia. Amiodarone retains its high value].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans | 1999 |
[Therapy of arrhythmia. Amiodarone retains its high value].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans | 1999 |
Cellular and in vivo electrophysiological effects of dronedarone in normal and postmyocardial infarcted rats.
Topics: Action Potentials; Age Factors; Amiodarone; Animals; Arrhythmias, Cardiac; Dose-Response Relationshi | 2000 |
Cellular and in vivo electrophysiological effects of dronedarone in normal and postmyocardial infarcted rats.
Topics: Action Potentials; Age Factors; Amiodarone; Animals; Arrhythmias, Cardiac; Dose-Response Relationshi | 2000 |
Approaches to Controlling Cardiac Arrhythmias: Focus on Amiodarone, the Last 15 Years. Proceedings of a symposium. Dallas, Texas, USA. November 7, 1998.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans | 1999 |
Approaches to Controlling Cardiac Arrhythmias: Focus on Amiodarone, the Last 15 Years. Proceedings of a symposium. Dallas, Texas, USA. November 7, 1998.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans | 1999 |
Bibliography. Current world literature. Arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Catheter Ablat | 2000 |
Bibliography. Current world literature. Arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Catheter Ablat | 2000 |
Na+-K+ pump inhibition caused by chronic amiodarone in guinea pig myocardium.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Digoxin; Electrocardiography; Enz | 1999 |
Na+-K+ pump inhibition caused by chronic amiodarone in guinea pig myocardium.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Digoxin; Electrocardiography; Enz | 1999 |
Positive Coombs' test results in two dogs treated with amiodarone.
Topics: Amiodarone; Anemia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coombs Test; Dog Diseases | 2000 |
Positive Coombs' test results in two dogs treated with amiodarone.
Topics: Amiodarone; Anemia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coombs Test; Dog Diseases | 2000 |
Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Interactions; H | 2000 |
Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Interactions; H | 2000 |
Life-threatening arrhythmias and therapy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Critical Care | 2000 |
Life-threatening arrhythmias and therapy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Critical Care | 2000 |
An old drug with new tricks. Amiodarone hits the streets.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Contraindications; Electrocardiography; Em | 2000 |
An old drug with new tricks. Amiodarone hits the streets.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Contraindications; Electrocardiography; Em | 2000 |
Acquired long QT syndromes and the risk of proarrhythmia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Long QT Syndrome | 2000 |
Acquired long QT syndromes and the risk of proarrhythmia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Long QT Syndrome | 2000 |
Influence of CYP3A metabolizer status on the pharmacokinetics and pharmacodynamics of amiodarone.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Aryl Hydrocarbon Hydroxylases | 2000 |
Influence of CYP3A metabolizer status on the pharmacokinetics and pharmacodynamics of amiodarone.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Aryl Hydrocarbon Hydroxylases | 2000 |
Serious arrhythmias in patients with apical hypertrophic cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmi | 2001 |
Serious arrhythmias in patients with apical hypertrophic cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmi | 2001 |
[Amiodarone-induced keratopathy].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cataract; Corneal Diseases; Female; | 2001 |
[Amiodarone-induced keratopathy].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cataract; Corneal Diseases; Female; | 2001 |
Beneficial effects of amiodarone and dronedarone (SR 33589b), when applied during low-flow ischemia, on arrhythmia and functional parameters asssessed during reperfusion in isolated rat hearts.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Circu | 2001 |
Beneficial effects of amiodarone and dronedarone (SR 33589b), when applied during low-flow ischemia, on arrhythmia and functional parameters asssessed during reperfusion in isolated rat hearts.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Circu | 2001 |
Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cost-Benef | 2001 |
Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cost-Benef | 2001 |
Silymarin and vitamin E do not attenuate and vitamin E might even enhance the antiarrhythmic activity of amiodarone in a rat reperfusion arrhythmia model.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antioxidants; Arrhythmias, Cardiac; Disease Models, Ani | 2001 |
Silymarin and vitamin E do not attenuate and vitamin E might even enhance the antiarrhythmic activity of amiodarone in a rat reperfusion arrhythmia model.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antioxidants; Arrhythmias, Cardiac; Disease Models, Ani | 2001 |
Amiodarone-Induced thyroid dysfunction and ventricular tachyarrhythmias during long-term therapy in Japan.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Drug Evaluation; Female; Follow-Up Studies; Humans; H | 2001 |
Amiodarone-Induced thyroid dysfunction and ventricular tachyarrhythmias during long-term therapy in Japan.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Drug Evaluation; Female; Follow-Up Studies; Humans; H | 2001 |
Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome.
Topics: Action Potentials; Administration, Oral; Amiodarone; Anesthesia; Animals; Anti-Arrhythmia Agents; Ar | 2001 |
Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome.
Topics: Action Potentials; Administration, Oral; Amiodarone; Anesthesia; Animals; Anti-Arrhythmia Agents; Ar | 2001 |
Summaries for patients. Cost-effectiveness of implantable defibrillators versus the drug amiodarone to prevent abnormal heart rhythms after heart attack.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Computer S | 2001 |
Summaries for patients. Cost-effectiveness of implantable defibrillators versus the drug amiodarone to prevent abnormal heart rhythms after heart attack.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Computer S | 2001 |
Proarrhythmic effects of intravenous quinidine, amiodarone, D-sotalol, and almokalant in the anesthetized rabbit model of torsade de pointes.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Amiodarone; Animals; Anti-Arrhythmi | 2002 |
Proarrhythmic effects of intravenous quinidine, amiodarone, D-sotalol, and almokalant in the anesthetized rabbit model of torsade de pointes.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Amiodarone; Animals; Anti-Arrhythmi | 2002 |
Coital headaches induced by amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coitus; Headache; Humans; Male; Middle Age | 2002 |
Coital headaches induced by amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coitus; Headache; Humans; Male; Middle Age | 2002 |
Lack of interaction between amiodarone and mexiletine in cardiac arrhythmia patients.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bayes Theorem; Biological Availabili | 2002 |
Lack of interaction between amiodarone and mexiletine in cardiac arrhythmia patients.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bayes Theorem; Biological Availabili | 2002 |
Intravenous amiodarone modifies autonomic balance and increases baroreflex sensitivity in conscious rats.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Baroreflex; Blood Pressure; Consc | 2002 |
Intravenous amiodarone modifies autonomic balance and increases baroreflex sensitivity in conscious rats.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Baroreflex; Blood Pressure; Consc | 2002 |
Successful treatment of amiodarone-induced thyrotoxicosis.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Autoantibodies; Carbimazole; Cohort Studies; Female; Humans; | 2002 |
Successful treatment of amiodarone-induced thyrotoxicosis.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Autoantibodies; Carbimazole; Cohort Studies; Female; Humans; | 2002 |
Iopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyroidectomy.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Drug Resistance; Enzyme Inhibitors; Female; Humans; Iodide P | 2002 |
Iopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyroidectomy.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Drug Resistance; Enzyme Inhibitors; Female; Humans; Iodide P | 2002 |
Antiarrhythmic drugs in cardiac arrest resuscitation: intravenous amiodarone or intravenous lidocaine?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Heart Arrest; Hu | 2002 |
Antiarrhythmic drugs in cardiac arrest resuscitation: intravenous amiodarone or intravenous lidocaine?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Heart Arrest; Hu | 2002 |
Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs' Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disease; Comorbidity; Death, | 2002 |
Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs' Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disease; Comorbidity; Death, | 2002 |
[Amiodarone hydrochloride and anesthesia in heart surgery. Use of an injectable form in the correction of peroperative rhythm disorders].
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Bloo | 1976 |
[Amiodarone hydrochloride and anesthesia in heart surgery. Use of an injectable form in the correction of peroperative rhythm disorders].
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Bloo | 1976 |
The treatment of supraventricular arrhythmias.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Arrhyt | 1979 |
The treatment of supraventricular arrhythmias.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Arrhyt | 1979 |
[Continuous ambulatory electrocardiographic recordings using the Holter system in the late phase of hospitalization for recent myocardial infarct. Value and limitations studied in a series of 100 patients].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Ambulatory Care; Amiodarone; Arrhythmias, Cardiac; Coronar | 1979 |
[Continuous ambulatory electrocardiographic recordings using the Holter system in the late phase of hospitalization for recent myocardial infarct. Value and limitations studied in a series of 100 patients].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Ambulatory Care; Amiodarone; Arrhythmias, Cardiac; Coronar | 1979 |
[Amiodarone in the treatment of disorders of cardiac rhythm. results of six years of clinical experience (author's transl)].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Complexes, Premature; Drug Evaluation; Humans | 1975 |
[Amiodarone in the treatment of disorders of cardiac rhythm. results of six years of clinical experience (author's transl)].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Complexes, Premature; Drug Evaluation; Humans | 1975 |
[Study of the effectiveness of cordaron in different types of arrhythmia].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Cardiac Complexes, Prematu | 1977 |
[Study of the effectiveness of cordaron in different types of arrhythmia].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Cardiac Complexes, Prematu | 1977 |
["Torsades de pointe" and reentry induced by anti-arrhythmia agents].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Flutte | 1978 |
["Torsades de pointe" and reentry induced by anti-arrhythmia agents].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Flutte | 1978 |
Amiodarone.
Topics: Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Drug Evaluation; Humans | 1979 |
Amiodarone.
Topics: Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Drug Evaluation; Humans | 1979 |
Amiodarone and the thyroid.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Humans; Male; Stimulation, Chemical; Thyroid G | 1979 |
Amiodarone and the thyroid.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Humans; Male; Stimulation, Chemical; Thyroid G | 1979 |
Newer antiarrhythmic drugs.
Topics: Administration, Oral; Adult; Amiodarone; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Ca | 1978 |
Newer antiarrhythmic drugs.
Topics: Administration, Oral; Adult; Amiodarone; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Ca | 1978 |
[Amiodarone in cardiac arrhythmias].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Digoxin; Female; Humans; Male; Middle Aged | 1979 |
[Amiodarone in cardiac arrhythmias].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Digoxin; Female; Humans; Male; Middle Aged | 1979 |
[Research on a rational basis for the origin and treatment of arrhythmia].
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Heart | 1977 |
[Research on a rational basis for the origin and treatment of arrhythmia].
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Heart | 1977 |
[Quantitative evaluation of the efficacy of anti-arrhythmia agents in chronic ventricular arrhythmia].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Computers; Electrocardiography; Heart Vent | 1979 |
[Quantitative evaluation of the efficacy of anti-arrhythmia agents in chronic ventricular arrhythmia].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Computers; Electrocardiography; Heart Vent | 1979 |
Electrophysiological effects of L 9394 (benzoyl-indolizine) in man.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Female; Heart Conduction System; Human | 1979 |
Electrophysiological effects of L 9394 (benzoyl-indolizine) in man.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Female; Heart Conduction System; Human | 1979 |
Amiodarone in the treatment of refractory supraventricular and ventricular arrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Drug Administration Sc | 1979 |
Amiodarone in the treatment of refractory supraventricular and ventricular arrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Drug Administration Sc | 1979 |
Control of refractory cardiac arrhythmias with amiodarone.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle Aged; Recur | 1979 |
Control of refractory cardiac arrhythmias with amiodarone.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle Aged; Recur | 1979 |
[ECG spike torsion and aminodarone].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Humans | 1979 |
[ECG spike torsion and aminodarone].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Humans | 1979 |
[Control of reciprocating atrioventricular arrhythmias].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Evaluation; Humans | 1979 |
[Control of reciprocating atrioventricular arrhythmias].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Evaluation; Humans | 1979 |
[Use of amiodarone in the treatment of cardiac dysrhythmias].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cornea; Electrocardiography; Female; Hum | 1979 |
[Use of amiodarone in the treatment of cardiac dysrhythmias].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cornea; Electrocardiography; Female; Hum | 1979 |
[The place of amiodarone in 1979 in the therapeutic arsenal of a cardiac intensive care unit].
Topics: Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Benzofurans; | 1979 |
[The place of amiodarone in 1979 in the therapeutic arsenal of a cardiac intensive care unit].
Topics: Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Benzofurans; | 1979 |
[Clinical efficacy of amiodarone in the treatment of intractable arrhythmias].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Corneal Diseases; Fem | 1979 |
[Clinical efficacy of amiodarone in the treatment of intractable arrhythmias].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Corneal Diseases; Fem | 1979 |
[Amiodarone in the treatment of cardiac arrhythmias in the course of chronic obstructive bronchopneumopathy (COBP). Evaluation of the effects of the drug on respiratory function].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Lung Diseases, Obstructive; Male; Middl | 1978 |
[Amiodarone in the treatment of cardiac arrhythmias in the course of chronic obstructive bronchopneumopathy (COBP). Evaluation of the effects of the drug on respiratory function].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Lung Diseases, Obstructive; Male; Middl | 1978 |
[Amiodarone and the thyroid gland: apropos of 2 cases of hypothyroidism].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Heart Block; Humans; Hypothyroidism; M | 1978 |
[Amiodarone and the thyroid gland: apropos of 2 cases of hypothyroidism].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Heart Block; Humans; Hypothyroidism; M | 1978 |
Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.
Topics: Acebutolol; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Bretylium Compounds | 1978 |
Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.
Topics: Acebutolol; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Bretylium Compounds | 1978 |
New antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Humans; Lidocaine; Mexiletine; | 1978 |
New antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Humans; Lidocaine; Mexiletine; | 1978 |
[Skin pigmentation caused by amiodarone].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cornea; Female; Humans; Male; Middle Age | 1978 |
[Skin pigmentation caused by amiodarone].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cornea; Female; Humans; Male; Middle Age | 1978 |
[Hyperthyroidism caused by amiodarone. Apropos of 4 clinical cases].
Topics: Adult; Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Female; | 1976 |
[Hyperthyroidism caused by amiodarone. Apropos of 4 clinical cases].
Topics: Adult; Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Female; | 1976 |
Quality of the ideal antiarrhythmic drug.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Conduction System; Humans | 1977 |
Quality of the ideal antiarrhythmic drug.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Conduction System; Humans | 1977 |
[Amiodarone hydrochloride in the treatment of arrhythmia in pre-excitation syndromes].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Evaluation; Electrocardiography; Female; Humans; | 1977 |
[Amiodarone hydrochloride in the treatment of arrhythmia in pre-excitation syndromes].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Evaluation; Electrocardiography; Female; Humans; | 1977 |
[Anti-arrhthmic effects of injectable amiodarone in resuscitation during cardiovascular surgery, 2 cases].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Cardiac Surgical Procedures; | 1976 |
[Anti-arrhthmic effects of injectable amiodarone in resuscitation during cardiovascular surgery, 2 cases].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Cardiac Surgical Procedures; | 1976 |
[Use of amiodarone in serious, intractable dysrhythmia in children (author's transl)].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Drug Evaluation; Female; Humans; Male | 1976 |
[Use of amiodarone in serious, intractable dysrhythmia in children (author's transl)].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Drug Evaluation; Female; Humans; Male | 1976 |
[Electrocardiographic study of the action of amiodarone on intracardiac conduction in humans. Comparison between intravenous and oral administration (author's transl)].
Topics: Administration, Oral; Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Depres | 1976 |
[Electrocardiographic study of the action of amiodarone on intracardiac conduction in humans. Comparison between intravenous and oral administration (author's transl)].
Topics: Administration, Oral; Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Depres | 1976 |
[Clinical study of injectable amiodarone in arrhythmia].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Evaluation; Female; Humans; Injecti | 1976 |
[Clinical study of injectable amiodarone in arrhythmia].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Evaluation; Female; Humans; Injecti | 1976 |
[Cardiac rhythm disorders and esophageal hiatal hernias].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Female; Hernia, Diaphragmatic; Hernia, Hiatal; Humans | 1976 |
[Cardiac rhythm disorders and esophageal hiatal hernias].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Female; Hernia, Diaphragmatic; Hernia, Hiatal; Humans | 1976 |
[Clinical and experimental results of treatment with amiodarone in coronary insufficiency].
Topics: Aged; Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Coronary Disease; Dipyridamole | 1975 |
[Clinical and experimental results of treatment with amiodarone in coronary insufficiency].
Topics: Aged; Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Coronary Disease; Dipyridamole | 1975 |
[Experimental analysis of some cardiovascular effects of Verapamil].
Topics: Amiodarone; Animals; Anura; Arrhythmias, Cardiac; Blood Pressure; Calcium Chloride; Cardiovascular S | 1975 |
[Experimental analysis of some cardiovascular effects of Verapamil].
Topics: Amiodarone; Animals; Anura; Arrhythmias, Cardiac; Blood Pressure; Calcium Chloride; Cardiovascular S | 1975 |
[Indications and surveillance of amiodarone and bretylium treatments].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Bretylium Compounds; Humans | 1975 |
[Indications and surveillance of amiodarone and bretylium treatments].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Bretylium Compounds; Humans | 1975 |
[Clinical evaluation of amiodarone hydrochloride as an anti-arrhythmia agent].
Topics: Administration, Oral; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofu | 1975 |
[Clinical evaluation of amiodarone hydrochloride as an anti-arrhythmia agent].
Topics: Administration, Oral; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofu | 1975 |
Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiomyopathy, Dilated; Echo | 1992 |
Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiomyopathy, Dilated; Echo | 1992 |
[Pneumopathy induced by amiodarone. Radiological data].
Topics: Adrenal Cortex Hormones; Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; | 1992 |
[Pneumopathy induced by amiodarone. Radiological data].
Topics: Adrenal Cortex Hormones; Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; | 1992 |
Drug treatment of arrhythmias during cardiopulmonary resuscitation. A statement for the Advanced Life Support Working Party of the European Resuscitation Council.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Atropine; Bretylium Compounds; Calcium; Cardiopulmonary R | 1992 |
Drug treatment of arrhythmias during cardiopulmonary resuscitation. A statement for the Advanced Life Support Working Party of the European Resuscitation Council.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Atropine; Bretylium Compounds; Calcium; Cardiopulmonary R | 1992 |
[Thyroid function in patients during long-term treatment with amiodarone].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Thyroid Diseases; | 1992 |
[Thyroid function in patients during long-term treatment with amiodarone].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Thyroid Diseases; | 1992 |
Treatment of amiodarone induced thyrotoxicosis with carbimazole alone and continuation of amiodarone.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Carbimazole; Humans; Male; Middle Aged; Thyrotoxicosi | 1992 |
Treatment of amiodarone induced thyrotoxicosis with carbimazole alone and continuation of amiodarone.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Carbimazole; Humans; Male; Middle Aged; Thyrotoxicosi | 1992 |
[Anti-arrhythmia agents in heart failure].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; C | 1992 |
[Anti-arrhythmia agents in heart failure].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; C | 1992 |
[Effects of treatment of arrhythmias requiring therapy in dilated cardiomyopathy with amiodarone on alpha human atrial natriuretic peptide].
Topics: Aged; Aldosterone; Amiodarone; Arginine Vasopressin; Arrhythmias, Cardiac; Atrial Natriuretic Factor | 1992 |
[Effects of treatment of arrhythmias requiring therapy in dilated cardiomyopathy with amiodarone on alpha human atrial natriuretic peptide].
Topics: Aged; Aldosterone; Amiodarone; Arginine Vasopressin; Arrhythmias, Cardiac; Atrial Natriuretic Factor | 1992 |
Protective effect of cycloprotobuxine-A against cardiac arrhythmias induced by ouabain.
Topics: Alkaloids; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Electr | 1992 |
Protective effect of cycloprotobuxine-A against cardiac arrhythmias induced by ouabain.
Topics: Alkaloids; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Electr | 1992 |
A proposed trial of amiodarone for atrial fibrillation.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans | 1992 |
A proposed trial of amiodarone for atrial fibrillation.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans | 1992 |
Effects of intravenous amiodarone on electrical dispersion in normal and ischaemic tissues and on arrhythmia inducibility: monophasic action potential studies.
Topics: Action Potentials; Amiodarone; Animals; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Dogs; Elec | 1992 |
Effects of intravenous amiodarone on electrical dispersion in normal and ischaemic tissues and on arrhythmia inducibility: monophasic action potential studies.
Topics: Action Potentials; Amiodarone; Animals; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Dogs; Elec | 1992 |
Flecainide in quinidine-resistant atrial fibrillation.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Drug Therapy, Combination; Electrocardiograph | 1992 |
Flecainide in quinidine-resistant atrial fibrillation.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Drug Therapy, Combination; Electrocardiograph | 1992 |
Use of amiodarone during pregnancy.
Topics: Amiodarone; Arrhythmias, Cardiac; Female; Fetal Blood; Humans; Hypothyroidism; Infant, Newborn; Lact | 1992 |
Use of amiodarone during pregnancy.
Topics: Amiodarone; Arrhythmias, Cardiac; Female; Fetal Blood; Humans; Hypothyroidism; Infant, Newborn; Lact | 1992 |
Efficacy and safety of short intravenous amiodarone in supraventricular tachyarrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Dose-Response Re | 1992 |
Efficacy and safety of short intravenous amiodarone in supraventricular tachyarrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Dose-Response Re | 1992 |
[Bilateral optic neuropathy following amiodarone therapy].
Topics: Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Coronary Disease; Fluorescein Angiography; Humans | 1992 |
[Bilateral optic neuropathy following amiodarone therapy].
Topics: Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Coronary Disease; Fluorescein Angiography; Humans | 1992 |
Serial pulmonary function tests in patients treated with low-dose amiodarone.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Female; Humans; Lung; Mal | 1992 |
Serial pulmonary function tests in patients treated with low-dose amiodarone.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Female; Humans; Lung; Mal | 1992 |
Rapid suppression of spontaneous ventricular arrhythmias during oral amiodarone loading.
Topics: Administration, Oral; Aged; Amiodarone; Arrhythmias, Cardiac; Drug Administration Schedule; Electroc | 1992 |
Rapid suppression of spontaneous ventricular arrhythmias during oral amiodarone loading.
Topics: Administration, Oral; Aged; Amiodarone; Arrhythmias, Cardiac; Drug Administration Schedule; Electroc | 1992 |
Amiodarone, adrenoceptor responsiveness and ischaemia- and reperfusion-induced arrhythmias.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Coronary Disease; In Vitro Techniques; Male; Myocardial C | 1991 |
Amiodarone, adrenoceptor responsiveness and ischaemia- and reperfusion-induced arrhythmias.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Coronary Disease; In Vitro Techniques; Male; Myocardial C | 1991 |
[Peripheral neuropathy possibly caused by amiodarone therapy].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Demyelinating Diseases; Humans; Male; Peripheral Nervous Sys | 1991 |
[Peripheral neuropathy possibly caused by amiodarone therapy].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Demyelinating Diseases; Humans; Male; Peripheral Nervous Sys | 1991 |
Use of amiodarone for short-term and adjuvant therapy in young patients.
Topics: Administration, Oral; Adolescent; Adrenergic beta-Antagonists; Adult; Amiodarone; Arrhythmias, Cardi | 1991 |
Use of amiodarone for short-term and adjuvant therapy in young patients.
Topics: Administration, Oral; Adolescent; Adrenergic beta-Antagonists; Adult; Amiodarone; Arrhythmias, Cardi | 1991 |
[Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Electrocardiography, Am | 1990 |
[Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Electrocardiography, Am | 1990 |
Antiarrhythmic effect of chronic oral amiodarone treatment in dogs with myocardial infarction and reproducibly inducible sustained ventricular arrhythmias.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Electric Stimulation; Elect | 1990 |
Antiarrhythmic effect of chronic oral amiodarone treatment in dogs with myocardial infarction and reproducibly inducible sustained ventricular arrhythmias.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Electric Stimulation; Elect | 1990 |
Effects of amiodarone on cardiac electrophysiology and inducibility of arrhythmias in chronically infarcted dogs: late arrhythmias, haemodynamics, and sympatholytic actions.
Topics: Action Potentials; Amiodarone; Animals; Arrhythmias, Cardiac; Chronic Disease; Dogs; Electrocardiogr | 1990 |
Effects of amiodarone on cardiac electrophysiology and inducibility of arrhythmias in chronically infarcted dogs: late arrhythmias, haemodynamics, and sympatholytic actions.
Topics: Action Potentials; Amiodarone; Animals; Arrhythmias, Cardiac; Chronic Disease; Dogs; Electrocardiogr | 1990 |
[Long-term treatment with amiodarone].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Elec | 1991 |
[Long-term treatment with amiodarone].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Elec | 1991 |
[Amidaron-induced dermatopathy resulting from unnecessary Cordarone therapy of ventricular parasystole].
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cyanosis; Diagnostic Errors; Drug Er | 1991 |
[Amidaron-induced dermatopathy resulting from unnecessary Cordarone therapy of ventricular parasystole].
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cyanosis; Diagnostic Errors; Drug Er | 1991 |
Postoperative unilateral pulmonary edema: possible amiodarone pulmonary toxicity.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Electric Countershock; Humans; Male; Middle Aged; Prostheses | 1992 |
Postoperative unilateral pulmonary edema: possible amiodarone pulmonary toxicity.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Electric Countershock; Humans; Male; Middle Aged; Prostheses | 1992 |
Antiarrhythmics and VPD suppression.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Survival Analysis | 1991 |
Antiarrhythmics and VPD suppression.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Survival Analysis | 1991 |
Early hepatitis during intravenous amiodarone administration.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Chemical and Drug Induced Liver Injury; Humans; Infusions, I | 1991 |
Early hepatitis during intravenous amiodarone administration.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Chemical and Drug Induced Liver Injury; Humans; Infusions, I | 1991 |
Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs. Antiarrhythmic Drug Evaluation Group (ADEG).
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocar | 1991 |
Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs. Antiarrhythmic Drug Evaluation Group (ADEG).
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocar | 1991 |
Relationship between myocardial amiodarone concentration and antiarrhythmic effect in dogs with myocardial infarction and electrically induced ventricular arrhythmias.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Electric Stimulation; Heart | 1991 |
Relationship between myocardial amiodarone concentration and antiarrhythmic effect in dogs with myocardial infarction and electrically induced ventricular arrhythmias.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Electric Stimulation; Heart | 1991 |
Influence of amiodarone on genetically determined drug metabolism in humans.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Arylamine N-Acetyltransferase; Cyt | 1991 |
Influence of amiodarone on genetically determined drug metabolism in humans.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Arylamine N-Acetyltransferase; Cyt | 1991 |
[Cytologic changes in bronchoalveolar lavage in amiodarone treated patients].
Topics: Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Bronchoalveolar Lavage Fluid; Bronchoscop | 1991 |
[Cytologic changes in bronchoalveolar lavage in amiodarone treated patients].
Topics: Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Bronchoalveolar Lavage Fluid; Bronchoscop | 1991 |
[Treatment of arrhythmias in chronic cardiac insufficiency].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disea | 1990 |
[Treatment of arrhythmias in chronic cardiac insufficiency].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disea | 1990 |
Amiodarone versus bretylium for suppression of reperfusion arrhythmias in dogs.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Blood Pressure; Bretylium Compounds; Dogs; Drug Evaluatio | 1991 |
Amiodarone versus bretylium for suppression of reperfusion arrhythmias in dogs.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Blood Pressure; Bretylium Compounds; Dogs; Drug Evaluatio | 1991 |
Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cardiomyopathy, Hypertrophic; Death, S | 1991 |
Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cardiomyopathy, Hypertrophic; Death, S | 1991 |
Low dose amiodarone in congestive heart failure.
Topics: Amiodarone; Arrhythmias, Cardiac; Heart Failure; Humans | 1991 |
Low dose amiodarone in congestive heart failure.
Topics: Amiodarone; Arrhythmias, Cardiac; Heart Failure; Humans | 1991 |
Continuous spinal anaesthesia for abdominal surgery in a patient receiving amiodarone.
Topics: Adenocarcinoma; Amiodarone; Anesthesia, Spinal; Arrhythmias, Cardiac; Bupivacaine; Colon; Colonic Ne | 1991 |
Continuous spinal anaesthesia for abdominal surgery in a patient receiving amiodarone.
Topics: Adenocarcinoma; Amiodarone; Anesthesia, Spinal; Arrhythmias, Cardiac; Bupivacaine; Colon; Colonic Ne | 1991 |
Plasma concentration time course and pharmacological effects of a standardized oral amiodarone dosing regimen in humans.
Topics: Administration, Oral; Aged; Amiodarone; Arrhythmias, Cardiac; Drug Administration Schedule; Electroc | 1991 |
Plasma concentration time course and pharmacological effects of a standardized oral amiodarone dosing regimen in humans.
Topics: Administration, Oral; Aged; Amiodarone; Arrhythmias, Cardiac; Drug Administration Schedule; Electroc | 1991 |
Designing clinical trials in the post CAST era--where do we go from here?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudden; F | 1991 |
Designing clinical trials in the post CAST era--where do we go from here?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudden; F | 1991 |
[An attempt to use cordarone in the treatment of rhythm disorders in patients with circulatory insufficiency].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Digoxin; Drug Therapy, Combination; Femal | 1991 |
[An attempt to use cordarone in the treatment of rhythm disorders in patients with circulatory insufficiency].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Digoxin; Drug Therapy, Combination; Femal | 1991 |
Effects of amiodarone on serum lipoprotein levels.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Hum | 1991 |
Effects of amiodarone on serum lipoprotein levels.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Hum | 1991 |
[Effect of amiodarone and disopyramide on the results of electrocardiographic exercise stress testing in patients with coronary disease].
Topics: Amiodarone; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Electrocardiography; Exercise Test | 1990 |
[Effect of amiodarone and disopyramide on the results of electrocardiographic exercise stress testing in patients with coronary disease].
Topics: Amiodarone; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Electrocardiography; Exercise Test | 1990 |
Serious interactions of sotalol with amiodarone and flecainide.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Drug Administration Schedule; Drug Interactions; Drug Therap | 1990 |
Serious interactions of sotalol with amiodarone and flecainide.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Drug Administration Schedule; Drug Interactions; Drug Therap | 1990 |
Flecainide acetate dose-concentration relationship in cardiac arrhythmias: influence of heart failure and amiodarone.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Body Weight; Dose-Response Relationship, Drug; Drug I | 1990 |
Flecainide acetate dose-concentration relationship in cardiac arrhythmias: influence of heart failure and amiodarone.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Body Weight; Dose-Response Relationship, Drug; Drug I | 1990 |
[Postoperative hyperkinetic arrhythmias treated with amiodarone].
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Drug Evaluation; Electrocardiography; Humans; | 1990 |
[Postoperative hyperkinetic arrhythmias treated with amiodarone].
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Drug Evaluation; Electrocardiography; Humans; | 1990 |
Amiodarone- and desethylamiodarone-induced myelinoid inclusion bodies and toxicity in cultured rat hepatocytes.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Inc | 1990 |
Amiodarone- and desethylamiodarone-induced myelinoid inclusion bodies and toxicity in cultured rat hepatocytes.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Inc | 1990 |
Effect of amiodarone on erythrocyte shape and membrane properties.
Topics: Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Cholesterol; Elasticity; Erythrocyte Defo | 1990 |
Effect of amiodarone on erythrocyte shape and membrane properties.
Topics: Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Cholesterol; Elasticity; Erythrocyte Defo | 1990 |
[The effectiveness of amiodarone seems to depend highly on the pathology underlying the arrhythmia].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Female; Heart Disea | 1990 |
[The effectiveness of amiodarone seems to depend highly on the pathology underlying the arrhythmia].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Female; Heart Disea | 1990 |
Reply to: Amiodarone and quinidine for postoperative atrial arrhythmias (J Thorac Cardiovasc Surg 1990;99:942)
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Humans; Quinidine | 1990 |
Reply to: Amiodarone and quinidine for postoperative atrial arrhythmias (J Thorac Cardiovasc Surg 1990;99:942)
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Humans; Quinidine | 1990 |
Rapid control of refractory atrial tachyarrhythmias with high-dose oral amiodarone.
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Drug Ev | 1990 |
Rapid control of refractory atrial tachyarrhythmias with high-dose oral amiodarone.
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Drug Ev | 1990 |
[Treatment of heart rhythm disorders].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart; Humans | 1990 |
[Treatment of heart rhythm disorders].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart; Humans | 1990 |
[Effects of cordarone on the contractile function of the left ventricle].
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Output; Echocardiography; Electrocardiography; Humans; Myo | 1990 |
[Effects of cordarone on the contractile function of the left ventricle].
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Output; Echocardiography; Electrocardiography; Humans; Myo | 1990 |
[Cardiac arrhythmias. Amiodarone liver].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Diagnosis, Differential; Female; Humans; Liver; Tomography, | 1990 |
[Cardiac arrhythmias. Amiodarone liver].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Diagnosis, Differential; Female; Humans; Liver; Tomography, | 1990 |
Acute treatment of torsades de pointes with amiodarone: proarrhythmic and antiarrhythmic association of QT prolongation.
Topics: Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Humans; Long QT Syndrome; Male; Middle Aged; | 1990 |
Acute treatment of torsades de pointes with amiodarone: proarrhythmic and antiarrhythmic association of QT prolongation.
Topics: Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Humans; Long QT Syndrome; Male; Middle Aged; | 1990 |
Amiodarone and anaesthesia.
Topics: Administration, Oral; Amiodarone; Anesthesia, General; Arrhythmias, Cardiac; Cardiac Surgical Proced | 1990 |
Amiodarone and anaesthesia.
Topics: Administration, Oral; Amiodarone; Anesthesia, General; Arrhythmias, Cardiac; Cardiac Surgical Proced | 1990 |
Long-term follow-up of amiodarone therapy in the young: continued efficacy, unimpaired growth, moderate side effects.
Topics: Adolescent; Adult; Amiodarone; Arrhythmias, Cardiac; Chemical and Drug Induced Liver Injury; Child; | 1990 |
Long-term follow-up of amiodarone therapy in the young: continued efficacy, unimpaired growth, moderate side effects.
Topics: Adolescent; Adult; Amiodarone; Arrhythmias, Cardiac; Chemical and Drug Induced Liver Injury; Child; | 1990 |
Amiodarone in children: borrowing from the future?
Topics: Amiodarone; Arrhythmias, Cardiac; Child; Humans | 1990 |
Amiodarone in children: borrowing from the future?
Topics: Amiodarone; Arrhythmias, Cardiac; Child; Humans | 1990 |
[Esophageal pacing in children. 38 consecutive cases].
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Child; Child, Preschool; E | 1990 |
[Esophageal pacing in children. 38 consecutive cases].
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Child; Child, Preschool; E | 1990 |
[Anti-arrhythmia therapy in transition?].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Output; Electrocardiography; Human | 1990 |
[Anti-arrhythmia therapy in transition?].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Output; Electrocardiography; Human | 1990 |
[Peculiarities of anti-arrhythmia treatment of heart failure].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Output; Heart Failure; Humans; Myo | 1990 |
[Peculiarities of anti-arrhythmia treatment of heart failure].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Output; Heart Failure; Humans; Myo | 1990 |
[Use of kordaron in parasystole].
Topics: Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Heart; Humans | 1990 |
[Use of kordaron in parasystole].
Topics: Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Heart; Humans | 1990 |
Interventional treatment for ventricular arrhythmias: the initial South Carolina case.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Coronary Disease; Drug Administration Schedule; Electric Cou | 1990 |
Interventional treatment for ventricular arrhythmias: the initial South Carolina case.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Coronary Disease; Drug Administration Schedule; Electric Cou | 1990 |
[Cardiac rhythm disorders after pneumonectomy].
Topics: Adenocarcinoma; Adult; Aged; Aging; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Carcinoma | 1985 |
[Cardiac rhythm disorders after pneumonectomy].
Topics: Adenocarcinoma; Adult; Aged; Aging; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Carcinoma | 1985 |
Antiarrhythmic drugs. Clinical pharmacology of the old and the new agents.
Topics: Acecainide; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden; Delayed-Action | 1985 |
Antiarrhythmic drugs. Clinical pharmacology of the old and the new agents.
Topics: Acecainide; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden; Delayed-Action | 1985 |
[Anti-arrhythmic action of combinations of trimecaine with quinidine, novocainamide and cordaron (clinico-experimental study)].
Topics: Acetanilides; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Cardiac Complexes, Premature; | 1985 |
[Anti-arrhythmic action of combinations of trimecaine with quinidine, novocainamide and cordaron (clinico-experimental study)].
Topics: Acetanilides; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Cardiac Complexes, Premature; | 1985 |
Monophasic action potential studies in human subjects with prolonged ventricular repolarization and long QT syndromes.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Bradycardia; Cardiac Complexes, Premature | 1985 |
Monophasic action potential studies in human subjects with prolonged ventricular repolarization and long QT syndromes.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Bradycardia; Cardiac Complexes, Premature | 1985 |
Delayed ventricular repolarization as an anti-arrhythmic principle.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bund | 1985 |
Delayed ventricular repolarization as an anti-arrhythmic principle.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bund | 1985 |
[Interstitial pneumopathy and amiodarone].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Complexes, Premature; Humans; Male; Pul | 1986 |
[Interstitial pneumopathy and amiodarone].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Complexes, Premature; Humans; Male; Pul | 1986 |
[Experience in using kordaron in parasystole and extrasystole].
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Drug Evaluation; Electrocardiography | 1986 |
[Experience in using kordaron in parasystole and extrasystole].
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Drug Evaluation; Electrocardiography | 1986 |
[Arrhythmia in patients with a DDD bicameral pacemaker].
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Electroc | 1986 |
[Arrhythmia in patients with a DDD bicameral pacemaker].
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Electroc | 1986 |
Amiodarone photoreactions.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Humans; Male; Middle Aged; Photosensitivity Disorders; Skin | 1987 |
Amiodarone photoreactions.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Humans; Male; Middle Aged; Photosensitivity Disorders; Skin | 1987 |
Effects of diet-induced hypokalaemia on the antiarrhythmic and electrophysiological actions of prolonged oral treatment with either amiodarone or disopyramide in the anaesthetised rat.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Diet; Disopyramid | 1987 |
Effects of diet-induced hypokalaemia on the antiarrhythmic and electrophysiological actions of prolonged oral treatment with either amiodarone or disopyramide in the anaesthetised rat.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Diet; Disopyramid | 1987 |
Treatment of ventricular arrhythmia after corrective cardiac surgery in a neonate with intravenous amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Female; Humans; Infant, Newborn; Infu | 1987 |
Treatment of ventricular arrhythmia after corrective cardiac surgery in a neonate with intravenous amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Female; Humans; Infant, Newborn; Infu | 1987 |
[Acute antiarrhythmia treatment with amiodarone and blood levels of thyroid hormones].
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Female; Humans; Male; Middle Aged; T | 1987 |
[Acute antiarrhythmia treatment with amiodarone and blood levels of thyroid hormones].
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Female; Humans; Male; Middle Aged; T | 1987 |
Clinical value of cordarone as an antiarrhythmic agent.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, P | 1987 |
Clinical value of cordarone as an antiarrhythmic agent.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, P | 1987 |
The antiarrhythmic efficacy of amiodarone and desethylamiodarone, alone and in combination, in dogs with acute myocardial infarction.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Dogs; Dose-Response Relatio | 1988 |
The antiarrhythmic efficacy of amiodarone and desethylamiodarone, alone and in combination, in dogs with acute myocardial infarction.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Dogs; Dose-Response Relatio | 1988 |
[Therapy resistance of amiodarone-induced hyperthyroidism].
Topics: Aged; Amiodarone; Antithyroid Agents; Arrhythmias, Cardiac; Drug Therapy, Combination; Female; Human | 1988 |
[Therapy resistance of amiodarone-induced hyperthyroidism].
Topics: Aged; Amiodarone; Antithyroid Agents; Arrhythmias, Cardiac; Drug Therapy, Combination; Female; Human | 1988 |
Antiarrhythmic effects of desethylamiodarone in dogs with subacute myocardial infarction and inducible ventricular arrhythmias.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Dogs; Electric Stimulation; Infusions, Intravenous; Male; | 1989 |
Antiarrhythmic effects of desethylamiodarone in dogs with subacute myocardial infarction and inducible ventricular arrhythmias.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Dogs; Electric Stimulation; Infusions, Intravenous; Male; | 1989 |
[Drug-induced major anomalies of ventricular repolarization masked by a left branch block].
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Beprid | 1989 |
[Drug-induced major anomalies of ventricular repolarization masked by a left branch block].
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Beprid | 1989 |
[Supraventricular tachyarrhythmia of recent onset in the absence of documented cardiac pathology: different therapeutic approaches].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Electric Countershock; | 1989 |
[Supraventricular tachyarrhythmia of recent onset in the absence of documented cardiac pathology: different therapeutic approaches].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Electric Countershock; | 1989 |
The electrophysiologic effects of enoximone in patients with preexisting ventricular tachyarrhythmias.
Topics: Administration, Oral; Aged; Amiodarone; Arrhythmias, Cardiac; Blood Pressure; Cardiac Pacing, Artifi | 1989 |
The electrophysiologic effects of enoximone in patients with preexisting ventricular tachyarrhythmias.
Topics: Administration, Oral; Aged; Amiodarone; Arrhythmias, Cardiac; Blood Pressure; Cardiac Pacing, Artifi | 1989 |
Treatment of amiodarone induced hyperthyroidism with potassium perchlorate and methimazole during amiodarone treatment.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Drug Evaluation; Drug Therapy, Combination; Humans; Hyperthy | 1989 |
Treatment of amiodarone induced hyperthyroidism with potassium perchlorate and methimazole during amiodarone treatment.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Drug Evaluation; Drug Therapy, Combination; Humans; Hyperthy | 1989 |
Characteristics, prognosis and treatment of the ventricular arrhythmias of right ventricular dysplasia.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardio | 1989 |
Characteristics, prognosis and treatment of the ventricular arrhythmias of right ventricular dysplasia.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardio | 1989 |
QT prolongation and arrhythmia suppression.
Topics: Acecainide; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Deafness; Death, Sudden; Elect | 1985 |
QT prolongation and arrhythmia suppression.
Topics: Acecainide; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Deafness; Death, Sudden; Elect | 1985 |
Control of cardiac arrhythmias by selective lengthening of repolarization: theoretic considerations and clinical observations.
Topics: Acecainide; Action Potentials; Amiodarone; Arrhythmias, Cardiac; Depression, Chemical; Electrocardio | 1985 |
Control of cardiac arrhythmias by selective lengthening of repolarization: theoretic considerations and clinical observations.
Topics: Acecainide; Action Potentials; Amiodarone; Arrhythmias, Cardiac; Depression, Chemical; Electrocardio | 1985 |
[Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, Pr | 1985 |
[Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, Pr | 1985 |
Amiodarone in chronic heart failure.
Topics: Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Chronic Disease; Heart F | 1989 |
Amiodarone in chronic heart failure.
Topics: Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Chronic Disease; Heart F | 1989 |
Anti-arrhythmic effects of amiodarone and desethylamiodarone on malignant ventricular arrhythmias arising as a consequence of ischaemia and reperfusion in the anaesthetised rat.
Topics: Amiodarone; Anesthesia, Intravenous; Animals; Arrhythmias, Cardiac; Coronary Disease; Heart Ventricl | 1989 |
Anti-arrhythmic effects of amiodarone and desethylamiodarone on malignant ventricular arrhythmias arising as a consequence of ischaemia and reperfusion in the anaesthetised rat.
Topics: Amiodarone; Anesthesia, Intravenous; Animals; Arrhythmias, Cardiac; Coronary Disease; Heart Ventricl | 1989 |
[Lung changes in amiodarone therapy].
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Male; Middle Aged; Pulmonary Fibrosis | 1989 |
[Lung changes in amiodarone therapy].
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Male; Middle Aged; Pulmonary Fibrosis | 1989 |
[Monitoring the effectiveness of amiodarone in the treatment of ventricular ectopic arrhythmias].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Electrocardiography; Fema | 1989 |
[Monitoring the effectiveness of amiodarone in the treatment of ventricular ectopic arrhythmias].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Electrocardiography; Fema | 1989 |
[Evaluation of the use of amiodarone in outpatients].
Topics: Adult; Ambulatory Care; Amiodarone; Arrhythmias, Cardiac; Female; Heart Rate; Humans; Male; Middle A | 1989 |
[Evaluation of the use of amiodarone in outpatients].
Topics: Adult; Ambulatory Care; Amiodarone; Arrhythmias, Cardiac; Female; Heart Rate; Humans; Male; Middle A | 1989 |
[Neuropathy caused by amiodarone: clinico-pathologic study of 2 cases].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Axons; Biopsy; Female; Humans; Lipid Metabolism; Male | 1989 |
[Neuropathy caused by amiodarone: clinico-pathologic study of 2 cases].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Axons; Biopsy; Female; Humans; Lipid Metabolism; Male | 1989 |
[Multicenter clinical trial on the prevention of sudden death after myocardial infarction by the use of anti-arrhythmia agents. Investigator Group of the Spanish Study on Sudden Death].
Topics: Amiodarone; Arrhythmias, Cardiac; Captopril; Death, Sudden; Humans; Metoprolol; Multicenter Studies | 1989 |
[Multicenter clinical trial on the prevention of sudden death after myocardial infarction by the use of anti-arrhythmia agents. Investigator Group of the Spanish Study on Sudden Death].
Topics: Amiodarone; Arrhythmias, Cardiac; Captopril; Death, Sudden; Humans; Metoprolol; Multicenter Studies | 1989 |
Long term efficacy and toxicity of amiodarone in the treatment of refractory cardiac arrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Brain; Cornea; Digestive System; Female; Follow-Up St | 1989 |
Long term efficacy and toxicity of amiodarone in the treatment of refractory cardiac arrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Brain; Cornea; Digestive System; Female; Follow-Up St | 1989 |
Ventricular arrhythmias--update on the use of amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Heart Ventricles; Humans | 1989 |
Ventricular arrhythmias--update on the use of amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Heart Ventricles; Humans | 1989 |
Long-term effects of amiodarone on hepatic function.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Female; Follow-Up Stud | 1989 |
Long-term effects of amiodarone on hepatic function.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Female; Follow-Up Stud | 1989 |
Amiodarone-induced pulmonary mass.
Topics: Amiodarone; Arrhythmias, Cardiac; Diagnosis, Differential; Humans; Lung Diseases; Lung Neoplasms; Ma | 1989 |
Amiodarone-induced pulmonary mass.
Topics: Amiodarone; Arrhythmias, Cardiac; Diagnosis, Differential; Humans; Lung Diseases; Lung Neoplasms; Ma | 1989 |
[Pneumonitis following amiodarone therapy].
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Male; Middle Aged; Pneumonia; Radiography | 1989 |
[Pneumonitis following amiodarone therapy].
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Male; Middle Aged; Pneumonia; Radiography | 1989 |
Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac | 1989 |
Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac | 1989 |
Amiodarone-induced complications after cardiac operation for obstructive hypertrophic cardiomyopathy.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Cardiac Output, Low; Cardiomyopathy, Hypertrophic; Chemical | 1989 |
Amiodarone-induced complications after cardiac operation for obstructive hypertrophic cardiomyopathy.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Cardiac Output, Low; Cardiomyopathy, Hypertrophic; Chemical | 1989 |
Amiodarone toxicity: recurrence of interstitial pneumonitis after withdrawal of the drug.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Male; Methylprednisolone; Middle Aged; Pulmonary Fibrosis; | 1989 |
Amiodarone toxicity: recurrence of interstitial pneumonitis after withdrawal of the drug.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Male; Methylprednisolone; Middle Aged; Pulmonary Fibrosis; | 1989 |
[Myocardial refractory changes after single intravenous administration of cordarone (electrophysiologic study of the heart)].
Topics: Amiodarone; Arrhythmias, Cardiac; Atrioventricular Node; Female; Heart Atria; Heart Conduction Syste | 1989 |
[Myocardial refractory changes after single intravenous administration of cordarone (electrophysiologic study of the heart)].
Topics: Amiodarone; Arrhythmias, Cardiac; Atrioventricular Node; Female; Heart Atria; Heart Conduction Syste | 1989 |
Comparative evaluation of antiarrhythmic agents.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardio | 1985 |
Comparative evaluation of antiarrhythmic agents.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardio | 1985 |
Drug interaction studies and encainide use in renal and hepatic impairment.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anilides; Anti-Arrhythmia Agents; Anticoagulants; An | 1986 |
Drug interaction studies and encainide use in renal and hepatic impairment.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anilides; Anti-Arrhythmia Agents; Anticoagulants; An | 1986 |
Antiarrhythmic effect of acute and chronic amiodarone treatment in conscious rats.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Coronary Vessels; Drug Administration Schedule; Ligation; | 1986 |
Antiarrhythmic effect of acute and chronic amiodarone treatment in conscious rats.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Coronary Vessels; Drug Administration Schedule; Ligation; | 1986 |
Antiarrhythmic effect of desethylamiodarone in conscious rats.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Injections, Intraperitoneal; Male | 1987 |
Antiarrhythmic effect of desethylamiodarone in conscious rats.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Injections, Intraperitoneal; Male | 1987 |
[Amiodarone therapy in childhood: efficacy and side effects].
Topics: Administration, Oral; Adolescent; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiomegaly; Child | 1985 |
[Amiodarone therapy in childhood: efficacy and side effects].
Topics: Administration, Oral; Adolescent; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiomegaly; Child | 1985 |
Amiodarone optic neuropathy.
Topics: Amiodarone; Arrhythmias, Cardiac; Disease Susceptibility; Humans; Optic Nerve Diseases | 1988 |
Amiodarone optic neuropathy.
Topics: Amiodarone; Arrhythmias, Cardiac; Disease Susceptibility; Humans; Optic Nerve Diseases | 1988 |
Amiodarone-induced hypothyroidism. A common complication of prolonged therapy: a report of eight cases.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Hypothyroidism; Iodides; Iodine | 1985 |
Amiodarone-induced hypothyroidism. A common complication of prolonged therapy: a report of eight cases.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Hypothyroidism; Iodides; Iodine | 1985 |
[Adverse effects during chronic treatment with low-dose amiodarone].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Drug Interactions; Eye Diseases; | 1985 |
[Adverse effects during chronic treatment with low-dose amiodarone].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Drug Interactions; Eye Diseases; | 1985 |
Amiodarone pulmonary toxicity: functional and ultrastructural evaluation.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Inclusion Bodies; Leukoc | 1986 |
Amiodarone pulmonary toxicity: functional and ultrastructural evaluation.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Inclusion Bodies; Leukoc | 1986 |
Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Captopril; Enalapril; Exercise Test; Female; Heart Fa | 1987 |
Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Captopril; Enalapril; Exercise Test; Female; Heart Fa | 1987 |
[Symposium: Sudden cardiac death. The importance of amiodarone in the treatment of life-threatening arrhythmia. Munich, 10-11 June 1988].
Topics: Amiodarone; Arrhythmias, Cardiac; Death, Sudden; Heart Arrest; Humans | 1988 |
[Symposium: Sudden cardiac death. The importance of amiodarone in the treatment of life-threatening arrhythmia. Munich, 10-11 June 1988].
Topics: Amiodarone; Arrhythmias, Cardiac; Death, Sudden; Heart Arrest; Humans | 1988 |
Efficacy of amiodarone in patients with Chagas' disease and life-threatening arrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Chagas Cardiomyopathy; Drug Evaluation; Humans; Progn | 1986 |
Efficacy of amiodarone in patients with Chagas' disease and life-threatening arrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Chagas Cardiomyopathy; Drug Evaluation; Humans; Progn | 1986 |
Use of amiodarone in childhood.
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Child, Preschool; Corneal Diseases | 1986 |
Use of amiodarone in childhood.
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Child, Preschool; Corneal Diseases | 1986 |
Intravenous amiodarone: UK clinical experience survey.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Child, Preschool; Dru | 1986 |
Intravenous amiodarone: UK clinical experience survey.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Child, Preschool; Dru | 1986 |
Amiodarone and the cardiomyopathies.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiomyopathies; Cardiomyopathy, Dilated; Car | 1986 |
Amiodarone and the cardiomyopathies.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiomyopathies; Cardiomyopathy, Dilated; Car | 1986 |
Human electrophysiology: mechanisms of arrhythmia prevention and the action of amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrophysiology; Heart; Humans | 1986 |
Human electrophysiology: mechanisms of arrhythmia prevention and the action of amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrophysiology; Heart; Humans | 1986 |
Newer antiarrhythmic drugs in children.
Topics: Adolescent; Adult; Amiodarone; Anilides; Arrhythmias, Cardiac; Child; Child, Preschool; Electrocardi | 1987 |
Newer antiarrhythmic drugs in children.
Topics: Adolescent; Adult; Amiodarone; Anilides; Arrhythmias, Cardiac; Child; Child, Preschool; Electrocardi | 1987 |
[Ultra-sensitive TSH levels: an aid in the screening for amiodarone-induced thyroid dysfunction].
Topics: Amiodarone; Arrhythmias, Cardiac; Female; Humans; Hyperthyroidism; Male; Middle Aged; Thyrotropin; T | 1986 |
[Ultra-sensitive TSH levels: an aid in the screening for amiodarone-induced thyroid dysfunction].
Topics: Amiodarone; Arrhythmias, Cardiac; Female; Humans; Hyperthyroidism; Male; Middle Aged; Thyrotropin; T | 1986 |
Determinants of hospital cost and length of stay for patients undergoing electrophysiologic testing.
Topics: Amiodarone; Arrhythmias, Cardiac; Costs and Cost Analysis; Diagnosis-Related Groups; Electrophysiolo | 1987 |
Determinants of hospital cost and length of stay for patients undergoing electrophysiologic testing.
Topics: Amiodarone; Arrhythmias, Cardiac; Costs and Cost Analysis; Diagnosis-Related Groups; Electrophysiolo | 1987 |
Association of seminal desethylamiodarone concentration and epididymitis with amiodarone treatment.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Epididymitis; Humans; Male; Semen | 1988 |
Association of seminal desethylamiodarone concentration and epididymitis with amiodarone treatment.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Epididymitis; Humans; Male; Semen | 1988 |
[Concentrations of amiodarone and flecainide in plasma and saliva--indications for the active transport of flecainide].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Biological Transport, Active; Fema | 1988 |
[Concentrations of amiodarone and flecainide in plasma and saliva--indications for the active transport of flecainide].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Biological Transport, Active; Fema | 1988 |
[Worsening of ventricular arrhythmia in the dynamic ECG in patients treated with anti-arrhythmia drugs].
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Therapy, Com | 1988 |
[Worsening of ventricular arrhythmia in the dynamic ECG in patients treated with anti-arrhythmia drugs].
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Therapy, Com | 1988 |
Side effects and complications of amiodarone therapy.
Topics: Amiodarone; Arrhythmias, Cardiac; Ataxia; Benzofurans; Drug Eruptions; Drug Interactions; Female; Ga | 1985 |
Side effects and complications of amiodarone therapy.
Topics: Amiodarone; Arrhythmias, Cardiac; Ataxia; Benzofurans; Drug Eruptions; Drug Interactions; Female; Ga | 1985 |
[Hyperpigmentation caused by amiodaron].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Eruptions; Facial Dermatoses; Humans; Male | 1985 |
[Hyperpigmentation caused by amiodaron].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Eruptions; Facial Dermatoses; Humans; Male | 1985 |
[Indications for subtotal thyroidectomy in patients with amiodarone- (iodine-) induced hyperthyroidism].
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Hyperthyroidism; Male; Middle Aged; Thyroidectomy | 1988 |
[Indications for subtotal thyroidectomy in patients with amiodarone- (iodine-) induced hyperthyroidism].
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Hyperthyroidism; Male; Middle Aged; Thyroidectomy | 1988 |
[Anti-arrhythmic action of 4'-methyl-7-([2-hydroxy-3-(beta-propinamidoethyl)amino]propoxy) flavone hydrochloride (SIPI-644)].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Female; Flavonoids; Flavono | 1988 |
[Anti-arrhythmic action of 4'-methyl-7-([2-hydroxy-3-(beta-propinamidoethyl)amino]propoxy) flavone hydrochloride (SIPI-644)].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Female; Flavonoids; Flavono | 1988 |
Spontaneous disappearance of blue-gray facial pigmentation during amiodarone therapy (out of the blue).
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Humans; Male; Photosensiti | 1988 |
Spontaneous disappearance of blue-gray facial pigmentation during amiodarone therapy (out of the blue).
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Humans; Male; Photosensiti | 1988 |
[A combination of kordaron with ritmilen: its effect on the electrophysiology of the heart and its clinical effectiveness].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Disopyramide; | 1988 |
[A combination of kordaron with ritmilen: its effect on the electrophysiology of the heart and its clinical effectiveness].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Disopyramide; | 1988 |
[Effect of cordarone on the eye (results of long-term follow-up of the treatment and prevention of arrhythmia)].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Corneal Diseases; Dose-Response Relationship, Drug; F | 1988 |
[Effect of cordarone on the eye (results of long-term follow-up of the treatment and prevention of arrhythmia)].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Corneal Diseases; Dose-Response Relationship, Drug; F | 1988 |
Effects of low doses of amiodarone on cardiac arrhythmias in patients with chronic ischaemic heart disease.
Topics: Aged; Amiodarone; Angiocardiography; Arrhythmias, Cardiac; Coronary Disease; Dose-Response Relations | 1988 |
Effects of low doses of amiodarone on cardiac arrhythmias in patients with chronic ischaemic heart disease.
Topics: Aged; Amiodarone; Angiocardiography; Arrhythmias, Cardiac; Coronary Disease; Dose-Response Relations | 1988 |
Amiodarone drug interactions: potential beneficial and adverse effects.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Interactions; Humans | 1987 |
Amiodarone drug interactions: potential beneficial and adverse effects.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Interactions; Humans | 1987 |
Arrhythmias in heart failure--the role of amiodarone.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Death, Sudden; Female; Follow-Up Studies; Heart Failure; Hum | 1988 |
Arrhythmias in heart failure--the role of amiodarone.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Death, Sudden; Female; Follow-Up Studies; Heart Failure; Hum | 1988 |
Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Corneal Diseases; Female; Follow-Up Studies; Humans; Male; M | 1988 |
Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Corneal Diseases; Female; Follow-Up Studies; Humans; Male; M | 1988 |
[Clinico-pharmacological interactions of digoxin with ethmozine, disopyramide and amiodarone].
Topics: Amiodarone; Arrhythmias, Cardiac; Coronary Disease; Digoxin; Disopyramide; Drug Synergism; Drug Ther | 1988 |
[Clinico-pharmacological interactions of digoxin with ethmozine, disopyramide and amiodarone].
Topics: Amiodarone; Arrhythmias, Cardiac; Coronary Disease; Digoxin; Disopyramide; Drug Synergism; Drug Ther | 1988 |
Safety and efficacy of amiodarone. The low-dose perspective.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; E | 1988 |
Safety and efficacy of amiodarone. The low-dose perspective.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; E | 1988 |
Effects of amiodarone therapy on thyroid iodine content as measured by x-ray fluorescence.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Hyperthyroidism; H | 1988 |
Effects of amiodarone therapy on thyroid iodine content as measured by x-ray fluorescence.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Hyperthyroidism; H | 1988 |
Effect on growth of children with cardiac dysrhythmias treated with amiodarone.
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Body Constitution; Bone Development; Child; Child, Pre | 1988 |
Effect on growth of children with cardiac dysrhythmias treated with amiodarone.
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Body Constitution; Bone Development; Child; Child, Pre | 1988 |
Lessons learned from the automatic implantable cardioverter-defibrillator: past, present and future.
Topics: Amiodarone; Arrhythmias, Cardiac; Electric Countershock; Electrocardiography; Electrodes, Implanted; | 1988 |
Lessons learned from the automatic implantable cardioverter-defibrillator: past, present and future.
Topics: Amiodarone; Arrhythmias, Cardiac; Electric Countershock; Electrocardiography; Electrodes, Implanted; | 1988 |
The automatic implantable cardioverter-defibrillator: efficacy, complications and survival in patients with malignant ventricular arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Electric Countershock; Electrodes, Implan | 1988 |
The automatic implantable cardioverter-defibrillator: efficacy, complications and survival in patients with malignant ventricular arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Electric Countershock; Electrodes, Implan | 1988 |
Noncardiac side-effects of long-term oral amiodarone in the elderly.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Aspartate Aminotran | 1988 |
Noncardiac side-effects of long-term oral amiodarone in the elderly.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Aspartate Aminotran | 1988 |
Gallium lung scintigraphy in amiodarone pulmonary toxicity.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Female; Gallium Radioisotopes; Hum | 1988 |
Gallium lung scintigraphy in amiodarone pulmonary toxicity.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Female; Gallium Radioisotopes; Hum | 1988 |
Concentration response relationships of amiodarone and desethylamiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Electrocardiography; Humans; Tim | 1988 |
Concentration response relationships of amiodarone and desethylamiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Electrocardiography; Humans; Tim | 1988 |
Amiodarone and thyroid status in refractory arrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Drug Evaluation; El | 1988 |
Amiodarone and thyroid status in refractory arrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Drug Evaluation; El | 1988 |
Anti-amiodarone antibodies: detection and relationship to the development of side effects.
Topics: Adult; Aged; Amiodarone; Antibodies; Arrhythmias, Cardiac; Female; Humans; Immunoassay; Male; Middle | 1988 |
Anti-amiodarone antibodies: detection and relationship to the development of side effects.
Topics: Adult; Aged; Amiodarone; Antibodies; Arrhythmias, Cardiac; Female; Humans; Immunoassay; Male; Middle | 1988 |
Elevation of serum total cholesterol and triglyceride levels during amiodarone therapy.
Topics: Amiodarone; Arrhythmias, Cardiac; Cholesterol; Coronary Disease; Female; Humans; Longitudinal Studie | 1988 |
Elevation of serum total cholesterol and triglyceride levels during amiodarone therapy.
Topics: Amiodarone; Arrhythmias, Cardiac; Cholesterol; Coronary Disease; Female; Humans; Longitudinal Studie | 1988 |
Reye's syndrome-like illness in a patient receiving amiodarone.
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Humans; Liver; Male; Reye Syndrome | 1988 |
Reye's syndrome-like illness in a patient receiving amiodarone.
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Humans; Liver; Male; Reye Syndrome | 1988 |
Efficacy and safety of intravenous amiodarone in acute refractory arrhythmias.
Topics: Acute Disease; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Female; Heart Ventricles; Humans; Infu | 1988 |
Efficacy and safety of intravenous amiodarone in acute refractory arrhythmias.
Topics: Acute Disease; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Female; Heart Ventricles; Humans; Infu | 1988 |
Use of intravenous amiodarone for emergency treatment of life-threatening ventricular arrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Bradycardia; Cardiac Pacing, Artificial; Electrocardiography; Emer | 1988 |
Use of intravenous amiodarone for emergency treatment of life-threatening ventricular arrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Bradycardia; Cardiac Pacing, Artificial; Electrocardiography; Emer | 1988 |
Myopathy during amiodarone treatment: a case report.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Biopsy; Electromyography; Female; Heart Ventricles; Humans; | 1987 |
Myopathy during amiodarone treatment: a case report.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Biopsy; Electromyography; Female; Heart Ventricles; Humans; | 1987 |
Bronchoalveolar lavage cellular analysis and gallium lung scan in the assessment of patients with amiodarone-induced pneumonitis.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Bronchoalveolar Lavage Fluid; Coronary Disease; Follo | 1987 |
Bronchoalveolar lavage cellular analysis and gallium lung scan in the assessment of patients with amiodarone-induced pneumonitis.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Bronchoalveolar Lavage Fluid; Coronary Disease; Follo | 1987 |
Amiodarone for recurring ventricular arrhythmias: assessment by 24-hour Holter ambulatory electrocardiography.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Female; Heart | 1986 |
Amiodarone for recurring ventricular arrhythmias: assessment by 24-hour Holter ambulatory electrocardiography.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Female; Heart | 1986 |
Effect of amiodarone on coronary reperfusion-induced ventricular arrhythmias in dogs.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Coronary Circulation; Coronary Disease; Dogs; Female; Mal | 1986 |
Effect of amiodarone on coronary reperfusion-induced ventricular arrhythmias in dogs.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Coronary Circulation; Coronary Disease; Dogs; Female; Mal | 1986 |
Amiodarone: therapeutic but toxic.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans | 1987 |
Amiodarone: therapeutic but toxic.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans | 1987 |
A comparison of bepridil with amiodarone in the treatment of established atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Bepridil; Chron | 1987 |
A comparison of bepridil with amiodarone in the treatment of established atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Bepridil; Chron | 1987 |
[Ambulatory ECG in cardiomyopathies].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Cardiomyopathy, Dilated; | 1987 |
[Ambulatory ECG in cardiomyopathies].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Cardiomyopathy, Dilated; | 1987 |
Asystole produced by the combination of amiodarone and digoxin.
Topics: Amiodarone; Arrhythmias, Cardiac; Digoxin; Drug Interactions; Electrocardiography; Heart Arrest; Hum | 1987 |
Asystole produced by the combination of amiodarone and digoxin.
Topics: Amiodarone; Arrhythmias, Cardiac; Digoxin; Drug Interactions; Electrocardiography; Heart Arrest; Hum | 1987 |
[Complications after oral and intravenous administration of amiodarone (cordaron)].
Topics: Administration, Oral; Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Hyp | 1986 |
[Complications after oral and intravenous administration of amiodarone (cordaron)].
Topics: Administration, Oral; Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Hyp | 1986 |
Antiarrhythmic and hemodynamic effects of prifuroline.
Topics: Amiodarone; Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electric Stim | 1986 |
Antiarrhythmic and hemodynamic effects of prifuroline.
Topics: Amiodarone; Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electric Stim | 1986 |
Relation between amiodarone and desethylamiodarone plasma concentrations and electrophysiologic effects, efficacy and toxicity.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Coronary Disease; Dose-Response Relationship, Drug; Electroc | 1987 |
Relation between amiodarone and desethylamiodarone plasma concentrations and electrophysiologic effects, efficacy and toxicity.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Coronary Disease; Dose-Response Relationship, Drug; Electroc | 1987 |
Life-threatening postoperative pulmonary complications in patients with previous amiodarone pulmonary toxicity undergoing cardiothoracic operations.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Female; Heart Diseases; Humans; Male; Middle Aged; Postopera | 1987 |
Life-threatening postoperative pulmonary complications in patients with previous amiodarone pulmonary toxicity undergoing cardiothoracic operations.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Female; Heart Diseases; Humans; Male; Middle Aged; Postopera | 1987 |
[Pulmonary toxicity associated with the use of amiodarone].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Lung; Male; Middle Aged; Pulmonary Fibrosis; | 1986 |
[Pulmonary toxicity associated with the use of amiodarone].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Lung; Male; Middle Aged; Pulmonary Fibrosis; | 1986 |
Arrhythmogenesis--a European perspective.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Utilization; Europe; Humans; Mexileti | 1987 |
Arrhythmogenesis--a European perspective.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Utilization; Europe; Humans; Mexileti | 1987 |
Intravenous amiodarone for malignant dysrhythmias of hypertrophic cardiomyopathy.
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Humans; Injections, Intr | 1987 |
Intravenous amiodarone for malignant dysrhythmias of hypertrophic cardiomyopathy.
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Humans; Injections, Intr | 1987 |
Pseudotumor cerebri with amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Heart Ventricles; Humans; Male; Middle Aged; Pseudotumor Cerebri | 1987 |
Pseudotumor cerebri with amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Heart Ventricles; Humans; Male; Middle Aged; Pseudotumor Cerebri | 1987 |
Alterations in thyroid function induced by chronic administration of amiodarone.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Euthyroid Sick Syndromes; Female; Humans; Hyperthyroi | 1987 |
Alterations in thyroid function induced by chronic administration of amiodarone.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Euthyroid Sick Syndromes; Female; Humans; Hyperthyroi | 1987 |
Usefulness of electrophysiologic study to determine the clinical tolerance of arrhythmia recurrences during amiodarone therapy.
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Electrophysiology; Follow-Up Studies; | 1987 |
Usefulness of electrophysiologic study to determine the clinical tolerance of arrhythmia recurrences during amiodarone therapy.
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Electrophysiology; Follow-Up Studies; | 1987 |
Electrophysiologic testing and follow-up of patients with aborted sudden death.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Catheteri | 1987 |
Electrophysiologic testing and follow-up of patients with aborted sudden death.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Catheteri | 1987 |
Relationship of steady-state serum concentrations of amiodarone and desethylamiodarone to therapeutic efficacy and adverse effects.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; | 1987 |
Relationship of steady-state serum concentrations of amiodarone and desethylamiodarone to therapeutic efficacy and adverse effects.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; | 1987 |
Amiodarone induced encephalopathy and diabetes insipidus.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Basal Ganglia Diseases; Brain Stem; Diabetes Insipidus; Huma | 1987 |
Amiodarone induced encephalopathy and diabetes insipidus.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Basal Ganglia Diseases; Brain Stem; Diabetes Insipidus; Huma | 1987 |
[3-week saturation with amiodarone before heart valve surgery. Study of postoperative rhythm disorders and plasma and myocardial levels of amiodarone].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Drug Administration Schedule; Elec | 1987 |
[3-week saturation with amiodarone before heart valve surgery. Study of postoperative rhythm disorders and plasma and myocardial levels of amiodarone].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Drug Administration Schedule; Elec | 1987 |
Predictors of efficacy of amiodarone and characteristics of recurrence of arrhythmia in patients with sustained ventricular tachycardia and coronary artery disease.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Coronary Disease; Female; Follow | 1987 |
Predictors of efficacy of amiodarone and characteristics of recurrence of arrhythmia in patients with sustained ventricular tachycardia and coronary artery disease.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Coronary Disease; Female; Follow | 1987 |
[Usefulness of the electrophysiologic study in the prognostic evaluation of patients with syncope of uncertain origin].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Female; Follo | 1987 |
[Usefulness of the electrophysiologic study in the prognostic evaluation of patients with syncope of uncertain origin].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Female; Follo | 1987 |
Amiodarone--phenytoin interaction.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Drug Interactions; Humans; Male; Phenytoin | 1987 |
Amiodarone--phenytoin interaction.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Drug Interactions; Humans; Male; Phenytoin | 1987 |
[Hyperthyroidism during treatment with amiodarone in the light of observations of 7 cases].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Hyperthyroidism; Male; Middle Aged | 1987 |
[Hyperthyroidism during treatment with amiodarone in the light of observations of 7 cases].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Hyperthyroidism; Male; Middle Aged | 1987 |
Dissociation of electrophysiologic and pharmacologic stability during an abbreviated oral loading regimen of amiodarone.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Chromatography, High Pressure Liquid; Drug Administration Sc | 1987 |
Dissociation of electrophysiologic and pharmacologic stability during an abbreviated oral loading regimen of amiodarone.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Chromatography, High Pressure Liquid; Drug Administration Sc | 1987 |
The relationship between the QT interval and plasma amiodarone concentration in patients on long-term therapy.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Female; Heart Rate; Humans; Male | 1987 |
The relationship between the QT interval and plasma amiodarone concentration in patients on long-term therapy.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Female; Heart Rate; Humans; Male | 1987 |
Rapid suppression of complex ventricular arrhythmias with high-dose oral amiodarone.
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Administration Schedule; E | 1986 |
Rapid suppression of complex ventricular arrhythmias with high-dose oral amiodarone.
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Administration Schedule; E | 1986 |
Amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Interactions; Heart Diseases; Heart Ventricles; | 1986 |
Amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Interactions; Heart Diseases; Heart Ventricles; | 1986 |
Amiodarone therapy effects on childhood thyroid function.
Topics: Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Child; Chi | 1986 |
Amiodarone therapy effects on childhood thyroid function.
Topics: Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Child; Chi | 1986 |
Probable early acute hepatitis with parenteral amiodarone.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Biopsy; Chemical and Drug Induced Liver Injury; | 1986 |
Probable early acute hepatitis with parenteral amiodarone.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Biopsy; Chemical and Drug Induced Liver Injury; | 1986 |
Amiodarone-induced torsades de pointes.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Benzofurans; Dru | 1986 |
Amiodarone-induced torsades de pointes.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Benzofurans; Dru | 1986 |
Amiodarone and desethylamiodarone distribution in the atrium and adipose tissue of patients undergoing short- and long-term treatment with amiodarone.
Topics: Adipose Tissue; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Surgical Procedu | 1986 |
Amiodarone and desethylamiodarone distribution in the atrium and adipose tissue of patients undergoing short- and long-term treatment with amiodarone.
Topics: Adipose Tissue; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Surgical Procedu | 1986 |
Long-term tolerance of amiodarone treatment for cardiac arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Child, Preschool; Dru | 1986 |
Long-term tolerance of amiodarone treatment for cardiac arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Child, Preschool; Dru | 1986 |
An experimental approach to the choice of antiarrhythmic therapy.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cats; Coronary Disease; Diltiazem | 1986 |
An experimental approach to the choice of antiarrhythmic therapy.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cats; Coronary Disease; Diltiazem | 1986 |
[Amiodarone (Cordarone). A very effective anti-arrhythmia agent with many side-effects].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans | 1986 |
[Amiodarone (Cordarone). A very effective anti-arrhythmia agent with many side-effects].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans | 1986 |
[Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Therapy, Combination; Electrocardio | 1986 |
[Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Therapy, Combination; Electrocardio | 1986 |
Evidence for an inhibition of thyroid hormone effects during chronic treatment with amiodarone.
Topics: Adolescent; Adult; Aged; Amiodarone; Antithyroid Agents; Arrhythmias, Cardiac; Benzofurans; Female; | 1986 |
Evidence for an inhibition of thyroid hormone effects during chronic treatment with amiodarone.
Topics: Adolescent; Adult; Aged; Amiodarone; Antithyroid Agents; Arrhythmias, Cardiac; Benzofurans; Female; | 1986 |
Clinical significance of bifid T waves.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Cerebrovascular Disorders; Child; Child, Preschool; Electro | 1986 |
Clinical significance of bifid T waves.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Cerebrovascular Disorders; Child; Child, Preschool; Electro | 1986 |
New antiarrhythmic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Flecainide; Humans; Kinetics; Mexiletine; | 1986 |
New antiarrhythmic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Flecainide; Humans; Kinetics; Mexiletine; | 1986 |
Intravenous and oral amiodarone for arrhythmias in children.
Topics: Administration, Oral; Adolescent; Amiodarone; Arrhythmias, Cardiac; Atrial Flutter; Child; Child, Pr | 1986 |
Intravenous and oral amiodarone for arrhythmias in children.
Topics: Administration, Oral; Adolescent; Amiodarone; Arrhythmias, Cardiac; Atrial Flutter; Child; Child, Pr | 1986 |
[Combined amiodarone and quinidine treatment in refractory tachyarrhythmias; clinical observation and experimental electrophysiologic study].
Topics: Action Potentials; Adult; Aged; Amiodarone; Animals; Arrhythmias, Cardiac; Drug Therapy, Combination | 1986 |
[Combined amiodarone and quinidine treatment in refractory tachyarrhythmias; clinical observation and experimental electrophysiologic study].
Topics: Action Potentials; Adult; Aged; Amiodarone; Animals; Arrhythmias, Cardiac; Drug Therapy, Combination | 1986 |
Predictive value of electrophysiologic testing in the treatment of drug-refractory ventricular arrhythmias with amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Electrophysiology; Female; Heart Ventricles; Hemodynamics; Humans; | 1986 |
Predictive value of electrophysiologic testing in the treatment of drug-refractory ventricular arrhythmias with amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Electrophysiology; Female; Heart Ventricles; Hemodynamics; Humans; | 1986 |
[Amiodarone-induced hyperpigmentation].
Topics: Aged; Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Photosen | 1986 |
[Amiodarone-induced hyperpigmentation].
Topics: Aged; Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Photosen | 1986 |
Amiodarone, thyroid hormone indexes, and altered thyroid function: long-term serial effects in patients with cardiac arrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Thyroid Diseases; Thyroid Funct | 1986 |
Amiodarone, thyroid hormone indexes, and altered thyroid function: long-term serial effects in patients with cardiac arrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Thyroid Diseases; Thyroid Funct | 1986 |
Combined therapy with disopyramide and amiodarone: a report of 11 cases.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Disopyramide; Drug Therapy, Combination; Female; Huma | 1986 |
Combined therapy with disopyramide and amiodarone: a report of 11 cases.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Disopyramide; Drug Therapy, Combination; Female; Huma | 1986 |
Thyroid dysfunction during chronic amiodarone therapy.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Cholesterol; Female; Humans; Hyperthyroidism; Hypothyroidism | 1987 |
Thyroid dysfunction during chronic amiodarone therapy.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Cholesterol; Female; Humans; Hyperthyroidism; Hypothyroidism | 1987 |
Amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans | 1986 |
Amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans | 1986 |
Ventricular arrhythmias in dilated cardiomyopathy: efficacy of amiodarone.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, D | 1987 |
Ventricular arrhythmias in dilated cardiomyopathy: efficacy of amiodarone.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, D | 1987 |
Papillopathy caused by amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Drug Therapy, Combination; Eye Hemorrhage; Humans; Male; Middle Ag | 1987 |
Papillopathy caused by amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Drug Therapy, Combination; Eye Hemorrhage; Humans; Male; Middle Ag | 1987 |
Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Biotransformation; Chromatography, High Pres | 1985 |
Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Biotransformation; Chromatography, High Pres | 1985 |
Asystole during treatment with amiodarone in a patient with persistent atrial tachycardia.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Digoxin; Drug Therapy, | 1985 |
Asystole during treatment with amiodarone in a patient with persistent atrial tachycardia.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Digoxin; Drug Therapy, | 1985 |
Treatment of fetal cardiac arrhythmias.
Topics: Amiodarone; Arrhythmia, Sinus; Arrhythmias, Cardiac; Chromosome Aberrations; Chromosome Disorders; D | 1985 |
Treatment of fetal cardiac arrhythmias.
Topics: Amiodarone; Arrhythmia, Sinus; Arrhythmias, Cardiac; Chromosome Aberrations; Chromosome Disorders; D | 1985 |
Amiodarone-treated patients with suppressed TSH test are at risk of thyrotoxicosis.
Topics: Adolescent; Adult; Aged; Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Female; Hum | 1985 |
Amiodarone-treated patients with suppressed TSH test are at risk of thyrotoxicosis.
Topics: Adolescent; Adult; Aged; Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Female; Hum | 1985 |
Amiodarone. The dilemma of hyperthyroxinaemia and the treatment of thyrotoxicosis.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Carbimazole; Coronary Disease; Humans; Hyperthy | 1985 |
Amiodarone. The dilemma of hyperthyroxinaemia and the treatment of thyrotoxicosis.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Carbimazole; Coronary Disease; Humans; Hyperthy | 1985 |
[Anti-arrhythmic effect of amiodarone in the 24 hours following a single oral loading dose. Clinical and pharmacological study].
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Dru | 1985 |
[Anti-arrhythmic effect of amiodarone in the 24 hours following a single oral loading dose. Clinical and pharmacological study].
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Dru | 1985 |
Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Coronary Disease; Female; Hu | 1985 |
Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Coronary Disease; Female; Hu | 1985 |
QT prolongation and the antiarrhythmic efficacy of amiodarone.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Pacing, Artificial; Electrocardiography | 1986 |
QT prolongation and the antiarrhythmic efficacy of amiodarone.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Pacing, Artificial; Electrocardiography | 1986 |
Role of electrophysiologic studies in identifying arrhythmogenic properties of antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electric Stimulation; Electrophysiology; H | 1986 |
Role of electrophysiologic studies in identifying arrhythmogenic properties of antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electric Stimulation; Electrophysiology; H | 1986 |
Amiodarone for refractory cardiac arrhythmias: 10-year study.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Coro | 1986 |
Amiodarone for refractory cardiac arrhythmias: 10-year study.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Coro | 1986 |
Thyroxine and triiodothyronine kinetics in cardiac patients taking amiodarone.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Humans; Kinetics; Middl | 1986 |
Thyroxine and triiodothyronine kinetics in cardiac patients taking amiodarone.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Humans; Kinetics; Middl | 1986 |
Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Blood Pressure; Dopamine; Electrocardiog | 1986 |
Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Blood Pressure; Dopamine; Electrocardiog | 1986 |
Interrelationships between serum levels of amiodarone, desethylamiodarone, reverse T3 and the QT interval during long-term amiodarone treatment.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Female; Follow-Up S | 1986 |
Interrelationships between serum levels of amiodarone, desethylamiodarone, reverse T3 and the QT interval during long-term amiodarone treatment.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Female; Follow-Up S | 1986 |
Amiodarone, phaeochromocytoma and cardiomyopathy.
Topics: Adrenal Gland Neoplasms; Aged; Amiodarone; Anesthesia, General; Arrhythmias, Cardiac; Benzofurans; C | 1986 |
Amiodarone, phaeochromocytoma and cardiomyopathy.
Topics: Adrenal Gland Neoplasms; Aged; Amiodarone; Anesthesia, General; Arrhythmias, Cardiac; Benzofurans; C | 1986 |
Comparative antiarrhythmic efficacy of verapamil, 17-monochloracetylajmaline, mexiletine and amiodarone in patients with severe chagasic myocarditis: relation with the underlying arrhythmogenic mechanisms.
Topics: Adult; Ajmaline; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Chagas Cardiomyopathy; Female; Human | 1986 |
Comparative antiarrhythmic efficacy of verapamil, 17-monochloracetylajmaline, mexiletine and amiodarone in patients with severe chagasic myocarditis: relation with the underlying arrhythmogenic mechanisms.
Topics: Adult; Ajmaline; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Chagas Cardiomyopathy; Female; Human | 1986 |
Flecainide and amiodarone interaction.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Interactions; Female; Flecainide; H | 1986 |
Flecainide and amiodarone interaction.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Interactions; Female; Flecainide; H | 1986 |
Intravenous and oral loading versus oral loading alone with amiodarone for chronic refractory ventricular arrhythmias.
Topics: Administration, Oral; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Chronic Disease; Heart Ve | 1985 |
Intravenous and oral loading versus oral loading alone with amiodarone for chronic refractory ventricular arrhythmias.
Topics: Administration, Oral; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Chronic Disease; Heart Ve | 1985 |
Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone.
Topics: Adult; Aged; Ambulatory Care; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; El | 1985 |
Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone.
Topics: Adult; Aged; Ambulatory Care; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; El | 1985 |
Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrioventr | 1985 |
Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrioventr | 1985 |
Effect of peripheral thyroid hormone metabolism on cardiac arrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Iopanoic Acid; Male; Middle Aged | 1985 |
Effect of peripheral thyroid hormone metabolism on cardiac arrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Iopanoic Acid; Male; Middle Aged | 1985 |
Effect of long-term amiodarone therapy on thyroid hormone levels and thyroid function.
Topics: Age Factors; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Hyperthyroidism; H | 1985 |
Effect of long-term amiodarone therapy on thyroid hormone levels and thyroid function.
Topics: Age Factors; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Hyperthyroidism; H | 1985 |
Amiodarone and thyroid hormone action.
Topics: Adult; Aged; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Cell Nucleus; Coronary Disease; | 1985 |
Amiodarone and thyroid hormone action.
Topics: Adult; Aged; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Cell Nucleus; Coronary Disease; | 1985 |
Use of amiodarone during pregnancy.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Maternal-Fetal Exchange; Pregn | 1985 |
Use of amiodarone during pregnancy.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Maternal-Fetal Exchange; Pregn | 1985 |
The effect of antiarrhythmic drugs on life-threatening arrhythmias induced by the interaction between acute myocardial ischemia and sympathetic hyperactivity.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cats; Coronary Disease; Disease M | 1985 |
The effect of antiarrhythmic drugs on life-threatening arrhythmias induced by the interaction between acute myocardial ischemia and sympathetic hyperactivity.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cats; Coronary Disease; Disease M | 1985 |
Amiodarone. Haemodynamic profile during intravenous administration and effect on pacing-induced ischaemia in man.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Coronary Disease; Hemodynamics; Humans; Myoc | 1985 |
Amiodarone. Haemodynamic profile during intravenous administration and effect on pacing-induced ischaemia in man.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Coronary Disease; Hemodynamics; Humans; Myoc | 1985 |
Amiodarone treatment in patients with ventricular arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Administration Schedule | 1985 |
Amiodarone treatment in patients with ventricular arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Administration Schedule | 1985 |
[Efficacy and side effects of long-term treatment with amiodarone. Retrospective study. Apropos of 460 cases].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Coronary Disease; Fem | 1985 |
[Efficacy and side effects of long-term treatment with amiodarone. Retrospective study. Apropos of 460 cases].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Coronary Disease; Fem | 1985 |
Amiodarone pulmonary toxicity. Chest radiography and CT in asymptomatic patients.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Lung Diseases; Radiography, Tho | 1985 |
Amiodarone pulmonary toxicity. Chest radiography and CT in asymptomatic patients.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Lung Diseases; Radiography, Tho | 1985 |
[Clinical significance of the serum drug levels and reverse T3 (rT3) levels during amiodarone therapy].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle | 1985 |
[Clinical significance of the serum drug levels and reverse T3 (rT3) levels during amiodarone therapy].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle | 1985 |
[Severe arrhythmia induced by amiodarone: review of 11 cases].
Topics: Adams-Stokes Syndrome; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; M | 1985 |
[Severe arrhythmia induced by amiodarone: review of 11 cases].
Topics: Adams-Stokes Syndrome; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; M | 1985 |
[Role of the dynamic changes in serum rT3 levels during long-term administration of amiodarone].
Topics: Adolescent; Adult; Aged; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Mal | 1985 |
[Role of the dynamic changes in serum rT3 levels during long-term administration of amiodarone].
Topics: Adolescent; Adult; Aged; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Mal | 1985 |
Life-threatening ventricular arrhythmias provoked by amiodarone treatment.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Digoxin; Electrocardiograp | 1985 |
Life-threatening ventricular arrhythmias provoked by amiodarone treatment.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Digoxin; Electrocardiograp | 1985 |
[Amiodarone as an anti-arrhythmia agent].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Evaluation; Humans | 1985 |
[Amiodarone as an anti-arrhythmia agent].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Evaluation; Humans | 1985 |
Value of hepatic computerized tomographic scanning during amiodarone therapy.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Female; Humans; Liver; Mal | 1985 |
Value of hepatic computerized tomographic scanning during amiodarone therapy.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Female; Humans; Liver; Mal | 1985 |
[Amiodarone by intravenous route].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Injections, Intravenous | 1985 |
[Amiodarone by intravenous route].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Injections, Intravenous | 1985 |
Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapy.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; E | 1985 |
Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapy.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; E | 1985 |
Cardiac function in patients on chronic amiodarone therapy.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Blood Pressure; Female; Heart; Heart Rat | 1985 |
Cardiac function in patients on chronic amiodarone therapy.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Blood Pressure; Female; Heart; Heart Rat | 1985 |
Intravenous amiodarone in the treatment of refractory arrhythmias.
Topics: Administration, Oral; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Critical Care; Heart Atri | 1985 |
Intravenous amiodarone in the treatment of refractory arrhythmias.
Topics: Administration, Oral; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Critical Care; Heart Atri | 1985 |
Amiodarone and the American Way.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Evaluation; Electrophysiology; Humans; Recurrenc | 1985 |
Amiodarone and the American Way.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Evaluation; Electrophysiology; Humans; Recurrenc | 1985 |
[Monitoring of anti-arrhythmia drugs with the Holter system and the determination of their blood levels (mexiletine (mexitil) and amiodarone)].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Evaluation; Drug Tolerance; Electro | 1985 |
[Monitoring of anti-arrhythmia drugs with the Holter system and the determination of their blood levels (mexiletine (mexitil) and amiodarone)].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Evaluation; Drug Tolerance; Electro | 1985 |
The yield of programmed ventricular stimulation in mitral valve prolapse patients with ventricular arrhythmias.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Electrophysiology; Female; Heart Arres | 1985 |
The yield of programmed ventricular stimulation in mitral valve prolapse patients with ventricular arrhythmias.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Electrophysiology; Female; Heart Arres | 1985 |
Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long term follow-up.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Resistance; Electrocard | 1985 |
Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long term follow-up.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Resistance; Electrocard | 1985 |
[Primary arrhythmias in pediatrics. Study of 104 patients and review of the literature].
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Child; Child, Preschool; Digoxin; Female; Follow-Up St | 1985 |
[Primary arrhythmias in pediatrics. Study of 104 patients and review of the literature].
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Child; Child, Preschool; Digoxin; Female; Follow-Up St | 1985 |
Pharmacokinetics of amiodarone, desethylamiodarone and other iodine-containing amiodarone metabolites.
Topics: Adolescent; Adult; Aged; Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Female; Hal | 1985 |
Pharmacokinetics of amiodarone, desethylamiodarone and other iodine-containing amiodarone metabolites.
Topics: Adolescent; Adult; Aged; Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Female; Hal | 1985 |
[Clinical study of Amiodarone in heart rhythm disorders].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Evaluation; Female; Humans; Male; Middle | 1974 |
[Clinical study of Amiodarone in heart rhythm disorders].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Evaluation; Female; Humans; Male; Middle | 1974 |
[Medical treatment of disturbances of the heart rhythm].
Topics: Ajmaline; Amiodarone; Arrhythmias, Cardiac; Digoxin; Disopyramide; Humans; Procainamide; Propranolol | 1973 |
[Medical treatment of disturbances of the heart rhythm].
Topics: Ajmaline; Amiodarone; Arrhythmias, Cardiac; Digoxin; Disopyramide; Humans; Procainamide; Propranolol | 1973 |